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Tuesday 7:30 pm Keynote Speaker 
1  Chromosome Cohesin and Condensation
   
Wednesday 9:00 am 2  G1 and Cdk Regulation 
   
Wednesday 2:00 pm 3  Poster Session I 
   
Wednesday 4:30 pm Wine and Cheese Party * 
   
Wednesday 7:30 pm 4  S-Phase 
   
Thursday 9:00 am 5  The DNA Damage Response 
   
Thursday 2:00 pm 6  Poster Session II 
   
Thursday 7:30 pm 7  Cell Cycle Regulatory Pathways 
   
Friday 9:00 am 8  Chromosome Segregation 
   
Friday 2:00 pm 9  Metaphase / Anaphase 
   
Friday 6:00 pm Concert 
 7:00 pm Banquet 
   
Saturday 9:00 am 10  Proteolysis  
 
 
Poster sessions are located in Bush Lecture Hall 
* Airslie Lawn, weather permitting 
Mealtimes at Blackford Hall are as follows:   
Breakfast   7:30 am-9:00 am 
Lunch       11:30 am-1:30 pm 
Dinner       5:30 pm-7:00 pm 
Bar is open from 5:00 pm until late 
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PROGRAM 
 
 
TUESDAY, May 18—7:30 PM 
 
 
SESSION 1 CHROMOSOME COHESIN AND CONDENSATION 
 
Chairperson: D. Morgan, University of California, San Francisco 
J.-M. Peters, Research Institute of Molecular Pathology,  
  Vienna, Austria 
 
 
KEYNOTE SPEAKER 
 
Douglas Koshland 
University of California, Berkeley 
 
“Lessons learned from trying to answer to a higher order" 
 
 
Cohesin and sororin are recruited to chromatin by distinctly 
different mechanisms 
Jane Song, Andrea L. Lafont, Susannah Rankin. 
Presenter affiliation: Oklahoma Medical Research Foundation, 
Oklahoma City, Oklahoma. 
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Identification and characterization of a novel cohesin proteinase 
mediating sister chromatid segregation 
Anil K. Panigrahi, Debananda Pati. 
Presenter affiliation: Texas Children's Cancer Center, Baylor College 
of Medicine, Houston, Texas. 
 
 
 
 
2 
  
Cohesin subunit Scc1 promotes caspase activation and cell death 
in mitosis 
Laura A. Diaz-Martinez, Zemfira Karamysheva, Soonjoung Kim, 
Hongtao Yu. 
Presenter affiliation: Howard Hughes Medical Institute and UT 
Southwestern Medical Center, Dallas, Texas. 
 
 
 
 
 
3 
  
Condensin and microtubule tension drive de-catenation by 
topoisomerase II through stable modification of DNA topology 
Jonathan Baxter, Jorge B. Schvartzman, John F. Diffley, Luis Aragon. 
Presenter affiliation: MRC Clincial Sciences Centre, London, United 
Kingdom. 
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 vi 
Regulation of sister chromatid cohesion and chromatin structure 
by cohesin 
Jan-Michael Peters. 
Presenter affiliation: Research Institute of Molecular Pathology, 
Vienna, Austria. 
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WEDNESDAY, May 19—9:00 AM 
 
 
SESSION 2 G1 AND CDK REGULATION 
 
Chairperson: S. Haase, Duke University, Durham, North Carolina 
J. Lees, Massachusetts Institute of Technology,  
Cambridge 
 
  
Cycling without cyclins—CDKs are modulators and effectors of a 
transcription network oscillator 
Steven B. Haase, Laura A. Simmons Kovacs, David A. Orlando, 
Michael B. Mayhew, Sayan Mukherjee. 
Presenter affiliation: Duke University, Durham, North Carolina. 
 
 
 
 
6 
  
Cell cycle commitment 
Andreas Doncic, Jan M. Skotheim. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
7 
  
A sequence of counteracting phosphorylations restricts an 
asymmetric gene expression program to early G1 
Emily Mazanka, Eric L. Weiss. 
Presenter affiliation: Northwestern University, Evanston, Illinois. 
 
 
 
8 
  
Different levels of cyclin-Cdk order mitotic events in S. cerevisiae 
Catherine Oikonomou, Frederick Cross. 
Presenter affiliation: Rockefeller University, New York, New York. 
 
 
9 
  
Bistability may allow for wave-like propagation of mitotic activity 
and maintain cell synchronization 
Jeremy B. Chang, James E. Ferrell Jr. 
Presenter affiliation: Stanford University, Stanford, California. 
 
 
 
10 
  
 vii 
The DNA replication checkpoint promotes E2F-dependent cell-
cycle transcription in response to a DNA replication block 
Cosetta Bertoli, Tatyana I. Kalashnikova, Clare H. McGowan, Curt 
Wittenberg, Robertus A. de Bruin. 
Presenter affiliation: MRC Laboratory for Molecular Cell Biology, UCL, 
London, United Kingdom. 
 
 
 
 
 
11 
  
The MuvB complex differentially regulates the expression of early 
and late cell cycle genes 
Subhashini Sadasivam, Yong Zhang, Velmurugan Soundarapandian, 
X. Shirley Liu, James A. DeCaprio. 
Presenter affiliation: Dana-Farber Cancer Institute, Boston, 
Massachusetts. 
 
 
 
 
 
12 
  
E2F regulation is dispensable for growth control mediated by 
pRB 
Matthew J. Cecchini, Frederick A. Dick. 
Presenter affiliation: London Regional Cancer Program, Children’s 
Health Research Institute, London, Canada. 
 
 
 
 
13 
  
Dissecting the unique role of the retinoblastoma tumor 
suppressor during cellular senescence 
Agustin Chicas, Xiaowo Wang, Chaolin Zhang, Zhen Zhao, Mila 
McCurrach, Scott W. Lowe. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
 
 
 
 
 
14 
  
The retinoblastoma protein regulates fate choice and lineage 
commitment 
Eliezer Calo, Jacqueline Lees. 
Presenter affiliation: David H. Koch Institute of Integrative Cancer 
Research, MIT, Cambridge, Massachusetts. 
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WEDNESDAY, May 19—2:00 PM 
 
 
SESSION 3 POSTER SESSION I 
 
  
Cdc14-dependent dephosphorylation of a kinetochore protein 
prior to anaphase 
Bungo Akiyoshi, Sue Biggins. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington. 
 
 
 
 
16 
  
 viii 
Max1 links MBF-dependent transcription to completion of S 
phase 
Gómez-Escoda Blanca, Ivanova Tsvetomira, Calvo A. Isabel, Alves-
Rodrigues Isabel, Hidalgo Elena, Ayté José. 
Presenter affiliation: Universitat Pompeu Fabra, Barcelona, Spain. 
 
 
 
 
17 
  
Role of ATR and CHK1 haploinsufficiency in replication and 
chromosomal fragility 
Hayat Arzouk, Zeina Majed, Sandie Tuduri, Helene Fontaine, Charles 
Theillet, Arnaud Coquelle. 
Presenter affiliation: Cancer Research Institute of Monptellier (IRCM), 
Montpellier, France. 
 
 
 
 
 
18 
  
GCP6, a component of the gamma-TuRC is required for 
centrosome duplication 
Ramona Bahtz, Marc Arnold, Ingrid Hoffmann. 
Presenter affiliation: German Cancer Research Center, Heidelberg, 
Germany. 
 
 
 
 
19 
  
The molecular chaperone Hsp90 is required for cell cycle exit in 
Drosophila 
Jennifer L. Bandura, Huaqi Jiang, Bruce A. Edgar. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington. 
 
 
 
 
20 
  
Protein-protein interactions link transcription factor network to 
Clb regulation in the yeast cell cycle 
Matteo Barberis, Christian Linke, Hans Lehrach, Edda Klipp, Sylvia 
Krobitsch. 
Presenter affiliation: Humboldt University Berlin, Berlin, Germany; Max 
Planck Institute for Molecular Genetics, Berlin, Germany. 
 
 
 
 
 
21 
  
Sic1 plays a role in timing and oscillatory behaviour of B-type 
cyclins in budding yeast 
Matteo Barberis, Christian Linke, Miquel A. Adrover, Hans Lehrach, 
Francesc Posas, Sylvia Krobitsch, Edda Klipp. 
Presenter affiliation: Max Planck Institute for Molecular Genetics, 
Berlin, Germany; Humboldt University Berlin, Berlin, Germany. 
 
 
 
 
 
22 
  
The Skp2 promoter integrates signaling through the NF-κB/IKK, 
p53 and Akt/GSK3β pathways to regulate autophagy and 
apoptosis in response to DNA damage 
Benjamin Barré, Neil D. Perkins. 
Presenter affiliation: Centre Paul Papin, Angers, France. 
 
 
 
 
23 
  
 ix 
Regulation of Aurora B kinase by Cullin3 mediated ubiquitination 
Jochen Beck, Sarah Maerki, Markus Posch, Jason R. Swedlow, 
Izabela Sumara, Matthias Peter. 
Presenter affiliation: ETH Zurich, Zurich, Switzerland. 
 
 
 
24 
  
Tyrosine phosphorylation of p27Kip1 serves as a cyclin D-cdk4 
ON/OFF switch 
Melissa James, Nuria Ferrandiz, Weizhen Ye, Stacy W. Blain. 
Presenter affiliation: SUNY Downstate Medical Center, Brooklyn, New 
York. 
 
 
 
 
25 
  
Regulation of S. cerevisiae Glc7 (PP1) cell cycle function by Shp1 
Stefanie Böhm, Alexander Buchberger. 
Presenter affiliation: University of Würzburg, Würzburg, Germany. 
 
 
26 
  
Defects in cell cycle checkpoint functions are specific to breast 
cancer molecular subtypes 
Jacquelyn J. Bower, Leah D. Vance, William K. Kaufmann. 
Presenter affiliation: Lineberger Comprehensive Cancer Center, 
Chapel Hill, North Carolina. 
 
 
 
 
27 
  
Mitotic exit control of the Ndr/LATS kinase Cbk1 regulates the 
final act of cell division 
Jennifer L. Brace, Jonathan Hsu, Eric L. Weiss. 
Presenter affiliation: Northwestern University, Evanston, Illinois. 
 
 
 
28 
  
Estrogen-mediated proliferation of breast cancer cells requires 
Mdm2 to bypass the G1 checkpoint 
Angelika Brekman, Kathryn E. Talbott, Alla Polotskaia, Jill Bargonetti. 
Presenter affiliation: Hunter College, New York, New York; The 
Graduate Center of the City University of New York, New York, New 
York. 
 
 
 
 
 
29 
  
The DNA replication checkpoint couples the cell-cycle 
transcription program with cell-cycle progression 
Sara L. Bristow, Laura A. Simmons Kovacs, David A. Orlando, Steven 
B. Haase. 
Presenter affiliation: Duke University, Durham, North Carolina. 
 
 
 
 
30 
  
Characterisation of the centrosome protein Cep63 
Nicola Brown, Vincenzo Costanzo. 
Presenter affiliation: Cancer Research UK Clare Hall Laboratories, 
South Mimms, United Kingdom. 
 
 
 
31 
  
 x 
Lack of cyclin D1 kinase activity leads to reduced levels of ErbB2-
induced senescence and activation of autophagy in the mammary 
gland 
Nelson E. Brown, Charlotte Kuperwasser, Philip W. Hinds. 
Presenter affiliation: Tufts-Medical Center, Boston, Massachusetts. 
 
 
 
 
32 
  
Mechanisms ensuring robust cell cycle exit upon terminal 
differentiation in Drosophila melanogaster 
Laura Buttitta, Alexia J. Katzaroff, Bruce A. Edgar. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington. 
 
 
 
 
33 
  
Endocycling cells do not aopotose in response to rereplication 
and DNA damage 
Bingqing Zhang, Madhura Kadaba, Sonam Mehrotra, Jhomar 
Marquez, Brian Calvi. 
Presenter affiliation: Indiana University, Bloomington, Indiana. 
 
 
 
 
34 
  
Use of fluorescent tools for monitoring cell cycle in live and fixed 
cells 
Scott Clarke. 
Presenter affiliation: Molecular Probes / Life Technologies, Eugene, 
Oregon. 
 
 
 
 
35 
  
The spindle checkpoint stabilizes Geminin and allows 
accumulation of Cdt1-Geminin complexes to couple replication-
licensing to successful mitosis 
Linda Clijsters, Janneke Ogink, Maria Jose Villalobos Quesada, Rob 
Wolthuis. 
Presenter affiliation: The Netherlands Cancer Institute, Amsterdam, 
Netherlands. 
 
 
 
 
 
 
36 
  
Active metabolism in quiescent fibroblasts 
Johanna Scarino, Xiao-Jiang Feng, Bryson D. Bennett, Aster Legesse-
Miller, Joshua D. Rabinowitz, Hilary A. Coller. 
Presenter affiliation: Princeton University, Princeton, New Jersey. 
 
 
 
37 
  
Generation of fluorescently tagged endogenous proteins by rAAV 
recombinomics to study mitosis in human cells 
Philippe Collin, Oxana Nashchekina, Jonathon Pines. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
 
 
 
 
38 
  
 xi 
Actin-dependent cellular proliferation is mediated by tropomyosin 
Tm5NM1 
Jason D. Coombes, Galina Schevzov, Justine Stehn, Sarah Creed, 
Melissa DeSouza, Cuc Bach, Geraldine O'Neill, Elizabeth Musgrove, 
Peter Gunning. 
Presenter affiliation: University of New South Wales, Sydney, Australia; 
University of Sydney, Sydney, Australia. 
 
 
 
 
 
 
39 
  
Mitotic chromosome condensation mediated by the 
retinoblastoma protein is tumor suppressive 
Courtney H. Coschi, Alison L. Martens, Kieran Ritchie, Sarah M. 
Francis, Subrata Chakrabarti, Nathalie G. Berube, Frederick A. Dick. 
Presenter affiliation: Schulich School of Medicine and Dentistry, 
University of Western Ontario, London, Canada. 
 
 
 
 
 
40 
  
A DNA damage response screen identifies Rhino—A 9-1-1 
interacting protein required for homologous recombination 
Cecilia Cotta-Ramusino, E. Robert McDonald, Mathew E. Sowa, J. 
Wade Harper, Stephen J. Elledge. 
Presenter affiliation: Brigham and Women's Hospital, Harvard 
University Medical School, Boston, Massachusetts. 
 
 
 
 
 
41 
  
The Myc/Max/Miz pathway regulates the expression of the aurora-
A kinase following topoisomerase I inhibition 
Julia Cherier, Sandy Courapied, Arnaud Vigneron, Claude Prigent, 
Erick Gamelin, Benjamin Barré, Olivier Coqueret. 
Presenter affiliation: Paul Papin Cancer Center, Angers, France. 
 
 
 
 
42 
  
Nuclear size promotes variable nuclear division cycle timing in a 
multinucleate cell 
Cori A. D'Ausilio, Amy S. Gladfelter. 
Presenter affiliation: Dartmouth College, Hanover, New Hampshire. 
 
 
 
43 
  
The mechanism and function of PIP box/CRL4Cdt2-mediated 
destruction of E2f1 during S phase 
Jean M. Davidson, Robert J. Duronio. 
Presenter affiliation: University of North Carolina-Chapel Hill, Chapel 
Hill, North Carolina. 
 
 
 
 
44 
  
MTG8 is critical for proper cell cycle progression and DNA 
damage control 
Laura M. DeBusk, Marion Sauer, Jialing Yuan, Scott W. Hiebert. 
Presenter affiliation: Vanderbilt University, Nashville, Tennessee. 
 
 
 
45 
  
 xii 
The NoCut checkpoint prevents Rho2 GTPase activation at the 
bud neck in order to inhibit abscission 
Martin Dinkel, Harald Rauter, Yves Barral. 
Presenter affiliation: ETH Zurich, Zurich, Switzerland. 
 
 
 
46 
  
Studying centromeric histone dynamics through the use of FRET 
Paul Donlin-Asp, Yamini Dalal. 
Presenter affiliation: NCI, National Institutes of Health, Bethesda, 
Maryland. 
 
 
 
47 
  
Specific roles of Target of Rapamycin in the control of stem cells 
and their progeny in the Drosophila ovary 
Leesa LaFever, Feoktistov Alexander, Hsu Hwei-Jan, Daniela 
Drummond-Barbosa. 
Presenter affiliation: Johns Hopkins University, Bloomberg School of 
Public Health, Baltimore, Maryland; Vanderbilt University Medical 
Center, Nashville, Tennessee. 
 
 
 
 
 
 
48 
  
A proteomic screen reveals new proteins involved in DNA 
damage response in fission yeast 
Li-Lin Du. 
Presenter affiliation: National Institute of Biological Sciences, Beijing, 
China. 
 
 
 
 
49 
  
Size is a major determinant of cellular lifespan 
Huzefa M. Dungrawala, Jingye Yang, Arkadi M. Manukyan, Hui Hua, 
Abraham Lesley, Wesley Lane, Holly Mead, Brandt Schneider. 
Presenter affiliation: Texas Tech University Health Sciences Center, 
Lubbock, Texas. 
 
 
 
 
50 
  
Insights into the TPR complex of the APC from a CDC26-APC6 
crystal structure 
Billy T. Dye, Jing Wang, Kanagalaghatta R. Rajashankar, Igor Kurinov, 
Brenda A. Schulman. 
Presenter affiliation: Howard Hughes Medical Institute, St. Jude 
Children's Research Hospital, Memphis, Tennessee. 
 
 
 
 
 
51 
  
Higher levels of dNTPs suppress genetic instability in 
Saccharomyces cerevisiae hypomorphic mec1 (ATR) mutants 
Michael Fasullo, Andrei Chabes, Olga Tsaponina, Sun Mingzeng. 
Presenter affiliation: Ordway Research Institute, Albany, New York; 
State University of New York, Albany, New York. 
 
 
 
 
52 
  
 xiii 
A revised quantitative model of CDK-mediated control of the 
temporal order of S-phase and mitosis 
Liliana Krasinska, Daniel Fisher. 
Presenter affiliation: IGMM, Montpellier, France. 
 
 
 
53 
  
Monopolar spindles induced by Eg5 inhibition can be rescued by 
altering microtubule dynamics 
Stefan Florian, Thomas U. Mayer. 
Presenter affiliation: University of Konstanz, Konstanz, Germany. 
 
 
 
54 
  
Significance of Cdc20 destruction for cell cycle fidelity 
Scott A. Foster, David O. Morgan. 
Presenter affiliation: University of California, San Francisco, San 
Francisco, California. 
 
 
 
55 
  
Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for 
efficient DNA replication 
Andre Franz, Julien Mouysset, Alexandra Deichsel, Remi Sonneville, 
Anton Gartner, Thorsten Hoppe. 
Presenter affiliation: University of Cologne, Cologne, Germany. 
 
 
 
 
56 
  
Contribution of the miR-11 microRNA to the de2f1 function 
Maxim V. Frolov, Mary Truscott, Abul Islam, Catherine Reinke, Richard 
Carthew, Nuria Lopez-Bigas. 
Presenter affiliation: University of Illinois at Chicago, Chicago, Illinois. 
 
 
 
57 
  
Studies of the spindle assembly checkpoint in Xenopus 
Elizabeth Garner, Vincenzo Costanzo. 
Presenter affiliation: Cancer Research UK, South Mimms, United 
Kingdom. 
 
 
 
58 
  
Fam64A is a novel cell cycle-regulated protein involved in the 
establishment of a bipolar spindle 
Lacy K. George, Michael L. Whitfield. 
Presenter affiliation: Dartmouth Medical School, Hanover, New 
Hampshire. 
 
 
 
 
59 
  
Anaphase regulation by securin in normal human somatic cells 
Kelly A. George, Prasad V. Jallepalli. 
Presenter affiliation: Memorial Sloan-Kettering Cancer Center, New 
York, New York. 
 
 
 
60 
  
 xiv 
CDK-dependent phosphorylation of Lte1 restricts cell polarization 
through inhibition of Ras and Bud1 
Marco Geymonat, Adonis Spanos, Steven G. Sedgwick. 
Presenter affiliation: National Institute for Medical Research, London, 
United Kingdom. 
 
 
 
 
61 
  
Protein tyrosine kinase 6 expression is regulated by p53-
dependent and independent mechanisms in response to DNA-
damage 
Jessica J. Gierut, Ansu O. Perekatt, Jin Han, Angela L. Tyner. 
Presenter affiliation: University of Illinois at Chicago, Chicago, Illinois. 
 
 
 
 
62 
  
Identification of Forkhead transcription factors necessary for cell 
cycle progression in U2OS cells by real time monitoring of 
periodic gene expression 
Gavin D. Grant, Joshua Gamsby, Xiaoyang Zhang, Jay C. Dunlap, 
Michael Whitfield. 
Presenter affiliation: Dartmouth Medical School, Hanover, New 
Hampshire. 
 
 
 
 
 
 
63 
  
Molecular crosstalk between the APC/C and JNK 
Gustavo J. Gutierrez, Ze'ev A. Ronai. 
Presenter affiliation: Sanford-Burnham Medical Research Institute, La 
Jolla, California. 
 
 
 
64 
  
JNK-mediated phosphorylation of Cdc25C regulates cell cycle 
entry and G2/M DNA damage checkpoint 
Gustavo J. Gutierrez, Ze'ev A. Ronai. 
Presenter affiliation: Sanford-Burnham Medical Research Institute, La 
Jolla, California. 
 
 
 
 
65 
  
Plk 1-mediated phosphorylation of tankylase 1 regulates its 
stability and poly(ADP-ribosyl)ation activity during mitosis 
Geun-Hyoung Ha, Chang-Woo Lee. 
Presenter affiliation: Sungkyunkwan University School of Medicine, 
Suwon, South Korea. 
 
 
 
 
66 
  
The dynamics of exit from mitosis in budding yeast 
Baris Hancioglu, Kathy Chen, John J. Tyson. 
Presenter affiliation: Virginia Tech, Blacksburg, Virginia. 
 
 
67 
  
Structural basis of dimerization-dependent ubiquitination by the 
SCFFbx4 ubiquitin ligase 
Yunfeng Li, Bing Hao. 
Presenter affiliation: University of Connecticut Health Center, 
Farmington, Connecticut. 
 
 
 
 
68 
 xv 
PCNA—Not just a bystander in CRL4Cdt2-mediated ubiquitylation 
Courtney G. Havens, Richard C. Centore, Lee Zou, Johannes Walter. 
Presenter affiliation: Harvard Medical School, Boston, Massachusetts. 
 
 
69 
  
Investigation into spindle assembly checkpoint function in 
Drosophila melanogaster 
Ashleigh Herriott, Michael Whitaker, Junyong Huang. 
Presenter affiliation: University of Newcastle, Newcastle upon Tyne, 
United Kingdom. 
 
 
 
 
70 
  
Phosphoproteomic analysis of the effect of cytoplasmic depletion 
of mitotic cyclins in budding yeast 
Woong Kim, Steven P. Gygi, Jennifer K. Hood-DeGrenier. 
Presenter affiliation: Wellesley College, Wellesley, Massachusetts. 
 
 
 
71 
  
The role of Krüppel-like factor 4 (KLF4) proteolysis in TGF-beta 
signaling 
Dong Hu, Yong Wan. 
Presenter affiliation: University of Pittsburgh School of Medicine, 
Pittsburgh, Pennsylvania. 
 
 
 
 
72 
  
A novel function of yeast GSK-3 kinase homologue, Mck1p, in the 
control of DNA replication 
Amy E. Ikui. 
Presenter affiliation: Brooklyn College/The City University of New York, 
Brooklyn, New York. 
 
 
 
 
73 
  
The Mps1 protein kinase controls the cytosolic and kinetochore-
based branches of the spindle checkpoint in human cells 
John Maciejowski, Kelly A. George, Marie-Emilie Terret, Chao Zhang, 
Kevan M. Shokat, Prasad V. Jallepalli. 
Presenter affiliation: Memorial Sloan-Kettering Cancer Center, New 
York, New York. 
 
 
 
 
 
74 
  
Cytokinesis in the presence of lagging chromosomes induces 
DNA damage 
Aniek Janssen, Geert J. Kops, René H. Medema. 
Presenter affiliation: Cancer Genomics Center, UMC Utrecht, Utrecht, 
Netherlands. 
 
 
 
 
75 
  
A role of the transcription factor network oscillator in controlling 
cell-cycle period 
Yuanjie Jin, Chenchen Huang, Qingyun Li, Matthew S. Crowe, Rosie 
Jiang, Steven B. Haase. 
Presenter affiliation: Duke University, Durham, North Carolina. 
 
 
 
 
76 
 xvi 
Cdc2-Nedd1-Plk1 axis regulates bipolar spindle formation via two 
distinct mechanisms 
Yoshikazu Johmura, Nak-Kyun Soung, Jung-Eun Park, Li-Rong Yu, 
Ming Zhou, Jeong K. Bang, Timothy D. Veenstra, Kyung S. Lee. 
Presenter affiliation: National Institutes of Health, Bethesda, Maryland. 
 
 
 
 
77 
  
DCDC5, a novel midbody linker between dynein, microtubules 
and Rab-8/Rab-6 vesicles 
Anna Kaplan, Orly Reiner. 
Presenter affiliation: Weizmann Institute of Science, Rehovot, Israel. 
 
 
 
78 
  
Modification of neural lineage size along the anteroposterior axis 
Daniel Karlsson, Magnus Baumgardt, Stefan Thor. 
Presenter affiliation: Linköping University Medical School, Linköping, 
Sweden. 
 
 
 
79 
  
Phospho-regulation of the γ-tubulin complex—Clues from the 
yeast centrosome phosphoproteome 
Jamie Keck, Michele Jones, Catherine Wong, Jonathon Binkley, John 
R. Yates III, Mark Winey. 
Presenter affiliation: University of Colorado, Boulder, Colorado. 
 
 
 
 
80 
  
How cells measure size—Relative Wee1 and Cdc25 levels are 
surrogates for the nuclear:cytoplasmic ratio 
Daniel Keifenheim, Nicholas Rhind. 
Presenter affiliation: University of Massachusetts Medical School, 
Worcester, Massachusetts. 
 
 
 
 
81 
  
Ssu72 is a cohesin-binding protein that regulates the resolution 
of sister chromatid arm cohesion 
Hyun-Soo Kim, Chang-Woo Lee. 
Presenter affiliation: Sungkyunkwan University School of Medicine, 
Suwon, South Korea; Samsung Biomedical Research Institute, Suwon, 
South Korea. 
 
 
 
 
 
82 
  
p53 modification modulation determined cell fate by microtubule 
inhibitor drugs 
Jae Hyung Kim, Eun -Kyung Yoon, Hye-Jin Chung, Sun Shin Kim, 
Kyungtae Kim. 
Presenter affiliation: National Cancer Center, Goyang, South Korea. 
 
 
 
 
83 
  
Activation of the S-Phase checkpoint inhibits degradation of the 
F-box protein Dia2 
Andrew C. Kile, Deanna M. Koepp. 
Presenter affiliation: University of Minnesota, Minneapolis, Minnesota. 
 
 
 
84 
  
 xvii 
Cell cycle re-entry of terminally differentiated muscle cells in C. 
elegans 
Jerome P. Korzelius, Inge The, Mike Boxem, Vincent C. Portegijs, 
Teije Middelkoop, Marian J. Groot Koerkamp, Frank C. Holstege, 
Sander van den Heuvel. 
Presenter affiliation: Utrecht University, Utrecht, Netherlands. 
 
 
 
 
 
85 
  
Loading of Sororin onto chromatin requires Eco in Xenopus 
laevis extracts 
Andrea L. Lafont, Susannah Rankin. 
Presenter affiliation: Oklahoma Medical Research Foundation, 
Oklahoma City, Oklahoma. 
 
 
 
 
86 
  
Aurora B control of the spindle assembly checkpoint pathway in 
mouse oocytes 
Simon I. Lane, Heng-Yu Chang, Phoebe C. Jennings, Keith T. Jones. 
Presenter affiliation: University of Newcastle Australia, Newcastle, 
Australia. 
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Genetic analysis of the essential nuclear pore complex protein 
SONBNup98 to determine its role in the DNA damage response 
Jennifer R. Larson, Stephen A. Osmani. 
Presenter affiliation: The Ohio State University, Columbus, Ohio. 
 
 
 
88 
  
Mammalian Fbh1 is important to restore normal mitotic 
progression following decatenation stress 
Corentin Laulier, Anita Cheng, Nick Huang, Jeremy M. Stark. 
Presenter affiliation: Beckman Research Institute of the City of Hope, 
Duarte, California. 
 
 
 
 
89 
  
Auto-regulatory mechanism of Plk1 recruitment to and 
dissociation from the kinetochores via the formation of the Plk1-
PBIP1-Cenp-Q complex 
Young H. Kang, Chi H. Park, Nak-Kyun Soung, Jung-Eun Park, Li-
Rong Yu, Ming Zhou, Timothy D. Veenstra, Kyung S. Lee. 
Presenter affiliation: NCI, National Institutes of Health, Bethesda, 
Maryland. 
 
 
 
 
 
 
90 
  
Differential catabolism of ubiquitinated proteins in proliferating 
and quiescent cells 
Aster Legesse-Miller, Erin Haley, Benjamin Lund, Daniel Wolle, Hilary 
Coller. 
Presenter affiliation: Princeton University, Princeton, New Jersey. 
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 xviii 
Human Timeless protein has roles in telomere mainteance 
Adam R. Leman, Eishi Noguchi. 
Presenter affiliation: Drexel University College of Medicine, 
Philadelphia, Pennsylvania. 
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Nuclear matrix association of Orc and Utp7p is inter-dependent, 
cell cycle-regulated, and required for pre-replicative complex 
assembly in budding yeast 
Xue Cheng, Jiafeng Wang, Zhen Xu, Chun Liang. 
Presenter affiliation: Hong Kong University of Science and Technology, 
Hong Kong, China. 
 
 
 
 
 
93 
  
Control of the DREAM complex and quiescence by a novel tumor 
suppressor protein kinase, DYRK1A 
Larisa Litovchick, Laurence Florens, Selene Swanson, Michael 
Washburn, Lynda Chin, James DeCaprio. 
Presenter affiliation: Dana-Farber Cancer Institute, Boston, 
Massachusetts. 
 
 
 
 
 
94 
  
Phosphorylation of CLIP-170 by both Plk1 and CK2 is essential 
for the formation of kinetochore-microtubule attachments 
Hongchang Li, Xiaoqi Liu. 
Presenter affiliation: Purdue University, West Lafayette, Indiana. 
 
 
 
95 
  
Plk1-mediated phosphorylation of GTSE-1 is essential for p53-
downregulation during G2 checkpoint recovery 
Shawn Liu, Hongchang Li, Song Bing, Xiaoqi Liu. 
Presenter affiliation: Purdue University, West Lafayette, Indiana. 
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Presenter affiliation: Chromatin Biology, Miami, Florida. 
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Overexpression of P27 T198 phosphomimetic mutant promotes 
breast cancer motility independent of cell cycle function 
Dekuang Zhao, Seth A. Wander, Michelle Larrea, Joyce M. 
Slingerland. 
Presenter affiliation: University of Miami, Miami, Florida. 
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Analysis of endoreplication in the Drosophila salivary gland 
Norman Zielke, Kerry J. Kim, Voung K. Tran, Shusaku Shibutani, 
Robert J. Duronio, Bruce A. Edgar. 
Presenter affiliation: Universität Heidelberg, Heidelberg, Germany; 
Fred Hutchinson Cancer Research Center, Seattle, Washington. 
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THURSDAY, May 20—7:30 PM 
 
 
SESSION 7 CELL CYCLE REGULATORY PATHWAYS 
 
Chairperson: P. O'Farrell, University of California, San Francisco 
B. Edgar, Universität Heidelberg, Germany 
 
  
Cycling toward the mid blastula transition 
Patrick H. O’Farrell, Mark L. McCleland, Jeffrey A. Farrell, Antony W. 
Shermoen. 
Presenter affiliation: UCSF, San Francisco, California. 
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Endocycle control—A growth-dependent transcriptional oscillator 
Kerry J. Kim, Norman Zielke, Vuong Tran, Shukasu T. Shibutani, 
Carmen Rotig, Christian F. Lehner, Robert J. Duronio, Bruce A. Edgar. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington. 
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Caenorhabditis elegans cyclin E and Cdk2 control GLD-1, the 
mitosis/meiosis decision and germline stem cells 
Johan Jeong, Jamie Verheyden, Judith Kimble. 
Presenter affiliation: University of Wisconsin-Madison, Madison, 
Wisconsin. 
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A novel cell cycle program directs developmentally regulated 
polyploid mitosis in Drosophila 
Donald T. Fox, Joseph G. Gall, Allan C. Spradling. 
Presenter affiliation: Howard Hughes Medical Institute and Carnegie 
Institution, Baltimore, Maryland. 
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CHK1 regulates stem cell proliferation and differentiation by 
regulating expression of the CDK specific inhibitor p57/KIP2 
Zakir Ullah, Christelle de Renty, Melvin L. DePamphilis. 
Presenter affiliation: NICHD, National Institutes of Health, Bethesda, 
Maryland. 
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Myc-nick—A cytoplasmic form of Myc that promotes tubulin 
acetylation and muscle differentiation 
Maralice Conacci-Sorrell, Celine Ngouenet, Robert Eisenman. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seatlle, Washington. 
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 xxxv 
CDK1-cyclin B1-dependent destruction of Mcl-1 during mitotic 
arrest sensitizes cells to microtubule poisons 
Paul R. Clarke, Lindsey A. Allan, Margaret E. Harley, Helen S. 
Sanderson. 
Presenter affiliation: University of Dundee, Dundee, United Kingdom. 
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Cell cycle exit induced by serum withdrawal regulates Rab11 
recycling endosome, trafficking Rab8 activation, and the 
assembly of the primary cilium 
Peter K. Jackson. 
Presenter affiliation: Genentech, Inc, S. San Francisco, California. 
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Cell cycle exit and re-entry from quiescence in budding yeast 
Lihong Li, Shawna Miles, Kate Braun, Amalthiya Prasad, Linda L. 
Breeden. 
Presenter affiliation: Fred Hutchinson Cancer Center, Seattle, 
Washington. 
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Spontaneous cancer cell quiescence with epigenetic remodeling 
arising during mitotic telophase 
Sridhar Ramaswamy, Anita Wolfer, Ipsita Guha, Ben S. Wittner, Albert 
Yeh. 
Presenter affiliation: Massachusetts General Hospital, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts. 
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FRIDAY, May 21—9:00 AM 
 
 
SESSION 8 CHROMOSOME SEGREGATION 
 
Chairperson: D. Pellman, Dana-Farber Cancer Institute, Boston,  
  Massachusetts 
T. Kapoor, Rockefeller University, New York, New York 
 
  
Cooperation of the Dam1 and Ndc80 complexes enhances 
kinetochore-microtubule coupling and is regulated by Aurora B 
Jerry F. Tien, Neil T. Umbreit, Daniel R. Gestaut, Andrew D. Franck, 
Beth Graczyk, Jeremy Cooper, Linda Wordeman, Tamir Gonen, 
Charles L. Asbury, Trisha N. Davis. 
Presenter affiliation: University of Washington, Seattle, Washington. 
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 xxxvi 
Reconstitution of dynamic microtubule attachment with purified 
kinetochore particles 
Bungo Akiyoshi, Andrew F. Powers, Krishna K. Sarangapani, Christian 
R. Nelson, Jeffrey A. Ranish, Charles L. Asbury, Sue Biggins. 
Presenter affiliation: Fred Hutchinson Cancer Research Center, 
Seattle, Washington. 
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Histone H3 Thr-3 phosphorylation by Haspin positions the 
chromosomal passenger complex at centromeres in mitosis 
Fangwei Wang, Jun Dai, Budhaditya Banerjee, P. Todd Stukenberg, 
Jonathan M. Higgins. 
Presenter affiliation: Brigham & Women’s Hospital, Harvard Medical 
School, Boston, Massachusetts. 
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Histone H3 phosphorylated on threonine 3 binds the CPC to 
activate the kinase Aurora B 
Alexander E. Kelly, Cristina Ghenoiu, John Z. Xue, Christian Zierhut, 
Hiroshi Kimura, Hironori Funabiki. 
Presenter affiliation: The Rockefeller University, New York, New York. 
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TAF-Iβ localizes to mitotic kinetochores in a Bub1-dependent 
manner to help recruiting Sgo1 
Guosheng Fu, Bing Li, Julie Covino, Hongtao Yu, Hui Zou. 
Presenter affiliation: University of Texas Southwestern Medical Center, 
Dallas, Texas. 
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Bub1 overexpression drives spontaneous tumorigenesis through 
a mechanism that is mitotic checkpoint independent but involves 
microtubule-kinetochore attachment errors 
Robin M. Ricke, Jan M. Van Deursen. 
Presenter affiliation: Mayo Clinic College of Medicine, Rochester, 
Minnesota. 
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The Astrin complex is targeted to kinetochores that are under 
tension to stabilize correct attachments 
Jens C. Schmidt, Chelsea B. Backer, Tatsuo Fukagawa, Iain M. 
Cheeseman. 
Presenter affiliation: Whitehead Institute for Biomedical Research, 
Cambridge, Massachusetts. 
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ORC subunits Orc2 and Orc3 are required for stable spindle 
attachment at human chromosome kinetochores during mitosis 
Shuang Ni, Supriya Prasanth, Kipp Weiskopf, Bruce Stillman. 
Presenter affiliation: Cold Spring Harbor Laboratory, Cold Spring 
Harbor, New York. 
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 xxxvii 
Loss of pRB causes centromere dysfunction and chromosomal 
instability 
Amity L. Manning, Michelle S. Longworth, Nicholas J. Dyson. 
Presenter affiliation: Massachusetts General Hospital and Harvard 
Medical School, Charlestown, Massachusetts. 
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A mechanism linking whole-chromosome aneuploidy to DNA 
breaks 
David Pellman. 
Presenter affiliation: Dana-Farber Cancer Institute, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts. 
 
 
 
 
221 
 
 
FRIDAY, May 21—2:00 PM 
 
 
SESSION 9 METAPHASE / ANAPHASE 
 
Chairperson: R. Medema, University Medical Centre Utrecht,  
The Netherlands 
T. Davis, University of Washington, Seattle 
 
  
Cep192 promotes centrosome-driven spindle assembly by 
engaging in organelle-specific Aurora A activation 
Vladimir Joukov, Arcangela De Nicolo, Alison Rodriguez, Johannes C. 
Walter, David M. Livingston. 
Presenter affiliation: Dana-Farber Cancer Institute, Boston, 
Massachusetts; Harvard Medical School, Boston, Massachusetts. 
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Cep152 is required for Plk4-induced centriole duplication 
Ingrid Hoffmann, Uta Haselmannn-Weiss, Claude Antony, Marc Arnold. 
Presenter affiliation: Deutsches Krebsforschungszentrum, Heidelberg, 
Germany. 
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Aurora A-dependent recruitment of TACC3 to spindles reveals a 
complex containing clathrin and a novel +TIP 
Alexander W. Bird, Nina C. Hubner, Per O. Widlund, Matthias Mann, 
Anthony A. Hyman. 
Presenter affiliation: Max-Planck-Institute of Molecular Cell Biology and 
Genetics, Dresden, Germany. 
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 xxxviii 
α-Endosulfine, a novel substrate of Greatwall kinase, ensures 
mitotic progression by inhibiting CDK-opposing PP2A-B55δ in 
Xenopus egg extracts 
Satoru Mochida, Tim Hunt. 
Presenter affiliation: Cancer Research UK, Potters Bar, Herts, United 
Kingdom. 
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Budding yeast Wee1 inhibits the metaphase to anaphase 
transition 
Liz Dodd-Moher, Noel Lianga, Erin Redmond, Adam Rudner. 
Presenter affiliation: University of Ottawa, Ottawa, Canada. 
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The mitotic exit oscillator at work 
Romilde Manzoni, Francesca Montani, Clara Visintin, Andrea Ciliberto, 
Rosella Visintin. 
Presenter affiliation: European Institute of Oncology, Milan, Italy. 
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A novel type of polo-box domain (PBD)-Dbf4 interaction controls 
mitotic exit 
Ying-Chou Chen, Michael Weinreich. 
Presenter affiliation: Van Andel Institute, Grand Rapids, Michigan. 
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Mechanism of cytokinesis inhibition by the checkpoint protein, 
Dma1 
Alyssa E. Johnson, Kathleen L. Gould. 
Presenter affiliation: Vanderbilt University, Nashville, Tennessee. 
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p27Kip1 controls cytokinesis via the regulation of Citron-Kinase 
activity 
Murielle P. Serres, Uta Kossatz, Yong Chi, James M. Roberts, Nisar P. 
Malek, Arnaud Besson. 
Presenter affiliation: CNRS, Toulouse, France. 
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Examining mechanisms that determine the position of the cell 
division plane 
Tarun Kapoor. 
Presenter affiliation: Rockefeller University, New York, New York. 
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FRIDAY, May 21—6:00 PM 
 
CONCERT 
Grace Auditorium 
 
Einav Yarden, piano 
Sergey Ostrovsky, violin 
 
Israeli pianist Einav Yarden has performed as a soloist with the Israel 
Philharmonic Orchestra, Minnesota Symphony, Calgary Philharmonic, Jerusalem 
Symphony, Plovdiv Philharmonic, The Israel Symphony, The Spirit of Europe 
Symphony, under Sir Neville Marriner, Aldo Ceccato, Leon Botstein, Mark 
Russell Smith, Mendi Rodan and others.  
 
She is a Prize Winner at the prestigious 2006 Minnesota International Piano-e-
Competition and was also a finalist at the 2003 Honens International Piano 
Competition. In addition, she won First Prize at the Aviv Competitions, the most 
highly acclaimed competition in Israel, taking the Guralnik Prize and the 
Zilbermann Prize. Other prizes include First Prize at the Katz Piano Competition, 
the Buchman-Heyman Prize for Excellence and Achievement amongst others. 
She was a recipient of the AICF scholarships, an important scholarship institution 
in Israel, between1996-2005. 
 
In 2005 completed four years of extensive study with renowned pianist Leon 
Fleisher at the Peabody Conservatory, earning her Masters of Music and 
Graduate Performance Diploma. Before moving to the USA, she graduated with 
highest honors from the Israel Rubin Music Academy (now the Mehta-Buchman 
School of Music) under the instruction of Emanuel Krasovsky and prior to that 
studied with Hadassa Gonen.  
 
She recently came back from a highly acclaimed debut recital at France's 
"Flâneries des Reims" Festival. Other recent appearances in France include solo 
recitals at Menton Festival and at Paris's prestigious Salle Cortot. In Switzerland, 
she was invited by Andras Schiff to take part in a special workshop on Beethoven 
concerti at the Lucerne Festival last summer. 
 
Aside to her solo performances, she is a highly enthusiastic chamber musician, 
and devotes herself to regular collaborations with other musicians. She toured in 
the USA, performing in such series’ as the prestigious Ravinia Rising Stars 
Series, the Dame Myra Hess Recital Series, Jupiter Symphony Chamber 
Players, Rockefeller University, and many others. She gives solo recitals in 
various venues in New York City, and in one of her projects initiated and 
engaged in a unique project with a poet, interweaving piano music and original 
poetry. 
 
Other than performing in Israel’s most important halls, she performs across the 
USA and Canada, and in Europe appeared in Austria, Italy, Switzerland, The 
Netherlands, France, Bulgaria, Scotland, and England. 
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Sergey Ostrovsky has performed as a quartet member and as a soloist at 
internationally renowned venues such as Carnegie Hall and Alice Tully Hall (New 
York), Kennedy Centre and The Library of Congress (Washington), Wigmore Hall 
and Royal Festival Hall (London), Auditorium du Louvre, Theatre du Chatelet, 
and Theatre de la Ville (Paris), De Doelen Rotterdam, Sydney Opera House, 
Tonhalle Zurich, Capetown City Hall, Durban Concert Hall, Cologne 
Philharmonie, Beethoven House (Bonn, Germany) Wiener Konzerthouse, 
Tchaikovsky Hall of Moscow Conservatory, Valensia Concert Hall and other 
venues in Israel, Germany, Austria, England, France, Ireland, Ireland, Holland, 
China, Canada, Portugal, South Africa, Brazil etc. 
 
As a soloist Sergey performed with orchestras such as Israel Philharmonic, Cape 
Town Philharmonic Verbier Festival Chamber Orchestra, Jerusalem Symphony 
Orchestra, Durban KZN Philharmonic, Moscow Philharmonic, Johannesburg 
Philharmonic, Brooklyn Philharmonic, Israel Chamber Orchestra, “Amadeus” 
Chamber Orchestra (Poland) Nizhny Novgorod (Gorky) Philharmonic a, Beer 
Sheva Sinfonet and “Tel Aviv Soloists” ensemble under the baton of Zubin 
Mehta, Yoel Levi, Philippe Entremont, Maxim Vengerov, Bernard Guller, Zeev 
Dorman, Uriel Segal, and the others. 
 
Sergey made a few recordings for Naxos label, and EMI Classics with Maxim 
Vengerov and UBS Verbier Chamber Orchestra. 
 
Sergey Ostrovsky was born in 1975 in Gorky (Nizhny Novgorod) to a family of 
musicians, began playing violin at the age of 6, and studied with David Lapidus 
as his first teacher. He made his first concert appearances at the age of 8, and 
performed for a first time with a symphony orchestra at the age of 13. In the 
Music College of Gorky Conservatory continued his studies with Lazar Gantman 
and Yury Gluchovsky. In 1991 immigrated to Israel with his family and continued 
his studies with Prof. Yair Kless and Irina Svetlova at the Rubin Academy Tel 
Aviv(from 2005-Buchmann-Mehta High School of Music) In 1996 Sergey founded 
the Aviv Quartet which moved for studies in Europe with the members of Alban 
Berg Quartet in Cologne Hochschule (1998-2000), and with members of Daniel 
Quartet in Rotterdam Conservatory, where he completed his Bachelor Degree 
Diploma with Natalia Morozova in 2000, and his Master Degree Diploma in 
Amsterdam Conservatory with Alexander Kerr in 2002. 
 
 
FRIDAY, May 21 
 
CONCERT 
 
Cocktails  7:00 PM Dinner  7:45 PM 
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SATURDAY, May 22—9:00 AM 
 
 
SESSION 10 PROTEOLYSIS 
 
Chairperson: B. Schulman, St. Jude Children's Research Hospital,  
  Memphis, Tennessee 
J. Pines, University of Cambridge, United Kingdom 
 
 
Structural studies of ubiquitination machinery 
Brenda Schulman. 
Presenter affiliation: St. Jude Children’s Research Hospital, Memphis, 
Tennessee. 
 
  
Structural electron microscopy studies of the COP9 signalosome 
in complex with neddylated SCF 
Radoslav Enchev, Anne Schreiber, Fabienne Beuron, Ed Morris. 
Presenter affiliation: The Institute of Cancer Research, London, United 
Kingdom. 
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Cell cycle control by replication-coupled protein destruction 
Robert Duronio. 
Presenter affiliation: University of North Carolina, Chapel Hill, North 
Carolina. 
 
 
 
233 
  
CRL4Cdt2 regulates G2/M progression by targeting the p53 and 
histone H4K20 methyltransferase Set8 for degradation 
Tarek Abbas, Etsuko Shibata, Jonghoon Park, Sudahkar Jha, Neerja 
Karnani, Anindya Dutta. 
Presenter affiliation: University of Virginia, Charlottesville, Virginia. 
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CRL4Cdt2 -dependent destruction of the Set8 histone 
methyltransferase in S phase and after DNA damage 
Richard C. Centore, Courtney G. Havens, Alice Tse, Johannes Walter, 
Lee Zou. 
Presenter affiliation: Massachusetts General Hospital, Charlestown, 
Massachusetts. 
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 xlii 
Phosphorylation by Casein kinase I promotes the turnover of 
Mdm2 via the SCFβTRCP ubiquitin ligase 
Hiroyuki Inuzuka, Alan Tseng, Daming Gao, Bo Zhai, Qing Zhang, 
Shavali Shaik, Lixin Wan, Xiaolu L. Ang, Caroline Mock, Haoqiang Yin, 
Jayne M. Stommel, Steven Gygi, Galit Lahav, Zhi-Xiong J. Xiao, 
William G. Kaelin, Wade Harper, Wenyi Wei. 
Presenter affiliation: Beth Israel Deaconess Medical Center, Boston, 
Massachusetts. 
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Mechanisms of ubiquitination by the anaphase-promoting 
complex 
Monica C. Rodrigo-Brenni, Scott A. Foster, David O. Morgan. 
Presenter affiliation: University of California, San Francisco, California. 
 
 
 
237 
  
Regulating the regulator—The SAC and the APC/C 
Jonathon Pines, Philippe Collin, Barbara di Fiore, Daisuke Izawa, 
Jöerg Mansfeld, Oxana Nashchekina. 
Presenter affiliation: University of Cambridge, Cambridge, United 
Kingdom. 
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Dissection of Acm1, a pseudosubstrate inhibitor of the anaphase 
promoting complex in budding yeast 
Janet L. Burton, Mark J. Solomon. 
Presenter affiliation: Yale University, New Haven, Connecticut. 
 
 
 
239 
  
SCF-Cyclin F-mediated degradation of CP110 maintains 
centrosome homeostasis and the fidelity of mitosis 
Vincenzo D'Angiolella, Valerio Donato, Anita Saraf, Laurence Florens, 
Michael P. Washburn, Brian Dynlacht, Michele Pagano. 
Presenter affiliation: NYU School of Medicine, New York, New York. 
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COHESIN AND SORORIN ARE RECRUITED TO CHROMATIN BY 
DISTINCTLY DIFFERENT MECHANISMS 
 
Jane Song, Andrea L Lafont, Susannah Rankin  
 
Oklahoma Medical Research Foundation, Cell Cycle and Cancer Biology, 
835 NE 13th St, Oklahoma City, OK, 73104 
 
Sister chromatid cohesion ensures that replicated chromosomes are held 
together from the time they are made until cell division. Sister chromatid 
cohesion is established and maintained by the actions of several proteins on 
cohesin, a large multi-subunit protein complex that is thought to entrap the 
sister chromatids. The mechanistic and topological details of how cohesin 
holds chromosomes together, and how cohesion is enhanced or affected by 
components of the replication fork are not known. 
 
In an effort to better understand how cohesion is regulated, we have 
investigated the dependencies among various cohesion factors, with 
particular emphasis on factors implicated in cohesion establishment. Using 
extracts from Xenopus eggs, we have tested the effects of DNA replication 
on chromatin loading of the two vertebrate cohesion establishment factors, 
Eco1 and Eco2. We have also tested the dependencies among cohesin, the 
Eco proteins, and sororin, a protein required for cohesion in vertebrates. 
 
Our data show that cohesin and sororin are recruited to the chromatin by 
distinctly different mechanisms. We show that sororin binds to a site that is 
depends on DNA replication, the cohesin complex, and the Eco family of 
acetyltransferases. Together our data suggest that sororin is a cohesion 
maintenance factor, recognizing and perhaps stabilizing cohesin that is 
modified during DNA replication. 
 2 
IDENTIFICATION AND CHARACTERIZATION OF A NOVEL 
COHESIN PROTEINASE MEDIATING SISTER CHROMATID 
SEGREGATION  
 
Anil K Panigrahi, Debananda Pati  
 
Texas Children's Cancer Center, Baylor College of Medicine, Department 
of Pediatric Hematology, Oncology, Molecular and Cellular Biology, 1102 
Bates Ave., Houston, TX, 77030 
 
From S phase until the onset of anaphase, the sister chromatids are held 
together by a multi-protein ring-like structure called Cohesin. The cohesin 
ring comprises of four proteins: Rad21, Smc1, Smc3 and one of SA1 or 
SA2. In higher eukaryotes, the resolution of sisters during mitosis is 
accomplished by a two-step removal of cohesin from the chromosomes. The 
bulk of cohesin is removed from chromosome arms in prophase in a process 
triggered by the kinase PLK1. The residual centromeric cohesin is removed 
at Metaphase-to-anaphase transition when cleaved by Separase, a CD-clan 
proteinase. Such cleavage opens the cohesin ring and releases the sisters, 
allowing them to segregate. Thus, maintenance and regulation of sister 
chromatid cohesion and separation is thought to be the primary function of 
Rad21. In recent years, however, Rad21 has been implicated in regulation 
of boundary elements, transcription and DNA damage repair. Our 
laboratory had earlier shown that Rad21 is cleaved during apoptosis at sites 
distinct from Separase cleavage, and functions both as a responder to, and 
stimulator of, apoptotic signals.  
 
In an effort to identify and purify the proteinase responsible for apoptotic 
cleavage of Rad21, we prepared nuclear extract from etoposide-treated 
Molt4 cells and fractionated over several chromatographic steps. The 
enriched active fractions were then bound to a Rad21-affinity matrix. The 
bound proteins were analyzed by LC/MS-MS, which revealed a single 
peptidase among 96 proteins identified. The lone proteinase is identified as 
the catalytic subunit of Calpain. We demonstrate that Calpain cleaves 
Rad21 in vitro; and also in vivo when intracellular calcium content is 
increased. Calpain has been implicated in apoptosis, necrosis, development 
and differentiation. However, Calpain-mediated cleavage of Rad21 is not 
associated with apoptosis or necrosis. Instead, Rad21 cleavage by calpain 
results in precocious segregation of the sister chromatids. The Calpain 
cleavage site on Rad21 is distinct from the ones cleaved by Separase. This 
work identifies Calpain as a novel cohesin-proteinase promoting sister 
chromatid separation, and suggests existence of a novel chromosome-
segregation pathway that integrates chromosome biology with cellular 
calcium signaling.  
 
(Supported by Award Number 1RO1 CA109478 from National Cancer 
Institute)  
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COHESIN SUBUNIT SCC1 PROMOTES CASPASE ACTIVATION 
AND CELL DEATH IN MITOSIS 
 
Laura A Diaz-Martinez1,2, Zemfira Karamysheva1, Soonjoung Kim1, 
Hongtao Yu1,2  
 
1UT Southwestern Medical Center, Pharmacology, Forest Park Rd, Dallas, 
TX, 75390, 2Howard Hughes Medical Institute, HHMI, Forest Park Rd, 
Dallas, TX, 75390 
 
Faithful chromosome segregation in mitosis relies on the precise regulation 
of sister chromatid cohesion. Sister chromatids ought to be cohered from 
the time of DNA replication to the onset of anaphase when cohesion is 
dissolved to allow chromosome segregation. Key to the regulation of sister 
chromatid cohesion is the spindle checkpoint. This surveillance mechanism 
delays anaphase onset in response to chromosome attachment defects, thus 
preventing aberrant chromosome segregation and genomic instability. 
Continued checkpoint activation, such as that caused by microtubule 
poisons (e.g., taxol), induces a prolonged mitotic arrest followed by 
apoptosis.  
 
Through a genome-wide siRNA screen we identified the cohesin subunit 
Scc1/Rad21 and the pro-apoptotic factor NOXA as factors that promote 
apoptosis during mitotic arrest. Depletion of Scc1 or NOXA delays 
apoptosis during taxol-induced arrest. Scc1 or NOXA depletion also 
increases the number of cells that are able to escape the taxol-induced arrest 
and become polyploid. Interestingly, the apoptotic role of Scc1 seems to be 
independent of its role in sister chromatid cohesion since depletion of other 
subunits of the cohesin complex does not delay apoptosis.  
 
Scc1 is a known caspase substrate that is cleaved when interphase cells 
undergo apoptosis in response to DNA damage. We provide evidence that 
Scc1 is also cleaved in a caspase-dependent manner during mitotic cell 
death. Surprisingly, we also found that when Scc1 is depleted caspase-3 
activation is abolished. These results suggest the existence of a feedback 
loop in which Scc1 is both a promoter and a target of caspase activity. 
Because of the known role of cohesin at chromosomes during mitosis and in 
light of this novel role for Scc1 as a pro-apoptosis factor during mitotic 
arrest, we hypothesize that cohesin might serve as a link between the 
mitotic machinery and the apoptosis network. 
 4 
CONDENSIN AND MICROTUBULE TENSION DRIVE DE-
CATENATION BY TOPOISOMERASE II THROUGH STABLE 
MODIFICATION OF DNA TOPOLOGY 
 
Jonathan Baxter1, Jorge B Schvartzman2, John F Diffley3, Luis Aragon1  
 
1MRC Clincial Sciences Centre, Cell Cycle Group, Hammersmith Hospital, 
Du Cane Rd, London, W12 0NN, United Kingdom, 2Centro de 
Investigaciones Biologicas , Departamento de Bioliogia Celular y del 
Desarrelo, Ramiro de Maeztu 9, Madrid, 28040, Spain, 3Cancer Research 
UK , Clare Hall Laboratories, Blanche Lane, South Mimms , EN6 3LD, 
United Kingdom 
 
The de-catenation of sister DNA molecules by topoisomerase II during 
mitosis is an absolute requirement to segregate replicated chromosomes. 
Topo II (Top2 in yeast) mediates topological change by generating a 
transient double stranded break in one segment of DNA (the G segment) 
and then transporting an unbroken segment of duplex DNA (the T segment) 
through the break before re-ligation. Thus the operation can either be intra-
molecular, which relaxes supercoils or inter-molecular to resolve 
catenations. A longstanding question of mitosis is what provides the 
directionality of Top2 action to remove all catenations on the replicated 
sister chromatids before cell division is completed 
Here we show that catenated yeast minichromosomes undergo a topological 
transition during mitosis that provides a stable substrate for topo II to 
resolve inter-plasmid catenanes in preference to intra-plasmid supercoils. 
This transition requires a centromere, microtubule tension and Condensin 
function. Analysis of the supercoiling of plasmids purified from mitotic 
cells indicates that the transition is characterised by overwinding of the 
replicated DNA. 
We therefore describe the first experimental evidence that Top2 de-
catenation during mitosis is driven by a topological modification of DNA 
mediated by condensin and spindle forces. 
 5 
REGULATION OF SISTER CHROMATID COHESION AND 
CHROMATIN STRUCTURE BY COHESIN 
 
Jan-Michael Peters  
 
Research Institute of Molecular Pathology, Peters Lab, Vienna, , 1030 
 
Throughout interphase, numerous sites in mammalian genomes are bound 
by cohesin complexes. During DNA replication these complexes establish 
physical connections between the newly synthesized sister chromatids. The 
resulting cohesion is essential for chromosome segregation and for DNA 
damage repair. Cohesion establishment depends on cohesin acetylation and 
coincides with particularly stable binding of cohesin to DNA. This binding 
mode depends on a cohesin associated protein, called sororin. Although 
cohesin is best known for its role in mediating cohesion, we and others 
discovered that cohesin has also important roles in gene regulation. We 
suspect that these functions are the reason why cohesin binds to chromatin 
already before cohesion is established and why cohesin associates with 
DNA even in postmitotic cells, which will never establish cohesion. We 
found that cohesin co-localizes in mammalian genomes with the 
transcriptional insulator protein CTCF and showed that cohesin is required 
for gene regulation at the imprinted H19-IGF2 locus. Gene expression at 
this locus is believed to be controlled by formation of a chromatin loop 
which forms between CTCF sites specifically on the maternal allele. Our 
recent work indicates that cohesin is required for this chromatin interaction. 
We will describe experiments in which we are addressing how cohesin 
might contribute to the formation of chromatin loops and how cohesin 
might be converted into a “cohesive” state during DNA replication. 
 6 
CYCLING WITHOUT CYCLINS: CDKs ARE MODULATORS AND 
EFFECTORS OF A TRANSCRIPTION NETWORK OSCILLATOR 
 
Steven B Haase1, Laura A Simmons Kovacs1, David A Orlando4, Michael B 
Mayhew2, Sayan Mukherjee3  
 
1Duke University, Biology, Durham, NC, 27008, 2Duke University, 
Computational Biology and Bioinformatics, Durham, NC, 27708, 3Duke 
University, Statistical Science, Durham, NC, 27708, 4 Whitehead, Biology, 
Cambridge, MA, 02142 
 
Although it is widely accepted that cyclin/CDK forms the central core of 
the cell-cycle oscillator, we have observed that periodic events continue in 
budding yeast cells lacking all S-phase and mitotic cyclin genes. We 
proposed that a transcription factor network sustains oscillations of bud 
emergence and activates the temporal program of transcription in these 
mutant cells that otherwise appear to be arrested at the G1/S border. These 
cyclin mutant cells still expressed G1 cyclins, and we proposed that G1 
cyclins act as part of the network oscillator, but it is not clear whether they 
play an essential role in supporting oscillations of the transcription network. 
To address this question, we examined global gene expression over time in 
cdc28-4 mutant cells that lack all cyclin/CDK activities at the restrictive 
temperature, and do not undergo re-budding cycles. We find that a 
significant number of genes are still periodically transcribed in the absence 
of all CDK activity. However, with decreasing levels of CDK activity, 
oscillations appear to be less synchronous within the population and the 
average period length is extended. CDKs are known to regulate several 
transcription factors within the network, providing both positive and 
negative feedback. Our data suggest that this feedback from CDK activity is 
important for robust oscillations in wild-type cells. Despite the fact that the 
cell-cycle transcription program continues in cdc28-4 cells, hallmark cell 
cycle events (e.g., budding, DNA replication, mitosis) do not occur. 
Together, our findings support a model in which a transcription factor 
network forms the core cell-cycle oscillator, however, the behavior of this 
scillator is modulated by CDKs, and CDKs are the essential effectors of the 
oscillator required for triggering cell-cycle events. 
 7 
CELL CYCLE COMMITMENT 
 
Andreas Doncic, Jan M Skotheim  
 
Stanford University, Department of Biology, 371 Serra Mall, Stanford, CA, 
94305 
 
In yeast, the G1 checkpoint Start determines if a cell enters the mitotic cycle 
or engages the mating program, but never both since the aims of the two 
programs are diametrically opposed: mating produces one cell from two, 
while mitosis produces two cells from one. This dichotomy is reflected in 
the antagonistic relationships between the underlying signaling molecules.  
 
When a mitotic cell cycle is selected, the upstream cyclin-Cdk complex 
(Cln3-Cdc28) initiates a transcriptional positive feedback loop of two more 
G1 cyclins (Cln1 and Cln2). In the presence of mating factor, a MAPK 
pathway activates Far1, which inhibits G1 cyclins to prevent cell cycle 
progression. We show that the inhibition of both Far1 and the MAPK 
scaffold protein Ste5 by Cln1 and Cln2 completes a double negative 
feedback system that is bistable. In this context, bistability is an effective 
way to generate mutually exclusive cell fates: if G1 cyclin activity is below 
threshold, pheromone-induced signaling drives it lower and the mating 
program ensues; however, if G1 cyclin activity (through positive feedback) 
is above threshold, pheromone-induced signaling is inhibited.  
 
We use quantitative fluorescence microscopy coupled with microfluidics to 
precisely determine the commitment point in individual cells that are 
abruptly exposed to a step increase in pheromone concentration. In WT 
cells, this occurs just after the initiation of the G1 cyclin positive feedback 
loop, where 50±10% of the initially nuclear transcriptional inhibitor Whi5 
(fused to GFP) has been phosphorylated by the G1 cyclins and removed to 
the cytoplasm. While the removal of cyclin feedback (cln1∆cln2∆) reduces 
the Whi5 threshold to ~20%, the removal of the 8 CDK sites on the MAPK 
scaffold Ste5 has no effect on the commitment point. However, STE5(8A) 
cells that are exposed to pheromone late in G1 (post-Whi5 exit) exhibit a 
mixed cell fate (15% of an asynchronous population). These mixed-fate 
cells initiate shmoo formation while failing to complete cytokinesis 
resulting in a 2C arrest. Thus, our data suggests a separation of function 
between G1 cyclin targets in the MAPK pathway: while the commitment 
point is set by the Cln1,2-Far1 interaction, CDK sites on Ste5 must also be 
phosphorylated to ensure exclusive expression of the mitotic program. 
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A SEQUENCE OF COUNTERACTING PHOSPHORYLATIONS 
RESTRICTS AN ASYMMETRIC GENE EXPRESSION PROGRAM TO 
EARLY G1 
 
Emily Mazanka, Eric L Weiss  
 
Northwestern University, BMBCB, 2205 Tech Dr , Evanston, IL, 60208 
 
Restricting gene expression to specific times in cell division and 
differentiation requires close control of both activation and inactivation of 
transcription. In budding yeast, strict spatiotemporal regulation of the 
transcription factor Ace2 ensures that it acts only once in a cell’s lifetime: at 
the M to G1 transition in newborn daughter cells. Phosphorylation by the 
Ndr/LATS family kinase Cbk1 activates Ace2 and drives its accumulation 
in daughter cell nuclei but it remains unclear how the transcription factor is 
inactivated. We found that Ace2’s nuclear localization requires continuous 
rephosphorylation by Cbk1, and that inhibition of the kinase leads to Ace2’s 
immediate loss of phosphorylation and export to the cytoplasm. Once 
exported, Ace2 cannot re-enter nuclei. This cytoplasmic sequestration 
involves phosphorylation of sites that block Ace2’s nuclear import by the 
G1 CDKs Pho85 and Cdc28/Cdk1. Additionally, Pho85 reinforces Ace2’s 
cytoplasmic retention through a mechanism independent of direct 
phosphorylation of the transcription factor. These findings show how 
sequential opposing kinase activities limit a daughter cell specific 
transcriptional program to a brief period during the cell cycle. 
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DIFFERENT LEVELS OF CYCLIN-CDK ORDER MITOTIC EVENTS 
IN S. CEREVISIAE 
 
Catherine Oikonomou, Frederick Cross  
 
Rockefeller University, Laboratory of Yeast Molecular Genetics, 1230 
York Ave., New York, NY, 10065 
 
Cell cycle events are triggered by a regulatory cyclin-dependent kinase 
(CDK) in complex with an activating cyclin. Different cyclin-CDK 
complexes are present at different times in the cell cycle, conferring order 
on the events they control. However, a single cyclin-CDK complex often 
triggers multiple events. In this case, what ensures that these events occur in 
the correct order? Stern and Nurse (1996), in their ‘quantitative model for 
cell cycle control,’ proposed that different activity levels of the kinase 
might trigger different events, leading to temporal order. In budding yeast, 
mitotic cyclin levels normally ramp up over a significant period of time; if 
different cyclin-CDK levels trigger different events, such events would then 
be temporally separated. Here we test this hypothesis by measuring levels 
of mitotic cyclin-CDK activity required to trigger distinct mitotic events. 
We apply a titrated pulse of activating cyclin and use time-lapse microscopy 
to measure the mitotic cyclin-CDK level required to trigger three mitotic 
events: growth depolarization, spindle formation, and spindle elongation. 
We observed that spindle formation required significantly more cyclin than 
growth depolarization, and spindle elongation required still more cyclin 
than spindle formation. These results, consistent with the temporal 
separation observed between these events in cycling cells, support the 
ordering hypothesis of Stern and Nurse.  
We next tested candidate Clb-CDK targets for mechanistic roles in spindle 
formation. We found that Clb-CDK phosphorylation of the spindle pole 
body (SPB) bridge protein Sfi1 promoted efficient SPB separation, a critical 
step in spindle assembly. In contrast, while cyclin-CDK activity stabilizes 
the Cin8 kinesin, which also promotes spindle assembly, this stabilization 
was not rate-limiting for spindle formation.  
Our results validate the Stern and Nurse model, demonstrating that variation 
in cyclin-CDK activity levels through the cell cycle can order cell cycle 
events. Additionally, we have used our system to begin to dissect critical 
steps in cyclin-Cdk control of spindle formation. 
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BISTABILITY MAY ALLOW FOR WAVE-LIKE PROPAGATION OF 
MITOTIC ACTIVITY AND MAINTAIN CELL SYNCHRONIZATION 
 
Jeremy B Chang, James E Ferrell Jr  
 
Stanford University, Chemical and Systems Biology, 259 Campus Dr., 
Stanford, CA, 94305-5174 
 
Diffusion imposes a natural speed limit by which signals, such as active 
protein kinase, can spread in a biological system. In addition, diffusion 
times increase with distance squared, implying that diffusion is much 
slower over relatively large length scales than small length scales. Large 
cells like Xenopus laevis eggs (1.2 mm diameter) might therefore be 
expected to have difficulty propagating intracellular signals quickly enough 
to maintain synchronization. However, the cleavage divisions of early 
embryos of Xenopus are nearly synchronous, suggesting that a mechanism 
other than diffusion coordinates mitosis throughout the embryo's large cells. 
Here, we propose a mechanism by which the bistability of the CDK1 
system, which includes the kinase Wee1 and phosphatase CDC25, may 
allow for CDK1 activation to spread in a wave-like manner that is faster 
than diffusion. We use time-lapse fluorescence microscopy of Xenopus 
cell-free egg extracts in a simple microfluidic channel to show that 
propagation of mitotic activity, as visualized by nuclear envelope 
breakdown, indeed spreads rapidly and linearly in time. We speculate that 
this mechanism of signal propagation may be a widely-employed 
mechanism to spread information quickly through large cells and through 
tissues. 
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THE DNA REPLICATION CHECKPOINT PROMOTES E2F-
DEPENDENT CELL-CYCLE TRANSCRIPTION IN RESPONSE TO A 
DNA REPLICATION BLOCK. 
 
Cosetta Bertoli1, Tatyana I Kalashnikova2, Clare H McGowan2, Curt 
Wittenberg2, Robertus A de Bruin1  
 
1MRC UCL, Laboratory for Molecular Cell Biology, Gower street, London, 
WC1E 6BT, United Kingdom, 2The Scripps Research Institute, Molecular 
Biology, North Torrey Pines Road, La Jolla, CA, CA 92037 
 
Sequential waves of gene expression are responsible, in large part, for 
imposing order on the events of the cell cycle, which is critical for the well 
being of cells and the organisms they compose. Our recent work has shown 
that the cell cycle transcriptional program in fission yeast, 
Schizosaccharomyces pombe, is, in turn, a target for cell cycle checkpoints 
required to maintain genome integrity. In fission yeast MBF activates 
transcription during the G1/S transition. A negative feedback loop, 
involving Nrm1p, ensures repression of MBF-dependent genes once cells 
transit into S-phase. However, in response to DNA replication stress the 
checkpoint protein kinases block timely repression of MBF-dependent 
genes by inactivating Nrm1 via phosphorylation, which is critical for the 
survival of the cell.  
Using the understanding derived from the studies with fission yeast, we 
have uncovered that the transcriptional response to DNA replication stress 
is conserved in mammals. In mammals G1/S transcriptional regulation is 
mediated by the E2F transcription factor family (E2F1-8) and the pocket 
proteins (pRb, p107 and p130), which are functionally analogous to MBF 
and Nrm1p respectively. We show that E2F-dependent transcription is 
derepressed in human cells in response to DNA replication arrest. 
Knocking-down or chemically inhibiting the DNA replication checkpoint 
protein kinase Chk1 abrogates that response. Our data suggests that 
sequential binding of different repressor E2Fs and pocket proteins are likely 
to ensures repression of E2F-dependent genes once cells transit into S-
phase. We present evidence that activation of the DNA replication 
checkpoint is likely to interfere with this control to block timely repression 
of E2F-dependent genes in response to DNA replication stress. 
Our work in fission yeast established a simple but elegant mechanism by 
which checkpoint activation can override the regular periodic transcriptional 
program by directly regulating a transcriptional repressor. We now show 
that similar mechanisms involving regulators of E2F-dependent 
transcription may be acting in human cells to control the cell cycle 
transcriptional program in response to perturbation of DNA replication. It 
will be important to establish the precise mechanism of this control in 
human cells and the importance of this regularegulation for genome 
integrity in Eukaryotes. 
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THE MUVB COMPLEX DIFFERENTIALLY REGULATES THE 
EXPRESSION OF EARLY AND LATE CELL CYCLE GENES 
 
Subhashini Sadasivam, Yong Zhang, Velmurugan Soundarapandian, X. 
Shirley Liu, James A DeCaprio  
 
Dana-Farber Cancer Institute, -, 44 Binney St, Boston, MA, 02115 
 
Transcriptional profiling in mammalian cells reveals a periodic expression 
of genes that peak in different phases of the cell cycle. Indeed, many genes 
involved in DNA replication and mitosis are transcribed and expressed just 
prior to when they are needed in the cell cycle. For example, CDC6 and B-
Myb expression begins during G1-S, while Cyclin B1 and PLK1 expression 
occurs during G2-M. Most, if not all genes with periodic expression during 
the cell cycle are repressed during quiescence. The DREAM complex (Dp, 
Rb, E2F and MuvB) containing p130, E2F4, DP1 and the LIN/MuvB 
proteins LIN9, LIN54, LIN37, LIN52 and RBBP4 occupies promoters of 
more than 800 cell cycle regulated genes and represses their transcription 
during quiescence. When quiescent cells are stimulated to re-enter the cell 
cycle, MuvB proteins dissociate from p130, E2F4 and DP1 and 
independently associate with B-Myb to form the Myb-MuvB complex. 
ChIP revealed that the Myb-MuvB complex bound exclusively to promoters 
of genes expressed late in the cell cycle, a specific subset of DREAM target 
promoters. Functional annotation of Myb-MuvB target genes revealed that 
they had well described functions in mitosis. Significantly, the Myb-MuvB 
complex bound to promoters of late cell cycle genes during S phase when 
these genes were not expressed. Furthermore, RNAi depletion of B-Myb 
and LIN54 revealed that B-Myb was required for MuvB binding to 
promoters and that MuvB was required for B-Myb binding. Using a 
combination of promoter reporter assays, ChIP and gene expression studies 
in synchronized cells, we determined that the MuvB complex served to 
repress B-Myb dependent transcription during S phase. The Myb-MuvB 
complex remained bound to late cell cycle gene promoters until G2, when 
phosphorylation dependent proteasomal turnover of B-Myb resulted in the 
transcriptional activation of late cell cycle genes ensuring their expression 
just before mitosis. Our study reveals that B-Myb serves an essential role in 
the periodic expression of genes during G2-M and that association of the 
MuvB complex alternately with p130/E2F4 in G0, and B-Myb in S 
regulates global periodic gene expression throughout the cell cycle. 
Support- NIH R01 CA63113 & P01 CA50661 (J.A.D) and Friends of DFCI 
(SS) 
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E2F REGULATION IS DISPENSABLE FOR GROWTH CONTROL 
MEDIATED BY PRB 
 
Matthew J Cecchini, Frederick A Dick  
 
London Regional Cancer Program, Children’s Health Research Institute, 
Biochemistry, Schulich School of Medicine and Dentistry, University of 
Western Ontario, London, N6A 5C1, Canada 
 
The retinoblastoma tumor suppressor (pRB) regulates the progression of 
cells into S-phase through at least the control of E2F transcription and 
regulation of p27 stability. pRB is also capable of forming complexes that 
contain both E2Fs and chromatin remodeling factors (CRFs) to alter the 
chromatin environment of E2F target genes. Interestingly, the contribution 
of these distinct interactions to the overall ability of pRB to control cell 
proliferation is not well understood because they have yet to be compared in 
a single study.  
We report the development of new pRB mutants that selectively disrupt 
individual protein interactions with pRB that allow us to characterize the 
contribution of each mechanism to a single cell cycle arrest. When 
examining individual interactions, the loss of the E2F-binding site results in 
only a partial decrease in pRB activity. Combined disruption of the E2F site 
along with other binding sites further reduces the activity of pRB in cell 
cycle arrest, suggesting that the other mechanisms participate 
simultaneously. This suggests that pRB can engage multiple growth arrest 
pathways. To explore the physiological relevance of non-E2F mechanisms 
of cell cycle control, we introduced substitutions into the mouse Rb1 gene 
to generate the pRb-G mutant protein that is unable to interact with and 
regulate E2Fs through its small pocket binding site. Fibroblasts derived 
from homozygous Rb1G/G mice have deregulation of E2F target gene 
expression yet remain capable of inducing a cell cycle arrest. Strikingly live 
Rb1G/G mice have been observed into adulthood and are indistinguishable 
from wild-type litter mates. In contrast, Rb1-/- mice are embryonic lethal.  
This suggests that non-E2F pathways can compensate for loss of E2F 
regulation to mediate cell cycle control. Cell culture data suggests that this 
compensation is mediated through the control of p27 levels by pRB-CdhI-
Skp2 complexes and is currently being investigated through the creation of 
Rb1G/G p27-/- animals. Taken together this work suggests that, pRB engages 
multiple mechanisms through distinct binding interfaces that can act 
redundantly to induce a cell cycle arrest. 
 14 
DISSECTING THE UNIQUE ROLE OF THE RETINOBLASTOMA 
TUMOR SUPPRESSOR DURING CELLULAR SENESCENCE 
 
Agustin Chicas, Xiaowo Wang, Chaolin Zhang, Zhen Zhao, Mila 
McCurrach, Scott W Lowe  
 
Cold Spring Harbor Lab, Cancer center, One Bungtown Road, Cold Spring 
Harbor, NY, 11724 
 
The RB protein family (RB, p107, p130) has overlapping and compensatory 
functions in cell cycle control. However, cancer-associated mutations are 
almost exclusively found in RB, implying that RB has a non-redundant role 
in tumor suppression. We demonstrate that RB preferentially associates 
with E2F target genes involved in DNA replication and is uniquely required 
to repress these genes during senescence but not other growth states. 
Consequently, RB loss leads to inappropriate DNA synthesis following a 
senescence trigger and, together with disruption of a p21-mediated cell 
cycle checkpoint, enables extensive proliferation and rampant genomic 
instability. Our results identify a non-redundant RB effector function that 
may contribute to tumor suppression and reveal how loss of RB and p53 
cooperate to bypass senescence. 
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THE RETINOBLASTOMA PROTEIN REGULATES FATE CHOICE 
AND LINEAGE COMMITMENT 
 
Eliezer Calo, Jacqueline Lees  
 
David H. Koch Institute of Integrative Cancer Research @ MIT, Biology, 
Cambridge, MA, 02139 
 
The Rb tumor suppressor is mutated in approximately one third of human 
tumors. Three tumor types, retinoblastoma, osteosarcoma and small cell 
lung cancer, are particularly associated with Rb mutation. However, the 
underlying basis of this tissue specificity is not well understood. Numerous 
functions have been ascribed to the product of the Rb gene, pRB. The best 
known is pRB’s ability to block cellular proliferation, at least in part, 
through inhibition of the E2F transcription factors. Less well appreciated is 
pRB’s ability to regulate a several transcription factors that are master 
differentiation inducers. Notably, depending on the factor and the context, 
pRB can either suppress or promote their transcriptional activity. For 
example, pRB binds to Runx2 and this seems to stimulate its ability to 
launch the osteogenic differentiation program. In contrast, pRB and E2F1 
act together to suppress the ability of PPARgamma to induce adipogenesis. 
These observations are extremely intriguing. However, to date, there is no 
evidence that pRB’s role in these differentiation complexes affects fate 
choice in vivo and/or the spectrum of Rb-deficient tumors. We have used a 
variety of mouse models, and the resulting cell lines, to address these 
questions in the context of mesenchymal tumors and tissue development. 
Our data show that Rb status plays a key role in establishing fate choice 
and/or fate commitment between brown fat and bone in vivo. 
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CDC14-DEPENDENT DEPHOSPHORYLATION OF A KINETOCHORE 
PROTEIN PRIOR TO ANAPHASE 
 
Bungo Akiyoshi, Sue Biggins  
 
Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 
 
Clb-CDKs drive entry into S phase and mitosis by phosphorylating 
hundreds of substrates. In budding yeast, the Cdc14 phosphatase reverses 
this CDK phosphorylation to allow mitotic exit. The activity of Cdc14 is 
therefore tightly controlled. Cdc14 is sequestered in nucleolus from G1 until 
the onset of anaphase when it is released into nucleus and cytoplasm to 
dephosphorylate Clb-CDK substrates. Although it has been thought that 
Cdc14 is inactive during metaphase, recent work suggests that there is an 
active pool of Cdc14 in the nucleolus prior to anaphase onset. However, it 
has not been known whether Cdc14 is active outside of the nucleolus in 
metaphase. We found that the Dsn1 kinetochore component is 
dephosphorylated in a Cdc14-dependent manner prior to anaphase. Dsn1 is 
a component of the Mis12 kinetochore subcomplex that is essential for 
kinetochore assembly, and the protein has not been detected in the 
nucleolus. Dsn1 exhibits a dynamic phosphorylation and dephosphorylation 
pattern during cell cycle that is CDK-dependent. We generated a phospho-
specific antibody against a CDK site in Dsn1 and found that it is 
dephosphorylated in metaphase in a Cdc14-dependent manner. Our results 
suggest that in addition to global localization control (i.e. by sequestering in 
nucleolus), the activity of Cdc14 is also regulated at substrate specificity 
and processivity levels, enabling efficient dephosphorylation of specific 
targets even when Clb-CDK activity is high. 
 17 
MAX1 LINKS MBF-DEPENDENT TRANSCRIPTION TO 
COMPLETION OF S PHASE 
 
Gómez-Escoda Blanca, Ivanova Tsvetomira, Calvo A Isabel, Alves-
Rodrigues Isabel, Hidalgo Elena, Ayté José  
 
Universitat Pompeu Fabra, Oxidative Stress & Cell Cycle Group, Doctor 
Aiguader 88, Barcelona, 08003, Spain 
 
The MBF complex controls the transcription of genes required for DNA 
synthesis in fission yeast, like cdc22 (ribonucleotide reductase), cdc18 
(CDC6) and cdt1. Transcription of these genes is cell cycle regulated, being 
activated early on G1 and inactivated at the end of S phase 1. We have 
purified the MBF complex and isolated proteins that co-purify with the 
complex. Among them, we have found Max1, which is a homeodomain-
containing protein that binds to the MBF complex and activates MBF-
dependent transcription at the M/G1 transition in a Cdc2/CDK dependent 
manner. Fission yeast cells in which max1 has been deleted are resistant to 
toxic concentrations of the DNA synthesis inhibitor hydroxyurea and show 
genomic instability (chromosome loss). We have also determined that when 
the DNA synthesis checkpoint is activated, Max1 is phosphorylated by the 
kinase Cds1/CHK1 2 resulting in the abrogation of its binding to the MBF 
complex. As a consequence, MBF-dependent transcription is maintained 
active until cells are able to overcome the cell cycle arrest. Thus, Max1 
couples normal cell cycle regulation and the DNA synthesis checkpoint in a 
single transcriptional complex.  
 
1. Ayte, J., Schweitzer, C., Zarzov, P., Nurse, P. & DeCaprio, J. A. 
Feedback regulation of the MBF transcription factor by cyclin Cig2. Nat 
Cell Biol 3, 1043-50 (2001).  
2. Boddy, M. N., Furnari, B., Mondesert, O. & Russell, P. Replication 
checkpoint enforced by kinases Cds1 and Chk1. Science 280, 909-12 
(1998).  
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ROLE OF ATR AND CHK1 HAPLOINSUFFICIENCY IN 
REPLICATION AND CHROMOSOMAL FRAGILITY 
 
HAYAT ARZOUK, ZEINA MAJED, SANDIE TUDURI, HELENE 
FONTAINE, CHARLES THEILLET, ARNAUD COQUELLE  
 
Cancer Research Institute of Monptellier (IRCM), Inserm U896, 208 Rue 
des Apothicaires, MONTPELLIER, 34298, France 
 
Common fragile sites (CFS) are sites of recurrent breaks on chromosomes, 
which are "expressed" under various stresses, most of them known to 
disturb DNA replication, as Aphidicolin (APH) treatment. The working 
model to explain the fragility of these sites is based on pertubation of 
replication, secondary DNA structures and the role of repair and 
checkpoints proteins. Among the actors involved in fragility that have be 
identified, it has been demonstrated that cell transiently depleted in ATR, a 
kinase involved in stalled replication fork signaling, or in one of its target, 
CHK1, show an enhanced chromosome fragility. However, it is now well 
established that these proteins, need a precise regulation and that 
haploinsufficiency of genes involved in ATR signaling pathway have 
functional significance. 
We developed an approach to establish a collection of isogenic clones, 
presenting naturally occurring mutations for these genes. We used the 
property of mismatch repair deficiency of the HCT116 cell line to 
spontaneously generate mutations in homopolymeric repeats. Indeed, when 
a homopolymere repetition is located in a coding sequence, it is prone to 
induce a frameshift in the gene, then leading to haploinsufficiency. 
Following this approach, we have isolated « natural » haploinsufficient 
mutant for ATR and CHK1 and combination of these mutations. As it could 
be expected from literature, we have first demonstrated that atr and chk1 
mutant clones are more sensitive to APH than their wild type counterpart 
and are prone to chromosome breakage, especially at CFS FRA3B and 
FRA16D. We next show by cytometry that mutant cells display anomalies 
in activation of the intra-S checkpoint and, by HALO and molecular 
combing, that they exhibit defects in genome-wide replication dynamics. 
Finally, preliminary data appear to show that double heterozygote clones 
have less replication issues than simple mutants. In good agreement with 
this observation, we found more activated forms of these proteins in simple 
mutants. An attractive hypothesis to explain these results is that gene 
dosage between ATR and CHK1 is important and finely regulated to allow 
a normal replication completion. 
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GCP6, A COMPONENT OF THE GAMMA-TURC IS REQUIRED FOR 
CENTROSOME DUPLICATION. 
 
Ramona Bahtz, Marc Arnold, Ingrid Hoffmann  
 
German Cancer Research Center, Cell Cycle Control and Carcinogenesis, 
Im Neuenheimer Feld 280, Heidelberg, 69120, Germany 
 
Centrosomes are the major microtubule-organizing centers of an animal 
cell. In G1-phase of the cell cycle cells contain only one centrosome. For 
the formation of a bipolar mitotic spindle centrosomes have to be duplicated 
which occurs at the G1/S-phase transition. It was previously shown that 
gamma-tubulin is required for centriole duplication. In vertebrate cells 
gamma-tubulin is organized in a large multi-protein complex, the gamma 
tubulin ring complex (gamma-TuRC), which forms an essential template for 
microtubule nucleation at the centrosomes. GCP6 is one of the core 
components of the gamma-TuRC. Its function in mammalian cells is only 
poorly characterized. We find that in HeLa cells stable expressing murine 
GCP6-GFP under the endogenous promoter, GCP6 localizes to the 
centrosomes all over the cell cycle. In addition to this a colocalization of 
GCP6 with the centriolar marker protein centrin as well as localization 
along the spindle microtubules is detected. Furthermore, we observed that 
GCP6 is required for the formation of a bipolar mitotic spindle as 
downregulation of GCP6 results in spindles with poorly separated poles, 
combined with an enrichment of mitotic cells in prometaphase. The 
monopolar spindles bear a reduced number of centrioles, indicating that 
GCP6 plays a role in centriole duplication. This was confirmed in 
centrosome overduplication experiments in which GCP6 depletion inhibits 
centrosome amplification in aphidicolin arrested U2OS cells. Future studies 
will be aimed at clarifying if GCP6 influences centriole duplication by 
effecting gamma-TuRC assembly, microtubule nucleation or gamma-
tubulin recruitment. 
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THE MOLECULAR CHAPERONE HSP90 IS REQUIRED FOR CELL 
CYCLE EXIT IN DROSOPHILA. 
 
Jennifer L Bandura1, Huaqi Jiang1, Bruce A Edgar2  
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1100 Fairview Ave. N., Seattle, WA, 98109, 2Heidelberg University, 
ZMBH-DKFZ Alliance, Im Neuenheimer Feld 282, Heidelberg, D-69120, 
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Proper development depends on the coordination of cell proliferation and 
differentiation to produce the correct number of cells in space and time. 
Robust mechanisms exist to ensure that cells enter a permanently non-
proliferative state upon terminal cell differentiation. For this cell cycle exit 
to occur normally, it is important that both the E2F/DP transcription factor 
and Cyclin E/Cdk2 activities be suppressed. However, the precise processes 
that act to restrain E2F/DP and Cyclin E/Cdk2 in differentiating cells are 
not clear. To learn more about the regulation of cell cycle exit, we have 
performed a genetic screen in Drosophila, designed to identify genes 
involved in silencing cell cycle gene transcription upon differentiation in 
the eye. This screen utilized a pcna-miniW+ reporter that is highly E2F-
responsive and results in a darker red eye color when crossed into genetic 
backgrounds that delay cell cycle exit. We have isolated a line mutant for 
Hsp83, the Drosophila homolog of mammalian Hsp90, which experiences 
increased E2F-dependent transcription and ectopic cell proliferation in 
pupal tissues at a time when neighboring wild-type cells are postmitotic. 
Further, these Hsp83 mutant cells contain increased Cyclin/Cdk activity and 
accumulate proteins normally targeted for proteolysis by the anaphase-
promoting complex/cyclosome (APC/C), suggesting that APC/C function is 
inhibited in cells lacking Hsp83. Future studies will focus on defining the 
mechanisms by which a loss of function of the chaperone Hsp83 results in 
increased Cyclin/Cdk activity and decreased APC/C function, as well as 
determining which effects are critical for delaying cell cycle exit. 
Characterization of this function of Hsp83 should provide new insights into 
the processes coordinating cell proliferation and terminal differentiation. 
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FACTOR NETWORK TO CLB REGULATION IN THE YEAST CELL 
CYCLE 
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The coupled activities of Cdk-Clb and transcription network oscillators are 
essential for cell cycle progression in eukaryotes. The budding yeast cell 
cycle is driven by periodic changes in the activity of the Cdk1 kinase, and 
different pools of cyclins (Clbs) associate with Cdk1 in sequential waves of 
expression. The strictly delimited expression of cyclin genes stems from 
both positive and negative transcriptional controls as well as by cell cycle-
dependent protein activity. Cdk1 has been implicated in transcriptional 
regulation either directly, by associating and phosphorylating transcription 
factors, or indirectly, by interacting with suppressors and activators of 
transcription factors. This results in inhibition or increase of transcription, 
respectively. However, the molecular mechanisms linking the transcription 
network oscillator to the activation of Cdk1-Clb complexes is not fully 
understood. 
It has been recently shown that transcription and phosphorylation are 
coupled by feed-forward loops for cell cycle regulation. Here, we suggest a 
specific transcriptional regulation driving phase-specific cell cycle events. 
By combining directed protein-protein interaction techniques, ChIP and 
expression profiling using Solexa technology, we show that the Cdk-Clb 
oscillator can be coupled with the transcriptional oscillator such that the 
sequential appearance of Clbs is controlled by specific transcription factors. 
In turn, Cdk-Clb could modulate the activity of the transcriptional oscillator 
by recruiting the same transcription factors via Clb-mediated interactions. 
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Biochemical feedback and feed-forward loops coordinate cell cycle 
oscillations occurring over a wide range of time scales. The budding yeast 
cell cycle oscillates between states of low and high cyclin-dependent kinase 
activity, driven by the association of Cdk1 kinase with B-type (Clb) cyclins. 
Various Cdk1-Clb complexes are activated and inactivated in a fixed, 
temporally regulated sequence during cell cycle progression, inducing the 
characteristic behaviour known as “waves of cyclins”. The mechanism that 
regulates the appearance on schedule of these complexes is currently 
unknown. 
Here, we analyse the molecular basis of the oscillations of the Clbs, with 
major focus on the role of their inhibitor Sic1. We compare mathematical 
networks differing in the regulatory interactions that Sic1 may establish 
with Cdk1-Clb complexes. Our analysis suggests that the wave-like cyclins 
pattern derives from the binding of Sic1 to all three Clb pairs rather than 
from the degradation of Clbs. We show that a specific sequence of 
molecular interactions reproduces the oscillation-like behaviour of the Clb 
cyclins waves and verify experimentally the model predictions by protein-
protein interaction techniques and time course experiments. Our results 
highlight a feed-forward regulation of Sic1 to synchronize the Cdk1-Clb 
complexes, acting as a timer in their appearance. 
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NF-κB and p53 are important regulators of the cellular response to stress. 
Here we demonstrate that p52/p100 NF-κB2 processing is induced upon 
DNA damage and that, in cooperation with p53, can regulate cell fate. 
Moreover, after DNA damage, the Skp2 gene, which contains binding sites 
for both factors, is regulated by p52 containing NF-κB complexes and p53. 
Importantly, this provides a node through which both pathways, together 
with signaling through the IKK, ATM and Akt pathways, can be integrated 
to regulate cell cycle arrest and autophagy. Underlining the importance of 
this pathway as a decision making nexus determining the response to DNA 
damage, p52 and p53 can either repress or induce Skp2 expression and this 
is dependent upon signaling through the Akt/GSK3β pathway. We show 
that GSK3β phosphorylation of p52 at serine 222 not only determines 
coactivator and corepressor recruitment to the Skp2 promoter, but also 
regulates p52 heterodimerisation specificity. 
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Tight control of mitotic events is required to ensure faithful chromosome 
segregation and cytokinesis. Recently, it was shown that the proper cellular 
localization of the chromosomal passenger complex (CPC) requires the 
activity of the ubiquitin ligase Cullin3 (Cul3). The kelch-repeat containing 
substrate specific adaptor proteins Klhl9, Klhl13 and Klhl21 were found to 
establish interaction of Cul3 with the passenger kinase Aurora B. When 
components of the Cul3 complexes are depleted by RNAi, the CPC fails to 
accumulate on spindle midzone microtubules after anaphase onset and 
remains associated with chromosomes. However, it is still unclear how 
ubiquitination of Aurora B affects CPC localization. 
 
To address this question we generated a cell line stably expressing Aurora B 
fused to a photoactivatable variant of GFP (paGFP). Using this cell line we 
are studying whether Aurora B relocalization from centromeres to the 
spindle midzone requires the degradation or transport of the chromosome-
associated pool of Aurora B. Furthermore, this cell line enables us to 
measure kinetics of distinct Aurora B populations in the presence or 
absence of Cul3 complexes by selectively photoactivating AuroraB-paGFP 
on different mitotic structures. Gathering this kinetic information should 
lead to a better understanding of how ubiquitination of Aurora B by Cul3 
regulates the localization of the CPC. 
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In addition to its well-characterized growth suppressive role, p27Kip1 
appears to promote proliferation by activating cyclin D-cdk4/6 kinase 
activity. We demonstrated that tyrosine (Y) phosphorylation of p27 
converts it from a cdk4/6 inhibitor to an activator, as the presence of the 
phosphate forces the tail of p27 from cdk4’s active site, permitting both 
ATP access and the required CAK phosphorylation of the cdk subunit. 
Thus, p27 functions as a bona fide "switch" turning cdk4/6 activity on or 
off, promoting or preventing proliferation respectively. Using two 
dimensional isoelectric focusing and p27 Y phospho-specific antibodies, we 
have found that p27 Y phosphorylation is tightly cell cycle regulated, and in 
non-transformed epithelial cells and T cells, is detected exclusively at the 
G0-G1 phase border or following release from quiescence. This correlates 
with the burst of cdk4/6 kinase activity seen during the G0-G1 phase 
transition, after which both p27 Y phosphorylation and cdk4/6 kinase 
activity decreases. Cdk4/6 activity is restored while p27 is still detected at 
G0 phase levels, suggesting that Y phosphorylation activates preassembled 
p27-cyclin D-cdk4 complexes. Cdk2 activity is not detected until p27 levels 
decrease, suggesting that activation of cdk4 and cdk2 correspond to the G0-
G1 and G1-S phase transitions respectively. We have also found using 
several different types of cancer cells that p27 Y phosphorylation is no 
longer cell cycle regulated and the pool of Y phosphorylated p27 is 
significantly increased. Due to increased Y kinase activity, the p27 Y 
phosphorylation switch may be “locked” into a constitutive activator mode. 
In many tumor types, cyclin D-cdk4/6 are oncogenes, and p27 itself is a 
tumor suppressor, whose activity appears to be reduced, due to increased 
degradation or cytoplasmic mislocalization. However, low p27 levels are 
almost always detected, suggesting there is a selective advantage to 
maintain residual p27, presumably to stabilize and activate cyclin D-cdk4/6 
complexes. While the pool of nuclear p27-cyclin D-cdk4 appears lower due 
to reduced or mislocalized p27, the percentage of Y phosphorylated, 
activated p27-cyclin D-cdk4/6 appears greater. Thus, we believe that p27 
has a growth-promoting role during normal cell cycle proliferation, which 
translates into an oncogenic role during tumor progression. 
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Glc7 is the only catalytic subunit of protein phosphatase 1 in S. cerevisiae. 
It plays major roles in regulating diverse cellular processes, including 
glycogen metabolism, cell cycle progression, chromosome segregation, 
sporulation, glucose repression, transcription, and meiosis. During the cell 
cycle Glc7 has been shown to oppose Ipl1 (Aurora B) kinase activity as bi-
polar chromosome attachments are established and to function in spindle 
checkpoint silencing. shp1 (suppressor of high-copy PP1) null alleles were 
identified in a screen for mutants suppressing the lethality of GLC7 
overexpression, and Shp1 is thought to be a positive regulator of Glc7. 
However, it remains unclear how Shp1 affects Glc7. 
Our detailed analysis of shp1 phenotypes revealed that the knockout has cell 
cycle defects similar to certain conditional glc7 mutants. At the permissive 
temperature Δshp1 cells show a significant delay in cell cycle progression 
during G2/M and arrest with separated spindle pole bodies and short 
spindles at 14°C. Overexpression of GLC7 in Δshp1 is not only tolerated, 
but suppresses the G2/M delay, resulting in a cell cycle distribution similar 
to wildtype. Furthermore, we demonstrate for the first time that a physical 
interaction between Glc7 and Shp1 exists in vivo. Currently we are 
investigating the specific role of Shp1 in regulation of Glc7 cell cycle 
functions. 
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Cancer is a disease of disregulated cell growth: thus, modern 
chemotherapeutic drug treatments often target tumor cells by interfering 
with the cell cycle of rapidly dividing cells. Breast cancer chemotherapy 
heavily relies on the topoisomerase II poison doxorubicin (Adriamycin). 
There are currently six molecular subtypes of breast cancer, luminal A, 
luminal B, basal-like, claudin-low, normal-like, and Her2+, each of which 
presents itself as an individual disease with different prognoses. These 
molecular subtypes are thought to share similar molecular signaling defects 
that may be targeted for personalized chemotherapy regimens. Here we 
describe the cell cycle checkpoint defects present in the luminal, basal-like, 
and claudin-low subtypes. A panel of breast cancer cell lines were examined 
to identify cell cycle checkpoint function using a set of flow cytometry 
based assays. The basal-like and claudin-low subtypes both displayed a 
defective spindle-damage checkpoint. These subtypes exhibited increased 
numbers of polyploid cells upon treatment with the spindle poisons 
colcemid and nocodazole and exhibited a decreased accumulation of mitotic 
cells in the presence of colcemid. In contrast, the luminal breast cancer cell 
lines retained an effective spindle damage checkpoint, but displayed a 
defective decatenation G2 checkpoint response to the topoisomerase II 
catalytic inhibitor ICRF-193. Luminal breast cancer cell lines exhibited 
decreased expression of the protein kinase ATM as measured by western 
immunoblot, suggesting a mechanism by which the decatenation G2 
checkpoint response might be attenuated. Furthermore, cytogenetic 
preparations of luminal lines treated with ICRF-193 displayed under-
condensed and entangled chromosomes, and preliminary colony formation 
data suggests that the luminal breast cancers may exhibit an increased 
sensitivity to ICRF-193, when compared to basal-like or claudin-low 
subtypes. These results indicate that the luminal breast cancers are more 
responsive to a topoisomerase II catalytic inhibitor than the basal-like breast 
cancers. This may represent a new vulnerability of the Luminal B subtype 
with poor response to hormone therapy. 
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The final act of budding yeast cell division is destruction of a septum 
deposited during cytokinesis, a process analogous to abscission in 
metazoans. It is not clear how this is forestalled until division is complete. 
Genes involved in septum destruction are induced by the M/G1 
transcription factor Ace2, which is driven into the daughter cell nucleus 
immediately before cytokinesis by the Ndr/LATS kinase Cbk1. Cbk1 is 
phosphorylated at a conserved hydrophobic motif (HM) regulatory site, a 
modification required for its in vivo function. This site becomes 
phosphorylated prior to mitotic exit: we found this requires activation of the 
FEAR (fourteen early anaphase release) pathway. However, using a gain-
of-function cbk1 allele that bypasses the need for phosphorylation of this 
site, we found that the kinase is still negatively regulated. Cbk1 cannot 
activate the Ace2 transcriptional program until final release of the mitotic 
phosphatase Cdc14, which is initiated downstream of the mitotic exit 
network (MEN). Treatment with the phosphatase does not increase the 
intrinsic enzymatic activity of the kinase in vitro, but activates the pathway 
in vivo. These findings indicate that Cdc14 activates Cbk1 and Ace2 
simultaneously by releasing both proteins from inhibitory phosphorylation. 
In this way, the rapid activation of Cbk1 and Ace2 are coordinated with the 
progress of mitotic exit. 
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Estrogen plays a major role in breast cancer development and progression. 
Increased cellular proliferation in the presence of estrogen allows for a 
higher mutation rate that can sabotage cellular genomic integrity. Over-
expression of the oncoprotein Mdm2, a major negative regulator of the p53 
tumor suppressor, is often observed in estrogen receptor positive breast 
cancers. To study the role of Mdm2 in estrogen-mediated cellular 
proliferation and survival, we examined the effect of estrogen on the 
Mdm2-p53 pathway in the estrogen receptor positive and p53 wild-type 
MCF-7 breast cancer cells. We observed that the estrogen-mediated 
increase in cellular proliferation correlated with an increase in the Mdm2 
protein level. Importantly, when we blocked Mdm2 expression in cells with 
inducible shRNA, estrogen could no longer up-regulate cell growth. Mdm2 
knockdown increased p21 and the percent of cells in G1 phase, which 
resulted in decreased cellular proliferation, whereas estrogen treatment 
could not overcome this effect. Furthermore, we observed that estrogen 
increased the Mdm2 protein level in cells exposed to the DNA damaging 
agent etoposide and the Mdm2 inhibitor Nutlin-3. We found that under 
these conditions, estrogen inhibited transcription of the pro-apoptotic gene 
puma without decreasing the p53 protein level or influencing p53 
recruitment to the chromatin. The estrogen-mediated decrease in puma 
transcription correlated with a decrease in Puma protein and an increase in 
Bcl-2. Overall, our findings suggest that Mdm2 is required for estrogen-
mediated cellular proliferation and survival, and that estrogen together with, 
or via, Mdm2 is signaling for cell cycle progression and programmed cell 
death inhibition.  
 
This work was supported by grants to J.B. from the Breast Cancer Research 
Foundation and the National Science Foundation MCB-0744316; and was 
facilitated by Grant Number RR03037 from the National Center for 
Research Resources (NCRR), a component of the National Institutes of 
Health (NIH) awarded to Hunter College. 
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In the budding yeast, Saccharomyces cerevisiae, approximately 20% of the 
genome is transcribed periodically during the cell cycle. Periodic 
transcription is thought to play an important role in ordering cell-cycle 
events. However, in cells lacking S-phase and mitotic cyclins, cell-cycle 
progression is halted but periodic transcription continues. This result 
demonstrates that the periodic transcription program can be uncoupled from 
cell-cycle progression. We have proposed that this periodic transcription 
program is controlled by a transcription factor network that may function as 
an independent cell-cycle oscillator. Our observation that the network 
oscillator can be uncoupled from cell-cycle progression was made in a non-
physiological arrest (S-phase and mitotic cyclin mutants). What happens to 
the network oscillator during a more “physiological” cell-cycle arrest, such 
as a checkpoint arrest? If periodic transcription is important for ordering 
cell cycle events, asynchrony between cell-cycle progression and the 
transcription factor network could cause problems for cells recovering from 
a checkpoint arrest. Thus we hypothesized that checkpoints regulate the 
network oscillator in order to couple it to cell-cycle progression. To test this 
hypothesis, we measured global mRNA dynamics over time in a 
synchronous population of G1 cells released into conditions that trigger the 
DNA replication checkpoint. We observe that a majority of the periodic 
genes in normally-cycling cells are no longer periodic when the cell cycle is 
arrested by the checkpoint. Although we find that periodic transcription is 
halted, many of the genes thought to be involved in overcoming replicative 
stress are continually expressed throughout the time course. Our data 
suggest that the DNA replication checkpoint pathway regulates the network 
oscillator to coordinate its progression with cell-cycle progression and to 
aid in overcoming replicative stress. 
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XCep63 was identified in a screen for ATM targets following the 
observation that DNA damage causes disruption of the mitotic spindle in 
Xenopus laevis egg extracts (Smith et al. 2009). 
 
Recombinant DNA double strand breaks introduced into egg extracts cause 
disruption of mitotic spindle assembly, which is dependent on ATM/ATR 
activation and phosphorylation of XCep63. Supplementing extract with 
XCep63 that cannot be phosphorylated by ATM/ATR rescues this spindle 
disruption phenotype. XCep63 is also important in unperturbed mitotic 
spindle assembly. Interestingly, it is only centrosome dependent spindle 
assembly that is disrupted by ATM and ATR activity. Anastral spindles, 
formed from microtubules nucleating from chromatin, are resistant to 
ATM/ATR signalling. These findings show that the centrosome is an 
important ATM and ATR target following DNA damage in mitosis. It 
appears that XCep63 is a major ATM and ATR centrosome target and its 
phosphorylation by ATM and ATR leads to inhibition of its function in 
bipolar spindle assembly. 
 
The proper segregation of chromosomes during mitosis is crucial for 
maintenance of genomic stability and there is a large amount of data 
describing the involvement of the centrosome in the DNA damage response. 
Since the response to DNA damage during mitosis is not well characterised, 
we are interested in studying the role of Cep63 in mammalian cells and 
postulate that it will serve as a key link between DNA damage signalling 
and regulation of mitotic progression. Cep63 is conserved in vertebrates and 
was originally identified in a screen for centrosome proteins (Andersen et 
al. 2003). Here we will present our current understanding of human Cep63 
function. 
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Overexpression of cyclin D1, as observed in a large proportion of human 
breast cancers, is believed to confer proliferative advantage through 
inactivation of the retinoblastoma protein, pRB. We have previously shown 
that a single amino-acid change that specifically abrogates the kinase-
dependent function of cyclin D1 is sufficient to render mice resistant to 
breast cancer initiated by ErbB2. In addition, we identified a population of 
mammary progenitors that requires cyclin D1 activity for its self-renewal 
and contains the cellular target for MMTV-ErbB2 mediated transformation. 
While these findings clearly support a role for cyclin D1 activity in the 
mammary stem-progenitor cell hierarchy, the mechanisms responsible for 
the reduced number of progenitors in mutant mammary glands remain 
unexplored. We hypothesize that reduction in cyclin D1-associated kinase 
activity triggers the activation of tumor suppressive mechanisms, which 
might impair the ability of mammary progenitors to self renew and to 
become transformed. Surprisingly, mammary glands derived from cyclin 
D1KE/KE/MMTV-ErbB2 mice exhibit high levels of proliferation that 
leads to prominent ductal hyperplasia despite the fact that proliferating cells 
do not progress to form tumors. Nevertheless, ectopic proliferation was 
accompanied by reduced levels of phosphorylation at Ser-780 of pRb, 
suggesting that other D-type cyclins were unable to compensate for the lack 
of cyclin D1-associated kinase activity observed in this tissue. Moreover, 
the proliferative defects observed in mutant mammary glands correlated 
with a failure to implement the senescence program along with an 
upregulation of autophagy. These latter findings are significant in light of 
recent studies indicating that autophagy may play an active role in caspase-
independent programmed cell death. Taken together, our data suggest a 
previously unknown role for cyclin D1-associated kinase activity in the 
orchestration of the premature senescence program and the suppression of 
autophagy in the pre-malignant mammary epithelium. 
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Different types of cellular quiescence are controlled in distinct ways, both 
in the manner of cell cycle inhibition and in the signaling pathways used to 
initiate withdrawal from the cell cycle. We have examined the process of 
cell cycle withdrawal upon terminal differentiation in the eyes and wings of 
Drosophila melanogaster. Terminal differentiation signals initiate cell cycle 
exit by repressing either the E2F transcription factor complex or by 
repressing Cyclin E/Cdk2 activity, the G1 Cyclin/Cdk responsible for S-
phase entry. While inhibition of only one of these factors is necessary to 
initiate cell cycle exit, we have found that long-term quiescence is stably 
maintained in terminally differentiated cells by simultaneously limiting both 
E2F and Cyclin E activities, an effect we call “double-assurance”. This 
disrupts the positive regulatory loop that normally exists between E2F and 
Cyclin E and ensures that cell cycle exit is robust to the de-regulation of a 
single cell cycle factor. Recently, we have found that E2F-Cyclin E positive 
feedback is limited after terminal differentiation by the degradation of E2F 
activator complexes and formation of Cyclin E-resistant E2F repressor 
complexes. In addition, Anaphase Promoting Complex (APC/C) activity 
increases upon terminal differentiation to promote cell cycle exit by 
degrading key cell cycle proteins. These mechanisms are critical for the 
robust exit of differentiated cells as bypassing them forces cell cycle re-
entry and leads to tumor-like outgrowths, composed of dividing but 
terminally differentiated cells. Currently we are working to identify the 
developmental signaling pathways that act to coordinate terminal 
differentiation with the decision to exit from the cell cycle. 
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The endocycle is comprised of alternating G and S phases and is 
widespread in nature, yet this modified cell cycle is not well understood. In 
Drosophila, a number of tissues switch from mitotic to endocycles in 
response to developmental signals. To understand these developmentally 
modified cell cycles, we have used a combined genomic, genetic, and cell 
biological approach, which has revealed differences in the cell cycle 
oscillator, cell growth, and checkpoints. Here we focus on our finding that 
endocycles have a distinct response to re-replication stress.  
 
In tissues comprised of mitotically proliferating cells, we find that an 
increased abundance of the pre-RC protein Cdt1 is sufficient to induce 
genotoxic re-replication stress, resulting in activation of ATM / ATR 
checkpoint kinases in numerous repair foci. Heterochromatic regions have 
more repair foci suggesting that they may represent re-replication fragile 
sites. The ultimate fate for most of these cells is an apoptotic cell death that 
is dependent on the fly orthologs of the Chk2 and p53 tumor suppressors, 
similar to the re-replication response in humans and other organisms. In 
endocycling cells from a variety of tissues, increased Cdt1 also results in re-
replication, genotoxic stress, and activation of ATM / ATR, but these cells 
do not apoptose. Our combined data suggest that endocycling cells do not 
apoptose because p53 transcriptional activity is blunted through epigenetic 
silencing of its target genes. Investigating how re-replication checkpoints 
and fragile sites differ among cell types may uncover conserved 
mechanisms relevant to tissue-specific genome instability and cancer in 
humans.  
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Current fluorescence measurements of cell cycle using either nucleic acid 
stains for mathematically modeling DNA content or fluorescently labeled 
antibodies against BrdU, Ki67, PCNA, or cyclins are essential for 
characterizing changes in cell cycle. In addition to these methods, several 
new methods have recently become available.  
Characterization of cell cycle using two fluorescent protein fusions which 
are cyclically targeted for degradation through an ubiquitination pathway is 
an elegant method pioneered by Miyawaki et al, for live cell cycle 
visualization, known by the acronym FUCCI (Fluorescence Ubiquitination 
Cell Cycle Indicator). Green and red fluorescent proteins (GFP and RFP) 
fused to geminin and Ctd1, respectively, balance in intensity near the entry 
into S-phase causing the nucleus to appear yellow when the color channels 
are merged. The green from GFP-geminin predominates through S, G2 and 
M phase, while the red from RFP-Ctd1 predominates during G1. Delivery 
of the FP chimeras is facilitated by baculovirus delivery technology which 
has been demonstrated to label primary and stem cells and most mammalian 
cultured cell lines. MAP4 RFP (microtubulin-associated protein 4) used 
with geminin FP chimeras provides additional information of cell cycle 
dynamics and can be used to identify cells in M phase.  
Cell cycle dynamics can be further dissected through the incorporation of a 
thymidine analog detectable with click chemistry labeling. This method 
offers an alterative method to using the traditional antibody detection of the 
thymidine analog BrdU (bromo-deoxyuridine) to measure proliferative 
potential. Cells actively replicating DNA incorporate the analog EdU 
(ethynyl deoxyuridine), when, after fixation and permeabilization they react 
with a dye azide to form a covalent fluorescent tag. Since standard antibody 
fixatives are used, the cells can then be antibody labeled with cell cycle 
relevant targets like cyclin B1, Ki67, and phosphohistone H3 and stained 
for DNA content using nucleic acid binding dyes. Use of both thymidine 
analogs, EdU and BrdU, for sequential pulse labeling of proliferating cells 
further expands the potential for measuring S-phase proliferation potential. 
Although requiring the more cumbersome methods for BrdU detection, dual 
pulse labeling offers insight to temporally based proliferation events. 
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Cycling cells must ensure that DNA replication is not initiated until after 
mitosis has completed. In mammalian cells, the Cdt1 protein, a pre-
replication complex (preRC) constituent, is rate-limiting for the recruitment 
of MCM proteins to Origins of replications (ORIs), directing replication 
licensing.  
 
Here we show that Cdt1, which is unstable in G2 phase, is stabilized in 
mitosis. This might require the spindle-checkpoint independent loss of 
cyclin A, leading to inactivation of SCF-dependent turn-over of Cdt1. 
Interestingly, Cdt1 protein synthesis escapes the general inhibition of 
translation in mitosis. Together, this results in accumulation of Cdt1 during 
prometaphase. Cdt1 that accumulates in mitosis is kept in check by binding 
to Geminin, which inhibits preRC-formation.  
 
To initiate preRC-formation in preparation of S-phase, Geminin needs to be 
degraded after mitosis. However, we found that Geminin destruction starts 
already when the chromosomes align at metaphase and is dependent on 
APC/C-Cdc20. Initiation of Geminin destruction is controlled by the 
spindle checkpoint. This is surprising because so far only two other 
proteins, cyclin B1 and Securin, have been identified as spindle checkpoint 
targets.  
 
In conclusion, our results indicate that mitosis and subsequent spindle 
checkpoint inactivation are required to direct S-phase licensing. We show 
that accumulation of Cdt1 in mitosis creates a distinct time window for the 
accumulation of Geminin-Cdt1 complexes. Spindle checkpoint-dependent 
Geminin destruction at metaphase releases Cdt1, allowing preRC-
formation. This sequence of events creates a unidirectional mechanism 
controlled by APC/C-Cdc20 that couples preRC-formation to a successful 
round of mitosis.  
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Many cells in the human body exist in the cellular state of quiescence, 
which is characterized by reversible exit from the cell cycle. Quiescent cells 
are widely reported to exhibit reduced cellular size, nucleotide synthesis and 
metabolic activity. Previous studies in lymphocytes and thymocytes have 
reported much lower glycolytic rates in quiescent compared with 
proliferating cells. In contrast to these previous findings, we show here that 
primary human fibroblasts continue to exhibit high metabolic rates when 
induced into quiescence via contact inhibition. The metabolic activity of 
quiescent fibroblasts (i.e., glucose consumption, lactate excretion) is 
comparable to that of their proliferating counterparts, yet they direct this 
activity differently. Using a metabolomics-based approach to monitor flux 
through metabolic pathways coupled with a computational model of 
metabolism based on ordinary differential equations (ODE), we were able 
to show that quiescent fibroblasts utilize glucose in all branches of central 
carbon metabolism including, surprisingly, the pentose phosphate pathway 
(PPP) and the tricarboxylic acid (TCA) cycle. Proliferating fibroblasts, on 
the other hand, attenuate the flow of glucose carbons from citrate into the 
rest of the TCA cycle. By feeding the cells with labeled glutamine, we also 
detected a “backwards” flux in the TCA cycle from α-ketoglutarate to 
citrate that was faster in quiescent than proliferating fibroblasts. The high 
metabolic activity of the fibroblasts is reflected in significantly increased 
production of the extracellular matrix proteins. We tested the functional 
significance of the high levels of PPP usage in quiescent fibroblasts by 
treating with a PPP inhibitor. Quiescent fibroblasts exhibited more cell 
death in response to treatment with a PPP inhibitor than proliferating 
fibroblasts, possibly reflecting the functional importance of NADPH 
generated by this pathway for free radical detoxification in quiescent cells. 
Our findings demonstrate that reduced metabolic activity is not a hallmark 
of the quiescent state. Further, quiescent cells, relieved of the biosynthetic 
requirements associated with generating progeny, may maintain a high 
metabolic rate, actively detoxify free radicals, and divert their metabolic 
potential toward the synthesis of proteins that are beneficial for the 
organism as a whole. 
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Mitosis is a highly dynamic process that is essential to generate two 
genetically identical daughter cells. Correct progression through mitosis 
requires the concerted actions of many regulatory pathways, which include 
protein phosphorylation/dephosphorylation and proteolysis. Live-Cell 
Imaging has been instrumental to our understanding of mitosis and its 
regulation, as it has allowed us to perform quantitative measurements of 
these pathways at high spatial and temporal resolution.  
An outstanding challenge in order to obtain an integrated model of mitosis 
(and of the cell cycle in general) will be to "connect" data coming from Cell 
Biology and Biochemistry in the most unbiased manner. To this end, we 
developed a strategy to generate human cell lines expressing fluorescently 
labeled endogenous proteins "in a blink of an eye" by homologous 
recombination. This is done through the use of recombinant Adeno-
Associated Virus (rAAV)-mediated knock-ins. The resulting reporter cell 
lines can then be used for quantitative Cell Biology and Biochemistry 
studies of your favorite endogenous protein. We show examples of 
insightful fluorescence quantifications of known mitotic regulators. 
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Progression through the cell cycle is associated with profound changes in 
the actin cytoskeleton. Disruption of the actin cytoskeleton with 
pharmacological agents causes arrest in G1 phase and failure to enter S-
phase, indicating that an intact actin cytoskeleton is required for cell cycle 
progression. The lack of specificity of these agents has hindered the 
analysis of the mechanisms responsible for this regulation. We have 
previously identified functionally distinct populations of actin filaments, 
each containing different isoforms of the actin filament-associated protein, 
tropomyosin (Gunning, Hardeman, O’Neill, Physiol Revs 2008). In the 
current study, we hypothesised that a specific population of Tm isoform-
containing actin filaments regulates cell proliferation. The role of 
Tm5NM1-containing actin filaments was investigated in knock-out, knock-
down, and overexpression model systems. Our data show that embryonic 
fibroblasts (MEFs) isolated from Tm5NM1/2-knockout mice have an 
impaired rate of proliferation in response to growth factor stimulation. This 
is accompanied by a dysregulation of MAPK signalling (phospho-ERK1/2) 
and decreased expression of the key G1-phase mediator, Cyclin D1. 
Neuroblastoma SHEP cells treated with siRNA against Tm5NM1/2 also 
have reduced proliferation rates and decreased Cyclin D1 expression. In 
comparison, Tm5NM1-overexpressing neuroblastoma-derived B35 cells 
display accelerated proliferation, and reduced propensity to withdraw from 
the cell cycle when treated with differentiation factors. These data suggest 
that actin-filaments containing Tm5NM1 mediate G1 phase progression, 
potentially via controlling the fidelity of signalling through the ERK/MAPK 
pathway. This indicates that Tm5NM1 has potential as a novel anti-
proliferative therapeutic target. 
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The retinoblastoma protein (pRB) is a well-known regulator of progression 
through G1 of the cell cycle. Recently, we uncovered a role for pRB that is 
critical for mitotic chromosome condensation, independent of G1 to S-
phase regulation. Condensation and segregation of mitotic chromosomes is 
a critical process for cellular propagation and in mammals, mitotic errors 
can contribute to cancer pathogenesis. Therefore, we investigated whether 
this novel role of pRB in mitosis contributes to its role as a tumor 
suppressor using mice with a defective pRB-LXCXE binding cleft 
(Rb1ΔL/ΔL).  
 
By means of video microscopy, we investigated the role of pRB in mitosis. 
Rb1ΔL/ΔL mouse embryonic fibroblasts (MEFs) exhibit a delay in initiating 
anaphase, a significantly wider metaphase plate, and an increased frequency 
of lagging chromosomes. Interestingly, similar phenotypes were observed 
in wild type MEFs with defective Condensin II. Accordingly, we 
demonstrate pRB association with Condensin II on chromatin. Thus 
chromosome condensation facilitated by pRB is important for faithful 
chromosome segregation.  
 
To investigate whether Rb1ΔL/ΔL contributes to tumorigenesis, we crossed 
Rb1ΔL/ΔL mice with Trp53+/- and -/- mice. Cancer prone Trp53-/- mice 
succumb to more aggressive cancers, with an increase in the frequency of 
whole chromosome and localized gains and losses. As well, mutant pRB 
accelerates loss-of-heterozygosity, leading to earlier tumor formation, in 
Trp53+/- mice. Therefore pRB’s ability to condense chromosomes is an 
important aspect of pRB-mediated tumor suppression.  
 
By utilizing Trp53-/- mice, we bypassed G1 to S-phase regulation and were 
able to study pRB in mitosis alone. We were also able to demonstrate an 
association of pRB with Condensin II, which helps facilitate chromosome 
condensation. These data reveal a new mechanism of tumor suppression, 
facilitated by pRB, in which genome stability is maintained by proper 
condensation of mitotic chromosomes. 
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The DNA damage response (DDR) is a protein kinase cascade that 
orchestrates DNA repair processes via transcriptional and post-translational 
mechanisms. Cell cycle arrest is a hallmark of the DDR. We performed a 
high throughput, genome-wide, image-based siRNA DDR screen and 
uncovered a critical role for homologous recombination (HR) proteins and 
of Fanconi Anemia proteins in the maintenance of prolonged cell cycle 
arrest and to prevent massive genomic instability. Over 100 high scoring 
DDR candidate genes were interrogated with >7 siRNA per gene for their 
role in the DDR. Of these we identified a novel protein RHINO that is 
recruited to DNA damage sites independently of H2AX. RHINO exists in 
complex with Rad18 and Ubc13 as well as the Rad9-Rad1-Hus1 clamp (9-
1-1) and TopBP1. RHINO is recruited to sites of DNA damage by the 9-1-1 
complex and is required for a subset of HR events in a pathway parallel to 
or downstream of Rad51. RHINO acts to promote cell cycle arrest 
independently of Chk1 and represents a new arm of DDR signaling 
emanating from the Rad17/9-1-1 sensor of DNA damage. 
*Authors contributed equally  
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During the G2 phase of the cell cycle, the Aurora-A kinase plays an 
important role in centrosome maturation and progression to mitosis. In this 
study, we show that Aurora-A expression is downregulated in response to 
topoisomerase I inhibition. Using chromatin immunoprecipitation assays, 
we have observed that the Myc transcription factor and its Max binding 
partner are associated with the Aurora-A promoter during the G2 phase of 
the cell cycle. RNA interference experiments indicated that Myc is 
necessary for the activation of the Aurora-A gene. Following topoisomerase 
I inhibition, the expression of Myc decreased whereas Mad was 
upregulated, and the association of Myc and Max with the promoter of the 
kinase was inhibited. In parallel, an increased association of Miz-1 was 
detected on DNA, associated with an inhibition of the recruitment of 
transcriptional coactivators. Further confirming the link between Myc and 
Aurora-A, these two proteins were found to be overexpressed in tumor 
samples isolated from colorectal cancers and this was associated with an 
increased genomic instability and a decreased expression of Miz, Mad and 
p21waf1 mRNAs.  
These results suggest a model by which the Aurora-A gene is inactivated by 
the G2 checkpoint following topoisomerase I inhibition. We propose that 
the overexpression of the Myc-Aurora-A pathway together with a 
downregulation of Mad and Miz-1 could be used as a prognosis signature of 
poor responses to topoisomerase I inhibitors. 
 
 
J.C and S.C contributed equally to this work. 
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Synthesis and accumulation of conserved regulators, such as cyclins, 
promote cell cycle progression in most eukaryotes. When cells at different 
stages of the cell cycle are fused to form heterokaryons, the complement of 
regulators, which shuttle between the nucleus and cytoplasm, induce the 
nuclei to become synchronized. Exceptions to this paradigm are 
multinucleate fungi or multinucleate cells triggering cell cycle checkpoints, 
which often display asynchronous nuclear division among nuclei in a shared 
cytoplasm. To study the cell biological basis for nuclear autonomous 
division in a common cytoplasm, we are using a model multinucleate 
fungus, Ashbya gossypii, which is highly related to S. cerevisiae (95% of 
genes are homologous and syntenic). Notably, each nucleus within an 
Ashbya cell divides asynchronously despite access to a shared cytoplasm. 
Using this model system, we are investigating if asynchrony in cell cycle 
progression within a syncytium is programmed by the cell cycle machinery 
or is a result of molecular noise. To address this, we tracked nuclear 
division timing for sister nuclei born from one mitosis event using 4D-
fluorescence microscopy. We then used statistical modeling to determine 
the relationship between sister division times. We found a positive 
association in division times indicating that sister nuclear division times are 
more closely related to one another than to the overall population of nuclei 
within the cell. One explanation for this relationship is that some nuclear 
feature (size, regulatory protein concentration, etc.) varies substantially 
between mitotic nuclei. This leads to similar sister timing but highly 
variable timing differences in the whole population of nuclei. To begin to 
test this, we looked at nuclear size and its relationship to cell cycle 
progression. We observed that nuclear volume at birth is highly variable 
(2.6 ± 1.1 μm3) and that small nuclei have longer nuclear division times. In 
addition, as with nuclear division time, sister nuclei are more similar in size 
to each other than the overall population. This indicates that nuclear size 
can influence division time even among nuclei within a common cytoplasm. 
However, nuclear volume immediately preceding mitosis is highly variable 
(5.6 ± 1.9 μm3) suggesting there is not an absolute size threshold that 
triggers division. In this work, we have demonstrated that nuclear size 
influences cell cycle progression of nuclei within a common cytoplasm. 
Variable nuclear size may be a conserved feature that promotes 
heterogeneous cell cycle behavior in a population of genetically identical 
CELLS. 
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Accurate progression through the cell cycle depends on the timely synthesis 
and destruction of a myriad of proteins. Recently it was discovered that the 
proteolysis of a small set of proteins is coupled directly to DNA synthesis 
occurring during S phase or DNA repair. We have shown that one of these 
proteins is the Drosophila melanogaster transcription factor E2f1, a 
member of the E2F family of transcriptional activators that plays a pivotal 
role in the G1-S transition. Like mammalian E2Fs, E2f1 is inhibited prior to 
S phase via interaction with the retinoblastoma protein (pRb) homolog, 
Rbf1. Activation of cyclin-dependent kinases during G1 results in hyper-
phosphorylation of Rbf1, thereby relieving E2f1 repression and activating a 
transcription program that promotes entry into S phase. E2f1 is then rapidly 
destroyed during S phase. We hypothesize that S phase-specific destruction 
provides an important Rbf1-independent negative regulation of E2f1 that is 
essential for normal cell cycle progression. S phase-specific destruction of 
E2f1 requires a PCNA interacting protein (PIP) box-containing degron in 
the E2f1 NH2-terminus and the CRL4Cdt2 E3 ubiquitin ligase complex. 
Current models suggest that PIP degrons direct proteins to replication fork 
associated PCNA and that this interaction promotes ubiquitylation by 
CRL4Cdt2 and subsequent proteolysis by the 26S proteasome. This results in 
an elegant mechanism for coupling protein destruction with ongoing DNA 
replication. We will present data investigating which biochemical activities 
of E2f1 (e.g. DNA binding, Dp binding) are required for this destruction 
mechanism as well as the biological consequences of improper regulation of 
E2f1 abundance during the cell cycle. We have shown that expression of a 
mutant version of E2f1 lacking a functional PIP box (E2f1PIP3A) in 
proliferating cells results in E2f1 accumulation during S phase, reduction of 
G1 length, and apoptosis. Our data indicate that S phase-coupled 
destruction of E2f1 and the induction of apoptosis by E2f1PIP3A occur 
independent of E2f1’s DNA binding domain. This result suggests that 
destruction during S phase inhibits an activity of E2f1 that cannot be 
achieved by removal of E2f1 from chromatin. We are testing this 
hypothesis in part by inducing destruction of E2f1 during mitosis rather 
than S phase and determining if this will relieve the phenotypic 
consequences (e.g. apoptosis) of E2f1PIP3A expression. We conclude that 
carefully regulated S phase-coupled proteolysis of E2f1 is essential for 
normal cell cycle progression. 
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Chromosomal translocations are closely associated with the development of 
acute leukemia and analysis of these translocations has led to the discovery 
of molecules that play important roles in the regulation of both growth and 
differentiation. One of the most common targets of chromosomal 
translocations in acute myeloid leukemia is the Myeloid Translocation Gene 
on Chromosome 8 (MTG8, also known as ETO). MTG8 is targeted by the 
t(8;21), which results in the fusion of the DNA binding domain of RUNX1 
to nearly all of MTG8. Germline deleted Mtg8-null mice displayed aberrant 
gut architecture, which was suggested to be due to a mesenchymal defect. 
Due to the mesenchymal defects in these null mice, we examined mouse 
embryonic fibroblasts (MEFs) derived lacking Mtg8. Using RT-PCR, we 
found that found that Mtg8 was expressed in both the wild type and 
heterozygous MEFs, but there was no discernible expression of Mtg8 in the 
null MEFs. We then measured cell proliferation and found that Mtg8-null 
cells grow at a slower rate than heterozygous or WT MEFs. FACS analysis 
using Propidium Iodide stained MEFs indicated a marked accumulation of 
cells with 4N DNA content, suggesting a checkpoint slowing G2/M 
progression in the Mtg8-null cells. These cell cycle defects prompted an 
assessment of the DNA damage response. 53BP1 and phosphorylated 
H2AX (γH2AX) are located at the sites of DNA double strand breaks as 
part of the DNA damage response. Anti-53BP1 and anti-γH2AX were used 
in immunofluorescence analysis on the MEFs. Significantly more 53BP1 
and γH2AX foci were detected in Mtg8-null MEFs compared to WT MEFs. 
Interestingly, Mtg8-null MEFs were protected from DNA damage when 
quiescent due to serum starvation, suggesting that the DNA damage 
occurred during DNA replication. Our work points to a cell cycle defect in 
Mtg8-null MEFs, and identifies a role for Mtg8 in S-phase progression and 
DNA damage control.  
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Abscission, the final step of cytokinesis, resolves the plasma membrane of 
the two daughter cells leading to their final separation. This process is 
regulated by the NoCut checkpoint in yeast and in mammalian cells. 
NoCut-dependent regulation of abscission prevents premature daughter cell 
separation and DNA damage. In yeast, the NoCut checkpoint depends on 
the activity of the Aurora B kinase Ipl1 and the two anillin-related proteins 
Boi1 and Boi2. Activation of Ipl1 at the midzone leads to Boi1 and Boi2 
shuffling from the nucleus to the bud neck and results in abscission 
inhibition. Here we report the identification of the Rho-GEF Tus1 , the 
Rho-GTPase Rho2 and the Tus1-interacting protein Cyk5 as new players of 
the abscission pathway. Furthermore, we show that Tus1 and Cyk5 are 
displaced from the bud neck, the site of cytokinesis, upon NoCut activation. 
Out of the 5 yeast Rho GTPases, Rho1, Rho2 and Rho4 localize to the bud 
neck in late mitosis. Deletion of Rho2 specifically impaired abscission, 
mapping Rho2 to the abscission pathway. Our data indicate that the NoCut 
checkpoint inhibits abscission through displacement of Tus1 and Cyk5 from 
the site of cytokinesis and thereby keeping Rho2 inactive. Accordingly, 
expression of a Rho2-GTP locked protein bypasses NoCut activation and 
permits cells to undergo abscission even in the presence of chromosome 
segregation defects. Thus, our data show that the Rho2 pathway is a key 
regulator of abscission and the major target of the NoCut checkpoint. 
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At the center of every chromosome is a region of immense importance and 
mystery, the centromere. This structure is both maintained and defined by a 
centromere-specific histone 3 variant (CenH3). CenH3s possess both a 
highly divergent sequences across different species, and are incorporated in 
a replication independent fashion. Replacing the canonical histone 3 in large 
alternating domains at the centromere, many questions still remain about the 
dynamics of CenH3 across the cell cycle, structure of the nucleosomes 
CenH3s are incorporated into, and how CenH3 serves as a platform to 
recruit kinetchore proteins. Here we propose through the use Acceptor-
Photobleaching Förster Resonance Energy Transfer (AP-FRET) the 
studying the dynamics of CenH3 will serve as a useful tool in pursuing the 
answers to these and additional questions. Our results with AP-FRET in 
HeLa cells, show that CenH3 possesses a unique dynamics when compared 
to canonical H3 across a variety of conditions. These results also serve as a 
proof of principle for the further use of AP-FRET in the study of 
centromeric chromatin dynamics. 
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Growth, proliferation and differentiation of cells depend on many inputs, 
including diet. In multicellular organisms, the effects of diet are mediated 
by circulating factors that impact many cells simultaneously. Yet, an 
intriguing question is how such systemic, nutrient-dependent factors elicit 
specific responses in different cells, even within the same tissue. We 
previously showed that germline stem cells (GSCs) and follicle stem cells 
(FSCs) and their progeny in the Drosophila ovary respond to diet via insulin 
signals. Insulin signals directly modulate the GSC cell cycle at the G2 
phase, and they also control the division and growth of their progeny. 
Additional factors, however, also contribute to the dietary control of 
oogenesis. Target of Rapamycin, or TOR, is part of a highly conserved 
nutrient-sensing pathway affecting growth, proliferation, survival, and 
fertility. Our recent unpublished studies show that TOR promotes GSC 
proliferation via G2 but independently of insulin signaling, and that TOR is 
required for the proliferation, growth and survival of differentiating germ 
cells. We also found that TOR activity modulates the proliferation of FSCs 
but, surprisingly, not of their dividing progeny, indicating specificity in the 
control of the stem cell cycle by TOR in the ovarian somatic lineage. TOR 
controls follicle cell number instead by promoting survival, independently 
of either the apoptotic or autophagic pathways. In addition, TOR controls 
the switch of follicle cells from mitotic divisions to the endoreplication 
program. These results uncover specific TOR functions in the control of 
stem cells versus their differentiating progeny, and reveal parallels between 
Drosophila and mammalian follicle growth. 
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Eukaryotic cells respond to DNA damage by recruiting a large number of 
DNA repair proteins and checkpoint signaling proteins to sites of DNA 
damage on chromatin. The local concentrations of these proteins often reach 
high enough level to form so-called DNA damage-induced nuclear foci that 
are visible by microscopy. 
 
Based on the premise that proteins localizing to sites of DNA damage are 
likely to play a role in DNA damage response, we have set up a system to 
visually screen for proteins involved in DNA damage response. A plasmid 
library expressing fission yeast ORFs fused with the yellow fluorescent 
protein (YFP) allows us to inspect the localization of each individual fission 
yeast protein. By engineering a fission yeast strain with a LacO repeat 
inserted next to an HO endonuclease cleavage site, we can simultaneously 
visualize the sub-nuclear location of the HO-induced DNA double-strand 
break (DSB) and the spatial distribution of the protein expressed from the 
library plasmid. We have screened nearly all 5000 proteins in the fission 
yeast proteome and identified 55 proteins that colocalize with the DSB 
markers. To our satisfaction, proteins known to act in DNA damage 
response are highly enriched in our screen hits. About one third of the 
screen hits have not been previously characterized. Many of these novel 
DNA damage response proteins are conserved in humans. In-depth analyses 
of the relocalization patterns of these proteins and the phenotypes of the 
corresponding deletion mutants have provided useful clues to their 
functions at DSBs. 
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Cultured normal human cells have a limited lifespan of ~50 doublings. 
These cells gradually enlarge as they age and lose their replicative potential. 
However, the biological relevance of the relationship between cell size and 
replicative potential is not well understood, and a causal role for size in 
cellular aging remains to be established. Deletion of many genes involved 
in ribosome biogenesis and cell growth convey a long-life phenotype on 
cells. Because we fortuitously noticed that many longevity genes 
concomitantly affect cell size, we have re-examined the potential linkage 
between cell size and lifespan. In yeast, many genes that encode ribosome 
proteins are present in duplicate pairs. Strikingly, deletion of only one gene 
of the pair results in small, long-lived cells. Moreover, long life nearly 
always correlates with reduced cell size. Therefore, we have tested the 
hypothesis that size determines cellular lifespan. Herein, we report that, 
regardless of birth size, yeast cells grow steadily with age and enter 
senescence at relatively constant cell size. Subsequently, lifespan is 
abnormally short in large cells. Moreover, mutations that increase cell size, 
decrease lifespan and vice versa. In addition, interestingly, deletion of 
protein components of the telomerase enzyme (e.g. est1 and est2 mutants) 
leads to abnormally large short-lived cells. Furthermore, epistatic 
interactions reveal that size per se modulates cellular lifespan. For example, 
induction or selection of abnormally large cells dramatically reduces 
cellular lifespan even in small cell mutants. In addition, nutrient starvation 
reduces the size and extends the lifespan of large cell mutants. Moreover, 
this ability is wholly dependent upon cell size effects. In examining a large 
number of mutants, we find that cell size modulates growth rate. In general, 
small cells grow slowly and vice versa. Subsequently, the rate at which cells 
increase in size over their lifetime determines cellular lifespan. Because 
both nutrients and specific genetic pathways regulate this rate, we conclude 
that size has an integral role in the control of cellular lifespan. 
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The anaphase promoting complex (APC) is a multisubunit ubiquitin E3 
ligase essential to cell cycle regulation. The CDC26 subunit was previously 
shown to have a role in APC assembly, but its precise molecular function 
remained unclear. Our studies revealed that CDC26 stabilizes the structure 
of APC6, a core TPR protein essential for APC integrity and function. The 
TPR domain of APC6 coils around the rod-like N-terminus of CDC26, as 
seen in the crystal structure of a proteolytically derived complex, CDC26N-
APC6TPR. CD analyses demonstrated that a CDC26-APC6 complex is 
structurally more stable than APC6 alone. Moreover, the N-terminal region 
of CDC26 (CDC26N) is sufficient to impart increased structural stability to 
APC6 in vitro and also rescues the temperature-sensitivity of a cdc26Δ 
yeast strain. Mutations predicted to disrupt the CDC26-APC6 interaction 
eliminate this rescue. Thus, the CDC26N-APC6TPR crystal structure reveals 
a protein-protein interaction critical to APC architecture. 
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MEC1, the essential yeast ATR/ATM homolog, controls the S phase 
checkpoint and prevents replication fork collapse at slow zones of DNA 
replication. MEC1 is required for increasing deoxynucleoside triphosphate 
(dNTP) levels in S phase, which involves the degradation of Sml1, a 
negative inhibitor of ribonucleotide reductase (Rnr). The growth of some 
hypomorphic mec1 mutants, is severely compromised in rad52 mutants, 
deficient in double-strand break repair, suggesting that replication fork 
collapse or incomplete replication generates recombinogenic lesions. We 
previously observed a six-fold, tenfold and 30-fold higher rate of 
spontaneous sister chromatid exchange (SCE) , heteroallelic recombination, 
and translocations, respectively, in mec1-21 mutants compared to wild type. 
Here we report that TEL1, MRE11, and RAD50 are also required for the 
hyper-recombination phenotype, suggesting that TEL1 promotes 
recombinational repair when replication forks collapse. The hyper-
recombination phenotype correlates with lower dNTP levels, compared to 
wild type. By introducing a dun1 mutation and eliminating inducible 
expression of RNR in mec1-21, rates of spontaneous SCE were increased 
15-fold above wild type. The hyper-recombination phenotypes of both 
mec1-21 and mec1-21 dun1 were suppressed by SML1 deletions, which 
increased dNTP levels. Measurements of each dNTP indicted that, 
compared to wild type, there was a significant decrease in basal dNTP 
levels in mec1-21 and mec1-21 dun1, while the basal dNTP levels of mec1-
21 sml1, mec1-21 dun1 sml1, and sml1 mutants were similar and about two-
fold higher than wild type. Interestingly, higher levels of dNTPs in mec1-21 
dun1 sml1 correlate with two-fold higher levels of spontaneous 
mutagenesis, compared to mec1-21 dun1. Thus , compared to wild type, 
more homologous recombination occurs in mec1-21, which correlates with 
lower dNTP levels. We suggest that higher dNTP levels in specific 
checkpoint mutants suppress the formation of recombinogenic lesions and 
instead promote error-prone replication.  
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Nearly 15 years ago, we proposed a quantitative model explaining how 
variations in activity of a single CDK through the cell cycle maintain the 
dependency of mitosis on DNA replication, and vice versa (Fisher & Nurse, 
1996). The molecular basis for the model is now known: low CDK activity 
is required for origin licensing, moderate CDK activity promotes formation 
of pre-initation complexes and replication initiation, and high activity 
triggers a feedback-dependent switch ensuring unidirectionality of the 
G2/M transition. Recently, using Xenopus egg extracts, we found that, 
unlike M-phase, there is no such switch-like behaviour in CDK-mediated 
control of S-phase (Krasinska et al, 2008). We hypothesized that PP2A 
activity might explain the different dynamic behaviour of CDK-mediated 
control of S-phase and M-phase, since active PP2A prevents mitosis onset 
(Mochida et al, 2009) but is required to replicate DNA by loading CDC45 
onto replication origins (Chou et al, 2002) – the same step at which CDKs 
act. Here, we find that mitosis and S-phase onset are controlled by an 
equilibrium between CDK activity and PP2A activity. This equilibrium is 
modulated by a checkpoint stimulated by unreplicated DNA. If PP2A is 
inhibited, switch-like behaviour at mitosis onset is abolished, and CDK 
activity is integrated over time to promote mitosis onset. However, PP2A is 
required for DNA replication independently of its role in preventing mitosis 
onset. These results show that the dynamic cell-cycle response to CDK 
activity is interpreted in the context of opposing phosphatases, which 
ultimately maintain the temporal order of S-phase and mitosis. 
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Studies on monopolar spindles have taught us a lot about the forces 
involved in bipolar spindle formation during mitosis. Eg5 is a kinesin which 
is essential for bipolar spindle formation. Its inhibition results in star-shaped 
monopolar spindles. Recently, it was shown that depletion of the molecular 
motor dynein, an antagonist of Eg5, rescues the formation of bipolar 
spindles in cells with reduced Eg5 activity. 
We performed an RNAi screen and found that depletion of chTOG, a 
known microtubule (MT) associated protein, can rescue inhibition of Eg5 as 
well. Consistent with its role as a microtubule stabilizer, the depletion of 
chTOG results in the formation of shorter than normal, often multipolar 
spindles. To understand how depletion of chTOG is able to separate spindle 
poles when Eg5 is inactive we followed spindle formation in such cells. 
Eg5-inhibited cells normally enter mitosis with two unseparated 
centrosomes which correspond to the microtubule organizing centers 
(MTOCs). Intriguingly, upon chTOG depletion, we found that (i) cells 
entered mitosis with more than two separated MTOCs which (ii) were 
organized into bipolar spindles in an Eg5-dependent manner. To understand 
if other perturbations of MT dynamics can have the same effect, we tried to 
rescue Eg5 inhibition with MT drugs nocodazole and taxol. Treatment with 
nocodazole was able to rescue bipolar spindle formation in HeLa and BSC-
1 cells. The rescue worked only if nocodazole was added before entry into 
mitosis. Thus, our data demonstrate that altered microtubule dynamics can 
rescue loss of Eg5.  
To our knowledge, we show for the first time that depletion of nonmotor 
proteins and changes in MT dynamics can rescue inhibition of Eg5. 
Changes in MT dynamics might lead to fragmentation of MTOCs shortly 
before mitosis or they might favor spontaneous MT nucleation at multiple 
sites and thus substitute for separated spindle poles. We are currently trying 
to understand the precise mechanism by which changes in MT dynamics 
can lead to formation of multiple MTOCs by analyzing how these are 
related to centrosomes. 
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The critical event of mitosis is the synchronous and equal segregation of 
sister chromatids to opposite poles of the cell. The Anaphase-Promoting 
Complex or Cyclosome (APC) is an E3 ubiquitin ligase that initiates 
anaphase by catalyzing the attachment of ubiquitin to key mitotic 
regulators, targeting them for destruction by the proteasome. APC activity 
requires association with the activator subunit Cdc20 at the metaphase-to-
anaphase transition and Cdh1 in late mitosis and G1. Cdc20 function is 
regulated through its abundance, with a transcriptional peak in early mitosis 
and APC-dependent destruction in late mitosis by two mechanisms: Cdc20-
dependent autoubiquitination and Cdh1-dependent ubiquitination. In this 
work, we addressed the significance of Cdc20 destruction in budding yeast 
by making Cdc20 mutants that cannot be ubiquitinated. We began by 
making a yeast Cdc20 mutant in which all 39 lysines are changed to 
arginines (K0 mutant). The K0 mutant is viable at 22°C, but not at 37°C, 
and is nonfunctional in vitro. To generate a more conservative non-
ubiquitinatable version of Cdc20, we analyzed the importance of lysines in 
different regions of Cdc20. We found that most Cdc20 ubiquitination in 
vitro is abolished by mutation of 9 lysines in an N-terminal 60 amino acid 
region, with some contribution from a single lysine in the C-terminal WD40 
domain. Mutation of these ten lysines (K29 mutant) blocks all 
ubiquitination in vitro. We also identified a non-ubiquitinatable mutant (K5 
mutant) that contains only five lysines in the WD40. Replacement of the 
wildtype copy of Cdc20 with the K29 or K5 mutant is not lethal, and both 
proteins are fully functional as activators in vitro. Overexpression of these 
mutants is lethal, and we are currently analyzing specific cell cycle defects 
in cells expressing these mutants under normal CDC20 transcriptional 
control. 
 56 
CELL CYCLE PROGRESSION REQUIRES THE CDC-48UFD-1/NPL-4 
COMPLEX FOR EFFICIENT DNA REPLICATION 
 
Andre Franz1,2, Julien Mouysset3, Alexandra Deichsel3, Remi Sonneville4, 
Anton Gartner4, Thorsten Hoppe1,2  
 
1University of Cologne, Institute for Genetics, Zuelpicher Srasse 47, 
Cologne, 50674, Germany, 2University of Cologne, Cologne Excellence 
Cluster on Cellular Stress Responses in Aging-Associated Diseases 
(CECAD), , Zuelpicher Srasse 47, Cologne, 50674, Germany, 3University 
of Hamburg, Centre for Molecular Neurobiology (ZMNH), Falkenried 94, 
Hamburg, 20251, Germany, 4 University of Dundee, College of Life 
Sciences, Wellcome Trust Centre for Gene Regulation and Expression, 
Dow Street, Dundee, DD1 5EH, United Kingdom 
 
Dividing cells have to ensure correct duplication and propagation of their 
genomic information to the daughter cells. Therefore, DNA replication and 
separation of sister chromatids are tightly controlled processes central for 
all eukaryotes. Our laboratory identified CDC-48 to play a crucial role 
during cell cycle progression in Caenorhabditis elegans. CDC-48 is a 
ubiquitin-selective chaperone with fundamental functions in diverse cellular 
pathways. Association with the cofactors UFD-1 and NPL-4 is essential for 
the cell cycle-related function of CDC-48. Consequently, depletion of the 
CDC-48UFD-1/NPL-4 complex by RNAi causes defects in the cell division 
cycle and chromatin structure. The cell cycle-delay of embryos lacking the 
CDC-48UFD-1/NPL-4 complex is suppressed by co-depletion of the S-Phase 
checkpoint kinases ATL-1/CHK-1. Moreover, chromosomal bridges 
between separating sister chromatids in anaphase and focal accumulation of 
the DNA repair protein RAD-51 indicate a crucial function of CDC-48 in 
the regulation of DNA replication. 
Currently, we analyze reporter strains expressing GFP-fusions of replication 
factors recapitulating distinct steps of DNA replication. The comparison of 
replication factor dynamics of RNAi-depleted to wild type embryos will 
provide detailed insight into the role of the CDC-48UFD-1/NPL-4 complex in 
cell cycle regulation. Furthermore, biochemical and genetic approaches 
have been initiated to identify additional targets. 
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MicroRNAs play roles in various biological processes, including cell 
proliferation, differentiation, and apoptosis. As these processes are 
implicated in a wide range of diseases, microRNAs are being studied to 
both understand the disease process, and as potential tools and targets for 
treatments. The E2F transcription factors are important regulators of cell 
proliferation and apoptosis while their deregulated activity is thought to 
drive proliferation in tumor cells. Curiously, the miR-11 microRNA is 
located within an intron of the Drosophila de2f1 gene. In order to 
understand a relationship between miR-11 and its host gene de2f1, we have 
generated a miR-11 mutant using homologous recombination. The miR-11 
mutant allowed us to study contribution of the microRNA to cellular 
function of de2f1. 
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The spindle assembly checkpoint (SAC) regulates passage through mitosis 
and represents a critical point of regulation that ensures the accurate 
segregation of the newly replicated genome. The kinetochore and 
centromeric regions of chromosomes govern this process in a complex 
structural and signalling hierarchy. An active SAC will arrest cells in 
mitosis and involves the recruitment of various factors to the chromatin and 
the downstream post-translational modification of SAC signalling factors.  
 
The Xenopus leavis cell free extract system is an ideal platform from which 
to identify novel players in SAC signalling and mitotic regulation since 
chromatin and proteins can be easily purified in large quantities. More 
importantly replicating chromatin can be added to actively cycling extracts, 
which can be manipulated by DNA damaging agents or drugs that cause 
defined perturbations to cell cycle progression. Using mass spectrometry 
analysis we examined the dynamics of proteins recruited to chromatin in the 
event of SAC activation. Here we present data from this study that reveals a 
mechanism by which the ATM dependent DNA damage checkpoint may 
converge with the spindle assembly checkpoint to regulate mitosis. 
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Successful segregation of chromosomes during mitosis requires the 
establishment of a bipolar spindle. Bipolar spindle formation relies on both 
microtubule dynamics and sliding, as depletion or inactivation of kinesin 
motor proteins Eg5 or Kif2A leads to monopolar spindles. To identify novel 
genes involved in spindle morphology, we utilized the gene expression 
profile of cycling HeLa cells and hierarchical clustering. Several 
uncharacterized genes were identified that show peak expression during 
G2/M phase and are co-expressed with genes known to function in 
establishing the mitotic spindle. Here, we use siRNA, epitope-tagging, fixed 
and live cell fluorescence imaging, and co-immunoprecipitations followed 
by mass spectrometry to examine the function of one candidate gene, 
Fam64A, in HeLa cells. Database queries for Fam64A show no known 
protein domains in the predicted protein sequence, and no sequence 
similarity to other human genes. The protein has uncharacterized orthologs 
in placental mammals. FAM64A is cell cycle-regulated at multiple levels. 
The mRNA shows periodic expression during the cell cycle with peak 
expression in G2/M phase. FAM64A protein is degraded by the proteasome 
at anaphase onset and during G1 phase, which is inhibited by the addition of 
MG132. Depletion of FAM64A using three independent siRNAs results in a 
10-fold increase in the number of mitotic cells exhibiting monopolar 
spindles. Expression of a non-siRNA targetable FAM64A-GFP construct 
results in a partial rescue of the monopolar defect, suggesting the phenotype 
is not an off-target effect. The FAM64A-GFP fusion protein localizes to the 
nucleus during interphase and to the cell cortex in mitosis. The inability to 
detect spindle localization suggests FAM64A contributes to spindle 
bipolarity through mechanisms that are independent of other motors like 
Eg5 and Kif2A. Analysis of GFP-FAM64A binding partners by co-
immunoprecipitation shows that it interacts with Borealin, AurKB, 
Survivin, INCENP and recovers endogenous FAM64A. Therefore, 
FAM64A may be a novel member of the Chromosomal Passenger 
Complex. 
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The irreversible step of sister chromatid separation at anaphase is regulated 
by the spindle assembly checkpoint (SAC) which monitors microtubule 
attachments to each and every kinetochore. Once all sister chromatids have 
formed bipolar attachments to the mitotic spindle, the anaphase promoting 
complex (APC) ubiquitylates substrates including cyclin B and securin, 
triggering their degradation and promoting sister chromatid separation by 
the activation of the cysteine protease separase. Securin is the inhibitory 
chaperone for separase which cleaves a subunit of the cohesin complex, 
dissolving the molecular glue holding sister chromatids together and thus 
allowing for their separation at anaphase. The inactivation of securin in 
budding yeast results in the early activation of separase and the separation 
of sister chromatids prior to bipolar attachment to the spindle. Additionally, 
securin is involved in a positive feedback loop involving its 
phosphorylation by cdc2/cyclin B providing for its rapid degradation upon 
satisfaction of the SAC. This feedback loop in budding yeast results in the 
switch-like behavior observed as the synchronous separation of sister 
chromatids at the onset of anaphase. In metazoans however, separase 
activity is also inhibited by phosphorylation by, and direct binding of, 
cdc2/cyclin B exclusive of securin binding. To explore securin regulation of 
separase activity at anaphase, a system in which securin is essential for 
efficient anaphase has been established. Retinal pigment epithelial cells 
immortalized with human telomerase (RPE1-hTERT) in which hSecurin 
can be conditionally inactivated have been generated. Within 48 hours of 
cre-mediated recombination, securin protein is lost, followed by the 
depletion of separase protein. These cells are unable to undergo multiple 
cell divisions and instead display a senescent phenotype. Efficient sister 
chromatid separation is largely absent as demonstrated by time-lapse 
microscopy and immunofluorescence of molecular markers of anaphase. 
Securin is therefore necessary for faithful chromosome segregation in non-
transformed human somatic cells and this provides a sensitized system in 
which to probe the function and post-translational regulation of securin 
during mitosis. 
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In the budding yeast S. cerevisiae completion of mitosis is controlled by a 
signal transduction cascade called the Mitotic Exit Network (MEN) that 
ultimately activates Cdc14 and inhibits CDK. Tem1, a small G-protein, is at 
the top of MEN and is negatively regulated by the two-component GAP 
Bfa1/Bub2. Lte1 promotes MEN activity but its molecular role remains 
unclear. Lte1 is a daughter-specific protein with a complex pattern of cell 
cycle-dependent phosphorylation. It contains a GEF-like domain and it was 
proposed to act directly on Tem1 as GEF but no biochemical evidence 
supports this model. Recently we described a role of Lte1 in controlling 
polarisome behaviour. Here we show that Lte1 controls cell polarization by 
inhibiting Ras and Bud1. Binding to and inhibition of Ras and Bud1 are cell 
cycle - dependent and rely on a complex Lte1 phosphorylation pattern 
determined by sequential steps of Cla4 and Clb/CDK activities. Cla4-
dependent phosphorylation is essential to increase Lte1 affinity for the 
polarisome and is a prerequisite for the subsequent Clb/CDK-dependent 
phosphorylation that increases the affinity for Ras. The importance of the 
regulation of Ras binding is demonstrated by the localization of the Lte1-8N 
allele that has lost the daughter specificity because is constantly bound to 
Ras. Importantly, over-expression of Lte1-8N leads to a Ras-dependent cell 
cycle arrest in G1, suggesting that once bound to Ras, Lte1 inhibits it. 
Mitotically arrested lte1Δ cells develop hyper-polarized buds, this 
phenotype can be suppressed by deletion of BUD1. Bud1, a small G-protein 
with high homology with Ras, is implicated in bud site selection. We show 
that Bud1 can also interact with Lte1 and we propose that, like Ras, Lte1 
binds and inhibits Bud1, contributing to the restriction of cell polarization in 
G2/M. 
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BACKGROUND & AIMS: Protein Tyrosine Kinase 6 (PTK6) is an 
intracellular tyrosine kinase that promotes epithelial cell differentiation and 
cell cycle exit in the normal intestine. However, following DNA damage, 
PTK6 is induced in proliferating crypt epithelial cells where it promotes 
apoptosis by inhibiting prosurvival signaling pathways. The tumor 
suppressor protein p53, which is frequently mutated in colon cancer, also 
plays a key role in DNA-damage induced apoptosis in the intestine. The aim 
of our study was to examine cross talk between PTK6 and p53 and 
determine contributions of PTK6 to p53-dependent and independent DNA-
damage induced apoptosis. METHODS: Isogenic HCT116 p53+/+ and p53-
/- cells were subjected to 20 Gy of gamma-irradiation and harvested at 0, 3, 
6, 24, 48, and 72 hours. Expression of PTK6, p53, p21, cleaved caspase-3, 
and beta-actin was examined by immunoblotting. Expression of mRNAs 
encoding PTK6 and the well-characterized p53 target gene p21 was 
examined by qRT-PCR. RESULTS: Irradiation led to rapid accumulation of 
wild type p53 protein in HCT116 p53+/+ cells and activation of the p53 
target gene encoding p21 by three hours post irradiation. Induction of PTK6 
was observed by 24 hours, with highest levels at 48 and 72 hours post 
irradiation. While PTK6 was induced in both HCT116 p53+/+ and p53-/- 
cell lines, higher levels of PTK6 protein and mRNA were detected in 
p53+/+ HCT116 cells suggesting a p53-dependent component in PTK6 
induction. However the PTK6 gene does not appear to be a direct target of 
p53. Highest levels of cleaved caspase-3 and apoptosis were detected in 
PTK6 positive p53-/- cells. Stable knockdown of PTK6 in HCT116 p53+/+ 
and p53-/- cells using two different shRNAs led to impaired apoptosis in 
HCT116 p53-/- cells. CONCLUSIONS: PTK6 expression is regulated by 
p53-dependent and independent mechanisms, and PTK6 is positively 
regulated by wild type p53. Expression of PTK6 promotes apoptosis of 
HCT116 p53-/- cells and enhances the response of p53-/- colon tumor cells 
to irradiation. 
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Deregulation of the cell cycle underlies nearly all cancers. To identify novel 
regulators of the cell cycle, we developed a system to monitor cell cycle-
regulated gene expression in real time. We used the LumiCycle system, 
initially developed for analysis of circadian gene expression, to monitor 
luciferase activity driven by either a minimal E2F1 promoter, which has 
peak expression in G1/S, or a basal promoter with six Forkhead DNA 
binding sites (6xDB), which has peak expression at G2/M. After cell 
synchronization, luciferase activity was measured every 10 minutes for up 
to four days, monitoring 3 – 4 synchronous cell cycles in a non-destructive 
manner. Luciferase activity driven by a constitutive SV40 promoter did not 
show periodic expression, whereas the 6xDB reporter showed peak 
expression at G2/M, which coincides with peak protein levels and 
phosphorylation of Forkhead box M1 (FOXM1). The 6xDB construct is 
responsive to FOXM1 induction, and FOXM1 binds to the reporter 
promoter as determined by chromatin IP. To identify other Forkhead box 
transcription factors that regulate the cell cycle, we used siRNAs to screen 
seven Forkhead transcription factors implicated in cell cycle control and 
assayed their effect on periodic gene expression. We identified two 
Forkhead genes FOXJ3, and FOXK1, that ablated cell cycle dependent 
oscillations when knocked down. Knockdown of these genes eliminated 
periodic expression from both the E2F1 promoter and the 6xDB construct, 
suggesting a general effect on the cell cycle. FACS analysis of cells treated 
with siRNAs against these two genes showed an increase in the number of 
cells in G1. Analysis of U2OS cells treated with FOXJ3 and FOXK1 
siRNAs shows decreased cell growth. Therefore, multiple FOX 
transcription factors, in addition to FOXM1, are necessary for proper cell 
cycle progression in human U20S cells. 
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The Anaphase-Promoting Complex or Cyclosome (APC/C) is a major 
ubiquitin ligase complex responsible for cell cycle transitions through 
timely and coordinated degradation of several key cell cycle regulators. 
APC/C activation is mainly ensured by binding with either Cdc20 or Cdh1 
subunits. c-Jun-NH2-terminal Kinase (JNK) is a stress-activated protein 
kinase that plays a central role in the regulation of cellular stress responses 
by controlling cell death and survival pathways. We report here that 
nuclear-localized JNK is degraded by APC/CCdh1 during exit from mitosis 
and G1 phase of the cell cycle. Expression of a non-degradable JNK in cells 
induces prometaphase-like arrest and aberrant mitotic spindle dynamics. 
Strikingly, we also found that JNK directly phosphorylates Cdh1 during G2 
and early mitosis. JNK-mediated phosphorylation of Cdh1 changed its 
subcellular localization, reducing its ability to associate with APC/C core 
components and attenuating the APC/CCdh1-mediated substrate 
ubiquitination during G2-M. The newly identified regulatory mechanism 
between JNK and Cdh1 reveals the role and function of JNK during the cell 
cycle. 
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c-Jun NH2-terminal Kinases (JNKs) play a central role in the cellular 
response to a wide variety of stress signals. Following their activation, 
JNKs induce phosphorylation of substrates which control proliferation, 
migration, survival, and differentiation. Recent studies suggest that JNKs 
may also play a role in cell cycle control, although the underlying 
mechanisms are largely unexplored. Here we show that JNK directly 
phosphorylates Cdc25C at Serine 168 during G2 phase of the cell cycle. 
Cdc25C’s phosphorylation by JNK negatively regulates its phosphatase 
activity and thereby Cdk1 activation, enabling a timely control of mitosis 
onset. Unrestrained phosphorylation by JNK, as obtained by a cell cycle-
stabilized form of JNK or as seen in some human tumors, results in aberrant 
cell cycle progression. Additionally, UV-irradiation-induced G2/M 
checkpoint requires inactivation of Cdc25C by JNK phosphorylation. JNK 
phosphorylation of Cdc25C, as well as Cdc25A, establishes a novel link 
between stress signaling and unperturbed cell cycle and checkpoint 
pathways. 
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Telomeres are essential for genome stability in all eukaryotes. Changes in 
telomere functions and the associated chromosomal abnormalities have 
been implicated in human diseases, such as aging and cancer. Human 
telomeres are regulated by telomerase, a reverse transcriptase that adds 
telomeric TTAGGG repeats onto the 3’ end of chromosomes, and telomeric 
repeat-binding proteins such as TRF1 and TRF2, two double-stranded DNA 
binding proteins. 
 
Tankylase 1 was identified as a TRF1-binding protein, and is a member of 
the PARP family of enzyme. Tankyrase 1 PARsylates its binding partner 
TRF1, and in doing so inhibits TRF1 binding to telomeres, allowing access 
of telomere to telomerase. Thus, tankylase 1 plays as a positive regulator of 
telomere length by antagonizing TRF1. 
 
Our recent approach to identify the interaction partners of polo-like kinase 1 
(Plk1) facilitated by proteomics and subsequent matrix-assisted laser 
desorption ionization-time of flight analyses reveals that tankylase 1 is a 
novel Plk1-binding protein. We are currently pursuing the molecular and 
cell biological functions of this candidate in regulating the telomere length 
and its potential relevance to human disease. 
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Cell cycle events in eukaryotes are regulated by periodic activation and 
inactivation of a family of cyclin–dependent kinases (Cdks). Entry into 
mitosis is initiated by accumulation of Cdk in complexes with B-type 
cyclins, and exit from mitosis requires inactivation of these Cdk-cyclin 
complexes and dephosphorylation of Cdk targets. In budding yeast, the 
Cdks are inactivated by Cdc20- and Cdh1-dependent proteolysis of Clb1 
and Clb2 and by binding with inhibitors Sic1 and Cdc6. Cdc14 is an 
essential phosphatase promoting mitotic exit, it activates Cdh1 and it 
dephosphorylates Cdk targets. Cdc14 is kept inactive by forming a complex 
with Net1 protein in the nucleolus, and it is released from the complex 
when Net1 becomes phosphorylated upon mitotic exit. We have developed 
a deterministic ODE model for the control of Cdc14 release as budding 
yeast cells exit from mitosis. Our model provides a rigorous account of the 
factors affecting the dual exit pathways, called FEAR (Cdc14 early 
anaphase release) and MEN (mitotic exit network). The model captures the 
dynamics of mitotic exit in wild-type and in all 100+ mutant yeast cells 
studied up to date. We propose a novel mechanism for 
multiphosphorylation of Net1 by several kinases: Cdk, Cdc5 (Polo) and 
Dbf2/Mob1 (through activation by Cdc15). Understanding how Polo-like 
kinase fit into the exit pathway is important because Polo-like kinase is 
being actively pursued as a therapeutic target in the treatment of human 
cancer. The model also clarifies the mitotic exit functions of separase 
(Esp1): its non-catalytic function in inhibiting PP2A and thereby promoting 
activation of the FEAR pathway, and its catalytic function in degrading 
cohesins and thereby promoting sister chromatid separation at anaphase I, 
spindle elongation at anaphase II, and MEN activation in telophase. 
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SCF (Skp1-Cul1-Rbx1-F box protein) ubiquitin ligases are a diverse family 
of enzymes that are critical for controlling the stability of a broad spectrum 
of cellular proteins in eukaryotes. The F-box proteins are the substrate-
recognition subunits of the SCF complexes and recruit substrates through 
their variable C-terminal protein-protein interaction domains. Recently, a 
large number of SCF ligases have been shown to dimerize through their F-
box subunits to mediate ubiquitination activity, but the underlying 
mechanism and regulation remain incompletely understood. In this project 
we carry out a structural and functional investigation into the dimeric F-box 
protein Fbx4 and elucidate the molecular basis of Fbx4 F-box protein 
dimerization in promoting the ubiquitination activity of the SCFFbx4 ligase. 
The SCFFbx4 ligase was recently identified as the E3 responsible for the 
ubiquitination and subsequent degradation of the cell-cycle regulator cyclin 
D1 and telomeric DNA-binding protein Pin2 (also known as TRF1). 
Inactivation of Fbx4 is associated with cyclin D1 accumulation in cancer 
and overexpression of Fbx4 results in enhanced Pin2 degradation and 
progressive telomere elongation. Using Pin2 as a model substrate, we 
demonstrated that Fbx4 dimerization is required for efficiently stimulating 
polyubiquitination of Pin2 in vitro. The crystal structure of the Skp1-Fbx4 
complex reveals an unusual antiparallel dimer configuration in which the 
linker domain of Fbx4 interacts with the C-terminal substrate-binding 
domain of the other protomer. Moreover, the C-terminal substrate-binding 
domain of the Fbx4 protein adopts a compact α/β fold that is distinct from 
those of the known F-box proteins, reinforcing the notion that Fbx4 
represents a new subfamily of substrate-recognition proteins in SCF ligases. 
Biochemical studies indicate that two regions in Fbx4 are critical for its 
dimerization, substrate binding and activation. These findings provide the 
first structural view of a dimeric F-box protein and suggest a role for F-box 
dimerization in the SCF-mediated ubiquitination reaction. 
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The E3 ligase Cul4-Ddb1-Cdt2 (CRL4Cdt2) is emerging as an important cell 
cycle regulator that ubiquitylates numerous proteins in S phase and after 
DNA damage. The substrates of CRL4Cdt2 include Cdt1, p21, CKI-1, fly 
E2F, and worm pol Eta. Recently, we have identified the histone methyl 
transferase Set8 as a new CRL4Cdt2 substrate (see Abstract by Centore et 
al.). All known substrates of CRL4Cdt2 contain a 'PIP degron', which 
consists of a classical PCNA interacting protein motif (PIP box) and a basic 
amino acid located four residues downstream of the PIP box ("B+4"). When 
a CRL4Cdt2 substrate uses its PIP degron to dock onto PCNA that is engaged 
in DNA replication or repair, CRL4Cdt2 is recruited to the complex 
dependent on the B+4 residue, whereupon the substrate is ubiquitylated. 
These observations suggest that CRL4Cdt2 might be the first example of a 
ubiquitin ligase that recognizes a composite degron motif consisting of two 
polypeptides (the PIP degron and PCNA). To test this model, we addressed 
what effect PCNA mutations have on CRL4Cdt2-mediated proteolysis. 
Mutation to alanine of two PCNA residues, E124 and D122, that cradle 
residue B+4 of the PIP degron completely abolished Cdt1 destruction in 
Xenopus egg extracts. Importantly, while these mutations had no effect on 
DNA replication or the ability of Cdt1 to dock onto PCNA, they abolished 
recruitment of CRL4Cdt2 to the PCNA-degron complex. Similar results were 
observed with Set8. Our results indicate that CRL4Cdt2 makes direct contacts 
not only with the PIP degron but also with PCNA, strongly supporting the 
model that CRL4Cdt2 recognizes a bipartite degron consisting of two 
polypeptides. 
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The spindle assembly checkpoint (SAC) delays the metaphase to anaphase 
transition in response to lack of kinetochore-microtubule attachment and 
tension, until bipolar attachment of all chromosomes has been achieved. 
Kinetochore dynamic checkpoint proteins including Cdc20, Mad2 and 
BubR1 (along with Bub3), are the key components of a mitotic checkpoint 
complex (MCC), which inhibits activation of the Anaphase Promoting 
Complex/Cyclosome (APC/C) to prevent cell progression until the 
checkpoint is satisfied. Although it is hypothesised that the sequential 
formation of this mitotic checkpoint inhibitory complex is the mechanism 
by which the activity of Cdc20 (as the activator of the APC/C) is 
sequestered, the necessary conditions for the formation of the MCC remains 
subject to speculation. This includes aspects such as the order of formation 
and direct requirement of the kinetochore in protein-protein interactions. 
With the apparent recruitment of key checkpoint proteins upon checkpoint 
activation, clearly the kinetochore plays an important role. Recent studies 
suggest that unattached kinetochores not only catalyze the production of the 
MCC, but may also amplify Cdc20 inhibition and initiate the inhibition of 
Cdc20 which is already bound to APC/C. But with MCC found to be 
present outside of metaphase in HeLa cells, and complex formation in yeast 
previously shown to be independent of intact kinetochores, it could be 
argued that direct kinetochore interaction may not always be required as the 
template for the generation of this complex. Using Drosophila as model, we 
hope to expand upon current knowledge of the requirements involved in the 
interactions between key MCC proteins, by looking at how the SAC may be 
affected should the activity/behaviour of components of the MCC be 
disrupted. 
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Sub-cellular compartmentalization is an important factor in determining the 
spectrum of substrate proteins that are phosphorylated by the various 
cyclin-cyclin-dependent kinase pairs that regulate cell cycle transitions. The 
four budding yeast mitotic cyclins, Clb1-4, all concentrate in the nucleus 
but are present at lower concentrations in the cytoplasm. Clb2 also exhibits 
specific localization to the septin ring at the mother-bud neck. We have 
previously examined the cytoplasmic function of Clb2 by expressing a clb2 
protein with inactivating mutations in two nuclear export signals (clb2-
NESm) in a strain background lacking the other three mitotic cyclins 
(clb1,3,4∆). The resulting strain exhibited a Swe1-dependent elongated bud 
morphology and a defect in cell wall integrity. To further investigate the 
basis for these mutant phenotypes, we have performed a phosphoproteomic 
study employing stable isotope labeling with amino acids in cell culture 
(SILAC) and phosphopeptide enrichment by immobilized metal affinity 
chromatography (IMAC) to compare the spectrum of phosphorylated 
proteins in clb1,3,4∆ and clb1,3,4∆ clb2-NESm cells. Phosphorylated 
peptides that showed significant differences in abundance between the two 
strains included those derived from cell wall components, proteins of the 
cell wall integrity signaling pathway, and proteins involved in vesicle 
trafficking and the ubiquitin-proteasome pathway. 
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Krüppel-like factor 4 (KLF4) is a transcriptional factor, whose 
physiological role has been implicated in the regulation of a variety of 
biological processes, including cell proliferation, differentiation, apoptosis 
and stem cell reprogramming. How KLF4 is regulated has attracted 
considerable interest because of its putative role in carcinogenesis and stem 
cell biology. Recent studies have revealed that regulation of KLF4 is 
through epigenetic machineries, such as methylation and acetylation, that 
modulate its function in transcriptional activation. Besides the 
aforementioned epigenetic mechanisms, ubiquitin-dependent proteolysis 
has also been suggested to be involved in the regulation of KLF4, especially 
during cell cycle progression and in response to genotoxic stress. However, 
the exact mechanism by which KLF4 is regulated by the ubiquitin-
proteasome system remains largely unknown. In this study, we have 
analyzed the regulatory mechanism of KLF4 as related to protein 
degradation and further identified a novel role for KLF4 in mediating TGF-
beta signaling. We have shown that KLF4 undergoes proteolysis in 
response to TGF-beta signaling. TGF-beta-induced KLF4 destruction 
results in enhanced TGF-beta-responsive transactivation. We have further 
demonstrated that KLF4 interacts with Cdh1, a substrate factor for APC/C. 
Silencing Cdh1/APC by the RNA interference leads to stabilization of 
KLF4 and attenuation of TGF-beta response. Results from the mutagenesis 
study coupled with the ubiquitylation analyses suggest that a destruction 
box near the amino terminus of KLF4 (amino acid residues 45-48) mediates 
the catalysis of KLF4 ubiquitylation by Cdh1/APC in response to TGF-beta 
signaling. Stabilization of KLF4 inhibits TGF-beta-mediated PAI-1 activity 
and further abrogates TGF-beta-induced growth inhibition. In summary, the 
present results suggest that KLF4 plays an important role in TGF-beta 
signaling pathway and Cdh1/APC is the putative ubiuqitin-protein ligase 
that governs TGF-beta-induced proteolysis of KLF4. 
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Orc6p is a part of the pre-replicative complex (pre-RC) which binds to 
origin of DNA replication to promote initiation of DNA replication. DNA 
replication has to take place only once per cell cycle. After the initiation of 
DNA replication, S-phase cyclin (Clb5p) binds to Orc6p to inhibit the 
second round of DNA re-replication. To better understand the Orc6p 
function in S. cerevisiae, synthetic genetic array (SGA analysis) was 
performed using Orc6 mutant, ORC6-rxl. The ORC6-rxl mutation 
eliminates Clb5-Orc6 binding, but these strains are viable. We looked for 
haploid gene deletion strains in which ORC6-rxl was synthetically lethal; in 
other words, haploid deletion strains which require Clb5p-Orc6p protein 
binding for their survival. Interestingly, we found that mck1 deletion cells 
showed synthetic lethality with the cells containing the ORC6-rxl mutation. 
The mck1 deletion cells also caused synthetic lethality with cells with 
ORC6 or ORC2 phosphorylation mutations (ORC6-ps or ORC2-ps), but not 
with other pre-RC mutations such as MCM7-NLS or CDC6delNT. The 
phenotype of the synthetic lethality in mck1 ORC6-rxl using a temperature 
sensitive conditional mutant of mck1 (mck1-16) in combination with 
ORC6-rxl mutant was analyzed. The mck1-16 ORC6-rxl cells showed DNA 
content more than 2C DNA at non-permissive temperature. We previously 
reported that DNA re-replication is monitored by DNA damage checkpoint 
surveillance mechanism. Deletion of these checkpoint genes enhances DNA 
re-replication phenotype. The lethality in the mck1-16 ORC6-rxl cells was 
enhanced when DNA damage checkpoint gene, such as MEC1, was deleted. 
Furthermore the lethality in the mck1-16 ORC6-rxl was dependent on 
CLB6. We will discuss the possibility that Mck1p has a role in the control 
of DNA replication. 
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The spindle assembly checkpoint (SAC) in mammals comprises both a 
cytosolic “timer” and a kinetochore-based “catalyst” that together mediate 
the production of an anaphase-inhibitory signal. Here we use chemical 
genetics to show that the protein kinase Mps1 is a crucial regulator of both 
branches of the SAC. Human MPS1-null cells were generated via gene 
targeting and reconstituted with either the wildtype kinase (Mps1wt) or a 
mutant version (Mps1as) whose ATP-binding pocket was enlarged to 
accommodate bulky purine analogs. Mps1 inhibition caused two major 
defects in M phase progression: first, it dramatically accelerated mitotic 
timing, such that cells completed the NEB-to-anaphase interval in 12 
minutes, and prevented Cdc20’s association with either Mad2 or BubR1 
during interphase, i.e., before the appearance of functional kinetochores. 
Second, Mps1 inhibition during mitosis evicted all known SAC transducers 
(including Bub1, BubR1, Mad1, Mad2, and Zw10) from the outer 
kinetochore and provoked severe chromosome mal-orientation. However, 
contrary to a recent report, phosphorylation of Aurora B-dependent 
substrates was unaffected. Remarkably, cytosolic restoration of Mps1 
kinase activity circumvented these kinetochore defects and rescued M phase 
timing and SAC proficiency in the presence of spindle poisons. We 
conclude that Mps1 has two distinct but complementary roles in SAC 
regulation: (i) transient cytoplasmic activation of Cdc20 inhibitor(s), and 
(ii) recruitment of factors that promote sustained anaphase inhibition and 
chromosome bi-orientation to unattached kinetochores. 
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Aneuploidy is a common characteristic of tumor cells and a substantial 
amount of evidence has accumulated that suggests chromosome instability 
contributes to tumorigenesis. However, in apparent contradiction to this, 
aneuploidy has mainly been correlated with decreased viability of 
organisms and (untransformed) cells in culture. Aneuploidy is thought to 
arise as a consequence of chromosome segregation errors. The decrease in 
viability is thought to be caused by overall stress responses due to gene 
dosage imbalances. Recently it has been shown that single chromosome 
missegregation events can induce a p53-p21 dependent cell cycle arrest, 
which is thought to be caused mainly by activation of the p38-MAPK 
pathway (Thompson et al., 2010). However, it is currently unknown 
whether this is the only pathway that can lead to p53 activation after 
chromosome missegregations. 
In this study we show that within several hours after a chromosome 
missegregation event the ATM/ATR-dependent DNA damage pathway is 
activated. We observe phosphorylation of H2AX and localization of 53BP1 
to DNA positioned in the cleavage furrow in both U2OS and untransformed 
RPE cells, suggesting that cleavage furrow ingression could induce DNA 
damage. Consistent with this, inhibition of cytokinesis in the presence of 
chromosome missegregations reduces the DNA damage in the daughter 
cells. From these results we hypothesize that during a chromosome mis-
segregation event DNA can get trapped in the cleavage furrow of the 
dividing cell. This then damages the DNA, which activates the DNA 
damage response pathway, which in turn induces a cell cycle arrest. This 
DNA damage pathway activation could, in addition to p38 MAPK 
activation, play a role in the observed p53-p21 induction after chromosome 
segregation errors. 
 
 76 
A ROLE OF THE TRANSCRIPTION FACTOR NETWORK 
OSCILLATOR IN CONTROLLING CELL-CYCLE PERIOD 
 
Yuanjie Jin1, Chenchen Huang1, Qingyun Li1, Matthew S Crowe2, Rosie 
Jiang1, Steven B Haase1  
 
1Duke University, Department of Biology, Science Drive, Durham, NC, 
27708, 2Duke University, Program in Cell and Molecular Biology, Durham, 
NC, 27708 
 
Cyclin/Cdk complexes have long been regarded as the principal component 
of oscillator that drives cell-cycle progression in eukaryotes. However, 
previous work by our lab found that in Saccharomyces cerevisiae, 
oscillations in budding and periodic gene expression persist in the absence 
of B-Cyclin/Cdks, which normally regulate S phase and mitosis. We 
proposed that a transcription factor network, constructed from periodically 
expressed transcription factors, maintains these oscillations (Orlando et al. 
2008). If the network truly controls the cell-cycle period, we expect the 
oscillation period could be changed by manipulating the expression of 
transcription factors within the network. Therefore, we introduced two types 
of perturbations within the network: deletion of transcriptional repressors 
and constitutive expression of transcriptional activators. Indeed, we observe 
that some perturbations decrease the period of B-cyclin-independent 
oscillations, while others extend the period length. Together, our data 
suggest the transcription factor network oscillator plays a fundamental role 
in controlling cell cycle period.  
 
 
 
Orlando, D. A., C. Y. Lin, et al. (2008). "Global control of cell-cycle 
transcription by coupled CDK and network oscillators." Nature 453(7197): 
944-U78.  
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Establishment of spindle bipolarity is pivotal for proper chromosome 
segregation and mitotic progression. Mammalian polo-like kinase 1 (Plk1) 
has been thought to play a central role in this process. However, how Plk1 
contributes to this event remains unknown. Here we demonstrated that 
Cdc2-dependent phosphorylation on a  -TuRC recruitment protein, 
Nedd1/GCP-WD, at two distinct sites provides both temporal and spatial 
cues to timely bring about Plk1 functions to the centrosomes and spindles 
via phosphorylation-dependent interaction with the polo-box domain of 
Plk1. At centrosomes, Plk1 interacted with a C-terminal phosphorylated 
motif of Nedd1 to phosphorylate the latter, a step suggested to be important 
for centrosome-based microtubule nucleation. Immediately following this 
event, Plk1 also interacted with an N-terminal phosphorylated motif of 
Nedd1 along the spindles and phosphorylated an Augmin subunit, Hice1, to 
promote microtubule-based microtubule nucleation. Loss of Nedd1-
mediated Hice1 phosphorylation by Plk1 resulted in impaired Augmin 
interaction with microtubules and diminished  -tubulin recruitment to the 
spindles that ultimately led to defects in proper bipolar spindle formation 
and chromosome segregation. Taken together, the data provided here 
demonstrate the underlying mechanisms of how the two distinct Plk1-
Nedd1 interactions at the centrosomes and spindles are deciphered into 
different biochemical and cellular outcomes to achieve normal bipolar 
spindle formation and mitotic progression. 
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DCDC5 is a member of the Doublecortin (DCX) domain protein 
superfamily, in addition to a tandem DCX domain it possesses a 
carbohydrate-binding domain (Ricin-type beta-trefoil). DCX domains were 
first identified in the DCX protein, a neuronal microtubule-associated 
protein (MAP). Here we show that DCDC5 is specifically expressed during 
mitosis. The expression initiates at prophase and during metaphase DCDC5 
localizes to spindle microtubules and cortical sites. Later, DCDC5 
expression confined to the midbody and cytoplasm in telophase and 
cytokinesis. Following reduction of DCDC5 by shRNA, the function of the 
midbody was compromised by several criteria. Rab8- /Rab6-GFP vesicles 
failed to transport to the midbody, the position of the midbody deviated 
from the median of the cell, and cytokinesis time increased. Consequently, 
the number of multinucleated cells and apoptotic cells increased. Our 
biochemical results indicated that DCDC5 binds to microtubules and 
interacts with several key proteins involved in cell cycle regulation. DCDC5 
interacts with Polo kinase-1, dynein intermediate chain (DIC), NudC, LIS1 
and with an activated form of Rab6. Collectively, these data suggest that 
DCDC5 is a Microtubule Associated Protein, which acts as a potential 
linker protein, participating in microtubule associated dynein-mediated 
transport of Rab8-/6-vesicles to the midbody. 
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The nervous system contains vast numbers of neuronal sub-types, generated 
at the proper time, in the proper location, and in proper numbers. While 
tremendous progress has been made with respect to the underlying 
molecular genetic mechanisms controlling neuronal diversification per se, 
much less is known regarding how precise cell numbers of each neuronal 
sub-type are generated. Although poorly understood, this likely requires a 
complex interplay between positional, temporal and lineage-specific cues 
on the one hand, and the cell cycle machinery on the other. 
 
To address this issue, we are studying a specific neural progenitor cell and 
its lineage, the neuroblast 5-6, located in the Drosophila embryonic central 
nervous system (CNS). Previous studies have identified a number of 
regulatory genes and pathways acting to specify this progenitor cell and to 
control lineage progression, as well as to specify unique cell fates within 
this lineage. Many of these regulatory genes appear to play dual roles, both 
specifying intermediate and terminal cell fates, as well as controlling cell 
numbers of each cell type and overall lineage size. The combination of high 
resolution and the many regulatory genes identified makes this lineage a 
powerful model for addressing the interplay between regulatory genes and 
the cell cycle.  
 
The fly embryonic CNS contains 18 segments and one neuroblast 5-6 is 
generated in each hemi-segment. Neuroblasts stereotypically generate fixed 
lineage sizes, and in thoracic segments, the 5-6 neuroblast generates a 
lineage of 20 cells. However, lineage size is modified along the anterior-
posterior axis, indicating that positional cues act to modify this lineage, 
presumably by acting on the cell cycle machinery. We find that Hox genes, 
as well as Hox co-factors (Pbx/Meis) play critical roles in controlling 
lineage size of the 5-6 lineage. Surprisingly, Hox/Pbx/Meis act in different 
ways to control lineage size along the AP axis, indicating that these 
positional cues act in a context-dependent manner. 
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The yeast centrosome (known as the spindle pole body, SPB) serves as a 
microtubule-organizing center to nucleate microtubules in interphase and 
establish the mitotic spindle. Proper mitotic spindle function is important to 
maintain a diploid genome, as structural and numerical centrosomal defects 
are correlated with chromosome instability in many types of tumors. All of 
the SPB components have been identified; however, the regulation of SPB 
duplication and function is yet to be well described. A number of 
phosphorylation sites have been identified on SPB proteins, a few of which 
have been shown to contribute to assembly and function of the SPB. Here 
we provide an extensive inventory of phosphorylation events found on the 
18 core SPB proteins based on mass spectrometric analysis of intact SPB 
complexes. We have excellent peptide coverage across the proteins of the 
SPB and we have identified a total of 296 phosphorylation sites, including 
26 tyrosine phosphorylation sites and 49 potential Cdk sites. We have also 
identified phosphorylation on numerous SPB-associated proteins, including 
SPB-associated kinases and the mitotic exit complex. To correlate cell cycle 
timing with the function of phosphorylation, we also have mapped cell 
cycle specific sites found in SPBs from cells arrested in G1 (61 unique 
sites) or mitosis (111 unique sites). We have examined the conservation of 
phosphorylation sites in the orthologs of the 18 SPB proteins. The analysis 
of γ-tubulin reveals phosphorylation on the very conserved S360 residue. 
Mutation of S360 to alanine yields no phenotype; however, a 
phosphomimetic mutation of this site leads to a mitotic delay and a defect in 
SPB function. We are further characterizing this phenotype. Overall, our 
work greatly expands the understanding of centrosome structure by 
exploring the extent of phosphorylation within the protein complex; this 
information will allow analysis of the contribution of this prominent post-
translational modification in centrosome structure and function. 
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All cells have a characteristic size, which is regulated by the coordination of 
growth and cell division. Despite a wealth of knowledge about cell growth 
and division, little is understood of the direct mechanisms that control cell 
size. However, it is well accepted that nuclear content and cytoplasmic 
content play a role in cell size determination and that the 
nuclear:cytoplasmic ratio is a parameter that determines cell size. In the 
fission yeast Schizosaccharomyces pombe there is evidence for size 
checkpoints at the G1/S and the G2/M boundaries.  
 
We hypothesize that Wee1 and Cdc25 represent a self contained size-
control module that is a surrogate for the nuclear:cytoplasmic ratio at the 
G2/M boundary. In our hypothesis, the Wee1 mitotic inhibitor is expressed 
at a rate proportional to nuclear content whereas the Cdc25 mitotic inducer 
is expressed at a rate proportional to cytoplasmic volume. The amount of 
Wee1 and Cdc25 represent the nuclear:cytoplasmic ratio and determines 
cell size at division. In other words, during most of G2 the amount of Wee1 
is greater than the amount of Cdc25 and thus inhibits mitosis by inhibiting 
Cdk1. However, as the cell size increases the amount of Cdc25 increases 
and when the cell reaches a size threshold sufficient for mitosis to occur the 
amount of Cdc25 will surpass the amount of Wee1 and induce mitosis.  
 
We have tested our hypothesis by accurately measuring expression of Wee1 
and Cdc25 via luciferase fusions. Our initial results support a model where 
Wee1 expression stays relatively constant while Cdc25 expression increases 
as cell volume increases in G2. We are currently testing additional 
predictions of our hypothesis. 
 82 
SSU72 IS A COHESIN-BINDING PROTEIN THAT REGULATES  
THE RESOLUTION OF SISTER CHROMATID ARM COHESION  
 
Hyun-Soo Kim1,2, Chang-Woo Lee1,2  
 
1Sungkyunkwan University School of Medicine, Dept. of Molecular Cell 
Biology , 300 Cheoncheon-dong, Suwon, 440-746, South Korea, 2Samsung 
Biomedical Research Institute, Dept. of Molecular Cell Biology , 300 
Cheoncheon-dong, Suwon, 440-746, South Korea 
 
Cohesin is a multiprotein complex that establishes sister chromatid cohesion 
from S phase until mitosis or meiosis. In vertebrates, sister chromatid 
cohesion is dissolved in a stepwise manner: Most cohesins are removed 
from chromosome arms via a process that requires Plk1, aurora B and 
Wapl, while a minor amount of cohesin, found preferentially at the 
centromere, is cleaved by separase following its activation by the anaphase-
promoting complex/cyclosome. In the current study, we report that our 
fission yeast two-hybrid assay identified hsSsu72 as a Rad21-binding 
protein. Additional experiments revealed that Ssu72 directly interacts with 
Rad21 and SA2 in vitro and in vivo, and associates with mitotic sister 
chromatids. Interestingly, depletion or mutational inactivation of Ssu72 
phosphatase activity caused premature sister chromatid separation, whereas 
the overexpression of Ssu72 yielded high resistance to the resolution of 
sister chromatid cohesion. Further studies showed that Ssu72 regulates the 
cohesion of chromosome arms but not centromeres. Thus, our study 
provides important new evidence suggesting that Ssu72 is a novel cohesin-
regulatory protein capable of regulating cohesion between sister chromatid 
arms. 
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Tumour suppressor p53 plays important roles in cellular responses such as 
cell cycle arrest, senescence, DNA repair, apoptosis and autophagy by 
various stimuli. Previous reports showed DNA damage agent response 
correlated with p53 wild type existence, however, antimicrotubule drugs 
response did not correlated with p53 status even though its protein induced. 
The way of p53 responses distinguish different stimulus and has selectivity 
for cell death or survival still remains to be clarified. One possible layer of 
p53 regulations is stabilization and target gene selective activations through 
different modifications. To investigate antimicrotubule drugs induced 
various cellular response by p53 may involved different modification, we 
treated topoisomerase inhibitor etoposide, and two antimitotic drug, 
taxol/nocodazole in normal mammary epithelial cell (HMEC), human 
diploid fibroblast (HDF) and HCT116 cell, which all are p53 wild type 
cells. Etoposide appeared similar response of cell survival, but, taxol and 
nocodazole showed various cell survivals in three different cell types. 
Besides, mitotic check point proteins induction was similar, even activation 
time point was little different. Interestingly, p53 protein modifications 
showed different patterns; still p53 was up regulated in all three cells by 
both anti-microtubule drugs. Acetylations of p53 are more dramatic changes 
in death prone cell rather than phosphorylation. Inhibition of p53 
deacetylation by Sirt1 siRNA enhanced apoptosis, and HDAC inhibitor 
increased p53 acetylation, followed by apoptosis target proteins activation 
and increased apoptosis compare to taxol alone. These results demonstrate 
that p53 acetylation is the possible antimicrotubule drug induced apoptosis 
regulatory points and its regulation might enhance antimicrotubule 
chemodrug responsibility.  
 
* authors contributed equally. 
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A stable genome is critical to cellular viability and proliferation. The 
progression of DNA synthesis may be hindered by the presence of damaged 
DNA or genotoxic stresses, which can lead to replication fork stalling or 
fork collapse. Such events have the potential to induce genomic instability, 
one of the hallmarks of cancer cells. In response to replication stress, the S-
phase checkpoint pathway is activated to delay cell cycle progression and 
inhibit late origin firing. In budding yeast, the chromatin-bound F-box 
protein Dia2 is required to maintain genomic stability and may help 
replication complexes overcome sites of damaged DNA and natural fragile 
regions. SCF (Skp1/Cul1/F-box protein) complexes are modular ubiquitin 
ligases. We find that Dia2 is itself targeted for ubiquitin-mediated 
proteolysis and that activation of the S-phase checkpoint pathway inhibits 
Dia2 protein degradation. S-phase checkpoint mutants fail to stabilize Dia2 
in response to replication stress. Deletion of DIA2 from these checkpoint 
mutants exacerbates their sensitivity to hydroxyurea, suggesting that 
stabilization of Dia2 contributes to the replication stress response. Unlike 
other F-box proteins, deletion of the F-box domain in Dia2 does not 
stabilize the protein. Instead, a twenty amino acid motif in the N-terminus 
that is also required for nuclear localization is necessary for degradation. 
When a strong NLS is added to dia2 mutants lacking this motif, the Dia2 
protein is both stable and nuclear. Finally, expression of stable, nuclear 
Dia2 leads to changes in cell cycle dynamics. Together, our results indicate 
that Dia2 protein turnover does not involve an autocatalytic mechanism and 
that Dia2 proteolysis is inhibited by activation of the replication stress 
response. We propose that the inhibition of Dia2 proteolysis may be a novel 
target of the S-phase checkpoint pathway. 
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Permanent arrest of proliferation associated with terminal differentiation is 
thought to depend on CDK-inhibitory proteins, transcriptional repression by 
pRb family members and stable gene silencing. We study the 
differentiation-associated cell-cycle arrest of the C. elegans body wall 
muscle in vivo. Muscle cells exit the cell cycle and differentiate even in the 
apparent absence of lin-35 Rb and cki-1 Cip/Kip function. However, 
expression of G1 Cyclin/CDK combinations triggered gradual cell-cycle re-
entry of body wall muscle during larval development. Specifically, we 
observed S-phase reporter expression, DNA replication, chromosome 
condensation and nuclear division in post-embryonic muscle cells. 
Quiescent cells were much more efficiently induced to re-enter the cell 
cycle than differentiated cells, which indicates multiple levels of cell-cycle 
inhibition in differentiated cells. Importantly, induction of cell-cycle entry 
did not interfere with the differentiated state. Muscle-specific gene 
expression profiling revealed that cye-1 Cyclin E/cdk-2 CDK2 expression 
activates a specific cell-cycle transcriptional program enriched in E2F target 
genes. Expression of cyd-1 Cyclin D/cdk-4 CDK4/6 induced an overlapping 
but larger number of genes, triggered DNA replication more efficiently than 
cye-1/cdk-2, and down-regulated transcription of genes with catabolic 
functions while activating several anabolic genes. Our results highlight 
differential functions of the Cyclin D/CDK4 versus Cyclin E/CDK2 CDK 
complexes, and show that a cell-cycle transcriptional program can be 
activated coincident with the differentiated state and without general 
reprogramming of chromatin. 
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DNA replication creates identical sister chromatids that are held together 
until cell division by a large multi-subunit protein complex called cohesin. 
Cohesin is loaded onto chromatin prior to DNA replication. Several other 
activities ensure that cohesion is accurately established and maintained. In 
vertebrates, these include two acetyltransferases, Eco1 and Eco2, and a 
recently identified protein, sororin. The mechanism by which cohesion is 
established, and the nature and topology of the cohesin-DNA interaction are 
not well understood. We have been investigating the relationships among 
cohesion factors, with particular emphasis on vertebrate-specific 
elaborations, using extracts from eggs of Xenopus laevis.  
 
We have cloned and sequenced full length Xenopus orthologs of Eco1 and 
Eco2. Both proteins contain the functional motifs found in all other known 
members of this gene family; they also possess unrelated and poorly 
conserved N-terminal extensions, as have been seen in other vertebrates. 
Functional dependencies between these Eco family proteins and other 
cohesion factors were examined by depletion of the endogenous proteins 
from egg extracts. In particular, the relationships between Eco proteins, 
DNA replication and recruitment of various cohesion factors to the 
chromatin were analyzed. Our data show that Eco1 and Eco2 functionally 
interact with sororin to regulate cohesion, and that Eco2 levels are 
controlled by cell cycle progression. Experiments are currently underway to 
identify regions of the Eco proteins that are critical to this interaction. 
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The Spindle Assembly Checkpoint (SAC) acts to prevent mis-segregation 
of homologous chromosomes during the first meiotic division of 
mammalian oocytes. In mitosis, Aurora B kinase plays an essential role in 
the SAC response by affecting microtubule stability across sister 
kinetochores. Here we show, using the Aurora B inhibitor ZM447439 a 
similar function for Aurora B in mouse female meiosis. Thus ZM447439 
accelerated passage through meiosis I by about 1 hour, generated lagging 
chromosomes at anaphase, and caused a five fold increase in homolog non-
disjunction rates (from ~3% to 15%). It was able to overcome a SAC arrest 
imposed by the addition of nocodazole and this effect was shown, by cyclin 
B1-GFP imaging, to be due to reactivation of the Anaphase-Promoting 
Complex. Thus we were able to block cyclin B1 degradation by addition of 
nocodazole to maturing oocytes, and the further addition of ZM447439 
caused re-initiation of its degradation. We conclude that Aurora B serves 
similar meiotic SAC functions in mammalian oocytes to those observed in 
somatic cells during mitosis. This is despite differences in spindle 
architecture brought about the meiotic mono-orientation of sister 
kinetochores. 
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The nuclear pore complex proteins (Nups) have increasingly become 
implicated in various aspects of the response to DNA damage including the 
actual repair of damaged DNA. SONBNup98 is a conserved component of 
nuclear pore complexes and is essential in Aspergillus nidulans. The sonB1 
allele was identified in a screen for suppressors of the temperature sensitive 
nimA1 allele of the mitotic NIMA kinase. Importantly, subsequent genetic 
analyses using the sonB1 allele indicated SONBNup98 has a role in a novel 
response to DNA damage. sonB1 mutant cells are hypersensitive to DNA 
damaging agents and are lethal when combined with a deletion of scaANbs1, 
a breast cancer susceptibility gene in humans. We have extended the 
previous studies of SONBNup98 and SCAANbs1 to further characterize the role 
of SONBNup98 in the response to DNA damage using several approaches. 
We have performed a screen to isolate other genes that suppress the 
temperature sensitivity of the nimA1 allele that also confer DNA damage 
sensitivity, similar to the sonB1 allele. In addition to re-isolating sonB1, we 
have isolated several suppressors extragenic to nimA and sonB, and are in 
the process of identifying these genes. We are also taking a candidate 
approach to identify genes involved in the DNA damage response pathway 
with SONBNup98. Many proteins involved in the DNA damage response are 
also involved in telomere maintenance. Interestingly, sonB1 displays 
genetic interactions with genes that have roles both in telomere maintenance 
and the DNA damage response but not with genes that play a role in only 
the DNA damage response. Deletion of RADCRad52, a protein essential for 
maintenance of telomere length in the Alternative Lengthening of 
Telomeres (ALT) pathway, is lethal when combined with the sonB1 allele. 
Deletion of the putative S. pombe Rad9 homolog results in enhanced DNA 
damage sensitivity when combined with the sonB1 allele but not when 
combined with the scaA1 mutant allele. These results suggest that Rad9 is 
acting in the same pathway as SCAANbs1 and in parallel with SONBNup98 to 
maintain genomic integrity, possibly by maintaining telomere length via an 
ALT pathway. 
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Chromosome decatenation is essential for chromosome condensation and 
sister chromatid separation during mitosis. Accordingly, disruption of 
decatenation can lead to abnormal chromosome segregation and aneuploidy, 
which can lead to cancer development. Topoisomerase 2 (Top2) is a key 
enzyme in chromosome decatenation, such that Top2 catalytic inhibitors 
(e.g. ICRF-193) disrupt chromosome decatenation without inducing double-
strand breaks, thereby causing a decatenation stress. Since these Top2 
catalytic inhibitors are used during cancer therapy to limit cardiac toxicity 
of chemotherapeutic agents, it is important to characterize the range of 
mechanisms that protect genomic integrity from such decatenation stress. 
For example, activation of a decatenation checkpoint to delay mitosis onset 
appears to be important for proper chromosome segregation. However, this 
decatenation checkpoint appears defective in stem cells. Thus, stem cells 
likely rely on additional pathways to ensure normal mitotic progression 
following decatenation failure. In this study, we have identified a factor (F-
box helicase 1, or Fbh1) important for the recovery from a decatenation 
stress in mouse embryonic stem cells (ES). We have found that Fbh1-
deficient ES cells showed an increased sensitivity to ICRF-193 treatment. 
We also observed an accumulation micronuclei and multilobed nuclei in 
Fbh1-deficient cells after decatenation stress, which indicates increased 
genomic instability. Moreover, from time-lapse analysis of chromosomes in 
Fbh1-deficient mitotic cells, we find that Fbh1 is important to promote 
normal anaphase separation of chromosomes after decatenation stress. 
These findings provide further evidence for additional pathways that limit 
the genotoxic effects of decatenation stress in stem cells, which likely 
involve Fbh1. 
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Mammalian polo-like kinase 1 (Plk1) plays a pivotal role during M-phase 
progression. Plk1 localizes to specific subcellular locations through the 
targeting activity of the polo-box domain (PBD) that specifically interacts 
with S-pS/pT epitopes. However, the mechanism underlying this event 
remains largely elusive. Here we showed that Plk1 activity not only self-
regulates the timing of its association with the PBIP1-Cenp-Q complex to 
stable localize to the kinetochores but also self-promotes its own 
delocalization from the kinetochores by hyperphosphorylating the complex. 
During interphase and early mitosis, Plk1 phosphorylated PBIP1 at T78 and 
interacted with the latter via its PBD, which then allowed the former to 
phosphorylate Cenp-Q in a manner that required the prior formation of the 
PBIP1-Cenp-Q complex. Either inhibition of Plk1 activity or disruption of 
the PBIP1-Cenp-Q complex was sufficient to abolish the Plk1-dependent 
Cenp-Q phosphorylation. Later in mitosis, Plk1 activity induced 
dissociation of the Plk1-PBIP1-Cenp-Q complex from the kinetochores by 
the p-T78-dependent hyperphosphorylation of the complex. Depletion of 
Plk1 activity increased the fraction of the PBIP1-Cenp-Q complex 
associating with chromatin and induced relocalization of the complex to the 
kinetochores. Taken together, our results presented here demonstrate that 
Plk1 autonomously regulates the timing of not only its localization to the 
centromeres/early mitotic kinetochores but also its dissociation from the late 
mitotic kinetochores in a fashion that does not require an activity from a 
third component. 
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Quiescence (G0) is the reversible arrest of cell proliferation, during which a cell 
does not actively divide but nevertheless retains the ability to re-enter the cell 
cycle. Quiescence is a mechanism for cellular survival. For example, certain 
subsets of tumor cells exploit quiescence to avoid apoptosis normally induced 
by anticancer agents, and survive. We have found that primary quiescent 
fibroblasts are relatively resistant to proteasome inhibition-mediated cell death. 
This finding is of particular interest because proteasome inhibitors have been 
approved by the FDA for treatment of specific tumor types. Thus, 
understanding the mechanisms by which cells are resistant to proteasome 
inhibition is of basic and clinical importance. We hypothesized that the 
resistance of quiescent fibroblasts to proteasome inhibition could reflect the 
existence of other proteolytic pathways that permit quiescent cells to survive by 
compensating for the inhibition of proteasome activity. In primary fibroblasts 
we found that proteasome inhibition, both in proliferating and quiescent cells, 
leads to induction of autophagy, as measured by the conversion of the known 
autophagy marker LC3I to LC3-II. Down-regulation of the autophagy pathway 
gene using shRNA-targeting Beclin 1 decreases the resistance of contact-
inhibited quiescent cells to proteasome inhibition. These findings suggest that 
autophagy may reflect a compensatory mechanism for the turnover of 
ubiquitinated proteins, and that there may be cross-talk between the two protein 
degradation pathways. Additionally, we monitored the levels of a reporter for 
ubiquitin proteasome system (UPS) activity in proliferating and quiescent 
fibroblasts in the presence and absence of proteasome activity. In proliferating 
cells, the reporter protein accumulated to high levels in all cells when 
proteasome activity was inhibited. By comparison, in quiescent cells, the 
reporter protein was degraded in some cells even when proteasome activity was 
inhibited. Furthermore, proteasome inhibition leads to an accumulation of the 
poly-ubiquitinated form of the reporter in proliferating cells as expected, 
whereas decreased levels of the poly-ubiquitinated form were observed in 
quiescent cells. This may indicate differential activity of the ubiquitination or 
deubiquitination pathways in proliferating and quiescent cells, or the induction 
of an alternative pathway that eliminates ubiquitinated proteins in the quiescent 
cells. We hypothesize that pathways used by quiescent cells to maintain 
viability may be co-opted by tumor cells to ensure survival during dormancy 
and to resist chemotherapy, resulting in tumor recurrence. Elucidation of these 
pathways may assist in developing effective therapeutic approaches. 
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Timeless is a component of the replication fork protection complex (FPC) 
that is involved in the activation of the replication checkpoint and 
stabilization of replication forks. Timeless moves with replication forks and 
cooperates with the ChlR1 DNA helicase to preserve genomic integrity in 
human cells. Interestingly, in yeast, Timeless homologs have been reported 
to play a critical role in replication of repetitive DNA including rDNA and 
trinucleotide repeats. This is likely due to frequent arrest of replication forks 
in repeat regions, necessitating the demand of FPC to stabilize stalled forks. 
In an analogous fashion, telomeres, which are composed of hexameric 
nucleotide repeats, are likely to stall replication forks. Here, we describe the 
effect of Timeless-depletion on telomere DNA replication to understand 
how replisome components facilitate replication of repeat regions. We show 
that telomeres are significantly shortened when Timeless is inhibited. 
Additionally, we show that Timeless-depletion results in collapse of 
replication forks at telomeres and formation of telomere dysfunction-
induced foci (TIFs). When Timeless is downregulated, chromatin 
interaction of telomere-associated factors was altered while telomerase 
activity is still largely unaffected. Thus, Timeless seems to be involved in 
telomere lengthening in a manner independent of telomeraseactivity. 
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Eukaryotic DNA replication is regulated by the stepwise assembly and 
disassembly of pre-replicative complexes (pre-RCs) at replication origins. 
Some pre-RC proteins may become attractive markers for cancer detection 
and targets for cancer therapy, as they are highly expressed in cancer cells 
but not in non-proliferating normal cells.  
DNA synthesis occurs at replication factories or foci on the nuclear matrix. 
However, it is less certain whether or not DNA replication is also initiated 
at the nuclear matrix, although this is supported by some experimental 
evidence.  
From a yeast genetic screen, we have identified Utp7p as a protein required 
for initiation and elongation of DNA replication. We found that utp7-td 
cells lose single-ARS containing plasmid at a high rate and multiple-ARS 
containing plasmid at a much lower rate. utp7-td cells are defective in S 
phase entry and progression when Utp7-td protein is degraded. Utp7p 
interacts with ORC and MCM in co-IP from yeast extracts and in yeast two-
hybrid assays. utp7-td is synthetic lethal with replication mutants, and 
multicopy UTP7 can partially suppress the lethality of orc5-1 cells. 
Importantly, Utp7p is required for loading MCM proteins onto chromatin 
during the M-to-G1 transition, without affecting the levels of MCM 
proteins. Utp7p is also required for MCM chromatin association in both G1 
and S phases.  
We have also investigated the association of Utp7p and other replication-
initiation proteins with chromatin and the nuclear matrix by performing 
cellular fractionation assays using a high salt buffer extraction method 
combined with nuclease digestion of chromatin from formaldehyde 
crosslinked cells. We found that histone H3 is present mostly in the 
chromatin fraction, and Mcm2p, Orc3p, Utp7p and ARS elements exist 
mainly in the nuclear matrix fraction in G1 cells (pre-RC state) but mainly 
in the chromatin fraction in G2/M cells (post-RC state). Importantly, the 
nuclear matrix attachment of ORC and Utp7p is inter-dependent and is 
required for pre-RC assembly during the M-to-G1 transition, shedding new 
light on the mechanism of pre-RC assembly on the nuclear matrix. 
[Supported by the Hong Kong Research Grants Council]  
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The retinoblastoma (RB) family of proteins including pRB, p107 and p130, 
is essential for the ability of mammalian cells to enter G0/G1 or quiescent 
state. In fly and worm, RB-like proteins form a multisubunit complex with 
E2F, DP and five proteins related to the MuvB genes in C. elegans. In 
human cells, both p130 and p107 but not pRB are recruited into the related 
DREAM complex (DP, RB-like, E2F and MuvB-like proteins including 
LIN52, LIN54, LIN9, LIN37 and RBBP4). The DREAM binds to the 
promoters of more than 800 cell cycle-regulated genes and contributes to 
their repression in G0/G1. Upon entry into G0, p130 binds to the MuvB 
proteins and recruits E2F4 and DP1 to form the DREAM complex. During 
the G1/S phase transition, p130 dissociates from the MuvB proteins.  
To understand the mechanisms governing the DREAM assembly and entry 
into quiescence, we performed a global proteomic analysis of the post-
translational modifications of all components of the DREAM complex. This 
analysis revealed that serine 28 of LIN52 was always phosphorylated when 
p130 was bound to the MuvB proteins. The S28A-LIN52 point substitution 
mutant was not able to bind p130 and interfered with the DREAM 
assembly.  
Proteomic analysis also revealed that LIN52 bound to DYRK1A, the kinase 
that could directly phosphorylate S28 of LIN52. DYRK1A is located within 
the minimum region of chromosome 21 that has been implicated in both the 
mental defects and the decreased cancer incidence associated with Down 
syndrome. Array CGH analysis of human cancers revealed that DYRK1A 
gene copy number is reduced in a variety of human tumors. We confirmed 
the reduced DYRK1A copy number by in situ hybridization in U2OS 
osteosarcoma cells. Re-introduction of DYRK1A into U2OS cells resulted 
in an increase in S28-LIN52 phosphorylation, DREAM assembly and 
suppression of proliferation, supporting the tumor suppressor function of 
DYRK1A. Moreover, we found that DYRK1A is required for human cells 
to enter G0/G1 arrested state and for the DREAM assembly. In addition, 
stable expression of the LIN52 S28A mutant enabled primary human 
fibroblasts to escape oncogenic RAS induced senescence and to continue 
proliferation. Our findings identify an essential role for DYRK1A in the 
entry into quiescence that has implications relevant to cancer, stem cell 
biology and development. 
Supported by NIH R01 CA63113 and P01 CA50661 (J.A.D.) and DOD 
W81XWH-08-1-0048 (L.L.) 
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CLIP-170 is implicated in the formation of kinetochore-microtubule 
attachments through direct interaction with the dynein/dynactin complex. 
However, whether this important function of CLIP-170 is regulated by 
phosphorylation is unknown. Herein, we have identified Plk1 (Polo-like 
kinase 1) and CK2 (Casein kinase 2) as two kinases of CLIP-170 and 
mapped S195 and S1318 as their respective phosphorylation sites. We 
showed that a CK2 unphosphorylatable mutant lost its ability to bind to 
dynactin and to localize to kinetochores during prometaphase, indicating 
that the CK2 phosphorylation of CLIP-170 is essential for its dynactin-
mediated kinetochore localization. Furthermore, we provide evidence that 
Plk1 phosphorylation of CLIP-170 at S195 positively regulates its 
association with CK2. Finally, we showed that wild type CLIP-170, but not 
the unphosphorylatable mutants, S195A and S1318A, was able to reverse 
CLIP-170 depletion-induced mitotic defects, confirming that Plk1- and 
CK2-associated phosphorylations of CLIP-170 are essential for the 
formation of kinetochore-microtubule attachments in mitosis. 
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In order to enter mitosis after G2 DNA damage-induced arrest, mammalian 
cells have to go through a process called checkpoint recovery, in which the 
G2 checkpoint network will be silenced. Previous report suggested that p53 
is required to sustain the G2 arrest, but how p53 is eliminated during the 
recovery process is poorly understood. As an important cell-cycle regulator, 
Polo-like kinase-1 (Plk1) is essential for the G2 checkpoint recovery. 
During the recovery process, Plk1 were reported to play dual roles: it 
silences the DNA damage checkpoint through phosphorylation-induced 
degradation of Claspin, the adaptor protein between ATR and Chk1; it also 
directly contributes to abolishing the inhibition of cyclin B-Cdk1 via 
regulation of the phosphatase Cdc25B and Wee1 kinase. We found that 
Plk1-mediated phosphorylation of GTSE-1, a negative regulator of p53, is 
one mechanism to facilitate p53-degradation during the G2 checkpoint 
recovery. We showed that GTSE-1 is required for the G2 checkpoint 
recovery. Furthermore, phosphorylation of GTSE-1 at Serine 435 by Plk1 
promotes its nuclear localization, and then it shuttles p53 out of the nucleus 
to induce p53 degradation. Taken together, our results demonstrated that 
Plk1 plays an essential role in p53 elimination during G2 checkpoint 
recovery. 
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Cyclin-dependent kinases (Cdks), which govern progression through the 
cell cycle, are mainly controlled by transient interactions with cyclin 
regulatory subunits and by reversible phosphorylation reactions. Among 
cyclins, cyclin A2 is particularly interesting since it can activate two 
different Cdks and hence participates in the regulation of S phase 
(associated to Cdk2) and mitosis (associated to Cdk1). In order to better 
understand the biological significance of cyclin A2, we work on getting a 
dynamic map of cyclin A2 interactions with its partners, at the subcellular 
level and throughout the cell cycle. To this aim, we use in vivo imaging and 
interaction techniques, namely FRET (Förster/Fluorescence Resonance 
Energy Transfer) measured by FLIM (Fluorescence Lifetime Imaging 
Microscopy). These techniques are non-invasive, quantitative, and produce 
high resolution data in time and space. The proteins of interest are 
expressed as fusions with fluorophores (EGFP or mCherry), in breast 
epithelial cells. Vectors allowing transient expression of the proteins of 
interest as fusions with fluorophores have been produced and tested (human 
cyclin A2-EGFP, Cdk1-mCherry, Cdk2-mCherry). We have checked that 
the fluorescent proteins are functional (subcellular localisation, 
colocalisation with known partners by confocal microscopy, binding to 
interactors by immunoprecipitation, kinase assays, ubiquitination assays) 
and that their expression does not perturb cell cycle progression. Using 
FRET/FLIM, we have detected interactions of cyclin A2-EGFP with Cdk2-
mCherry in S phase and with ubiquitin-mCherry in mitosis, in MCF-7 cells. 
We were able to follow these interactions through time in the same cells. 
We thus got original data about the subcellular localisation of these 
interactions and their spreading through the cells during the cell cycle. 
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The retinoblastoma tumour suppressor protein (pRb) is a key regulator of 
cell cycle progression and is functionally inactivated in most tumours. 
Moreover reactivation of pRb in cancer cell lines induces senescence which 
is associated with cell cycle exit and ‘flat cell’ morphology. 
The well characterised central 'pocket' and carboxy C-terminal domains of 
pRb mediate regulation of E2F dependent transcription and block the G1/S 
cell cycle transition. Less is known about the function of the amino N-
terminal region, although it is conserved in pRb paralogues and 
orthologues. Importantly, a substantial number of missense mutations in this 
region are associated with hereditary retinoblastoma indicating that loss of 
function in this region is oncogenic. Recently the structure of this domain 
was solved revealing four potential surfaces that could be involved in 
protein-protein interactions. 
We aim to address the significance of the N-terminus through using 
functional analysis of structure-guided and cancer associated mutants. A 
panel of expression vectors with frame preserving pRbN mutations were 
prepared and tested in cell based assays for pRb function. We have 
identified three different types of defects within specific pRb variants: 1) 
mutants showing decreased stability, 2) mutants associated with reduced 
flat cell formation and 3) mutants associated with change in flat cell 
morphology. The first group of mutations affects the hydrophobic protein 
core and decreases proper folding of the whole pRb. The second group 
localises around two surfaces called: the “projection” and the cyclin wedge, 
whereas the third group touches the cyclin wedge and the hydrophobic 
conserved patch 2. 
This data demonstrates for the first time a loss of function in cancer derived 
mutants and confirms the existence of discrete functional surfaces within 
this pRbN domain. 
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In budding yeast, the major regulator of the mitotic exit network (MEN) is 
Tem1, a GTPase, which is inhibited by the GTPase-activating complex 
(GAP), Bfa1/Bub2. Asymmetric Bfa1 localization to the bud-directed 
spindle pole body (SPB) during anaphase controls mitotic exit, but the 
molecular mechanism and function of this localization are not well 
understood, particularly in unperturbed cells. Here, we identified novel 
Cdc5 target residues within the Bfa1 C-terminus, 452S, 453S, 454S, and 
559S. A Bfa1 mutant in which all of these residues have been changed 
simultaneously (called Bfa14A) persisted on both SPBs at anaphase and 
was hypo-phosphorylated, despite retaining its GAP activity against Tem1. 
These observations demonstrate a tight link between localization and 
phosphorylation, and no direct connection between asymmetric localization 
and GAP activity of Bfa1. Consistent with this, in kinase-defective cdc5-2 
cells, Bfa1 was unphosphorylated and localized to both SPBs. The BFA14A 
cells progressed through anaphase normally, but displayed a delayed mitotic 
exit in unperturbed cell cycles. Altogether, we suggest that Cdc5 modulates 
the asymmetric Bfa1 distribution to the bud-directed SPB independently of 
Bfa1 GAP activity at anaphase, and that Bfa1 asymmetry fine-tunes the 
timing of MEN activation. 
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Protein synthesis and proteolysis are critical to cell growth and division. 
Recent studies have revealed important connections between translation and 
cell cycle control systems. Cyclin—a protein whose synthesis is essential 
for mitotic entry—has long been considered and modeled to be synthesized 
continuously to drive the CDK1-APC oscillator. However, past studies of 
the stimulus-response relationship between cyclin and CDK1 showed that 
cyclin accumulation plateaus prior to mitosis. It was unclear if this result 
occurred due to a balance between cyclin synthesis and initial low APC 
activity, or if cyclin synthesis is blocked. We recently learned that cyclin 
levels plateau in proteasome-inhibited Xenopus cycling egg extract. This 
supports the idea that inhibition of cyclin synthesis alone is responsible for 
the lack of cyclin accumulation prior to mitosis. This pause correlates with 
increasing CDK1 activity, and we hypothesized there exists some kind of 
negative feedback that blocks cyclin synthesis. We then discovered that 
supplementing a proteasome-inhibited cycling egg extract with non-
degradable cyclin accelerated mitotic entry and blocked cyclin synthesis 
prematurely; this reduced the production of endogenous cyclin. Next, we 
determined that inhibiting CDK1 with roscovitine or constitutively active 
Wee1 delayed M-phase entry while permitting a prolonged period of cyclin 
synthesis. As a result, both treatments caused the extract to produce more 
cyclin. Finally, we found that adding cycloheximide to extracts at the point 
of this translational inhibition did not delay mitosis. Blocking translation at 
even earlier time points—in order to induce a premature and reduced 
plateau level of accumulated cyclin—delayed but permitted M-phase onset. 
Together, these results demonstrated that early embryonic mitoses do not 
require continuous cyclin synthesis. In fact, the oscillator itself confers an 
implicit negative feedback on cyclin production once a sufficient amount of 
stimulus has been produced. Modeling of this CDK1-APC system—driven 
by pulses rather than constant cyclin synthesis—yielded dynamics even 
more representative of experimentally measured CDK1 oscillations. We are 
currently investigating how the embryonic oscillator senses when sufficient 
stimulus has been produced, and are working to identify the factors in 
addition to CDK1 that are involved in this negative-feedback loop. 
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Origin Recognition Complex (ORC) plays critical roles in the initiation of 
DNA replication and cell cycle progression. In metazoans, ORC associates 
with origin DNA during G1 and with heterochromatin in post-replicated 
cells. However, what regulates the binding of ORC to chromatin is not 
understood. We have identified a novel, highly conserved, leucine-rich 
repeats and WD40 repeat domain-containing protein 1 (LRWD1) in human 
cells that interacts with multiple subunits of ORC. LRWD1 co-localizes 
with ORC and shows similar cell cycle dynamics. By using a cell line 
containing an artificially generated chromatin region, we have demonstrated 
that LRWD1 efficiently recruits ORC to chromatin. Furthermore, depletion 
of LRWD1 in human embryonic stem cells results in loss of ORC binding 
to chromatin and a subsequent arrest in G1 phase. Our findings demonstrate 
that LRWD1 is an essential protein that is required for loading ORC to 
chromatin and that in turn is critical to initiate preRC assembly in G1 and 
chromatin organization in post-G1 cells. 
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Initiation of DNA replication depends on loading of a MCM2-7 helicase 
complex at a replication origin prior to kinase dependent activation of the 
helicase and formation of the replication fork. We have reconstituted the 
first step of budding yeast replication initiation – formation of the pre-
Replication Complex (pre-RC) using purified proteins. During pre-RC 
formation ORC, Cdc6 and Cdt1 cooperate to load the MCM2-7 helicase 
onto DNA. The reconstituted reaction depends on all pre-RC proteins, DNA 
and Cdc6 ATP-hydrolysis for MCM loading. During pre-RC formation the 
MCM2-7 structure changes and loaded MCM2-7 assemble into a double-
hexamer. MCM2-7 loading depends on Cdc6 and Orc1 ATP hydrolysis, but 
it is unclear how ATP-hydrolysis and MCM double-hexamer formation are 
coordinated. Using a biochemical approach we found that a Cdc6 ATP-
hydrolysis mutant promotes an ORC-MCM2-7-single hexamer complex and 
that an Orc1 ATP-hydrolysis mutant allows assembly of a MCM2-7 double-
hexamer. We have analysed the MCM2-7 double hexamer interface using a 
mutagenesis approach and found that MCM-interface mutations block 
MCM2-7 loading onto DNA in vitro. When MCM interface mutants were 
over-expressed in vivo they resulted in a dominant lethal phenotype. These 
data suggest that ORC-Cdc6 initially associate with an MCM2-7 single 
hexamer, but after Cdc6 ATP hydrolysis the double-hexamer must be 
loaded onto DNA as a unit. 
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The complete and precise duplication of a eukaryotic genome presents a 
unique challenge during the cell cycle. During G1 phase thousands of 
replication origins are loaded with an inactive form of the replicative DNA 
helicase, the MCM complex. This replication licensing step is accomplished 
through the recruitment of MCM by the Cdt1 protein to origins where the 
Origin Recognition Complex (ORC) and Cdc6 protein then load MCM 
complexes onto DNA. ORC, Cdc6, and Cdt1 are then either destroyed or 
inhibited from the onset of S phase until mitosis to prevent relicensing and 
rereplication, whereas MCM complexes are unloaded as replication 
completes.  
 
Many perturbations to intracellular or extracellular environments have 
profound effects on cell cycle progression. Since MCM loading is 
coordinated with the cell cycle, we propose that any acute environmental 
change capable of perturbing cell cycle progression has the potential to 
directly influence MCM loading. One example of such a perturbation is 
DNA damage which triggers the degradation of both Cdt1 and Cdc6. We 
have investigated MCM loading in response to cellular stress which blocks 
the cell cycle but does not involve direct DNA damage. Unlike DNA 
damage, cellular stress does not cause the degradation of Cdt1, Cdc6, or any 
other licencing proteins. We find however, that treatment of cells in G1 
with either the inflammatory cytokine, TNFα, or an osmotic shock not only 
blocks de novo MCM loading, but also induces the rapid unloading of 
previously-loaded MCM complexes. This apparent licensing reversal is 
blocked by inhibitors of the MAP kinases central to the cellular stress 
signaling pathway, p38 and JNK. Activation of MAP kinases has no effect 
on the chromatin association of Orc2, Cdc6, or Cdt1.  
 
MCM reloading during S phase and G2 is normally blocked by the 
combined activities of CDKs and the Cdt1 inhibitor, geminin. During a 
G2/M arrest, direct inhibition of CDK activity results in both geminin 
destruction and MCM reloading. Activation of MAP kinases by acute 
cellular stress does not prevent this geminin destruction, but stress kinase 
signaling blocks inappropriate MCM reloading even when geminin levels 
are reduced. These findings may have additional implications for the 
regulation of MCM loading in normal cell cycles.  
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Eukaryotic genomes replicate in define patterns with some parts of the 
genome replicating early in S phase and other parts replicating later. 
Replication timing correlates with transcription, chromatin modification, 
sub-nuclear localization and genome evolution, suggesting an intimate 
association between replication timing and other important aspects of 
chromosome metabolism. However, the mechanism of replication timing is 
currently unknown. 
 
Genome-wide replication kinetics have been mapped in several organisms. 
The rich datasets that result contain more information than has been 
extracted by current methods of analysis. We have developed an analytical 
model that exploits previously unutilized information on the temporal 
aspects of replication. The model incorporates probabilistic initiation of 
origins, variable fork-progression rates, and passive replication. We used 
the model to fit a set of recently published time-course microarray data 
from Saccharomyces cerevisiae. We extracted the distribution of firing 
times for each origin and found that the later an origin fires on average, the 
greater the variation in firing times. This trend leads naturally to a model 
where earlier-firing origins have more initiator complexes loaded and a 
more-accessible chromatin environment. The model demonstrates how 
initiation can be stochastic and yet occur at defined times during S phase, 
without an explicit timing program. Furthermore, we propose that the 
initiators in this model correspond to loaded MCM complexes and that the 
timing of origin firing is regulated in by the number of MCM complexes 
loaded at an origin. Thus, for the first time, our model suggests a detailed, 
testable, biochemically plausible mechanism for the regulation of 
replication timing in eukaryotes. Preliminary experimental validation of our 
model confirms that early firing origins have more MCM loaded. We are 
currently extending this validation by ChIP-seq genome-wide quantitation 
of MCM occupancy. 
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The initiation of eukaryotic DNA replication is regulated by three protein 
kinase classes: cyclin dependent kinases (CDK), Dbf4-dependent kinase 
(DDK) and the DNA damage checkpoint kinases. CDK and DDK trigger 
initiation by activating the pre-loaded Mcm2-7 replicative helicase and 
promoting replisome assembly. CDK phosphorylation of two key initiation 
factors, Sld2 and Sld3, promotes essential interactions with Dpb11 whilst 
DDK acts by directly phosphorylating Mcm2-7 subunits. CDK plays a 
second essential role in replication by preventing the re-loading of Mcm2-7 
during S, G2 and M phases, thus preventing origin re-firing and re-
replication. During G1-phase, both CDK and DDK are down-regulated, 
which is required to prevent premature replication initiation. Origin firing is 
also inhibited during S phase when DNA damage or replication fork stalling 
activates the checkpoint kinases. Here we show that, similar to the situation 
in G1 phase, the checkpoint kinase Rad53 inhibits origin firing in budding 
yeast by interfering with both CDK- and DDK-dependent pathways. Rad53 
acts on DDK directly by phosphorylating Dbf4, whereas the CDK pathway 
is blocked by Rad53 phosphorylation of the downstream substrate, Sld3. 
Rad53 phosphorylation of Sld3 blocks its interactions with Dpb11 and 
Cdc45, an essential replisome component. This allows CDKs to remain 
active during S phase in the presence of DNA damage, which is crucial to 
prevent reloading of Mcm2-7 onto origins that have already fired. We show 
that global origin firing in the presence of active Rad53 only occurs when 
the phosphorylation of both Sld3 and Dbf4 is prevented. Our results explain 
how checkpoints regulate origin firing and show that the slowing of S phase 
by the ‘intra-S checkpoint’ is primarily due to the inhibition of origin firing. 
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Many factors required for chromosomal DNA replication have been 
identified in unicellular eukaryotes. However, DNA replication in complex 
multicellular organisms is poorly understood. Here, we report the 
identification of GEMC1, a novel vertebrate protein required for 
chromosomal DNA replication. GEMC1 is highly conserved in vertebrates 
and is preferentially expressed in proliferating cells. Using Xenopus egg 
extract we show that Xenopus GEMC1 (xGEMC1) binds to checkpoint and 
replication factor TopBP1, which promotes xGEMC1 binding to chromatin 
during pre-replication complex (pre-RC) formation. We demonstrate that 
xGEMC1 directly interacts with replication factors such as Cdc45 and 
Cdk2-CyclinE by which it is heavily phosphorylated. Phosphorylated 
xGEMC1 stimulates initiation of DNA replication whereas depletion of 
xGEMC1 prevents DNA replication onset due to impairment of Cdc45 
loading onto chromatin. Likewise, inhibition of GEMC1 expression by 
morpholino and siRNA oligos prevents DNA replication in embryonic and 
somatic vertebrate cells. These data suggest that GEMC1 promotes 
initiation of chromosomal DNA replication in higher eukaryotes by 
mediating TopBP1 and Cdk2 dependent recruitment of Cdc45 onto 
replication origins. 
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The G1/S phase transition is controlled by the Retinoblastoma protein (Rb) 
and cyclin-dependent kinases (Cdks). Cdks are known to phosphorylate Rb 
on several residues, which controls the interaction of Rb with E2F 
transcription factors. During the G1 phase, phosphorylation of Rb increases 
to the point where it dissociates from E2F and therefore E2F mediated 
transcription is activated, resulting in S phase entry. None of the published 
mouse knockout models displayed a sever defect in DNA replication. This 
included Cdk2, Cdk4, Cdk6, cyclin D’s, cyclin E’s, and cyclin A’s, all of 
which ought to have an important role in S phase. Only cyclin E1-/-E2-/- 
double knockout MEFs could not enter S phase after serum 
starvation&release but these DKO MEFs were fine under continuous 
growth conditions. The most pronounced S phase entry delay was observed 
in Cdk2-/-Cdk4-/- double mutants where Rb remains hypophosphorylated 
and as a consequence Cdk1 transcription is shut off. Previously, we had 
demonstrated that Cdk1 by interacting with cyclin E compensates for the 
loss of Cdk2 in S phase. In summary, these results suggested a possible role 
of Cdk1 in DNA replication. We have now generated conditional knockout 
mice for Cdk1 and are studying S phase in the absence of Cdk1. We will 
report our results of these investigations. 
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In human cells, CDK/cyclin complexes form in precise temporal order with 
a high degree of specificity. Cdk2 binds cyclin E nearly exclusively and 
out-competes Cdk1 in binding cyclin A—thus delaying activation of Cdk1 
until mid-S phase—despite being ~10-fold less abundant than Cdk1. 
Inhibition of CDK-activating kinase (CAK) in vivo revealed kinetic 
differences in activation of Cdk1 and Cdk2 that can account for Cdk2’s 
priority. A computational model suggests that higher affinity of cyclin A for 
Cdk2, and phosphorylation of the Cdk2 T-loop in the absence of cyclin by 
CAK, collaborate to ensure that cyclin A binds Cdk2 before Cdk1. This 
implied essential requirements for Cdk2 activity during G1 and early S 
phase. To test this idea, we replaced Cdk2 with a version sensitized to bulky 
purine analogs, Cdk2as, in human cells. Compared to wild-type Cdk2, 
Cdk2as had diminished binding to cyclin A (but not E) and T-loop 
phosphorylation in vivo; there were corresponding increases in abundance 
of Cdk1/cyclin A complexes in Cdk2as/as cells. ATP analogs rescued both 
cyclin-binding and phosphorylation defects in vivo, with efficacy that 
correlated with their inhibitory potency towards Cdk2as in vitro. We 
recapitulated the inverted cyclin A-binding preference (Cdk1>Cdk2), and 
its correction, in extracts of Cdk2as/as cells; different analogs restored 
binding of added cyclin A to endogenous Cdk2as—at the expense of 
Cdk1—with or without stimulating T-loop phosphorylation, consistent with 
the reinforcing mechanisms predicted by the model. A weak inhibitor, 6-
benzylaminopurine (IC50 ~1 μM), promoted Cdk2as activation in vivo and 
did not slow division of Cdk2as/as cells. An analog that restored Cdk2as-
cyclin A pairing and potently inhibited the kinase, 3-MB-PP1 (IC50 ~5 nM), 
decreased phosphorylation of Cdk2 substrates in vivo, impeded G1/S 
progression and blocked long-term cell proliferation. Therefore, when 
normal levels and pairing specificities of CDKs and cyclins are maintained, 
Cdk2 activity is essential for the mitotic cell cycle. 
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Eukaryotic genomes are duplicated from multiple origins during each cell 
cycle. To study the timing and location of origin firing events, two powerful 
approaches, chromatin-immunoprecipitation (ChIP) and DNA combing, 
have been widely used. However, these methods have drawbacks. ChIP 
measures the average behavior of replication events in many cells, such that 
rare events are lost and imperfect synchronicity obscures transient 
behaviors. Molecular combing eliminates averaging by studying replication 
profiles of single molecules, but provides only static data obtained at 
different time points, from which a dynamic picture must be inferred. To 
obtain a complete kinetic picture, one needs a dynamic means of observing 
origin firing and fork progression.  
We have developed a novel, fluorescence-based technique that allows us to 
directly visualize replication initiation and elongation on single DNA 
molecules in real time. Briefly, a well-stretched lambda phage DNA 
(48.5kb) is tethered at both ends to a coverslip within a microfluidic flow 
cell. Addition of Xenopus laevis egg extract promotes multiple initiations on 
each immobilized DNA molecule, leading to complete duplication. 
Importantly, the observed replication is dependent on Cdt1 and Cdk2, 
indicating it involves a physiological mechanism. By supplementing egg 
extracts with fluorescently-labeled Fen1, which binds PCNA during 
Okazaki fragment processing, we are able to mark sites of ongoing DNA 
replication. Thus, we can follow in real time the firing of individual origins 
and movement of individual forks. We validate this approach by comparing 
our kinetic data to static snapshots of nascent DNA at different times after 
initiation. Our preliminary data suggest that the inter-origin distance 
measured dynamically is lower than when using a static imaging approach. 
Thus, the number of initiation events is likely higher than suggested by 
previous approaches.  
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The accurate duplication of chromosomal DNA is required to maintain 
genomic integrity. However, from an evolutionary point of view, a low 
mutation rate during DNA replication is desirable. One way to strike the 
right balance between accuracy and limited mutagenesis is to employ a 
DNA polymerase that lacks proofreading activity, but contributes to DNA 
replication in a very restricted manner. DNA polymerase-α (pol-α) fits this 
purpose exactly, but little is known about its regulation at the replication 
fork. Minichromosome maintenance protein (Mcm) 10 regulates the 
stability of the catalytic subunit of pol-α in budding yeast and human cells. 
Cdc17, the catalytic subunit of pol-α in yeast, is rapidly degraded following 
depletion of Mcm10. Here, we show that Ubc4 and Not4 are required for 
Cdc17 degradation. Disruption of Cdc17 degradation resulted in sensitivity 
to hydroxyurea, suggesting that this pathway is important for DNA 
replication. Furthermore, overexpression of Cdc17 in ubc4 and not4 
mutants caused slow growth and synthetic dosage lethality, respectively. 
Our data suggest that Cdc17 levels are very tightly regulated through the 
opposing forces of Ubc4 and Not4 (degradation) and Mcm10 (stabilization). 
We conclude that regular turnover of Cdc17 via Ubc4 and Not4 is required 
for proper cell proliferation. 
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Upon checkpoint activation, the kinase Rad53 (Chk2 in mammals) blocks 
the firing of late replicating origins. The mechanism underlying this 
function of Rad53 remains unknown. Here, we show that the replication 
initiation protein Sld3 is phosphorylated by Rad53, and that this 
phosphorylation, along with phosphorylation of the Cdc7 kinase regulatory 
subunit Dbf4, blocks late origin firing. Upon exposure to DNA damaging 
agents, cells expressing SLD3 and DBF4 phosphorylation-deficient mutants 
(SLD3-m25 and dbf4-m25, respectively) proceed through S-phase faster 
than wild-type cells, and inappropriately fire late origins of replication. 
Moreover, SLD3-m25 dbf4-m25 cells grow poorly in the presence of the 
replication inhibitor hydroxyurea. We found that SLD3-m25 dbf4-m25 cells 
are delayed in recovering from transient blocks to replication, accumulate 
multiple Rad52 foci in S-phase and subsequently arrest at the DNA damage 
checkpoint. These data suggest that the intra-S-phase checkpoint functions 
to block late origin firing in adverse conditions to prevent genomic 
instability and maximize cell survival. 
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DNA inter-strand crosslink (ICL) occurs in the opposite strand of DNA that 
severely blocks replication fork progression. The products of lipid peroxidation 
and other forms of oxidative DNA damage are potential sources for endogenous 
ICLs. On the other hand, exogenous ICL agents, such as Cisplatin and 
Mitomycin C, are commonly used for anticancer drugs. Therefore, 
understanding cellular response to DNA ICL is critical for more effective 
utilization of these compounds and for the identification of novel therapeutic 
targets.  
 
ICL repair involves many distinct DNA repair pathways, including nucleotide 
excision repair, translesion synthesis and homologous recombination. 
Importantly, proteins implicated in the multigenic disease Fanconi anemia have 
a role in ICL repair. Fanconi anemia (FA) is a rare human genetic disease that 
causes severe bone marrow failure and an increased susceptibility to cancer. 
Thirteen different FA genes (FANC-A, -B, -C, -D1, -D2, -E, -F, -G, -I, -J, -L, -
M, and –N) have been identified and mutation of any one of the FA genes 
results in distinct chromosomal abnormalities and hypersensitivity to ICL 
agents.  
 
Despite the identification of thirteen of the FA genes, the mechanism by which 
proteins encoded by these genes protect a cell from ICLs remains to be 
elucidated. Among the open questions are how do FA proteins respond to DNA 
ICLs and interact with DNA, and what is the functional significance of these 
interactions. 
 
FANCM (FA complementation group M) and its binding partner, FAAP24 (FA-
associated protein of 24 kDa) anchor the multisubunit FA nuclear core complex 
to chromatin. Here we show that the FANCM/FAAP24 heterodimer is 
selectively required for the recruitment of replication protein A (RPA) to ICLs-
stalled DNA replication forks in vivo and in vitro. FANCM/FAAP24-dependent 
RPA foci formation is required for chromatin association of ATR and 
checkpoint activation. Interestingly, the DNA translocase activity of FANCM is 
dispensible for RPA recruitment, but DNA binding activity of FAAP24 is 
critical for this function. Taken together, our study demonstrate that 
FANCM/FAAP24 forms a unique structure with RPA and promote RPA 
binding at ICL-stalled replication forks, and this is required for ATR-mediated 
checkpoint response.  
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The DNA damage checkpoint kinase Mec1ATR is critical for maintaining the 
integrity of replication forks. While it has been proposed to promote fork 
repair, the mechanisms by which Mec1 regulates DNA repair factors remain 
unclear. Here we found that Mec1 mediates a key interaction between the 
fork protein Dpb11 and the DNA repair scaffolds Slx4-Rtt107 to regulate 
replication stress response. Dissection of the molecular basis of the 
interaction reveals that Slx4 and Rtt107 jointly bind Dpb11 and that Slx4 
phosphorylation is required. Mutation of Mec1 phosphorylation sites in 
Slx4 disrupts its interaction with Dpb11 and compromises the cellular 
response to replisomes blocked by DNA alkylation. Proteomic analysis 
reveals that multiple fork repair factors associate with Rtt107 or Slx4 
supporting that Mec1-dependent assembly of the Rtt107-Slx4-Dpb11 
complex functions to coordinate fork repair. Our results unveil a new role 
for Mec1 and establish a mechanistic link between DNA damage signaling 
and fork repair. 
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Entry into mitosis must occur abruptly, irreversibly, and at the correct time. 
Although the molecular players in this process are well known, their 
quantitative relationships had been lacking for mammalian cells. Recently, 
we established an in vitro system from human (HeLa) cell extract that 
recapitulates activation of the “engine” of mitosis, CDK1, in response to the 
mitotic cyclins. We found that CDK1 is activated in a multistage response 
to cyclin B that is orchestrated by the WEE1 and CDC25 feedback loops. 
As purified cyclin B is added to the extract, a low level of CDK1 activity is 
produced, and a complex is formed between cyclin B-CDK1, and WEE1. 
This low CDK1 activity phosphorylates and appears to activate WEE1 to 
prevent further increases in CDK1 activity despite addition of more cyclin 
B. Eventually, however, at a cyclin B concentration (~600 nM) equivalent 
to what drives mitosis in intact cells, cyclin B can overcome WEE1 
buffering, dissociate WEE1 from cyclin B-CDK1 complex, and activate 
CDC25 phosphatases to promote full CDK1 activation. Cyclin A augments 
the activation of CDK1 by weakening the WEE1 negative feedback loop. 
This system has helped elucidate several unappreciated facets of mitotic 
regulation. However, in cells the integrity of chromosomes is under 
constant assault. As a result the mitotic circuit is accompanied by a DNA 
damage response that blocks cell division in the presence of genomic 
insults. To understand the integration at a mechanistic level beyond what 
has been feasible in cells, we combined our mitotic entry system with DNA 
damage signaling. Addition of broken DNA to the extract leads to ATM and 
CHK2 phosphorylation with in vivo-like kinetics, and the subsequent 
reduction of both cyclin A- and B-dependent kinase activity. Importantly, 
the CDK1 inhibition is equivalent to that seen when CDC25 is inhibited, 
suggesting CDC25 as the damage response target. This effect can be 
overcome by blocking the checkpoint with caffeine to inhibit ATM or by 
obviating the need for CDC25 with an inhibitor of the WEE1 kinase. 
Currently we are assessing the relationship between the level of checkpoint 
(CHK2) activation and the inhibition of CDK1 activity. From these data we 
are creating a quantitative model that describes how a small amount of 
DNA damage can be amplified to a signal that can suppress CDK1 from 
fully activating and driving cell division. 
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p53 stability and localization is essential for its tumor suppressor function. 
Ubiquitination by the E3 ubiquitin ligase Mdm2 is the major regulatory 
mechanism of p53, which induces p53 nuclear export and degradation. 
However, it is unclear whether ubiquitinated cytoplasmic p53 can be 
recycled. We found that USP10, a cytoplasmic ubiquitin-specific protease, 
deubiquitinates p53, reversing Mdm2-induced p53 nuclear export and 
degradation. Following DNA damage, USP10 is stabilized and a fraction of 
USP10 translocates to the nucleus to activate p53. The translocation and 
stabilization of USP10 is regulated by ATM -mediated phosphorylation of 
USP10 at Thr42 and Ser337. USP10 suppresses tumor cell growth in cells 
with wild-type p53, with USP10 expression downregulated in a high 
percentage of clear cell carcinomas, known to have few p53 mutations. 
Most recently, we also found that USP10 is negatively regulated by G3BP1 
(RasGAP binding protein 1), which is frequently overexpressed in several 
cancers. We show that G3BP1 promote cancer cell growth by inhibiting p53 
through USP10. Overall, our findings reveal USP10 to be a novel regulator 
of p53, providing an alternative mechanism of p53 inhibition in cancers 
with wild-type p53. 
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Genome integrity is protected by checkpoint proteins such as Chk1 and p53 
that halt cell cycle progression in cells experiencing genotoxic- or 
replicative-stress. Half of all human cancers harbor a deletion or 
inactivating mutation of TP53 rendering them resistant to DNA damaging 
agents and anti-metabolites. Chk1 serves a protective function in p53 
deficient tumors as the combination of DNA damage and Chk1 inhibition 
induces selective killing of p53-deficient tumors. To date, experiments 
monitoring the selective killing of p53-deficient cells by combining DNA 
damage with Chk1 inhibition have utilized transformed cells cultured in 
vitro or grown as xenografts in vivo. Cultured cells accumulate many 
mutations as a result of continuous passaging in vitro. Thus, although TP53 
can be sequenced in each cell line and the integrity of the p53 pathway 
assessed, it is impossible to know all of the genetic changes that have taken 
place and how these alterations contribute to the experimental outcome. 
Therefore, in this study mice that were wild-type or null for either TP53 or 
its downstream effector p21Waf1/Cip1 were treated with the DNA 
damaging agent irinotecan followed by the Chk1 inhibitor UCN-01 and 
small intestinal epithelial cells were assessed for cell cycle arrest, DNA 
damage, checkpoint abrogation and apoptosis. The combination of 
irinotecan and UCN-01 induced selective checkpoint bypass and apoptosis 
in intestinal epithelial cells that were null for TP53 demonstrating that p53 
status is a key determinant of how cells with DNA damage respond to Chk1 
inhibition. intestinal epithelial cells null for p21Waf1/Cip1 exhibited 
enhanced DNA damage, checkpoint bypass and apoptosis relative to TP53 
null cells after exposure to the combination treatment. These results 
demonstrate that basal levels of p21 provide a protective effect against 
DNA damage and indicates that tumor with low levels of p21 may be 
particularly sensitive to therapies that combine a DNA damaging agent or 
anti-metabolite with a Chk1 inhibitor. 
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Eukaryotic cells are equipped with coordinated systems to contend with 
DNA damage, such as cell cycle arrest mechanisms, DNA repair pathways 
and the apoptotic response. Together, these maintain genomic integrity. 
These systems are partly regulated by transcriptional activation and 
repression. DNA damage alters the global pattern of gene expression to 
orchestrate a variety of cellular events. Following UV irradiation, about 4 % 
of transcripts show more than 3 fold changes. Transcriptional activation is 
relatively well characterized in this context with sequence specific 
transcriptional activators, such as p53 and NF-κB. However, transcriptional 
repression is largely unknown although 90 % of transcripts are 
downregulated. We recently found that DNA damage-induced suppression 
of cell cycle regulatory genes correlates with a reduction in histone H3-T11 
phosphorylation (H3-pT11) on their promoters that is partly mediated by 
dissociation of Chk1 from chromatin. The molecular mechanism(s) by 
which H3-T11 dephosphorylation triggers transcriptional repression 
remains unclear. Here, we identify protein phosphatase 1γ (PP1γ)-HDAC3 
complexes that provide combined phosphatase-HDAC activity that 
cooperatively deacetylates/dephosphorylates at H3-K9/T11. PP1γ activity is 
regulated by Cdk1-dependent PP1γ-T311 phosphorylation and NIPP1 
interaction. During unperturbed S phase, a Chk1-GCN5-E2F1 complex 
resides at the E2F binding sites of cyclin B1 and cdk1 promoters. After 
DNA damage, activated PP1γ dephosphorylates pRb, which results either in 
recruitment of the PP1γ-HDAC3-pRB complex to E2F1, or replacement of 
Chk1-GCN5-E2F1 with PP1γ-HDAC3-p107-E2F4. Both events ultimately 
lead to transcriptional repression of cyclin B1 and cdk1. Our results suggest 
that H3-K9/T11 at E2F binding sites functions as a “phospho-acetyl” code 
regulated by Chk1-GCN5 and PP1γ-HDAC3 complexes, whose usage is 
dependent on the level of Cdk activity. 
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Telomeric DNA resembles a DNA Double Strand Break (DSB), making 
telomeres vulnerable to recognition and processing by the DNA Damage 
Response (DDR). single-stranded DNA (ssDNA) binding proteins of the 
telomere cap, such as Cdc13 in budding yeast and POT1 in human cells, 
help prevent recognition of the telomeric DNA by the DDR. When Cdc13 is 
inactivated telomeres become ‘uncapped’ and extensive resection of the 
telomeric DNA occurs by nuclease activities to reveal many kilobases of 
ssDNA. Telomeric ssDNA then stimulates a potent checkpoint response and 
arrests the cell at metaphase, ultimately leading to cell death.  
 
Exo1 is the only nuclease so far identified that resects uncapped telomeres. 
We report that the helicase Pif1 as an essential component of a nuclease 
activity that functions in parallel to Exo1 to resect uncapped telomeres. The 
Pif1- and Exo1-dependent nucleases have different properties; ssDNA 
generated by Pif1 is sufficient, but not necessary, to cause checkpoint 
activation in the majority of cells, while ssDNA generated by Exo1 is 
sufficient to cause checkpoint activation in all cells. Inactivation of both the 
Pif1- and Exo1-dependent nuclease activities eliminates resection of the 
telomeric DNA at uncapped telomeres, preventing Rad53-dependent 
checkpoint activation and metaphase arrest in response to telomere 
uncapping. 
 
Remarkably, elimination of Pif1 and Exo1 overcomes the requirement for 
telomere capping by Cdc13, as CDC13 can be deleted. Interestingly, 
telomeres are maintained and increase in length over time in cells lacking 
Cdc13, suggesting that Cdc13-independent mechanisms of telomerase 
recruitment occur. 
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A common hallmark of human cancers is the overexpression of telomerase, 
a ribonulceoprotein complex responsible for maintaining the length and 
integrity of chromosome ends. Telomere length deregulation and telomerase 
activation is an early and perhaps necessary step in cancer cell evolution. In 
fact ~85% of human tumors show high levels of telomerase activity when it 
is dormant in most somatic cells. Efforts to elucidate in detail the complex 
mechanism of telomere replication by telomerase as well as attempts to 
discover cancer and aging therapies that target this enzyme have been 
hindered to a certain extend by the absence of structural information. 
 
The recent high-resolution structure of the catalytic subunit of telomerase 
from T. castaneum reveals a number of novel and unexpected results that 
greatly enhance our understanding of telomerase action on telomeres. The 
protein consists of four highly conserved domains, organized into a ring-
like structure that shares common features with retroviral reverse 
transcriptases, viral RNA polymerases and to a certain extend the 
bacteriophage B-family DNA polymerases. Domain organization places 
motifs implicated in substrate binding and catalysis in the interior of the 
ring, which can accommodate seven-to-eight bases of double stranded 
nucleic acid, which corresponds to the length of the RNA templating region 
of telomerase from this organism. We recently determined the high 
resolution structure of TERT in complex with its RNA-template and 
telomeric DNA, data that provides for the first time direct evidence of a 
partial telomerase elongation complex. 
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Activation of the DNA damage checkpoint causes a cell cycle arrest via 
inhibition of cyclin-dependent kinases (cdks). In order to successfully 
recover from the arrest, a cell should somehow be maintained in the proper 
cell cycle state. This problem is particularly eminent when a cell arrests 
in G2, as cdk-activity is important to establish a G2 state. We have 
identified the phosphatase Wip1 (PPM1D) as a factor that maintains a cell 
competent for cell cycle re-entry during an ongoing DNA damage response 
in G2. We show that Wip1 function is required throughout the arrest, and 
that Wip1 acts by antagonizing p53-dependent repression of crucial mitotic 
inducers. Our data show that the primary function of Wip1 is to retain 
expression of the proper cell cycle regulators during the arrest, rather than 
to silence the checkpoint to promote recovery. Our findings uncover Wip1 
as a first in class recovery “competence” gene, and suggest that the 
principal function of Wip1 in cellular transformation is to retain  
proliferative capacity in the face of oncogene-induced stress. In addition  
we found that the Forkhead transcription factor FoxM1, an important 
regulator of gene expression in the G2-phase of the cell cycle, is also 
required for cell cycle re-entry following DNA damage. We show that 
FoxM1 is transcriptionally active during a DNA damage-induced G2 arrest 
and this is essential for checkpoint recovery. Paradoxically, Cdk activity, 
although reduced after checkpoint activation, is required to maintain 
FoxM1-dependent transcription during the arrest and is essential for 
sustained expression of pro-mitotic targets, such as Cyclin A, Cyclin B and 
Plk1. Indeed we find that cells need to retain sufficient levels of Cdk 
activity during the DNA damage response to maintain cellular competence 
to recover from a DNA damaging insult. These data demonstrate that 
cellular competence to recover from a DNA damage-induced arrest needs to 
be actively sustained during the ongoing arrest. In addition, our studies have 
uncovered the first factors that control recovery competence and open the 
way for studies aimed to understand how cells determine their fate 
following a DNA damaging insult.
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Alzheimer’s disease is the predominant cause of age-associated dementia 
and one of the leading causes of death. Because this slow-progressing 
pathology affects some 10% of individuals over age 65 and almost half of 
those over 85, it imposes a tremendous emotional and financial burden on 
our society. It is widely accepted that a small 40-42 amino acid long 
Alzheimer’s Amyloid-beta (Aβ) peptide plays a key role in the generation 
and progression of this neuropathology. We established that aneuploidy is 
one of the hallmarks of Alzheimer’s disease and demonstrated that it might 
be induced by an Aβ-dependent mechanism. Our recent studies showed that 
Aβ impairs formation and stability of the mitotic spindle. Indeed, as was 
shown in the Xenopus egg extracts, addition of Aβ resulted in spindles that 
do not reach full length, are bent, atrophic, collapsed and display a disarray 
of microtubule fibers within the spindle. We attribute these phenotypes to 
malfunction of mitotic microtubule-based motor kinesins, particularly Eg5, 
KIF4A, and MCAK. Our further analysis confirmed that above-mentioned 
motor kinesins are directly bound to and inhibited by Aβ. Our results 
indicate that Aβ may disrupt binding of motor kinesins to microtubules, 
whereby abrogating the motor functions. We propose that Aβ-mediated 
inhibition of the kinesin motors is directly implicated in the generation of 
aneuploidy typical of Alzheimer’s disease.  
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The deubiquitinating enzyme BAP1 possesses growth inhibitory activity 
and functions as a tumor suppressor. In this study, we report that BAP1 also 
plays positive roles in cell proliferation. BAP1 depletion by RNAi inhibits 
cell proliferation as does overexpression of a dominant negative mutant of 
BAP1. Mass spectrometry analyses of copurified proteins revealed that 
BAP1 is associated with a cell cycle regulator, HCF-1, and transcription 
factors FoxK1 and FoxK2, suggesting that BAP1 may be involved in 
regulation of gene expression. We show that HCF-1, BAP1, and FoxK1/K2 
form a ternary complex, in which BAP1 bridges HCF-1 and FoxK1/K2. 
HCF-1 is a heterodimer of HCF-1N and HCF-1C, which are produced by 
proteolytic processing of a large precursor protein. The Kelch domain in 
HCF-1N binds to transcription factors such as E2F family members by 
recognizing a conserved peptide sequence, (D/E)HXY, known as the HCF-
1-binding motif (HBM). By functioning as a scaffold to recruit histone-
modifying enzymes to promoters, HCF-1 regulates gene expression through 
selective modulation of chromatin structure. We show that HCF-1N is 
modified with K48-linked polyubiquitin chains on its Kelch domain. The 
HBM of BAP1 is required for interaction with HCF-1N and mediates 
deubiquitination of HCF-1N by BAP1. The importance of the BAP1-HCF-1 
interaction is underscored by the fact that growth suppression by the 
dominant negative BAP1 mutant is entirely dependent on the HBM. These 
results suggest that BAP1 regulates cell proliferation by deubiquitination of 
CF-1. 
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A mammalian homologue of Drosophila diaphanous and a member of the 
formin-homology (FH) family of proteins, mDia3, has been reported to 
localize at kinetochores and siRNA-induced defects in metaphase 
chromosome alignment. However, how direct these effects are remains 
unclear. We are able to reproduce the observation that knock down of 
formin mDia3 using siRNA in mammalian cultured cells led to 
chromosome misalignment. The alignment could be rescued by a siRNA-
resistant form of wild-type mDia3, as well as a siRNA-resistant mDia3 
mutant that is defective in actin nucleation, but not in stabilizing 
microtubules. We subsequently mDia3 is phosphorylated by Aurora B 
kinase in vitro with purified recombinant components and in cultured cells. 
Cells expressing the non-phosphorylatable mDia3 mutant cannot position 
chromosomes at the metaphase plate. Strikingly, cells expressing the 
phosphomimetic mDia3 mutant are able to achieve metaphase chromosome 
alignment even in the presence of an Aurora B kinase inhibitor. However, 
the kinetochore fibers are not stable against cold treatment in cells with the 
phosphomimetic mDia3 mutant. Further, Aurora B phosphorylation reduced 
mDia3 microtubule stabilization activity in vitro using purified recombinant 
proteins. Thus, mDia3 is a physiological substrate of Aurora B in achieving 
stable kinetochore microtubule attachment in which Aurora B kinase 
directly regulates mDia3 microtubule stabilization activity.  
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Recent insights have expanded our understanding of sister chromatid 
cohesion pathways. Of particular interest is the growth in number of anti-
establishment factors. Current models suggest that anti-establishment 
factors preclude precocious pairing reactions until Ctf7/Eco1-dependent 
acetylation of Smc3. Of particular interest is deletion of anti-establishment 
factors greatly suppresses growth defects of ctf7/eco1 mutant cells. New 
studies have identified two classes of anti-establishment factors: those that 
are cohesin-associated (Rad61/WAPL and Pds5) and those that are DNA 
replication fork-associated (Elg1-RFC).  
Here, we report that anti-establishment activities of RAD61 and ELG1 are 
indistinguishable when assayed both genetically and functionally. These 
findings suggest that both perform within a singular anti-establishment 
mechanism that is sensitive to Smc3 acetylation. We also characterize 
further pro-establishment activities such as Ctf18-RFC - currently thought 
to promote Ctf7/Eco1 acetylation of Smc3. In contrast to this model, our 
results reveals that smc3 acetylation mimics fail to bypass the roles of 
CTF18 in cohesion establishment. In combination, these findings reveal that 
cohesion regulatory activities are much more complicated than currently 
discussed in the literature. 
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Separation of the duplicated centrosomes upon mitotic entry is essential for 
spindle formation and to avoid aneuploidy, the latter being one of the 
hallmarks of cancer cells. A critical kinase that is involved in centrosome 
separation during mitotic entry is the NIMA-related Nek2A kinase that 
displaces linker proteins between two centrosomes upon phosphorylation. 
Current models suggest that Nek2A activity reaches a critical threshold in 
prophase, which then dissolves this linkage. The data presented in this study 
revise this model, describing a novel function for Hippo pathway 
components at the centrosome. Hippo pathway is well known for its 
function in tissue/organ growth and apoptosis. Here, we report that two 
Hippo pathway components, the mammalian sterile 20-like kinase 2 (Mst2) 
and the scaffold protein Salvador (hSav1), regulate the NIMA-related 
kinase Nek2A in its ability to initiate centrosome disjunction at mitotic 
entry. Nek2A has a SARAH-like coiled-coil region at its extreme C-
terminus that mediates direct interaction with the SARAH domains of 
hSav1 and Mst2. siRNA depletion experiments reveal that Mst2 and hSav1 
are important for the centrosomal localization of Nek2A. Moreover, 
hSav1/Mst2-dependent recruitment of Nek2A to centrosomes regulates 
Nek2A-dependent phosphorylation of C-Nap1 and rootletin, centrosomal 
linker proteins whose phosphorylation triggers centrosome separation. Mst2 
directly phosphorylates Nek2A and Nek2A mutants that are no longer 
phosphorylated by Mst2 fail to induce centrosome splitting. We propose 
that hSav1 and Mst2 regulate localized activity of Nek2A at centrosomes 
thus resolving centrosome cohesion in early mitosis. 
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The spindle checkpoint, which blocks segregation until all sister chromatid 
(SC) pairs have been stably connected to the two spindle poles, is perhaps 
the biggest mystery of the cell cycle. The main reason seems to be that the 
spatial correlations imposed by microtubules between kinetochores and the 
nonlinear dependence on the increasing number of attached kinetochores, 
have been disregarded in earlier studies. From these missing parts a non-
equilibrium collective spindle-chromosome interaction is obtained for 
budding yeast (Saccharomyces cereviciae) (J. Phys. Cond. Matter 21 (2009) 
502101). In this interaction tension decreases nonlinearly with the number 
of attached kinetochores and becomes equally distributed between all 
bioriented SC pairs, blocking segregation until all sister chromatids pairs 
are bi-oriented without need of a "wait-anaphase" signal. The model thus 
explains how the committment to anaphase could be synchronized. It also 
predicts kinetochore oscillations at a frequency which agrees well with 
observation. Finally, a relationship between this model interaction and the 
force-extension formula of a single DNA molecule is obtained. 
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Background 
The FACT complex participates in chromatin assembly and disassembly 
during transcription elongation. Yeast mutants affected in the SPT16 gene, 
which encodes one of the FACT subunits, exhibit defects in the G1-S 
transition.  
 
Methodology/Principal Findings 
Here we show that the dysfunction of chromatin reassembly factors like 
FACT or Spt6 down-regulates the expression of the gene encoding the 
cyclin that modulates G1 length (CLN3) during this phase of the cell cycle, 
by specifically triggering the repression of its promoter. The G1 delay 
suffered by spt16 mutants is not mediated by the DNA-damage checkpoint, 
although mutation of RAD53 enhances the cell-cycle defects of spt16-197. 
We show that the dysfunction of FACT produces an accumulation of free 
histones evicted from transcribed chromatin. This accumulation is enhanced 
in a rad53 background and it leads to a delay in G1. We also show that the 
overexpression of histones in wild-type cells down-regulates CLN3 and 
causes a delay in G1. 
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Time series experiments on synchronized cell populations reveal dynamic 
behaviors underlying cell-cycle progression. Cell cycle-regulated genes, for 
example, often oscillate, peaking in expression at a particular cell-cycle 
phase. Comparison of measurements from two different time series 
experiments is made all the more difficult without knowledge of the time in 
which cells traverse the cell cycle and the time required for recovery from 
synchronization. Previous approaches (Orlando et al., Nature 2008) have 
relied on morphological features (eg. presence of buds in budding yeast, S. 
cerevisiae) in the cell populations to estimate these two parameters. Also, 
these approaches infer only one set of parameters per experiment, omitting 
the possibility of different period lengths. To address these two issues we 
developed a Bayesian statistical method for cell-cycle parameter inference. 
We applied the approach to time series gene expression data for a wild type 
strain and two different mutant strains of budding yeast. For one of the 
mutant strains, a strain capable of budding but lacking S phase and mitotic 
cyclin activity, we were able to consistently recover parameters comparable 
to those identified by previous methods. Upon comparison with wild type 
data, we found that nearly 1100 genes retained periodic patterns of 
expression in this strain. We were also able to recover parameters for the 
second mutant strain, cdc28-4. This strain lacked budding capability and 
had non-functional cyclin-dependent kinase activity at restrictive 
temperature. Comparison with wild type data revealed an extended cycle 
time for the cdc28-4 mutants and, surprisingly, almost 800 genes that 
remained periodically expressed in spite of the absence of a functional 
cyclin-dependent kinase. While we applied this approach to budding yeast 
experiments, the method is adaptable to time series measurements from 
other experiments and organisms. 
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DNA replication is fundamental for cell division where it is required for the 
duplication of genetic information that will be equally distributed into 
daughter cells during mitosis. Understanding factors required for DNA 
replication will enrich our knowledge of this important process and 
potentially identify vulnerabilities that can be exploited therapeutically in 
disease states typified by uncontrolled cell division such as cancer. To 
identify proteins with essential roles in DNA replication we developed an 
assay that measures the stability of maintenance of an episomal plasmid in 
human cells that have been transduced with short hairpin RNAi (shRNA) 
targeting the expression of 54 genes of poorly understood function. These 
genes are either up-regulated during G1/S or have been observed to interact 
with human ORC. RNA interference of known replication factors 
significantly impairs plasmid stability in cells supporting that the plasmid 
can be used as a reporter of DNA replication activity. We identified 6 genes 
from the screen that had no appreciated role in DNA replication but are 
required for plasmid stability. AND-1 is one of the genes identified and has 
recently been reported to have an essential activity in DNA replication. 
DDX5, a member of the family of DEAD-box RNA helicases, is another 
gene identified and multiple shRNA’s targeting this gene significantly 
impair both cell proliferation and plasmid stability. Consistent with an 
important role in DNA replication DDX5 knockdown results in down-
regulated expression of replication factors, reduced association of 
replication factors with chromatin during S-phase, and impaired S-phase 
entry/progression. Moreover we have found that the DDX5 locus is 
frequently amplified in breast cancer where cell lines containing 
amplification of the locus also overexpress DDX5 protein compared to cell 
lines that do not have amplification of the locus. Intriguingly, knockdown of 
DDX5 in an amplification containing breast cancer cell line impairs 
proliferation whereas knockdown in a non-amplification breast cancer cell 
line does not suggesting that DDX5 contributes toward breast cancer 
development. These results demonstrate a new activity for DDX5 in 
regulating DNA replication and support an oncogenic role for DDX5 in 
breast tumorigenesis. 
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Stem cell division patterns are unusual in that they generate two types of 
daughter cells: daughters that remain stem cells (self-renewal) and 
daughters that will differentiate into somatic cells. The balance between 
self-renewal and somatic cell production must be carefully balanced in 
order to produce an adequate number of somatic cells without depleting the 
stem cell population. A defect in this balance could cause tissue 
degeneration. Despite their obvious importance, the mechanisms that 
control the choice between self-renewal and somatic cell production are 
poorly understood. 
 
The unstable regulatory protein Geminin is thought to maintain cells in an 
undifferentiated state while they proliferate. Geminin is a bi-functional 
protein. It limits the extent of DNA replication to one round per cell cycle 
by binding and inhibiting the essential replication factor Cdt1. Loss of 
Geminin leads to replication abnormalities that activate the DNA replication 
checkpoint and the Fanconi Anemia (FA) pathway. Geminin also influences 
patterns of cell differentiation by interacting with Homeobox (Hox) 
transcription factors and chromatin remodeling proteins. 
 
To examine how Geminin affects the proliferation and differentiation of 
hematopoietic stem cells, we created a mouse strain in which Geminin is 
deleted from the proliferating cells of the bone marrow. Geminin deletion 
has profound effects on all three hematopoietic lineages. The production of 
mature erythrocytes and leukocytes is drastically reduced and the animals 
become anemic and neutropenic. In contrast, the population of 
megakaryocytes is dramatically expanded and the animals develop 
thrombocytosis. Interestingly, the extent of DNA replication is largely 
normal. We conclude that Geminin deletion causes a maturation arrest in 
some lineages and directs cells down some differentiation pathways at the 
expense of others. We are now testing how Geminin loss affects cell cycle 
checkpoint pathways, whether Geminin regulates hematopoietic 
transcription factors, and whether Geminin deficient cells give rise to 
leukemias or lymphomas. 
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The Mck1 protein kinase has proposed functions in a variety of pathways 
from chromosome segregation to calcium stress response. By performing a 
synthetic dosage lethality screen in an mck1 mutant, we identified Mih1 as 
a putative target of the Mck1 kinase. Mih1 is a tyrosine phosphatase that 
removes the Cdc28/Cdk1 inhibitory tyrosine phosphorylation imposed by 
the Swe1 kinase to transition cells through mitosis. Mih1 is hyper 
phosphorylated early in the cell cycle and is dephosphorylated as cells enter 
mitosis. We find changes in the phosphorylation state of Mih1 during the 
cell cycle in an mck1 mutant strain. Yet, we do not detect dramatic defects 
in the mck1 mutant’s mitotic cell cycle transition. Instead, our data suggests 
that the regulation of Mih1 by Mck1 may be important for a target other 
than mitotic Cdc28/Cdk1. Our current work is aimed at identifying 
additional targets of Mih1 and characterizing the interaction between Mck1 
and Mih1. 
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In a screen for cell-cycle regulators, we identified a Drosophila maternal 
effect-lethal mutant that we named “no poles” (nopo). Embryos from nopo 
females undergo mitotic arrest with barrel-shaped, acentrosomal spindles 
during the rapid S-M cycles of syncytial embryogenesis. The no poles 
(nopo) phenotype is similar to that observed when Checkpoint kinase 2 
(Chk2) is activated in the early Drosophila embryo. We showed that the 
spindle/centrosomal and developmental defects of nopo mutants are 
strongly suppressed by Chk2 mutation. Furthermore, we found that Chk2 
nopo mutants exhibit a significantly shorter interphase 11 as compared to 
wild type, suggesting that nopo mutants may enter mitosis with 
incompletely replicated DNA. We hypothesize that NOPO regulates timing 
of S-M transitions in syncytial embryos to ensure that S-phase is of 
sufficient length to allow completion of DNA replication prior to mitotic 
entry; however, the precise mechanism of NOPO function is unknown. 
 
nopo encodes an E3 ubiquitin ligase. We showed that NOPO interacts with 
the E2 conjugating enzyme, Bendless (BEN), via yeast two-hybrid assay. 
We also found that ben-derived embryos arrest during early embryogenesis 
and exhibit a nopo-like phenotype. We hypothesize that BEN and NOPO 
form an E2-E3 complex required during syncytial embryogenesis for 
genomic integrity, cell-cycle progression, and continuation of development. 
NOPO’s mammalian homolog, TRAF-interacting protein (TRIP), was 
identified for its role in TNF signaling, although it has been proposed to 
have additional functions. 
 
To gain insight into the biological roles of NOPO/TRIP, we performed a 
yeast two-hybrid screen for human TRIP interactors. We identified a family 
of DNA polymerases that facilitate the replicative bypass of damaged DNA 
(translesion synthesis) as TRIP interactors. We have also shown that NOPO 
interacts with Drosophila homologs of these DNA polymerases via yeast 
two-hybrid assays. We are currently testing these proteins as potential 
substrates of NOPO/TRIP E3 ligases. Future efforts will focus on placing 
NOPO/TRIP within a molecular framework so as to elucidate the 
mechanism by which it promotes genomic stability. 
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In budding yeast the protein phosphatase Cdc14 controls exit from mitosis. 
The activity of Cdc14 is regulated by a competitive inhibitor, Cfi1/Net1, 
which binds to and sequesters the phosphatase in the nucleolus from G1 up 
to metaphase. During anaphase, Cdc14 is released from its inhibitor and 
spreads throughout the nucleus and the cytoplasm, where it reaches its 
targets and triggers mitotic exit. The Cdc Fourteen Early Anaphase Release 
(FEAR) network promotes the release of Cdc14 from its inhibitor during 
early anaphase whereas the Mitotic Exit Network (MEN) promotes and 
maintains the release of Cdc14 during late stages of anaphase and telophase. 
Both the Polo-like kinase Cdc5 and the Clb2/CDK complex have been 
involved in promoting the release of Cdc14 in early anaphase as 
components of the FEAR network but their function and relationship in the 
network have remained unclear. We found that Cdc5 and Clb2/CDK 
cooperate to promote the release of Cdc14 from the nucleolus. Interestingly, 
we observed that in response to CDC5 overexpression and concomitant to 
Cdc14 release, Clb2 becomes phosphorylated. We are currently 
investigating the consequences of this(ese) phosphorylation event(s) on 
Clb2 and its(their) relevance for the release of Cdc14 in early anaphase. 
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The Drosophila egg chamber provides the opportunity to study regulation of 
mitosis, meiosis, and the endocycle in a single cluster of 16 germ cells. In 
wild type oogenesis, a single germ cell undergoes four incomplete, 
synchronous divisions to generate a cyst of 15 nurse cells and one oocyte. 
As the egg chamber grows, the oocyte is transcriptionally quiescent and 
arrests in Meiotic Prophase I. The oocyte chromosomes compact into a 
spherical karyosome. Meanwhile, the nurse cells are transcriptionally active 
and undergo many endocycles. For the first four endocycles, the nurse cell 
chromosomes are polytene and they exhibit a characteristic clumped 
morphology. Starting at the fifth endocycle, the chromosomal organization 
changes, leading to a more dispersed morphology.  
 
Three alleles of the previously unidentified Drosophila gene, fried, were 
uncovered in a clonal germline screen for oogenesis mutants on 
chromosome 3R. fried egg chambers contain 15 nurse cells and one oocyte, 
indicating that the early mitotic divisions and cell fate decisions occur 
normally. fried egg chambers grow poorly and fail to develop beyond stage 
8 (mid-oogenesis). The nurse cells in fried egg chambers accumulate less 
DNA than wild type chambers of a similar age. fried nurse cell 
chromosomes retain a polytene-like morphology until throughout egg 
chamber development. The fried mutant oocyte's karyosome is misshapen, 
and it appears fragmented. fried mutants are therefore likely to be defective 
in the cell cycle and/or DNA repair and packaging.  
 
Examination of fried homozygotes reveals that the gene is required earlier 
in development. fried larvae are small, and often fail to pupariate. fried 
pupae do not eclose. We have mapped fried to a 40 kb region of 3R using 
the Bloomington Deficiency kit. The fried region includes 8 candidate 
genes, including four genes with previously studied loss-of-function alleles. 
We will present our mapping and complementation data and phenotypic 
analysis.  
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Polo-kinase has been shown to be an essential regulator of many events that 
take place during preparation, entry, progression and exit from mitosis. 
Previous studies have shown that during these stages of the cell cycle Polo 
localizes to centrosomes, spindle microtubules, kinetochores and the 
midbody. However while much is known about its role in centrosomes, 
microtubules and the midbody little is know about the role of Polo at 
kinetochores.  
To study this process we have carried out a careful analysis of microtubule-
kinetochore interaction in the absence of Polo in Drosophila S2 cell and 
observed a new important phenotype that had been overlooked in previous 
studies. We observed that in POLO-depleted cells the majority of 
chromosomes fail to show normal amphitelic attachment and are mostly 
attached syntelically to spindle microtubules.  
The synthelic attachments are not corrected and Aurora B, which shows 
partial delocalization over chromosome arms and spindle microtubules, has 
compromised kinase activity. Yet in the absence of Aurora B, chromosomes 
are not as prone to syntelic attachments as when POLO is depleted from 
cells which clearly indicates that other aspects of POLO function are also 
required for attaining correct chromosome attachments. 
Indeed, the synthelic attachment observed in the absence of Polo is 
associated with changes on centromere structure. First, interkinetochore 
distance which represents centromere length is significantly decreased in 
POLO-depleted chromosomes. In addition, we observed that Mei-S332, a 
centromeric protein whose removal from mitotic chromosomes is dependent 
on POLO, changes its localization in the absence of Polo occupying a 
different spatial domain within the centromere. Accordingly, double-
depletion of POLO and Mei-S332 partially rescues the syntelic phenotype.  
Our results indicate that Polo is essential for the establishment of correct 
chromosome-spindle attachments not only through a regulatory role of the 
correction mechanism but also by conducting proper chromosome 
architecture. 
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Expression of genes like cyclin A, cyclin B, Cdc2 (cdk1) and Cdc25C on 
the transcriptional level is regulated by CDE and CHR promoter sites 
through repression in G0. The CDE is related to E2F sites. However, CDEs 
are distinct from E2F elements as they are always found in conjunction with 
a CHR four nucleotides downstream. Recently, the mammalian 
DREAM/LINC protein complex was shown by ChIP analyses to bind to 
several CDE/CHR-regulated promoters. Particularly more detailed 
experiments on the Cdc2 promoter showed binding of E2F4 to the 
E2F/CDE site requiring an intact CHR four nucleotides downstream. 
Furthermore, Lin54 appears to contact the CHR contributing to binding of 
DREAM/LINC to this CDE/CHR promoter. Until now the assumption was 
that E2F4 binding to E2F-like CDE sites is central to cell cycle-dependent 
transcriptional regulation and this association is only supported by the 
neighboring CHR stabilizing the interaction. However, some promoters are 
just controlled by a CHR with the sequence 5’-TTTGAA-3’ lacking a 
functional CDE or E2F site in the promoters. We have looked at protein 
binding to the mouse and human cyclin B2 promoters in nuclear extracts 
from G0 cells and observe that the DREAM/LINC complex binds to both 
promoters. Binding of E2F4, p107, p130, Lin9, Lin37 and Lin54 is 
decreased to background when the CHR is mutated. Importantly, cell cycle-
dependent regulation of the human cyclin B2 promoter solely depends on 
the CHR since it does not contain a functional E2F or CDE site. Thus, E2F4 
in a complex with other DREAM/LINC proteins can bind to the promoter 
through the CHR. We also observe binding of the complex in vivo in 
resting cells, but binding of E2F4, p107, p130 and Lin proteins is clearly 
reduced when cells enter S-phase. NF-Y-binding CCAAT-boxes are 
required for most of the transcriptional activity of mouse and human cyclin 
B2 promoters throughout the cell cycle. Our data suggest a model by which 
E2F4/DREAM components repress transcription in G0 and are primarily 
bound through the CHR. Binding of this complex is lost when the promoter 
is activated. Activation is dependent on NF-Y proteins binding to CCAAT-
boxes. 
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Quiescence (G0) is a cellular fate that allows cycling cells to reversibly cease 
cell division in culture and in vivo. The final decision to enter quiescence has 
long been suspected of occurring in the early G1 phase of the cell cycle, where 
cells can monitor their environment for conditions favoring either continuous 
growth or cell cycle arrest. The signaling events transmitting this information 
all converge on the pocket protein family, i.e. retinoblastoma protein (pRb), 
p107 and p130, all of which can interact with chromatin to suppress the G1-S 
transition and enable quiescent growth arrest. 
Here we report results suggesting that a heretofore unanticipated pathway that is 
centered in the G2 phase of the cell cycle and depends on the ubiquitous cellular 
phosphatase, PP2A, regulates quiescence. Inhibition of PP2A using okadaic 
acid during a limited time period in G2 released pocket proteins from chromatin 
and impaired quiescence in growth factor-deprived cultured cells as shown by 
continuous uptake of BrdU. The specific PP2A subcomplex necessary for 
quiescence contains the B56γ subunit, previously implicated in the 
transformation of mammalian cells when functionally inhibited [1]. 
Interestingly, inhibition of PP2A-B56γ using the oncoprotein SV40 small t, 
okadaic acid, or shRNA-mediated B56γ depletion caused hyperphosphorylation 
of several components of the so-called DREAM complex, comprising the 
pocket protein p130, E2F4 as well as members of the mammalian MuvB 
complex that has been shown previously to be crucial for quiescence 
establishment [2]. 
These data suggest a novel function for PP2A in G2 that is essential for cells to 
enter quiescence in the next G1. It likely depends, at least in part, on a 
functional interaction – direct or indirect – between PP2A and certain 
chromatin-bound pocket protein-containing complex(es). These findings 
challenge the notion that G1 is the one cell cycle phase during which the 
decision to enter quiescence occurs and could help to enhance one’s 
understanding of the mechanisms that trigger this key cellular state. 
Importantly, normal access to G0 is potentially involved in regulating such 
crucial processes as stem cell self-renewal and suppression of cancer 
development. 
 
[1] W. Chen, R. Possemato, K.T. Campbell, C.A. Plattner, D.C. Pallas, W.C. Hahn, 
Cancer Cell 5 (2004) 127-136. 
[2] L. Litovchick, S. Sadasivam, L. Florens, X. Zhu, S.K. Swanson, S. Velmurugan, R. 
Chen, M.P. Washburn, X.S. Liu, J.A.  
DeCaprio, Mol Cell 26 (2007) 539-551. 
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Most cancer cells exhibit high rates of mitotic chromosome mis-
segregation, which results in chromosome instability (CIN). CIN not only 
maintains aneuploidy (i.e., incorrect chromosome numbers), but correlates 
with malignancy. We recently found that one mechanism responsible for 
chromosome mis-segregation in CIN cells is the transient assembly of 
multipolar spindles. Within these multipolar spindles, chromosomes are 
very likely to establish erroneous attachments with the mitotic spindle, and 
this eventually leads to chromosome mis-segregation at later stages of 
mitosis. This study suggests that mitotic spindle geometry influences 
chromosome mis-attachments and mis-segregation. Thus we hypothesized 
that another mechanism by which chromosomes can establish erroneous 
attachments with spindle microtubules in CIN cells is by starting mitosis 
with incompletely separated spindle poles. To test our hypothesis, we first 
performed live-cell experiments using a cell line with GFP-labeled spindle 
poles, and found that cells with incomplete spindle poles separation upon 
mitotic entry, exhibited chromosome segregation defects indicative of 
defective chromosome/spindle attachment. We then experimentally delayed 
spindle pole separation to identify the mechanism by which chromosome 
mis-attachments are formed. Finally, to determine whether this mechanism 
is involved in cancer cell CIN, we analyzed a panel of cancer cell lines and 
found that 30-70% of them display unseparated spindle poles in early 
mitosis. In conclusion, our results suggest that spindle geometry plays a key 
role in CIN, and proteins involved in mitotic spindle morphology are 
potential targets for cancer therapy 
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The cyclin D-cdk4/6 complex has two distinct functions. Its catalytic role 
involves its ability to act as serine/threonine kinase, responsible for 
phosphorylation of substrates required for cell cycle transitions, while its 
sequestration function involves its ability to act as a reservoir for p27Kip1. 
This association sequesters p27 from cyclin E-cdk2 complexes, allowing 
them to remain active. We exploited the ability of TGF-β to induce 
p15Ink4b, to ascertain whether the catalytic and sequestration roles of cdk4 
and cdk6 were required equally during proliferation. p15 binding destroys 
the cyclin D/cdk4 complex, negating both the catalytic and sequestration 
functions and results in G1 arrest. Expression of wild-type, catalytically 
inactive or p15-resistant cdk4 or cdk6 mutants rendered Mv1Lu cells 
resistant to TGF-β-mediated growth arrest. Cells expressing a catalytically-
inactive, p15-resistant double cdk6 mutant were also resistant to TGF-β-
mediated arrest, proliferating in the absence of all cdk4/6 kinase activity. 
Expression of this cdk6 mutant acted as a sink for p27, allowing cdk2 to 
remain active, and suggested that the sequestration function was sufficient 
in asynchronously growing cells. Interestingly, the homologous cdk4 
mutant was unable to overcome TGF-β-mediated arrest. When contact 
arrested cells were released from quiescence in the presence of exogenous 
cdk4, the G0-G1 transition was accelerated in a kinase-dependent manner. 
In contrast, overexpression of both catalytic and non-catalytic cdk6 alleles 
accelerated G0 exit, suggesting that cdk6 may play a different role in the 
G0-G1 transition. Gel filtration analysis of cdk4 and cdk6 pools in 
proliferating and arrested cells revealed the presence of a previously 
unidentified cyclin D-cdk6 dimer, which may contribute to the differential 
activity of these kinases to promote proliferation of cells both in cycle and 
upon reentry from the quiescent state. Cdk4 appears unable to form a 
similar dimeric complex with cyclin D, suggesting that the structural 
interactions of these two kinases are distinct. 
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Functional inactivation of the Retinoblastoma (pRB) pathway is an early 
and obligatory event in tumorigenesis. This is widely attributed to the need 
of tumor cells to bypass the ability of pRB to promote cell cycle exit. While 
support of this is well documented, pRB is involved in other cellular 
processes that are less physiologically understood. Here we demonstrate 
that independently of cell cycle exit control, pRB, in cooperation with the 
Hippo tumor suppressor pathway, functions to maintain the terminally 
differentiated state. We found that mutations in the Hippo signaling 
pathway, wts or hpo, trigger widespread dedifferentiation of rbf mutant cells 
in the Drosophila eye. Initially rbf wts or rbf hpo double mutant 
photoreceptors are morphologically indistinguishable from their wild type 
counterparts as they properly differentiate, express mature neuronal 
markers, and develop axonal projections. However, double mutant cells 
stochastically lose their neuronal identity as they undergo dedifferentiation 
and become uncommitted eye specific cells. Surprisingly, this 
dedifferentiation is fully independent of cell cycle exit defects and occurs 
even when inappropriate proliferation is blocked by a de2f1 mutation. The 
implications of these findings suggest that one of the post-mitotic roles of 
the pRB pathway is to maintain a state of terminal differentiation and to 
prevent cells from reverting to a progenitor-like state. Thus, in addition to 
its role in promoting cell cycle exit, our results implicate another tumor 
suppressor property of the pRB pathway. 
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The Drosophila MEI-S332 protein localizes to centromeres in mitosis and 
meiosis when sister chromatids are attached. It is essential for the 
maintenance of centromere cohesion in meiosis until the sister chromatids 
segregate at anaphase II, and it also contributes to centromere cohesion in 
mitosis. We previously showed that in cell culture centromere localization 
of MEI-S332 is controlled by phosphorylation, with phosphorylation by 
Aurora B kinase being necessary for proper localization and 
phosphorylation by POLO kinase being required for MEI-S332 dissociation 
from the centromere at anaphase. To investigate the function of 
phosphorylation in vivo in mitosis and meiosis we have generated 
transgenic lines expressing mutant forms of MEI-S332 resistant to Aurora B 
phosphorylation or with mutations that mimic phosphorylation. We also 
have produced transgenic lines in which MEI-S332 is mutated to reduce 
binding to POLO or contains a phosphomimetic mutation in the POLO 
binding domain. We will present the effects of these mutations on MEI-
S332 centromere localization and chromosome segregation. 
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Defects in DNA replication can lead to increased gene copy number, known 
to be present in many cancer cells, but regulatory mechanisms that link 
DNA replication activity to the cell cycle in metazoan cells remain poorly 
understood. Drosophila melanogaster ovarian follicle cells are a superb 
model system to study metazoan DNA replication, as replication origins 
repeatedly fire at precise points in differentiation, resulting in gene 
amplification. We have uncovered EMS-induced mutations that result in 
BrdU incorporation patterns consistent with increased DNA replication 
activity in amplifying follicle cells. One such mutant, quadruple double, 
displays enhanced replication fork separation, premature cessation of origin 
firing, and ectopic sites of amplification. Mapping of these additional sites 
of amplification by comparative genomic hybridization (CGH) indicates 
that specific regions of the genome are susceptible to origin activation.  
Key regulators of the G1/S transition control gene amplification in 
Drosophila ovarian follicle cells. Loss of Rbf1 activity (the Drosophila 
retinoblastoma family homologue) results in additional rounds of 
endoreplication, which normally precede gene amplification. Rbf mutants 
also display BrdU incorporation patterns consistent with ectopic sites of 
gene amplification, and preliminary results to identify those sites of 
amplification will be presented. Additionally, CyclinE activity is necessary 
for proper gene amplification, and we have uncovered a mutant allele of 
cyclinE, cyclinE1f36, that results in increased replication fork progression. 
Our data suggest a direct role for CyclinE in modulating replication fork 
progression. Taken together, gene amplification in Drosophila ovarian 
follicle cells provides a tractable genetic, cytological, and biochemical 
system to uncover the regulatory mechanisms responsible for coordinating 
metazoan DNA replication with the cell cycle. 
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Cyclin A / cdk2 is the primary cyclin/cdk regulating G2 phase progression 
and the timing of progression into mitosis. Cyclin A / cdk2 activity peaks in 
G2 phase and its depletion by siRNA or drug inhibition causes a G2 phase 
delay. In this study we have examined the mechanisms by which cyclin A / 
cdk2 regulates the timing of entry into mitosis. Checkpoint kinase 1 is well 
known for its role in DNA damage responses, but published data has also 
suggested a role for Chk1 in normal G2 / M phase progression. In cyclin A / 
cdk2 depleted G2 phase cells, there was an elevated level of activated Chk1, 
and inhibiting or depleting Chk1 substantially reversed the G2 delay seen 
with cyclin A depletion. The activation of Chk1 was dependent on ATR.  
We have investigated the mechanisms by which cyclin A / cdk2 regulates 
Chk1. Cyclin A / cdk2 can bind to Chk1 in vivo and has been reported to 
phosphorylate Chk1 on two novel inhibitory sites, Ser286 and Ser301 in 
vitro 1. We found that cyclin A / cdk2 phosphorylates these sites in vivo, 
and mutation of these sites can delay entry into mitosis. In addition, we 
have examined the role of a known cdk2 substrate and mitotic regulator 
Cdh1, and its downstream targets Plk1 and Claspin. Our data revealed that 
surprisingly Plk1 levels, regulated by Cdh1, were relatively unaffected by 
cyclin A / cdk2 depletion. However, depletion of Cdh1 did substantially 
reverse the G2 phase delay imposed by cyclin A / cdk2 depletion, 
suggesting that Cdh1 is involved in the cyclin A / cdk2 dependent G2 phase 
delay. We have evidence of increased Claspin levels suggesting that this 
may be the point of Cdh1 involvement and that cyclin A / cdk2 may 
regulate both the activation as well as inactivation of Chk1. In addition to 
its role in regulating normal G2 / M progression, we will present evidence 
that cyclin A / cdk2 has a critical role in progression out of a G2 phase 
checkpoint arrest.  
 
1 Shiromizu, T., Goto, H., Tomono, Y., Bartek, J., Totsukawa, G., Inoko, 
A.,Nakanishi, M., Matsumura, F., and Inagaki, M. (2006) Genes Cells 11, 
477–485  
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ATTACHMENT BY REGULATING THE KINASE ACTIVITY OF 
AURORA B. 
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The establishment and maintenance of proper attachment of kinetochores to 
microtubules are required to prevent chromosome missegregation and 
consequent chromosomal instability and tumorigenesis. Although MST1 
(mammalian sterile 20–like kinase 1) has been implicated in many aspects 
of cell cycle regulation and tumor suppression, its precise mechanism of 
action has remained largely unknown. We now show that MST1 promotes 
accurate kinetochore-microtubule attachment by modulating the kinase 
activity of Aurora B. HeLa cells depleted of MST1 failed to develop stable 
end-on kinetochore-microtubule attachment, giving rise to unaligned 
mitotic chromosomes. The misaligned chromosomes activated the Mad2- 
and BubR1-dependent spindle checkpoint response, resulting in a delay in 
anaphase onset. The kinase activity of Aurora B, which promotes 
destabilization of kinetochore-microtubule attachment, was increased in 
cells depleted of MST1 or NDR1, a downstream kinase of MST1. 
Moreover, MST1 associated with and directly phosphorylated Aurora B. 
Depletion of Aurora B restored the stability of kinetochore-microtubule 
attachment in cells depleted of MST1 or NDR1. The MST-NDR1 complex 
is thus required for precise regulation of Aurora B activity and thereby 
ensures mitotic chromosome congression and accurate chromosome 
segregation. 
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Hdm2 oncoprotein is the key regulator of p53. In cells with Hdm2 over-
expression due to a single nucleotide polymorphism (SNP309 T to G) in the 
hdm2 P2 promoter, p53 activity is often compromised. Over forty hdm2 
splice variants exist, however, little is known about their functions. In both 
G/G and T/T cells, we found various splice variants such as P2hdm2C 
which is missing exons 5 through 9 that contain important domains for p53 
regulation and cell growth inhibition. Using exon-junction (4-10) specific 
primers for RT-PCR, we found that P2hdm2C was over-expressed in cancer 
cells with high Hdm2 levels. We developed an antibody to Hdm2C using 
the amino acid sequence of part of exons 4 and 10. Using this antibody we 
showed that cells over-expressing Hdm2 had more Hdm2C as compared to 
low Hdm2 expressing cells. In cells with wild type p53 and low Hdm2 
protein levels, the activation of p53 resulted in increased Hdm2C protein; 
suggesting a role for Hdm2C in normal feedback regulation of p53. In order 
to compare the influence of Hdm2 and Hdm2C on p53 function, we used 
isogenic cell lines derived from H1299 cells with inducible p53 and 
exogenous full length Hdm2 (FL Hdm2) or Hdm2C. We found that in the 
presence of induced p53, Hdm2C reduced the amount of p21 transcript 
while FL Hdm2 did not. In addition, Hdm2C expressing cells proliferated 
faster as compared to parental and FL Hdm2-expressing cells. Interestingly, 
FL Hdm2-expressing cells grew the slowest, thus correlating our work with 
that of others who have shown that FL Hdm2 has growth inhibitory effects. 
FL Hdm2 caused no decrease in p53 DNA binding activity as seen via 
chromatin immumoprecipitation and gel shift assays. Our results suggest 
that Hdm2C may be a reason for compromised p53 activity in cells that 
over-express Hdm2. Experiments are in progress to determine the influence 
of Hdm2C on p53 transcription, p53-chromatin interactions and co-factor 
recruitment.  
This work was supported by a grant to J.B., NSF MCB-0744316; and was 
facilitated by RR03037 from the National Center for Research Resources 
(NCRR), a component of the NIH.  
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The retinoblastoma (RB) tumor suppressor is a cell cycle regulator that is 
thought to repress cell cycle progression when bound to E2F-DP 
transcription factor heterodimers. Cell cycle regulated phosphorylation of 
RB by cyclin dependent kinases (CDKs) causes release from E2F-DP, 
thereby allowing cell cycle activation. However, there is now accumulating 
data suggesting that RB-E2F-DP ternary complexes may have roles in 
regulating gene expression in addition to their well established function as a 
cell cycle repressor.  
 
In the unicellular alga Chlamydomonas reinhardtii, RB (encoded by the 
MAT3 gene) controls cell division and regulates size homeostasis. As is the 
case in metazoans, MAT3/RB represses the activity of E2F-DP that are 
encoded by single copy genes. We have examined the cell cycle dynamics 
of MAT3/RB, E2F1 and DP1 and found that MAT3/RB is a 
phosphoprotein; that E2F1-DP1 can bind to a consensus E2F site; and that 
all three proteins interact in vivo to form a complex that can be 
quantitatively immunopurified. We examined the abundance of MAT3/RB 
and E2F1-DP1 in highly synchronous cultures of Chlamydomonas and 
found that they are synthesized and remain stably associated throughout the 
cell cycle with no detectable fraction of free E2F1-DP1. Consistent with 
their stable association, MAT3/RB and DP1 are constitutively nuclear and 
MAT3/RB does not require E2F1-DP1 heterodimers for nuclear 
localization. Together, our data show that cell cycle regulation by an RB-
related protein can occur without dissociation from E2F-DP subunits, and 
that other changes associated with the complex may be sufficient to convert 
RB-E2F-DP from a cell cycle repressor to an activator. 
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Precise regulation of centrosome duplication and inheritance is pivotal to 
the execution of error-free cell division. Centrosome amplification occurs 
frequently in most cancer types, and is a cause of chromosomal instability 
in cancer cells. It also underlies aberrant spindle organization which usually 
results in a chronic mitotic arrest, a phenotype elicited by most tubulin-
binding drugs. The exact nature and mechanism of the mitotic arrest, and 
factors dictating abnormal spindle morphogenesis however, remain elusive. 
We show that a novel microtubule-modulating agent, 9-bromonoscapine, 
induces formation of multipolar spindles containing ‘real’ centrioles at all 
the poles, indicating drug-induced centrosome amplification and persistent 
centrosome declustering. Cell-cycle phase-specific experiments showed that 
the cytotoxicity window of the drug encompasses the late S-G2 period. 
Drug treatment excluding the S-phase not only resulted in lower sub-G1 
population, but also significantly attenuated centrosome amplification and 
spindle multipolarity phenotypes, suggesting that drug-induced centrosome 
amplification is a chemotherapeutic strategy. Subsequent to a robust mitotic 
arrest, EM011-treated cells displayed diverse cellular fates suggesting a 
high-degree of intraline-variation. EM011 caused a range of irremediable 
outcomes including prolonged mitotic arrest, mitotic catastrophe and 
slippage, unrestrained asymmetric cytoplasmic and nuclear division 
culminating in apoptosis. Some ‘apoptosis-evasive’ cells underwent 
aberrant cytokinesis to generate rampant aneuploidy that perhaps 
contributed to drug-induced cell death. Our results therefore underscore that 
spindle multipolarity induction via centrosome amplification is potentially a 
powerful chemotherapeutic strategy. 
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Mammalian polo-like kinase 1 (Plk1) has been studied extensively as a 
critical element in regulating various mitotic events during M-phase 
progression. Plk1 function is spatially regulated through the targeting 
activity of the polo-box domain (PBD) that specifically recognizes S-pS/pT 
phosphoepitopes. The current prevailing model is that the PBD binds to a 
phospho-epitope generated by Cdk1 or other Pro-directed kinases. In 
addition to this well-appreciated nonself-priming and binding mechanism, 
evidence accumulated in recent years suggests the existence of an 
alternative self-priming and binding mechanism whose PBD-binding site is 
generated by Plk1 itself. However, whether the latter unusual biochemical 
mechanism is a physiologically significant process or a passively evolved 
event as a consequence of the unavailability of nonself-priming kinase at a 
particular time and subcellular location remains unknown. Here we 
demonstrated that mutation of a Plk1-dependent self-priming and binding 
site of PBIP1 to a Cdk-dependent nonself-priming site (PBIP1-cdk) resulted 
in an early recruitment of Plk1 to the interphase centromeres, but failed to 
achieve a drastic accumulation of Plk1 at the mitotic kinetochores as 
observed in the cells expressing wild-type PBIP1. As a consequence, both 
PBIP1-cdk and its binding protein, Cenp-Q, exhibited a prolonged 
association with chromatin fraction, thus likely causing chromosome 
missegregation and mitotic arrest. Taken together, the data provided here 
suggest that the self-priming and binding of PBIP1 by Plk1 is a unique 
biochemical event designed to maximize the efficiency of Plk1 recruitment 
to and delocalization from the kinetochores and to promote proper M-phase 
progression. 
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Aurora kinase A is a critical mitotic regulator that has been associated with 
tumor development and progression. Aurora A has become a relevant 
objective of study in cancer cell biology since it participates in the 
formation and maturation of the spindle, the main target of microtubule 
poisons, and it confers resistance to Taxol. Although the cellular effects of 
Aurora A inhibition have been deeply studied in culture cells and embryos, 
the consequences of Aurora A depletion have not been explored in adult 
mammals. Here, we generated and characterized a mouse model in which 
Aurora A depletion can be achieved in a conditional manner during 
adulthood. We show that Aurora A ablation is associated with a general 
lack of proliferation in vivo which induces loss of weight and bone density 
and a significant alteration of proliferative tissues. Furthermore, Aurora A 
depleted tissues are characterized by a significant increase in mitotic, 
apoptotic and DNA damage markers. We also show how the lack of 
proliferation found in Aurora A depleted tissues has an important impact in 
the regenerative processes that take place in mouse. Together, our results 
demonstrated an essential role of Aurora A in vivo for proliferative and 
regenerative processes and are of special significance for understanding 
possible side effects of Aurora inhibitors currently in development as 
anticancer agents. 
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The zebrafish circadian system is highly decentralized with the majority of 
tissues and cells of the body containing independent clocks, which are 
directly light-responsive. These circadian oscillators regulate the timing of 
fundamental aspects of cell biology, including the cell cycle. A functional 
circadian clock is present early in zebrafish development and appears to 
gate the timing of S phase in developing embryos. However, to date, very 
little is known about the molecular interactions between the circadian clock 
and the cell cycle during zebrafish development. To address this issue, we 
focused on the cyclin-dependent kinase inhibitor p21, a key regulator of the 
G1/S transition and a known inhibitor of DNA replication. Here, we 
demonstrate by quantitative PCR that p21 is expressed with a robust 
circadian rhythm in embryos raised on a light-dark cycle. Importantly, these 
rhythms peak at a time when DNA synthesis is low. Rhythmic expression of 
p21 starts early in development at one day post fertilization, persists in 
constant darkness, and is suppressed by constant light, a condition known to 
inhibit circadian clock function. These results indicate that p21 is regulated 
by the circadian clock and provide the first molecular link between the 
clock and the cell cycle during zebrafish development. By whole-mount in 
situ hybridization, we have localized p21 mRNA primarily to the 
developing digestive system, where its expression is strongly rhythmic, 
consistent with our qPCR data. We are currently investigating whether the 
circadian clock plays a role in the timing of S phase in the developing gut. 
Moreover, we are exploring the possibility that the circadian clock, through 
its regulation of p21, might directly influence the timing of gut development 
and differentiation. 
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Acquisition of lineage-specific cell cycle duration is fundamental during 
development. In early C. elegans embryo, the ATL-1/CHK-1 (ataxia 
telangectasia mutated and rad3 related/Chk1) checkpoint pathway controls 
the timing of cell division in the P lineage, or future germline, of the animal. 
However, the mechanisms regulating this pathway are still poorly 
understood. Here, we present a novel ATL-1 checkpoint pathway regulator, 
called LRR-1 (Leucine-Rich Repeat 1). We show that LRR-1 is a nuclear 
substrate-recruitment factor of a cullin 2-RING E3-ligase that promotes cell 
cycle progression by inactivating the ATL-1/CHK-1 checkpoint pathway in 
C. elegans. Loss of lrr-1 function causes a G2 cell-cycle arrest in the mitotic 
region of the germ line resulting in sterility owing to depletion of germ 
cells. Inactivation of ATR/Chk1 signaling components ATR/ATL-1, 
TopBP1/MUS-101, claspin/F25H5.5 and Chk1/CHK-1, fully suppresses 
these phenotypes and restores lrr-1 mutant fertility. Likewise in early 
embryo loss of lrr-1 function induces Chk1 phosphorylation and a severe 
cell cycle delay in the pace of P-lineage division causing embryonic 
lethality. Our findings demonstrate that the CRL2-LRR-1 complex silences 
the ATL-1/CHK-1 pathway in C. elegans and contributes to the timing of 
cell division in early embryos 
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In eukaryotic cells, DNA synthesis is initiated at numerous origins of 
replication, which are licensed by the sequential recruitment of initiation 
factors including the Mcm2-7 complex. During S-phase of the cell division 
cycle, initiation of licensed origins of replication requires the action of two 
S-phase promoting kinases, the cyclin-dependent kinase (CDK) and the 
Cdc7 kinase. Cdc7 is an essential serine/threonine kinase that is activated 
by association with its regulatory subunits, Dbf4 or Drf1. Cdc7 is able to 
phosphorylate several subunits of the chromatin-bound Mcm2-7 complex. 
Phosphorylation is thought to be required for the activation of Mcm2-7 
helicase activity, leading to DNA unwinding and chromatin association of 
Cdc45 and the DNA polymerase. Cdc7 is also believed to play a role in the 
response to DNA damage. 
 
Several small chemical molecules have recently been reported to be 
selective inhibitors of Cdc7/Dbf4 function and to exhibit anti-tumour 
activity. Pharmacological inhibition of the Cdc7 kinase represents a novel 
approach to cancer treatment by targeting origin initiation, an earlier stage 
in the process of DNA replication compared to anti-cancer therapeutics that 
affect DNA elongation. We present preliminary results from the 
characterisation of an ATP-competitive inhibitor, PHA-767491, in the cell-
free system derived from Xenopus eggs. We show that PHA-767491 
inhibits replication in a dose-dependent manner, which correlates with the 
inhibition of hyper-phosphorylation of chromatin-bound Mcm4. Mcm4 
hyper-phosphorylation has been shown to be Cdc7-dependent. This hyper-
phosphorylation is not affected when extracts were treated with p27Kip1 to 
inhibit CDK activity. 
 
Using cell-free extracts derived from Xenopus eggs, we are able to 
characterise the effects of PHA-767491 on DNA replication at a molecular 
level. This will allow the inhibitor to be used as a powerful tool for 
biochemical analyses of Cdc7 regulation during the cell cycle. 
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In frogs, flies, and other multicellular eukaryotes, the somatic cell cycle has 
an intrinsically slower rate of progression relative to its early embryonic 
counterpart. Prior work described a requirement for positive feedback in the 
CDK1-Wee1-Cdc25 module to sustain rapid CDK1-APC oscillations in 
early embryos. Using a non-phosphorylatable, positive-feedback-insensitive 
CDK1 (CDK1AF), this feedback loop was then shown to prevent rapid 
oscillatory behaviors in G1-phase somatic (HeLa) cells. Recent studies have 
uncovered surprising insights into why this behavior can be generated and 
the consequences that arise as a result. Live-cell imaging revealed that 
premature spindle assembly and disassembly corresponds with cellular 
oscillations of cyclin B1 in these cells, but becomes incoherent with 
chromatin condensation state. Incompletely condensed chromatin is 
maintained in a mass that is initially congressed within relatively normal 
bipolar spindles, but then undergoes decondensation and ejection to the 
spindle periphery. Cells stained for the nuclear pore complex showed that 
the large masses of decondensed chromatin appeared to possess a nuclear 
envelope but no nuclear pores. The chromatin in these pseudo-nuclear 
structures—as well as chromosome fragments remaining congressed within 
the spindle—stained positive for phospho-histone H3, indicating that the 
temporal organization of these mitotic processes had been lost. Staining for 
Aurora A, Aurora B, and Polo kinase revealed that these incoherent spindle 
and chromatin dynamics were found to occur in conjunction with the 
presence of all of these improperly accumulated, but properly localized 
mitotic kinases. With the occurrence of such premature but semi-functional 
mitotic structures in interphase cells, we inquired whether these abnormal 
spindle structures were inducing the metaphase-arrest checkpoint. 
Surprisingly, cyclin B1-YFP oscillated more rapidly in CDK1AF-
expressing daughter cells treated with hesperadin, and in cells also knocked 
down for Mad2. Positive feedback in CDK1 activation is therefore critical 
for the absolute destruction of mitotic substrates upon cell division. Without 
it, improperly stabilized components permit the premature initiation of 
cycling, though with a loss of coherence between all of the necessarily 
concurrent mitotic processes. 
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Temporal precision in mitosis is important in maintaining proper cell cycle 
progression. However, the duration of cell cycles between mitoses can be 
highly variable, depending on a variety of environmental and intracellular 
factors. Here we ask whether and how the events of mitosis are temporally 
insulated from the variable events that precede mitosis. Cdk1, the kinase 
which serves as the main trigger of mitosis, is regulated by multiple 
feedback loops. Our hypothesis is that the double-negative feedback loops 
(regulated by Wee1 and Myt1) and positive feedback loops (controlled by 
Cdc25 isoforms) involved in the rapid activation of Cdk1 serve to insulate 
the timing between mitotic events. To test the idea, we made use of 
Xenopus egg extracts incubated with different doses of non-degradable 
cyclin to make mitosis occur either quickly (high cyclin) or slowly (low 
cyclin), and we monitored the timing of the phosphorylation of early mitotic 
substrates (Wee1 and/or Cdc25) or a late mitotic substrate (the Cdc27 
subunit of the APC). We found that although the absolute timing at which 
the early mitotic phosphorylations occur can be made to vary over a huge 
range, the time interval between the early phosphorylations and the late 
phosphorylations is more robust. Compromising the positive feedback by 
immunodepleting Wee1 compromises the robustness of this interval; the 
high-cyclin-treated extracts tended to have shorter intervals, and the low-
cyclin-treated extracts tended to have longer intervals. This suggests that the 
abrupt, all-or-none activation of Cdk1 made possible by the bistable 
Cdk1/Cdc25/Wee1 system insulates the timing of mitotic events from the 
timing of the events that lead up to mitosis. 
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Many genes involved in cell cycle processes have altered expression during 
the cell cycle to impose the order and timing of events. During mitotic exit 
in budding yeast, two transcription factors, Swi5 and Ace2, transcribe many 
of the genes required for physically dividing the mother and daughter cells 
and beginning the next round of cell division. As cells exit mitosis, the 
cyclin dependent kinase (CDK) that has driven many of the cell cycle 
processes is inhibited and degraded, allowing many of the kinase substrates 
to return to their unphosphorylated state. Previously our lab has shown that 
locking mitotic cyclin levels, by inducing transcription of an undegradable 
form of the protein, causes dose-dependent delays in different cell cycle 
events. Interestingly, in these cells where mitotic cyclin levels were 
sustained, deletion of the transcription factor Swi5 increases the mitotic 
cyclin inhibition specifically of budding and cytokinesis. The contribution 
of Ace2 is still being investigated. 
 
Importantly, when phosphorylated by mitotic cyclin/CDK, Swi5 is excluded 
from the nucleus. Nevertheless in cells with sustained mitotic cyclin, Swi5 
still enters. In fact in some cells, Swi5 enters the nucleus several times 
before advancing in the cell cycle. Given previous studies from our lab 
showing that the release of Cdc14 phosphatase also oscillates under these 
conditions, the reentry of Swi5 may support a model that a 
kinase/phosphatase balance allows cell cycle progression in these cells. All 
this suggests that Swi5 transcribes genes important for promoting 
cytokinesis and budding despite high mitotic cyclin levels. Subsequent 
analysis will be necessary to see how specific targets of the mitotic exit 
transcriptional program contribute to the mitotic cyclin regulation of 
cytokinesis and budding. 
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The yeast Schizosaccharomyces pombe is used as a model organism to 
study the regulation of gene expression, both during the cell cycle and in 
response to DNA damage.  
 
The transcription factor complex MBF, which is analogous to metazoan 
E2F, regulates the cell cycle-dependent expression of a group of genes at 
the transition from G1 to S phase. Many of these genes encode components 
necessary for DNA replication. In order to ensure genomic integrity, 
eukaryotic cells respond to exogenous and endogenous DNA damage via 
checkpoint signalling pathways that are mediated by the conserved kinases 
ATM and ATR. It has recently become apparent that regulation of cell 
cycle-dependent gene expression is a vital feature of the checkpoint 
response in S. pombe cells. Stalled replication in S. pombe activates the 
Rad3 kinase (equivalent to ATR), which then upregulates MBF-dependent 
genes.  
 
However, at present there is still much to learn about the mechanisms 
underlying gene expression during the cell cycle and in checkpoint 
responses. We have identified a new regulator of MBF-dependent gene 
expression, and we are currently investigating the role of this protein both in 
cell cycle-dependent and checkpoint-mediated gene expression.  
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Cln3 plays a significant role in initiating the START transition in budding yeast 
by activating two transcription factors SBF (a heterodimer of Swi4/Swi6) and 
MBF (a heterodimer of Mbp1/Swi6). SBF promotes the production of G1 
cyclins (Cln1, Cln2) responsible for bud initiation, while MBF promotes the 
production of S phase cyclins (Clb5, Clb6) needed for DNA synthesis. SBF is 
turned off by mitotic cyclins (Clb1, Clb2); whereas MBF is turned off by Nrm1. 
A detailed mechanism of how these events are controlled is still unclear. 
 
Early on, it was thought that Cln3 phosphorylates Whi5, an inhibitor of SBF, 
and causes Whi5 to be exported from the nucleus, thereby removing its 
inhibition of SBF. However recent evidence (Wagner et al., PLoS ONE 4: 
e4300, 2009) showed that this might not be the sole mechanism. They found 
that Whi5-12A (non-phosphorylable by CDK) has the same size as wild type 
cells, indicating that Cln3 may activate SBF through an alternative mechanism, 
probably through phosphorylating Swi6. However, the authors found that Swi6-
SA4 (non-phosphorylable by CDK) also has the same size as wild type cells. 
Only the double mutant ‘Whi5A Swi6-SA4’ shows a delay in START transition 
with a size 1.4 times that of the wild type. Hence, SBF activation seems to 
require phosphorylation of either Whi5 or Swi6. 
 
There are additional problems with the Whi5 nuclear export mechanism. 
Evidence from Wagner’s paper (2009) and Queralt et al., (Mol. Cell. Biol. 
23:3132, 2003) suggests that Swi4 and Swi6 are needed for the nuclear export 
of phosphorylated Whi5. Furthermore it is known that Whi5 export occurs 
when SBF is activated in late G1, whereas Swi6 export occurs only when SBF 
is turned off in mid S-phase. To accommodate these findings, we propose that 
free Swi4/Swi6 dimers (unbound to promoters and not phosphorylated) may 
shuttle in and out of the nucleus to promote the export of phosphorylated Whi5 
when SBF is active. When SBF is turned off, Swi4/Swi6 become 
phosphorylated, and Swi6-P translocates to the cytoplasm.  
 
We have built a mathematical model of the START transition (SBF and MBF 
regulation) based on these hypothetical mechanisms. We use the model to 
explain the sizes of various START mutants and the localization of Whi5, Swi6 
and Swi4 at different phases of the cell cycle.  
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The survival of cells requires accurate chromosome segregation and 
transmission. The spindle assembly checkpoint (SAC) delays anaphase and 
mitotic exit until all chromosomes are bipolarly attached to the mitotic 
spindle. The duration of SAC-induced arrest is not indefinite and after a 
variable time, cells can progress into cell cycle even if errors have not been 
corrected with a process called “adaptation”. This process is largely 
responsible for the failure of chemotherapeutic compounds targeting the 
mitotic spindle to block tumour progression. Through a genetic screen 
designed to find adaptation-defective mutants in budding yeast, we 
implicated the RSC chromatin remodeling complex, and in particular its 
form bound to the Rsc2 accessory subunit, in this process. We found that 
RSC-Rsc2 inactivation prolongs the SAC activation's time and suppresses 
the ability of SAC mutants to exit mitosis upon spindle disruption, 
protecting cyclinB from degradation. Since we found that in yeast 
adaptation to the SAC requires the factors that are normally involved in 
mitotic exit, such as the Cdc14 phosphatase, we investigated a possible role 
of RSC-Rsc2 in Cdc14 regulation. Cdc14 is kept inactive in the nucleolus 
throughout most of the cell cycle, and released from the nucleolus by two 
pathways: the FEAR (fourteen early anaphase release) that promotes a 
partial Cdc14 release in early anaphase, and the MEN (mitotic exit network) 
that drives its complete release in telophase. We found that RSC2 deletion 
abolishes Cdc14 release in SAC-defective mutants treated with nocodazole 
and is either lethal or decreases the maximal permissive temperature of 
MEN-defective mutants, similarly to FEAR mutations. These data suggest 
that RSC-Rsc2 controls Cdc14 release acting together with the FEAR or 
through a parallel pathway. Strikingly, Rsc2 physically interacts with the 
polo kinase Cdc5, which has been extensively implicated in both the FEAR 
and MEN pathways. Thus, RSC-Rsc2 might promote adaptation to the SAC 
by stimulating Cdc14 release through regulation of the polo kinase.  
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In budding yeast, a reversible form of heterochromatin at telomeres, the 
telomere position effect (TPE), was discovered when auxotrophic markers 
were placed near chromosome ends. Selection for or against these markers 
demonstrated roles for several proteins in telomeric heterochromatin 
formation; these include the SIR protein complex, chromatin assembly 
factors (CAF-I, Asf1), DNA replication and DNA damage checkpoint 
proteins. One widely used assay to identify mutants with improper 
heterochromatin employs the URA3 gene at the telomere of chromosome 
VIIL; 5-Fluoroorotic Acid (5-FOA) containing medium requires cells to 
completely silence URA3 expression in order to survive.  
A component of the core DNA replication machinery that is central to 
chromatin formation is PCNA (POL30), tethering DNA polymerases to 
leading and lagging strands during DNA replication. To understand the role 
of PCNA in telomeric silencing, we analyzed the phenotype of the silencing 
defective pol30-8 (RD61,63AA) mutant using various TPE reporter strains. 
We found that while this mutant exhibits a heterochromatin defect, it is very 
subtle in comparison to a sir3Δ mutant. Through a genetic screen we 
identified new candidates involved in repression of URA3-VIIL in pol30-8 
mutant cells, amongst them thymidylate synthase (CDC21). CDC21 also 
suppresses the telomeric silencing defect of a strain deleted for DOT1, 
encoding the only histone H3K79 methyltransferase, but it does not 
suppress the 5-FOA sensitivity of a strain carrying endogenous URA3. Gene 
expression arrays for the pol30-8 mutant showed an upregulation of the 
ribonucleotide reductase (RNR) genes RNR2, RNR3 and RNR4. In 
agreement, we found less of the transcriptional co-repressor Ssn6 bound to 
the RNR2 promoter in pol30-8 cells by chromatin immunoprecipitation. 
Inhibition of RNR activity as well as mutations in the RAD53 DNA damage 
response pathway rescued the sensitivity of pol30-8 URA3-VIIL cells to 5-
FOA. These data raise the interesting possibility that in the context of low 
URA3 expression such as in a URA3-VIIL strain increased RNR activity is 
responsible for a higher conversion rate of 5-FOA into its toxic metabolites 
which accounts for the majority of the 5-FOA sensitivity seen in pol30-8 
URA3-VIIL mutants. The implications for the role of DNA damage 
checkpoint proteins in telomere repression will be discussed. 
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Damaged DNA binding protein-2 (DDB2) is encoded by the nucleotide 
excision repair gene XP-E. In human cells, expression of DDB2 is induced 
by p53 following DNA damage. We discovered two new functions of 
DDB2: (1) Ubiquitination and proteolysis of p21 and (2) transcriptional 
repression of the antioxidant genes. The findings are somewhat similar to 
the E3-ligase adapter Skp2, which functions in ubiquitination as well as in 
regulation of transcription. More importantly, these functions of DDB2 are 
critical in deciding cell fate following DNA damage.  
We observed that the DDB2-deficient cells fail to undergo apoptosis 
following DNA damage. The lack of apoptosis resulted from high-level 
accumulation of p21. We observed evidence that DDB2 induces proteolysis 
of p21 through the ubiquitin-proteasome pathway, which is critical for cells 
to undergo apoptosis after DNA damage. Deletion of p21 restores apoptosis 
in the DDB2-deficient cells. Because of the high-level accumulation of p21 
in the DDB2-deficient cells, we expected these cells to undergo premature 
senescence after DNA damage with greater efficiency. Surprisingly, we 
observed that the DDB2-deficient cells fail to undergo premature 
senescence induced by DNA damage. Moreover, the cells are refractory to 
premature senescence induced by culture shock, exogenous oxidative stress 
and oncogenic stress. We found that these cells did not accumulate reactive 
oxygen species (ROS) following DNA damage. The lack of ROS 
accumulation in DDB2-deficiency results from high-level expression of the 
antioxidant genes, in vitro and in vivo. DDB2 represses antioxidant genes 
by recruiting Cul4A and Suv39h, and by increasing histone-H3K9 tri-
methylation. Moreover, expression of DDB2 also is induced by ROS. 
Therefore, upon oxidative stress, DDB2 functions in a positive feed back 
loop, by repressing the antioxidant genes, to cause persistent accumulation 
of ROS and induce premature senescence. 
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A balance of opposing kinase and phosphatase activities regulates the 
function of many cell cycle proteins, however the mechanisms through 
which an appropriate balance is achieved remain relatively uncharacterized. 
Here we describe how competitive binding of Cyclin dependent kinases and 
protein phosphatase 1 (PP1) to the retinoblastoma tumor suppressor protein 
controls Rb phosphorylation state and activity in suppressing cell growth. A 
crystal structure identifies an enzyme-docking site in the Rb C-terminal 
domain that is required for efficient PP1 activity towards Rb. The 
phosphatase-docking site overlaps with the known Cyclin dependent 
kinase-docking site, and we demonstrate that each enzyme can directly 
inhibit the other by sequestering Rb substrate. PP1 competition with Cdk-
Cyclins for Rb binding is sufficient to maintain hypophosphorylated Rb and 
block cell cycle advancement. These results provide the first detailed 
molecular insights into Rb activation and establish a novel mechanism for 
regulation in which kinase and phosphatase compete for substrate docking. 
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Heterochromatin in the budding yeast Saccharomyces cerevisiae is composed of 
polymers of the SIR (Silent Information Regulator) complex bound to 
nucleosomal DNA. Assembly of heterochromatin requires all three proteins of 
the SIR complex: the histone deacetylase, Sir2 and the histone binding proteins 
Sir3 and Sir4. Changes in the locations and boundaries of heterochromatin are 
critical during development of multicellular organisms, and de novo 
establishment of heterochromatin in yeast is the best understood example of 
how these dynamic changes occur in the context of cell cycle progression. 
 
De novo assembly of heterochromatin in budding yeast requires between one 
and five cell divisions, and at least one cycle of DNA replication. Previous 
studies have shown that this assembly is not regulated by active DNA 
replication but by another event that occurs in the S-phase of the cell cycle. 
Recent work has suggested that the cell cycle inhibition of chromatin modifying 
enzymes that block heterochromatin formation may be the mechanism for how 
cells limit when they can assemble new sites of heterochromatin. Halving the 
levels of Sir4 in cells causes a dramatic loss of silencing, and these data have 
led us to test an alternative hypothesis: the abundance of Sir4 protein regulates 
the assembly of new regions of heterochromatin, and its regulated destruction 
may prevent this assembly during the G1 phase of the cell cycle. 
 
We are currently examining de novo assembly of heterochromatin using an 
assay for establishment of a site of heterochromatin in individual cells. 
Introduction of additional copies of Sir4 on low copy plasmids leads to a 
marked increase in the number of cells that are able to establish heterochromatin 
after only one cellular division. Addition of Sir4 at high copy number leads to 
ablation of this effect, while overexpression of Sir4 prevents establishment of 
heterochromatin.  
 
Sir4 abundance in G1 may be regulated by the anaphase-promoting complex 
(APC), an E3 ubiquitin ligase. Mutation of potential APC recognition sites 
(destruction boxes) in Sir4 lead to an increase in silencing and we are currently 
testing if these mutants will allow more rapid de novo assembly of 
heterochromatin. The APC is shut off at the start of S-phase, and its regulation 
of Sir4 abundance may provide an additional explanation for why cell cycle 
establishment of heterochromatin occurs only after the initiation of S-phase. 
 
 
 
 163 
A REGULATORY NETWORK CONTROLLING CELL DIVISION 
DURING C. ELEGANS DEVELOPMENT 
 
Sarah Buck, R. Mako Saito  
 
Dartmouth Medical School, Genetics, 601 Vail, Hanover, NH, 03755 
 
During the development of the model organism, C. elegans, the cell cycle is 
tightly controlled such that the location and timing of each division is 
essentially invariant. We use the development of the vulva as a model to 
reveal the general mechanisms used to achieve such a level of 
spatiotemporal control over the cell cycle. In particular, we examine the 
vulva precursor cells (VPCs) that are directed to undergo cell-cycle 
quiescence soon after their generation.  
 
We performed genome-wide RNAi and forward genetic screens which 
collectively identified over one hundred genes that are necessary for the 
cell-cycle quiescence of the VPCs. Each of the identified genes is an 
important component of the developmental network regulating the VPC cell 
cycle, since the loss of activity of any single gene disrupts the temporary 
cell-cycle arrest and results in extra VPC divisions. Thus, we have 
identified the core components of a developmental pathway that promotes 
cell-cycle quiescence. Our ultimate aim is to generate a comprehensive 
description of the regulatory interactions that determine the selection 
between division and quiescence. The organization of this hierarchy is 
being revealed using a combination of genetic and biochemical approaches. 
 
To establish a foundation from which to extend our analyses, we focus 
initially on the regulation of cdc-14. The C. elegans cdc-14 locus encodes 
the singular Cdc14-like phosphatase. Unlike its fungal counterparts, cdc-14 
is not required for mitosis and, in fact, it is not intrinsically necessary for 
cell-cycle progression. Rather, cdc-14 displays a role that is conserved with 
mammalian Cdc14B in the negative regulation of G1 progression. Our 
analyses have determined that a collaboration between alternative splice 
form usage and Crm1-mediated nucleocytoplasmic shuttling of CDC-14 
protein restricts cdc-14 activity to guide cell-cycle quiescence during 
development. Currently, experiments are ongoing to integrate the 
remaining, newly identified genes into a rational interpretation of this cell 
cycle regulatory network. 
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An important challenge in cell biology is to understand how the 
combination of molecular motors and microtubule-associated proteins 
(MAPs) contribute to bipolar spindle assembly and cooperate to govern its 
steady-state architecture. Although much is known about molecular motors, 
such as Kinesin-5 or Kinesin-14, little information is available about the 
role of non-motor MAPs, like PRC1 or MAP4. Here we show, using 
siRNA-mediated protein depletion, that MAP4, the major structural MAP in 
non-neuronal cells, is essential for building a mitotic spindle with normal 
morphology. In MAP4-depleted cells, around half of spindles lose their 
normal elliptical shape, appear bent or diamond-shaped and undergo a 
series of rotational movements in the z-axis. We also show that the timing 
of chromosome alignment is delayed, with 1-2 chromosomes failing to 
reach the metaphase plate, resulting in a mitotic arrest. Why does loss of 
MAP4 result in such phenotypes? We reveal that depletion of MAP4 leads 
to a decrease in the rate of kinetochore-MT (KT-MT) plus-end turnover, 
thus explaining the failure in chromosome congression. To confirm that 
MAP4 affects MT dynamics, we directly measured the dynamic properties 
of individual MTs in living cells using the plus-end marker EB3-tdTomato. 
So far these experiments have revealed an increase in the growth rate of 
astral-MTs, thereby confirming that MAP4 regulates MT dynamics and 
explaining the spindle orientation defects. To test whether MAP4 also 
affects non-KT MTs in the spindle, we removed KT-MTs by depleting the 
KT protein Nuf2R. In Nuf2R/MAP4 co-depletion, we observed an additive 
effect in which spindles completely lost their normal shape and began 
rotating in both z- and x-y axes. Surprisingly, new spindle poles also 
formed de novo within the existing mitotic spindle. We propose that MAP4 
sets the base-rate of MT dynamics throughout the mitotic spindle, probably 
as a result of physical interactions with the MT lattice, and cooperates with 
kinetochore-mediated mechanisms to maintain spindle architecture and 
orientation. 
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The unconventional myosin, myosin-10, contributes to the structural 
integrity and/or function of various cellular structures including filopodia 
and meiotic and mitotic spindles. Like all myosins, myosin-10 is comprised 
of an amino-terminal head domain that binds actin and hydrolyzes ATP and 
a carboxy-terminal tail domain. The tail of myosin-10 harbors multiple 
functional domains, which facilitate interactions with various 
macromolecules including microtubules, phospholipids and integral 
membrane proteins. Previous imaging studies from our lab in the fully 
intact epithelium of the Xenopus laevis embryo revealed that myosin-10 
localizes to the mitotic spindle and depletion of myosin-10 protein results in 
several mitotic spindle-related phenotypes including spindle elongation, 
failed anchoring, mitotic delay and pole fragmentation. However, the 
mechanisms by which myosin-10 contributes to proper spindle structure and 
function are poorly understood. For instance, while myosin-10 distributes 
throughout the entire mitotic spindle it appears to concentrate near the 
spindle poles. How this restricted localization is achieved and whether or 
not it is important for mitotic functions of myosin-10 is not known. In the 
current research we have characterized the distribution of GFP-tagged 
myosin-10 as well as several GFP-tagged myosin-10 fragments in the 
embryo epithelium via 4-D microscopy (4-D = x, y, z and time). Our data 
demonstrate that different fragments of myosin-10 exhibit unique 
distributions with respect to the mitotic spindle and cell cycle stage, 
indicating that various interaction domains within the myosin-10 protein 
regulate different aspects of its function. Accordingly, in order to identify 
novel myosin-10 interacting proteins that may contribute to its mitotic 
spindle-related localization and/or functions, a yeast 2-hybrid screen was 
performed with a fragment of the myosin-10 tail. Interestingly, the mitotic 
kinase Wee1 scored the most positive hits in this screen, and here we show 
independent verification of a direct interaction between myosin-10 and 
Wee1 proteins. Furthermore, we provide evidence for a genetic interaction 
between myosin-10 and Wee1 with respect to some of the spindle 
phenotypes. These data lead us to hypothesize that myosin-10, with its 
ability to interact with Wee1, a mitotic regulatory kinase, and cytoskeletal 
components such as filamentous actin and microtubules, functions as an 
important link between cell cycle regulatory systems and physical 
regulation of the mitotic spindle. 
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Cell populations able to generate a large repertoire of genetic variants have 
increased potential to generate tumor cells that can survive through the 
multiple selection steps involved in tumor progression. A proposed 
mechanism for the generation of aneuploid cancer cells involves the 
formation of tetraploid cells that gradually lose chromosomes. A major 
obstacle in this scenario, however, is that induction of tetraploidy in normal 
cells causes cell cycle arrest or cell death.  
 
We show that the p110 CUX1 homeodomain transcription factor 
contributes to the establishment of a transcriptional program that allows 
tetraploid cells to sustain a robust mitotic checkpoint thereby favoring 
multi-centrosomes clustering and bipolar division. CUX1 enables the 
survival of tetraploid cells in tissue culture, but frequent defective 
chromosome attachments leads to the emergence of chromosomally 
unstable aneuploid cells that evolve to become tumorigenic. A similar 
passage through a tetraploid state is also apparent in a transgenic mouse 
model. The fact that over 80% of mammary tumor cells in MMTV-CUX1 
transgenic mice display a sub-tetraploid chromosome content suggests that 
CUX1 induces tumor development by enabling tetraploid cells to undergo 
bipolar mitosis and generate aneuploid genetic variants. 
 
Transcriptional targets of CUX1 involved in replication and bipolar mitosis 
defines a gene expression signature that, across 12 breast cancer gene 
expression datasets, is associated with poor clinical outcome. Not only is 
high expression of these genes found more frequently in breast tumor 
subtypes that exhibit a poor prognosis, like the basal-like and HER2+, but it 
also identifies poor outcome among estrogen receptor positive/node 
negative patients, a sub-group considered to be at lower risk. 
 
The CUX1 signature therefore represents a novel criterion to stratify 
patients and provides insight into the molecular determinants of poor 
clinical outcome. 
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The Spindle Assembly Checkpoint (SAC) is a safety device that monitors 
microtubule-kinetochore attachment and delays anaphase onset until all 
sister chromatids have achieved bipolar attachment to the mitotic spindle. 
Protein phosphorylation by mitotic kinases is crucial for the SAC. Among 
the core components of the SAC, several proteins, including Aurora B, 
Bub1, BubR1, and Mps1, have a kinase domain. Here, we report the 
characterization of two checkpoint kinases, Aurora B and Mps1, using cell-
permeable small molecules selectively targeting their kinase activities. 
Firstly, we describe the characterization of a new Mps1 inhibitor named 
Reversine as an inhibitor of the SAC. Importantly, Reversine treatment led 
to undetectable levels of Zwilch and Mad1 at unattached kinetochores, 
which is consistent with the powerful SAC override observed in the 
presence of this inhibitor. Intriguingly, we found that after a recovery from 
a STLC block (that leads to a monopolar spindle whit several synthelic KT-
MT attachments), Reversine-treated cells show a large number of mis-
aligned chromosomes, indicating that besides its role in the SAC, Mps1 also 
plays a role in the correction of improper kinetochore-microtubule 
attachments. Aurora B was also implicated in error correction whereas its 
role in the SAC is controversial. Using the Aurora B inhibitor Hesperadin, 
we demonstrate that Aurora B, like Mps1, is strictly required for the SAC. 
While partial inhibition of Aurora B is still compatible with the checkpoint 
response to unattached kinetochores, complete ablation of its kinase activity 
leads to severe impairment of localization of SAC proteins at unattached 
kinetochores. Our findings suggest that a core component of the SAC, 
including the Aurora B and Mps1 kinases, responds to unattached as well as 
tensionless kinetochores. Thus, error correction is intimately intertwined 
with the sac, establishing a new paradigm in the sac. 
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Mitosis is unquestionably one of the most spectacular events in cell biology, 
as it brings unparalleled morphological changes in the cell. At the heart of 
most of these changes are the mitotic cyclin dependent kinase, Cdk1, and its 
regulatory subunit cyclin B1. The Cdk1:CyclinB1 complex in embedded in 
two interlinked positive feedback regulatory loops generating a bistable 
switch, which allows the activity of the complex to change abruptly as a 
stimulus (like the concentration of cyclin) is continuously varied. In 
addition, the spatial distribution of the Cdk1Cyclin B1 complex is also 
dynamically regulated. During interphase, Cdk1:CyclinB1 shuttles between 
nucleus and cytoplasm with export rates much faster then import rates. At 
the onset of mitosis, however Cdk1:CyclinB1 translocate from the 
cytoplasm to the nucleus in a rapid, abrupt manner. The switch-like nature 
of this import led us to hypothesize that spatial regulation of the 
Cdk1:CyclinB1 complex may be coupled to the control of its activation. In 
other words, is the switch-like nature of the Cdk1:CyclinB1 nuclear import 
an in-build spatial component that confers robustness to Cdk1:CyclinB1 
bistable switch? We approached this question by combining mathematical 
modeling with quantitative single cell imaging studies in HeLa cells and 
discovered that a spatial-positive feedback triggers the translocation of 
active Cdk1:CyclinB1 from the cytoplasm to the nucleus, where a supra-
threshold increment of localized nuclear Cdk1:CyclinB1 results in more 
Cdk1:CyclinB1 import. Importantly, when feedback regulation is 
compromised, Cdk1:CyclinB1 nuclear import is delayed and becomes more 
graded. In addition, the normal interval of timing of mitotic events is 
disrupted rendering completion of mitosis a more variable, sluggish process. 
Together, our studies strongly suggest that coupling of spatial positive 
feedback regulation to activation control in the cascades that govern mitosis 
promotes robust unidirectionality, insulation and synchronicity of cell 
division. 
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Protein ubiquitination of cell cycle regulators plays a critical role in cell 
cycle progression. The SCF and APC multiprotein ubiquitin ligases (E3s), 
with their cognate ubiquitin-conjugating enzymes (E2s) are required for G1-
S phase and mitotic cell cycle progression. Ubiquitin-conjugating enzymes 
and ubiquitin ligases catalyze the attachment of ubiquitin (Ub) to lysine 
residues in substrates and Ub during monoubiquitination and 
polyubiquitination. Lysine selection is important for generating diverse 
substrate-Ub structures, which provides versatility to this pathway in 
targeting proteins to different fates. The mechanisms of lysine selection 
remain poorly understood, with previous studies suggesting that 
ubiquitination site/s are selected by E2/E3-mediated positioning of lysine/s 
toward the E2/E3 active site. By studying polyubiquitination of the yeast 
Cdk inhibitor and regulator of G1-S phase progression, Sic1, by the E2, 
Cdc34, and the RING E3, Skp1/Cul1/F box protein (SCF), we now 
demonstrate that in addition to E2/E3-mediated positioning, proximal amino 
acids surrounding the lysine residues in Sic1 and Ub are critical for 
ubiquitination. This mechanism is linked to key residues composing the 
catalytic core of Cdc34 and independent of SCF. Changes to these core 
residues altered the lysine preference of Cdc34 and specified if this enzyme 
monoubiquitinated or polyubiquitinated Sic1. These new findings indicate 
that compatibility between amino acids surrounding acceptor lysine 
residues and key amino acids in the catalytic core of ubiquitin-conjugating 
enzymes is an important mechanism for lysine selection during 
ubiquitination. 
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During cell division, mitotic spindle formation is essential for proper 
segregation of chromosomes. Mitotic kinesin KSP (human Eg5) plays a 
critical role in centrosome separation before nuclear membrane breakdown, 
and is required for bipolar organization of spindle. KSP is localized along 
onto k-fiber microtubules of metaphase bipolar spindle, but the function of 
KSP on k-fibers remains to be elucidated. 
To make a better understanding of KSP function on spindle formation after 
nuclear membrane breakdown, we utilized mitotic inhibitors on HeLa cells; 
a microtubule destabilizing agent and KSP inhibitors. In mitotic cells 
treated with nocodazole, KSP seemed to translocate from the peri-
centrosome area to the chromosome area to form foci surrounded with 
kinetochores just after nuclear membrane breakdown. In the fraction of 
immuno-purified KSP from such nocodazole-treated cells, several factors 
related to chromosome-derived microtubule nucleation and elongation, 
including TPX2, Aurora A, RHAMM and γ-tubulin, were also identified by 
MALDI-TOF MS and werstern blotting assay. Corresponding to the 
biochemical result, co-localization of KSP with TPX2 and RHAMM was 
observed on the chromosome area in nocodazole-treated cells. Simultaneous 
treatment with nocodazole and an STLC-derived KSP inhibitor altered the 
KSP localization to whole cell area diffuse distribution to result in 
dissolution of the co-localization with TPX2 and RHAMM. Removal of 
nocodazole from such double-treated cells could promote microtubule 
elongation preferentially from kinetochores, but the microtubule fibers 
associated with TPX2 seemed to be thinner and shorter compared with 
those released from nocodazole in the cell pretreated with only nocodazole. 
These results suggest that, in normal mitotic progression, a portion of KSP 
localizes on kinetochores with TPX2 and RHAMM after nuclear membrane 
breakdown to play a role in proper elongation of chromatin-derived 
microtubules through its activity of microtubule bundling. 
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The anaphase promoting complex (APC/C) is a multisubunit E3 ubiquitin 
ligase governing the metaphase to anaphase transition and mitotic exit. 
Knowledge of its structure is essential for understanding its mode of action 
and regulation. 
So far electron microscopy (EM) studies have provided structural insights 
into the overall shape and dimensions of the APC/C, and characterised 
functionally important states of the APC/C bound to co-activators (Cdc20 
and Cdh1) and the mitotic checkpoint complex. Although antibody labeling 
experiments could localise the approximate positions of APC/C subunit 
epitopes, three dimensional mapping of individual APC/C subunits has not 
previously been reported. 
To map the position and extent of APC/C subunits within the overall 
molecular envelop of the APC/C we developed a recombinant expression 
and purification method for S. cerevisiae APC/C. We demonstrated its 
correct assembly by showing its specific ubiquitylation activity dependent 
on Cdh1 and functional D-box and KEN-box motifs within substrates. 
Furthermore, we compared the structures of recombinant and endogenous 
APC/C by using single particle EM analysis. Additionally, we have 
analysed various subcomplexes by EM and mass spectrometry. These 
studies provide insights into APC/C stoichiometry as well as its three 
dimensional subunit architecture at around 20Å. The established subunit 
boundaries enable unambiguous docking of available X-ray structures and 
homology models. 
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The STAT3 transcription factors are cytoplasmic proteins that induce gene 
activation in response to growth factor stimulation. Following tyrosine 
phosphorylation, STAT3 proteins dimerize, translocate to the nucleus, and 
activate specific target genes involved in cell-cycle progression. Despite its 
importance in cancer cells, the molecular mechanisms by which this protein 
is regulated in response to DNA damage remain to be characterized.  
In this study, we show that STAT3 is activated in response to topoisomerase 
I inhibition. Following treatment, STAT3 is phosphorylated on its C-
terminal serine 727 residue but not on its tyrosine 705 site. We also show 
that topoisomerase I inhibition induced the upregulation of the cdk5 kinase, 
a protein initially described in neuronal stress responses. In 
coimmunoprecipi-tations, cdk5 was found to associate with STAT3 and pull 
down experiments indicated that it associates with the C-terminal activation 
domain of STAT3 upon DNA damage. Using RNA interference and 
chromatin immunoprecipitation assays, we found that cdk5 phosphorylates 
the transcription factor on its serine 727 residue and that this is necessary to 
downregulate the cyclin D1 and Myc genes. Importantly, the cdk5-STAT3 
pathway reduced DNA damage in response to topoisomerase I inhibition 
through the upregulation of Eme1, an endonuclease involved in DNA 
repair.  
We therefore propose that the cdk5-STAT3 oncogenic pathway plays an 
essential role in the expression of DNA repair genes and that these proteins 
could be used as predictive markers of tumors that will fail to respond to 
chemotherapy 
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Cyclin E is often over-expressed in breast cancers and is an adverse 
prognostic indicator. Cyclin E expression is regulated by the ubiquitin 
proteasome system, whereby degradation of active cyclin E occurs via the 
SCFFbw7 pathway. We have utilized organotypic, three-dimensional (3D) 
cultures of MCF10a human mammary epithelial cells (HMECs) on a 
reconstituted basement membrane, which yields acini-like spheroids that 
recapitulate several aspects of glandular architecture in vivo. Unexpectedly, 
we found that overexpression of hyper-stable cyclin E mutant (T->A 
substitution at position 380 (T380A)), which is resistant to Fbw7-mediated 
degradation, leads to reduced cell proliferation and impaired acinar 
morphogenesis of HMECs, but only when cultured in 3D conditions. The 
arrested morphogenesis was associated with induction of p21Cip1, p27Kip1, 
and markers of cellular senescence. We investigated the mechanism of 
cyclin E- mediated growth arrest and found that the expression of hypoxia 
inducible factor (HIF1α) was increased in arrested acini. Small hairpin 
RNA-mediated knockdown of HIF1α resulted in reversal of growth arrest 
and normalization of p21 and p27 levels and acinar morphogenesis. HIF1α 
is one subunit of the heterodimeric transcription factor HIF1, which is a 
major regulator of cellular responses to decreased O2 concentration. Under 
normoxic conditions, hydroxylation of key proline residues of HIF1α by 
PHD proteins results in VHL binding and degradation. We found that 
dysregulated cyclin E causes reduced expression of PHD proteins in 
HMECs grown in 3D, resulting in stabilization of HIF1α. Also, high cyclin 
E expression, in 3D cultures and in mammary cells in vivo, caused 
increased expression of HIF1α. Our data indicate that HIF1α opposes 
proliferation induced by high cyclin E in mammary epithelial cells and 
suggest that HIF1α may be a barrier against tumorigenesis associated with 
high cyclin E and Fbw7 mutations. 
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The effect of cannabinoid on the cell cycle and cell fate is little known. 
Cortical dysplasia is a malformation resulted from altered location of 
neurons in cortical layers during brain development. Recent studies have 
shown that the cyclin-dependent kinase (cdk) inhibitors play important roles 
in cell cycle progression in normal cells. Alterations in the cdk inhibitors 
may be important in cortical dysplasia development. Cannabinoid receptors 
(CBR) and melatonin have cellular protective effects in development. Thus, 
in this study, we evaluated alterations of cannabinoid receptor-1 protein 
expression and possible associations between melatonin and cannabinoid-1 
receptor (CB1R) expression alterations in experimental cortical dysplasia 
model. Wistar female rats mated after vaginal smear controls and 
experimental cortical dysplasia model was generated by using 
administration of DNA alkilating agent (carmustin) during pregnancy. Five 
different experimental groups were conducted, including; control, ethanol, 
melatonin, carmustin, carmustin plus melatonin administered rats. Newborn 
rat brain tissue sections were evaluated under light microscopy after 
staining with hematoxylin-eosin, luxol-fast blue and 
immunohistochemistry. Comparisons of CB1R staining levels between five 
experimental groups have revealed that CB1R expression levels in brain 
tissues were reduced in carmustin and carmustin plus melatonin groups 
compared to remaining groups. Also, CB1R staining level was reduced in 
carmustin group compared to carmustin plus melatonin group. In 
conclusion; our preliminary dates give clues about the association between 
CB1R expression and melatonin administration should reveal formation 
mechanisms of cortical dysplasia and to detect new treatment approaches on 
cortical dysplasia. 
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Eukaryotic DNA replication uses kinase regulatory pathways to facilitate 
coordination with other processes during cell division cycles and response 
to environmental cues. At least two cell cycle-regulated protein kinases, the 
S phase-specific cyclin-dependent protein kinases (S-CDKs) and the Dbf4-
Cdc7 kinase (DDK, the Dbf4-dependent protein kinase) are essential 
activators for initiation of DNA replication. While the essential mechanism 
of CDK activation of DNA replication in Saccharomyces cerevisiae has 
been established, exactly how DDK acts has been unclear.  
 
We have shown that the N-terminal serine/threonine-rich domain (NSD) of 
Mcm4 plays both inhibitory and facilitating roles in DNA replication 
control and that the sole essential function of DDK is to relieve an 
inhibitory activity residing within the NSD. By combining an mcm4 mutant 
lacking the inhibitory activity with mutations that bypass the requirement 
for CDKs for initiation of DNA replication, we show that DNA synthesis 
can occur in G1 phase when CDKs and DDK are limited. However, DDK is 
still required for efficient S phase progression. In the absence of DDK, 
CDK phosphorylation at the distal part of the Mcm4 NSD becomes crucial. 
Moreover, DDK-null cells fail to activate the intra-S-phase checkpoint in 
the presence of hydroxyurea-induced DNA damage and are unable to 
survive this challenge. Our studies have established that the NSD of Mcm4 
has evolved to integrate multiple protein kinase regulatory signals for 
progression through S phase.  
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During the cell cycle in Saccharomyces cerevisiae, approximately 20% of 
the genome is transcribed periodically. Regulation of this periodic gene 
expression program is likely important for the timing of cell-cycle events. 
Although it is widely accepted that cyclin/CDK activity controls periodic 
gene expression, we have recently shown that a majority of the periodic 
gene expression program is maintained in yeast cells lacking both S-phase 
and mitotic cyclins. We proposed that a transcription factor network with 
the ability to oscillate maintains periodic gene expression in these mutants. 
This conflict raises the question: What is the role of CDKs in cell-cycle 
oscillations? To address this question, we examined global gene expression 
over time under conditions in which yeast cells lack all cyclin/CDK 
activity. We find that a significant number of genes are still periodically 
transcribed in the absence of all CDK activity, suggesting that a 
transcription factor network could maintain these oscillations independent 
of all CDK activity. However, with decreasing levels of CDK activity, 
oscillations appear to be less synchronous within the population and the 
average period length is extended. CDKs are known to interact with the 
transcription factor network at several points, providing both positive and 
negative feedback. Our data suggest that this feedback from CDK activity is 
important for robust oscillations in wild-type cells and that removal of this 
feedback may lead to damped oscillations. Together our data support a 
model in which a transcription factor network forms the core cell-cycle 
oscillator; however, the behavior of this oscillator is modulated by CDK 
activities. 
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Zoledronic acid, a widely used aminobisphosphonate, has elicited 
significant attention due to its potential antitumoral activity, however, its 
underlying mechanism of action remains unclear. Here, we analyze the anti-
tumor effects of zoledronic acid using both, in vitro and in vivo approaches 
to define the existence of a novel nuclear mechanism for promoting cancer 
growth which involves stabilization of the pro-proliferative transcription 
factor NFATc2 by GSK-3β-mediated phosphorylation of the serine rich N-
terminal SP2 motif. Treatment with zoledronic acid, however, inhibits 
GSK3β kinase activity, thus disrupts NFATc2 phosphorylation and 
stabilization in the nucleus, and finally allows the 26S proteasomal 
machinery to target NFATc2 for degradation. Mechanistically, HDM2, the 
human homologue of the E3-ligase MDM2, accumulates in the nucleus 
upon treatment binds to NFATc2 and transfers ubiquitin to lysines K-684 
and K-897. Ubiquitination of K-684 and K-897 requires an 
unphosphorylated status of NFATc2 in the nucleus and is key for the 
subsequent recognition and degradation by the 26S proteasome. The net 
cellular outcome of GSK3β -NFATc2 pathway disruption and degradation 
of the transcription factor is a progredient halt of cancer cells at the G1 cell 
cycle phase. Collectively, these results significantly expand our basic 
mechanistic understanding of a key oncogenic pathway (GSK-3β-NFATc2-
HDM-2) and suggest that double-targeting of this pathway accounts for the 
potent and sustained antitumoral effects of zoledronic acid. 
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p27 plays an important role in regulating the G1-S phase transition. p27 also 
appears to promote tumor cell motility and invasiveness. Here we provide 
additional evidence for p27 as a mediator of tumor metastasis. The 
phospho-inositol 3’ kinase (PI3K) is frequently activated in human cancers. 
Downstream of PI3K, AGC kinases catalyze p27 phosphorylation at T157 
and T198 to stabilize p27 and impair its nuclear import, causing its 
accumulation in the cytoplasm. Prior work by Besson and Roberts showed 
that p27 can bind RhoA to disrupt the cytoskeleton and increase cell 
motility. We showed that T198 phosphorylation promotes p27 binding to 
RhoA. PI3K effectors RSK, SGK, and mTOR all promote p27:RhoA 
binding and enhance directed cell migration as assessed by wound-healing 
and modified transwell assays. This motility phenotype is p27-dependent 
since lentiviral p27 knockdown reverted this hyper-motile phenotype to 
levels in parental cells. The contribution of deregulated p27 to tumor cell 
invasion and metastasis was assayed in xenografts using variants of the 
human breast cancer line, MDA-MB-231, selected for metastatic tropism to 
lung, MDA-MB-231-4175, and to bone, MDA-MB-231-1833. Both cell 
lines demonstrate hyperactivation of PI3K effectors, mTOR, SGK, RSK, 
and AKT, with concomitant elevation of cellular p27, and cytoplasmic 
mislocalization of p27. These cells demonstrate increased p27:RhoA 
binding and increased p27-dependent invasiveness. Following tail vein 
injection, the high degree of lung tumor formation in the MDA-MB-231-
4175 line was strikingly reduced to near parental levels following shRNA-
mediated knockdown of p27. Notably, p27 knockdown in MDA-MB-231-
4175 did not alter cell cycle profiles and Ki67 staining in lung tumors from 
4175 and 4175 shRNA p27 xenografted animals were similar, thus the 
reduction of lung tumor formation was not due to cell cycle effects of p27. 
These results indicate the importance of PI3K activation in the pro-
oncogenic role of p27: signaling via PI3K and AGC kinase family members 
promotes p27 phosphorylation, cytoplasmic mislocalization, RhoA 
inhibition and other cytoskeletal effects that promote tumor cell motility 
and invasion. Deregulation of p27 localization and its consequences on the 
cytoskeleton and cell motility may be pivotal to PI3K driven tumor 
metastasis in vivo. Effects of p27 knock-down on miRNA and genes known 
to regulate EMT will be presented. 
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Genetic mutations in the mitotic regulatory kinase BubR1 are associated 
with the cancer susceptible disorder mosaic variegated aneuploidy (MVA). 
In patients with biallelic mutations, a missense mutation pairs with a 
truncating mutation. Here we show that cell lines derived from MVA 
patients with biallelic mutations have an impaired mitotic checkpoint, 
chromosome alignment defects, and low overall BubR1 abundance. Ectopic 
expression of BubR1 restored mitotic checkpoint activity, proving that 
BubR1 dysfunction causes chromosome segregation errors in the patients. 
Combined analysis of patient cells and functional protein replacement 
demonstrates that all MVA mutations fall in two distinct classes: those that 
impose specific defects in checkpoint activity or microtubule attachment 
and those that lower BubR1 protein abundance. Low protein abundance is 
the direct result of the absence of transcripts from truncating mutants 
combined with high protein turnover of missense mutants. In this group of 
missense mutants, the amino acid change consistently occurs in or near the 
BubR1 kinase domain. Our findings provide a molecular explanation for 
chromosomal instability in patients with biallelic genetic mutations in 
BubR1. 
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Ipl1/Aurora B is the catalytic subunit of a complex that is required for 
chromosome segregation and nuclear division. Prior to anaphase, 
Ipl1/Aurora B localizes to kinetochores, where it is required to establish 
proper kinetochore-microtubule associations and regulate the spindle 
assembly checkpoint. At anaphase, the complex migrates to the spindle, 
where it stabilizes the spindle and regulates cytokinesis. The protein 
phosphatase Glc7/PP1 opposes Ipl1/Aurora B for some of these activities 
but the regulatory/targeting subunit(s) required for this activity are not well 
known. Several proteins have been identified that by genetic criteria could 
act as nuclear regulatory subunits for Glc7, but biochemical evidence 
suggests that they act as inhibitors. To more thoroughly characterize the 
Glc7/PP1 phosphatase activity that opposes Ipl1, we have isolated 
suppressors of ipl1-2 inviability at the non-permissive temperature. In 
addition to mutations in genes previously known to suppress the 
temperature sensitivity of ipl1-2 (GLC7, SDS22 and YPI1), we recovered a 
null mutant in TCO89, which encodes a subunit of the TOR Complex 1 
(TORC1), the conserved rapamycin-sensitive kinase activity that regulates 
cell growth in response to nutritional status. Suppression of the growth 
defect of ipl1-2 is accompanied by increased fidelity of chromosome 
segregation. The temperature sensitivity of ipl1-2 can also be suppressed by 
null mutations in TOR1, or by administration of pharmacological TORC1 
inhibitors, indicating that reduced TORC1 activity is responsible for the 
suppression. Nuclear Glc7 levels are reduced in a tco89 mutant, suggesting 
that TORC1 activity is required for the nuclear accumulation of Glc7. In 
support of this hypothesis, several mutant GLC7 alleles that suppress the 
temperature sensitivity of ipl1-2 exhibit negative synthetic genetic 
interactions with TORC1 mutants. Together, our results suggest that 
TORC1 positively regulates the Glc7 activity that opposes Ipl1 and provide 
a mechanism to tie nutritional status with cell cycle regulation. 
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The Mps1 protein kinase is a key component of the spindle assembly 
checkpoint. Here, we describe a novel Mps1 inhibitor, AZ3146 and use it to 
probe the role of Mps1’s catalytic activity during mitosis. 
When spindle assembly is inhibited, AZ3146 prevents both establishment 
and maintenance of the checkpoint. During an otherwise unperturbed 
mitosis, AZ3146 accelerates anaphase onset and frequently induces 
chromosome missegregation. Consistent with our previous observations 
(Tighe, A. et al. J Cell Biol. 181:893-901. 2008), we show that kinetochore 
localization of Mad2 is critically dependent on Mps1 kinase activity, while 
Mad1 localization is less so. We also demonstrate that the anti-Mad2 
antibody used for these studies preferentially recognizes the open 
conformation of Mad2 (O-Mad2). Consequently this antibody cannot detect 
C-Mad2 bound to Mad1 at the kinetochore. Subsequently we show that 
when Mps1 activity is inhibited, the Mad1-C-Mad2 complex is still bound 
to kinetochores; thus Mps1 activity plays a key role in recruiting O-Mad2 to 
the Mad1-C-Mad2 complex. 
Mps1 has also been shown to promote chromosome alignment via 
activation of Aurora B (Jelluma, N. et al. Cell. 132:233-246. 2008). While 
AZ3146 can indeed compromise chromosome alignment we see no obvious 
effect on Aurora B activity. By contrast, AZ3146 has a profound effect on 
kinetochore recruitment of the kinesin-related motor, Cenp-E. Moreover, 
we show that inhibition of Mps1 activity increases its own abundance at 
kinetochores and that Mps1 can dimerise in cells. 
We propose a model whereby Mps1 trans-phosphorylation results in its 
release from kinetochores, thus facilitating recruitment of O-Mad2 and 
Cenp-E, thereby simultaneously promoting checkpoint signaling and 
chromosome congression. 
*AT and LH contributed equally to this work. 
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The G1-S-phase transition is critical to cell cycle progression. In the 
budding yeast Saccharomyces cerevisiae, this transition is driven by a wave 
of gene expression, which is under the control of the cell cycle-regulated 
transcription factors SBF and MBF. SBF mainly targets genes involved in 
timing, morphogenesis and spindle pole body duplication, whereas MBF 
regulates many genes involved in DNA replication and repair. During S-
phase the DNA replication checkpoint detects DNA replication stress and 
generates a global response, which includes the transcriptional induction of 
genes involved in DNA replication and repair. We have previously shown 
that transcriptional induction in response to DNA replication stress in the 
fission yeast Schizosaccharomyces pombe is exerted through the inhibition 
of SpNrm1, a transcriptional corepressor of MBF, by the checkpoint kinase 
Cds1. Here, we show that there is also a transcriptional induction of genes 
involved in DNA replication and repair in response to DNA replication 
stress in S. cerevisiae. That response depends upon the DNA replication 
checkpoint pathway acting via ScNrm1, like in fission yeast. To establish 
the set of genes induced in response to DNA replication stress, we have 
examined genome-wide transcription dynamics in synchronized populations 
of budding yeast treated with hydroxyurea (HU), methyl methane sulfonate 
(MMS) or camptothecin (CPT). We find that a large fraction of the genes 
induced in response to HU and MMS are MBF targets, while the majority 
of SBF target genes remain unaffected. The analysis also reveals that CPT 
activates only a small subset of G1/S genes along with a unique subset of 
compound specific genes. We conclude that the transcriptional induction of 
G1/S genes is a conserved response to DNA replication stress in eukaryotes. 
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The retinoblastoma susceptibility gene, RB1, is one of the best-known 
tumor suppressor genes. The functional inactivation of its product, pRB, is 
thought to occur in most human tumors. Despite many years of 
investigation, the precise molecular interactions that mediate the tumor 
suppressing activity of pRB remain unclear. pRB has been proposed to 
interact with a very large number of cellular proteins, and the difficulty in 
interpreting the pRB literature is that there are too many potential mediators 
of pRB function. Currently it is unclear whether “pRB function” is 
mediated through just a few of its interacting proteins, or whether “pRB 
function” is the compound effect of its interaction with many different 
targets. The current evidence suggests that different pRB-associated 
proteins are likely to be important in different cellular contexts.  
We have assembled a collection of lentiviral expressed shRNAs that target 
the expression of 227 proteins that have been either reported to interact with 
pRB, or that associate with pRB in vitro. Using assays that assess specific 
readouts of pRB activity (cell cycle arrest, senescence, differentiation, 
transcriptional repression) we are screening this collection to identify pRB-
binding proteins that are necessary for each activity. In parallel, we have 
screened through a set of shRNAs that target 411 human kinases to identify 
signaling pathways that are needed for the pRB-induced changes. The goal 
of these studies is to identify the critical mediators pRB function, and to 
link them with specific signaling pathways. 
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Chromosomes trigger spindle formation through activating Aurora B, the 
kinase subunit of the chromosomal passenger complex (CPC). Spatial 
regulation of the signaling after this initial chromosomal activation step 
remains unclear. Here we reveal that the local phosphorylation reactions 
mediated by Aurora B are insufficient for spindle assembly: chromosomally 
activated Aurora B must be targeted to microtubules. While the CPC is 
enriched on chromosomes in metaphase, we establish that a fraction of the 
CPC is targeted to the metaphase spindle. Using Xenopus egg extracts, we 
demonstrate that active Aurora B must be linked to the microtubule-
targeting module of the CPC to drive spindle assembly. Moreover, although 
the CPC-microtubule interaction can activate Aurora B, which further 
promotes microtubule assembly, this positive feedback is not initiated 
without chromosomes. We propose that the dual detection of chromosomes 
and microtubules by the CPC induces spindle assembly around and only 
around chromosomes. 
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Perturbation of the DNA replication initiation pathway arrests human 
somatic cells in G1, pointing towards a cell cycle checkpoint for 
replication-competent origins. We used RNAi against Cdc7 kinase to block 
replication initiation and dissect the molecular nature of this checkpoint in 
primary fibroblasts. Our results show that the checkpoint response is 
dependent on three axes coordinated through the Forkhead transcription 
factor FoxO3a. In G1 arrested cells, FoxO3a activates the 
ARF┤Mdm2┤p53→p21 pathway and mediates upregulation of p15. P53 in 
turn activates expression of the Wnt/ -catenin signaling antagonist 
Dickkopf 3 (Dkk3), leading to Myc and cyclin D1 downregulation. Gene 
expression microarrays show the resulting loss of CDK activity inactivates 
the Rb-E2F pathway, overriding the regular G1/S transcriptional program. 
Primary fibroblasts concomitantly depleted of Cdc7/FoxO3a, Cdc7/p15, 
Cdc7/p53 or Cdc7/Dkk3 are all able to bypass the cell cycle blockade and 
proceed into an abortive S phase followed by apoptosis. Our findings 
explain how somatic cells delay S phase entry until a threshold of 
replication-competent origins is reached to ensure complete genome 
duplication. The lack of redundancy between the checkpoint axes and 
reliance on several tumour suppressor proteins commonly inactivated in 
human tumours provides a mechanistic basis for the cancer cell specific 
killing observed with cdc7 small molecule inhibitors. 
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The efficiency by which embryonic stem cells respond to DNA damage and 
regulate the onset of apoptosis is crucial as these cells have the potential to 
differentiate in adult lineages and therefore represent outermost ideal 
candidates for therapeutic applications. The cell cycle of embryonic stem 
cells (mES) differs from that of somatic cells as it is characterized by a 
short duration, and a very short G1 phase. It has been proposed that p53 
function may be compromised in these cells, although contrasting data on 
the role of p53 in mediating cell cycle arrest at the G1/S boundary after 
DNA damage have been reported.  
 
We have thoroughly analyzed the DNA damage response of mouse 
embryonic stem cells after exposure to divers DNA damaging agents, in 
either asynchronous or synchronous cell populations, as well as using 
different cell culture conditions. Overall we have observed that mES cells 
are generally more sensitive to DNA damage than somatic cells. 
Nevertheless our results show that DNA damage induces rapid ATM/ATR-
dependent p53 phosphorylation. Cell fractionation experiments demonstrate 
that phosphorylated p53 accumulates on chromatin after induction of DNA 
damage and analysis of gene expression by real time PCR demonstrates 
rapid induction of p53 targets. Moreover we observed degradation of the 
CDC25A phosphatase, induction of both Chk1 and H2AX phosphorylation 
as well as a clear cell cycle delay after exposure of mES cells to MMS. 
Altogether, these findings indicate that in mES cells p53 functions in a 
similar manner to somatic cells in the context of DNA damage, to induce 
cell cycle arrest.  
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The coordination of cell growth and proliferation with differentiation events 
is crucial during development. In addition to signals to arrest cell division or 
exit the cell cycle, modified cell cycles are exploited for particular 
developmental strategies such as rapid embryogenesis or the production of 
large cells with specialized functions. Despite the tight correlation between 
developmental and cell cycle events, the in vivo developmental signals that 
modify cell division are poorly understood in many species. We are using 
the Drosophila embryonic cycles, which undergo several modifications that 
are tightly correlated with key developmental transitions, to address this 
question. Following 13 rapid S-M nuclear divisions, the cellularized embryo 
goes through three postblastoderm divisions on a S-G2-M cycle. Due to 
large maternal stockpiles and because cell division is not required for larval 
growth, the majority of the previously identified mitotic mutants in 
Drosophila arrest at late larval or early pupal stages. Mitotic mutants 
arresting at the postblastoderm stages (mid embryogenesis) are rare, but our 
laboratory isolated a collection of lethal mitotic mutants that arrest at the 
postblastoderm divisions. These mutants cause mitotic arrest or the 
presence of polyploid nuclei. We are currently mapping and identifying 
gene products affected by three of these mutants. In addition, we are 
defining the developmental role and regulation of these genes using a 
combination of cytological and live cell imaging analysis. These studies 
will provide insights into unique regulatory features of the S-G2-M 
postblastoderm divisions. 
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Recent studies have demonstrated a critical role for the ubiquitin-
proteasome system (UPS) in regulating the signaling network for DNA 
damage responses and DNA repair. To search for new UPS targets in the 
DNA damage signaling pathway, we have carried out a non-biased assay to 
identify fast-turnover proteins induced by various types of genotoxic stress. 
This endeavor led to the identification of Rad17 as a protein exhibiting a 
distinctive pattern of up regulation followed by subsequent degradation 
after exposure to UV radiation in human primary cells. Our characterization 
showed that UV-induced Rad17 oscillation is mediated by Cdh1/APC, a 
ubiquitin-protein ligase. Studies utilizing a degradation-resistant Rad17 
mutant demonstrated that Rad17 stabilization prevents the termination of 
checkpoint signaling, which in turn attenuates the cellular re-entry into cell 
cycle progression. In addition, pathological analyses unveiled the aberrant 
accumulation of Rad17 in a variety of human tumor specimens. The 
findings provide an insight into how the proteolysis of Rad17 by Cdh1/APC 
regulates the termination of checkpoint signaling, as well as a possible 
connection between regulation of Rad17 proteolysis and carcinogenesis.  
 189 
INVESTIGATION OF THE CELL-CYCLE-DEPENDENT EXPRESSION 
OF A LYSINE DEACETYLASE REVEALS THE REGULATION 
THROUGH FORKHEAD TRANSCRIPTION FACTORS  
 
Mengqiao Wang1,2, Ruth Collins2  
 
1Program in Biochemistry, Cell and Molecular Biology, Cornell University, 
Ithaca, NY, 14853, 2Department of Molecular Medicine, Cornell 
University, Ithaca, NY, 14853 
 
Different transcription factors dictate the cell-cycle-dependent expression of 
various genes. Forkhead family transcription factors are conserved from 
yeast to human, and are important for expression of genes involved in cell 
growth, proliferation and differentiation. Two partially redundant forkhead 
genes, FKH1 and FKH2, are found in S. cerevisiae. and are important for a 
number of genes whose expression display a cell-cycle-related oscillation 
and peak at G2/M transition. Such expression patterns are essential for cell 
cycle control (especially G2/M transition) and activation of proper 
downstream effectors.  
 
Hos3, which encodes for a Type II lysine deacetylase, has two Fkh1p and 
two Fkh2p binding sites within its promoter, and both these factors are 
known to be recruited to the HOS3 promoter. Upon release from G1 arrest, 
the Hos3p level decreases quickly but peaks later at G2/M transition. In 
forkhead transcription factor mutants, the cell-cycle-dependent expression 
pattern of Hos3p is altered. The effect of forkhead transcription factors on 
the expression of Hos3p suggests a cell-cycle-related function of this lysine 
deacetylase, which needs further characterization. 
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Cdc14 dual-specificity phosphatase plays key roles in yeast cell cycle 
control. There are two mammalian Cdc14 homologues, Cdc14A and 
Cdc14B. Cdc14A is thought to function in centrosome cycling, whereas 
Cdc14B’s function remains elusive. To probe the physiological function of 
Cdc14B, we generated mice deficient in this phosphatase. We found that 
Cdc14B is not essential for mitosis and the mutant mice can survive to 
adulthood. However, Cdc14B-deficency resulted in reduced fertility and 
deficits in learning and memory. Furthermore, Cdc14B mutant mice showed 
elevated rates of early onset cataracts, a sign of premature aging. At cellular 
level, loss of Cdc14B also caused premature senescence with concomitant 
upregualtion of p21Cip1 and more accumulated endogenous DNA damage. 
These data indicate a role of Cdc14B in the prevention of premature aging 
at both cellular and organismic levels.  
 
Keywords: Cdc14B, Knock-Out, Cellular Senescence, DNA Damage. 
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Regulated proteolysis of proteins is essential to progress cell division 
cycles. The Anaphase Promoting Complex/Cyclosome plays a role in both 
mitosis and meiosis by ubiquitinating and targeting specific substrate 
proteins for degradation by the 26S proteasome. Although known targets 
such as Securin, Cyclin A, Cyclin B, and Cyclin B3 must be degraded to 
permit exit from both mitosis and meiosis, there may be proteins uniquely 
targeted for degradation in meiosis. To explore this we are investigating a 
meiosis specific form of the APC/C. Drosophila express two APC/C 
activators during mitosis: fzy/cdc20 and fzr/cdh1. During female meiosis, 
however, fzy/cdc20 is expressed in addition to a novel, meiosis-specific 
activator cortex. Both cortex and fzy/cdc20 are necessary for the completion 
of meiosis. The non-redundancy of fzy/cdc20 and cortex suggests either 
they have unique substrates or are subject to unique regulation. 
 
We are taking two approaches to identify potential substrates and regulators 
of Cortex. First, we screened for deletions in the Drosophila genome that 
dominantly suppress the meiotic arrest resulting from reduced levels of 
Cortex protein. These intervals may contain negative regulators of Cortex 
and/or novel meiotic substrates of the APC/C. Five suppressing deficiencies 
have been found. Second, proteins that bind to a functional Myc-Cort fusion 
protein expressed in the Drosophila ovary were identified by mass 
spectrometry. As expected, subunits of the APC/C were recovered. 
Additionally, proteins involved in processes such as microtubule 
binding/motors, chromosome segregation and mitosis/meiosis were 
immunoprecipitated with Myc-Cort. These proteins are candidate substrates 
and regulators of Cortex. 
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Expression of the replication-dependent histone mRNAs are restricted to S 
phase of the cell cycle. Their regulation is primarily post-transcriptional and 
controlled in part by the histone Stem-loop Binding Protein (SLBP). We have 
used RNA-binding protein IPs (RIP) followed by microarray analysis (RIPchip) 
and ultra-highthroughput (UHTP) sequencing (RIPseq) to identify targets of the 
SLBP. Prior analysis of SLBP by RIPchip indicated replication-dependent 
histone mRNAs were the only verifiable targets. We have repeated the analysis 
of SLBP by RIPchip and RIPseq to confirm and extended these results. Nine 
SLBP IPs were performed from polyribosomes and in each case, a negative 
control was performed in parallel. RNA isolated from the bound and unbound 
fractions was analyzed on whole-genome DNA microarrays. Aliquots of the 
same samples were pooled and analyzed by Solexa UHTP sequencing. Analysis 
of SLBP targets on DNA microarrays and selection of probes by Significance 
Analysis of Microarrays (SAM; FDR <0.001%) identified 82 enriched probes. 
66 probes mapped to 58 replication-dependent histone mRNAs, the remainder 
to non-histone mRNAs. Analysis by Solexa UHTP sequencing gave >15M 
sequencing reads of 25 nt from the SLBP-RNA complex, the Ab:peptide 
negative control and a no-antibody negative control. Overlapping reads were 
collapsed and mapped to known RefSeq genes. For each gene, we calculated the 
reads per kilobase of exon model per million mapped reads (RPKM), which is a 
representation of transcript abundance corrected for bias introduced by variable 
transcript size. We evaluated the reproducibility of this data by comparing the 
histone mRNA enrichment observed by RIPseq with that observed by RIPchip. 
Of the most abundant gene transcripts identified by RIPseq, there is significant 
enrichment for replication-dependent histone mRNAs. Of the top 82 genes by 
RIPseq, 53 are histone mRNAs representing 50 different genes. In total, 66 
histone transcripts were identified by RIPseq and RIPchip, including 62 
replication-dependent histone mRNAs, two pseudogene mRNAs (H2BFS, 
HIST2H3PS2), and the replacement variants H2AFX and H2AFJ. 42 genes 
were identified by both methods, 16 only by RIPchip, and 8 only by RIPseq. 
The non-histone genes enriched by RIPchip were not enriched by RIPseq and 
vice versa. Our data demonstrate that RIPseq provides similar sets of targets as 
RIPchip, but has the advantage that one does not need to pre-specify the RNA 
sequences on the array, allowing for discovery of new targets and binding sites. 
We are currently extending these methods to include protein-RNA cross-linking 
followed by nuclease digestion (CLIP) and UHTP sequencing to precisely 
identify binding sites for RNA-binding proteins involved in histone mRNA 
regulation. 
 
Supported by NIH grant 5R01HG004499 to MLW. 
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The APC/C ubiquitin ligase is activated at prometaphase by mitotic 
phosphorylation and increased binding of its activator Cdc20. This initiates 
cyclin A destruction, while cyclin B1 is stabilized by the mitotic spindle 
checkpoint.  
 
Upon spindle checkpoint release, it was proposed that the RXXL 
destruction motif (D-box) directs recruitment of cyclin B1 to either core 
APC/C or Cdc20. We studied APC/C substrate-capturing in cells and report 
that endogenous cyclin B1-Cdk1 is recruited to the checkpoint-inhibited, 
phosphorylated APC/C in prometaphase, independently of Cdc20 or the 
cyclin B1 D-box.  
 
Like cyclin A, cyclin B1 binds the phosphorylated APC/C in a way 
dependent on the Cdk-subunits of the Cks family and APC3. Prior binding 
to APC/C-Cdc20 mediates efficient degradation of cyclin B1 in metaphase 
to control mitotic exit and cytokinesis. We also show that this Cks-mediated 
recruitment of cyclin B1-Cdk1 to the APC/C contributes to mitotic slippage 
of cells that are arrested with an active spindle checkpoint.  
 
We conclude that, in cells, factors that bind APC/C substrates can direct the 
processivity of their ubiquitination. Further we propose that the spindle 
checkpoint does not prevent cyclin B1 recruitment to APC/C-Cdc20, but 
rather may inhibit the ability of APC/C-Cdc20 to recognize the D-box of 
bound cyclin B1.  
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Faithful segregation of sister chromatids during cell division is essential for 
the accurate transmission of genetic material from one generation to the 
next. This process is mediated by sister chromatid cohesion (SCC), which 
ensures sister chromatids remain coupled until anaphase. SCC is mediated 
by the cohesin complex, a multi-subunit protein complex which is thought 
to form a ring that physically encircles the sister chromatids.  
In addition to the cohesin complex, many other proteins are required for 
SCC, including sororin, a positive regulator of SCC that interacts with the 
cohesin complex in vitro. Sororin is required for the increased stability of 
the cohesin complex on chromatin following DNA replication and the 
maintenance of sister chromatid cohesion during G2, yet seems to be 
dispensable for cohesin complex loading. The mechanism by which sororin 
ensures cohesion is currently unknown.  
In this study, we have undertaken a structure/function analysis of the 
sororin protein. The primary sequence of sororin does not suggest the 
presence of any known structural or functional motifs, though sequence 
alignment of sororin proteins across several species indicates the presence 
of particularly well-conserved regions. We hypothesize these regions are 
likely to be important for function. Here we show that mutations within the 
conserved c-terminus of sororin fail to rescue a sororin knockdown 
phenotype. We show that this region of the protein is not important for 
chromatin association. Together, these data suggest that sororin is recruited 
to the chromatin by a mechanism independent of its ability to regulate 
cohesion. Further studies are being conducted to identify regions of sororin 
that mediate interaction with the cohesin complex. 
 195 
INTERACTION NETWORK OF DNA REPLICATION-INITIATION 
PROTEINS AND DIMERIZATION OF ORC AND NOC3P IN PRE-
REPLICATIVE COMPLEX ASSEMBLY IN BUDDING YEAST 
 
Rentian Wu1,2, Chuchu Zhang1, Fenju Lai1, Jeffrey Yeung1, Jiafeng Wang1, 
Lin Huo1, Yuanliang Zhai1, Chun Liang1  
 
1Hong Kong University of Science and Technology, Dept. of Biochemistry 
and Center for Cancer Research, KLN, Hong Kong, HK, China, 2HKUST, 
Bioengineering Postgraduate Program, KLN, Hong Kong, HK, China 
 
Initiation of eukaryotic DNA replication involves the sequential association 
of replication-initiation proteins with replication origins, such as ORC, 
Noc3p, Cdc6p, Cdt1p, MCM, Cdc45p, Mcm10p, Sld2p, Dbp11p, Sld3p and 
GINS. Using the yeast two-hybrid assay, we have systematically studied the 
interactions between most of these proteins. We found many novel 
interactions, including interactions of Noc3p with four ORC subunits, 
Cdt1p and Mcm6p, further supporting the role of Noc3p as a connector 
between ORC and other pre-RC proteins. Moreover, we have found novel 
self-interactions of some ORC subunits and Noc3p.  
ORC is the platform for pre-replicative complexes (pre-RCs) at replication 
origins. It remains unclear as to what happens to ORC and the replication 
origins after the initiation of DNA replication. We found that the self-
interaction of Orc6p occurs at G1 phase, but not S or G2/M phase. 
Furthermore, with the same cell number equivalent of proteins for each 
time-point sample loaded in SDS-PAGE, we found that the chromatin-
bound ORC remains constant throughout S and G2 phases and increases at 
late M phase as pre-RCs are formed, suggesting that ORC forms a dimer at 
the M-to-G1 transition to support pre-RC assembly, and each ORC dimer 
separates into two monomers to bind both copies of each replication origin 
after replication initiation.  
Noc3p is essential for both ribosome biogenesis and replication initiation. 
We mapped the Noc3p self-interaction domains to the two coiled-coil 
motifs (CC1 and CC2) and found that both CC1 and CC2 deletion mutants 
grow slowly and are defective in S phase entry but not S phase progression, 
with the CC2 deletion mutant being more defective than the CC1 deletion 
mutant. CC2 deletion affects ribosome biogenesis strongly at 37°C and only 
slightly at 30°C, and CC1 deletion does not affect ribosome biogenesis. 
Therefore, the two Noc3p mutant strains show different degrees of defects 
in ribosome biogenesis and DNA replication.  
Based on these results, we have come up with a model for DNA replication 
initiation, which involves ORC, Noc3p and MCM dimer formation. 
[Supported by Hong Kong Research Grant Council] 
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Cullins are a family of evolutionarily conserved proteins that bind to the 
small RING finger protein, ROC1, to constitute potentially a large number 
of distinct E3 ubiquitin ligases. Cullin-7 (CUL7) has been identified as a 
simian virus 40 large T antigen-binding protein. Disruption of CUL7 gene 
in mice causes intrauterine growth retardation and perinatal death. CUL7 
germlined mutations have been found in patients with autosomal-recessive 
3-M and Yakuts short stature syndromes, indicating CUL7 plays a critical 
role in cell growth. We have found that CUL7 is enriched on mitotic 
apparatus. Knocking down CUL7 in U2OS cells reduces cell proliferation, 
and causes tetraploidy, interconnected daughter cells, and cell death during 
cytokinesis. Further study shows that CUL7 depletion delays chromatids 
alignment, resulting in a prolonged prometaphase. Additionally, cells 
depleted of CUL7 show early inactivation of Aurora B at late telophase, a 
protein which has been reported to stabilize the mid-body. Accordingly, 
cells depleted of CUL7 is either impaired to form or prematurely 
disassemble mid-body. These findings suggest that CUL7 is a crucial 
regulator of mitosis/cytokinesis. The mitotic/citokinesis defects caused by 
CUL7 loss may attribute to essential activity of Cul7 in mouse development 
and/or the onset of human 3-M and Yakuts syndromes. 
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Growth arrest specific gene two (Gas2) was discovered in mouse fibroblasts 
grown under arresting conditions. The protein contains two functional 
domains; the Gas2 domain and a calponin homology domain targeted by 
caspase cleavage. Studies of Gas2 expression in the developing embryo 
have indicated roles for the gene in chondrocyte and adipocyte 
differentiation and proliferation, apoptosis of interdigital tissues in the 
developing embryo, and the development of several organ systems. Gas2 
expression has also been seen to change in injured adult tissues, and may be 
involved in wound healing and remodeling of affected tissues. There is 
evidence that Gas2 functions as a regulator of apoptosis, participating in 
cytoskeletal rearrangements of the cell as well as acting as a part of the p53 
apoptotic pathway. In order to understand the physiological role of Gas2 in 
the mammal, we have generated the first mouse in which expression of the 
Gas2 gene has been knocked out. The mutant mice are capable of surviving 
to adulthood, but the females display reduced fertility. Histological sections 
have shown structural differences in the ovary of the mutant mouse. Of 
interest is the number and ratio of maturing and mature follicles within the 
ovary. Of the thousands of primordial follicles present in the developing 
mouse ovary, greater than ninety percent will disappear before they reach 
maturity. The process of controlled follicular death, called atresia, is 
regulated by the controlled apoptosis of the granulosa cells of the 
developing follicle, and the structure of the follicles found in the Gas2 
mutant is similar to that which has been observed in both caspase-2 and p27 
knockout mice. Mutant ovaries display small sized follicles, and a larger 
number of immature structures. Superovulated mutant ovaries contain fewer 
mature structures. Increased apoptosis of the granulosa cells has been 
confirmed by immunohistological staining of cleaved caspase-3 in ovarian 
sections taken from our mutant mice. Conversely embryonic fibroblasts 
isolated from mutant embryos show delayed senescence compared to wild 
type, however this may further explain the lack of mature and differentiated 
granulosa cell types in the superovulated ovary. Therefore, it seems that the 
infertility of the Gas2 mutant mice is due to failed follicular maturation due 
to excessive apoptosis of the granulosa cell population, though further work 
is necessary to confirm the mechanism by which Gas2 regulates apoptosis n 
the maturing follicle. 
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Proper bipolar spindle formation requires centrosome maturation at G2/M 
transition, during which the additional pericentriolar material (PCM) 
proteins are recruited to the centrosome and enhance the microtubule 
nucleation ability. Polo-like kinase 1 (Plk1) is a highly conserved Ser/Thr 
kinase that has essential role in the centrosome maturation. However, the 
mechanism by which Plk1 recruits the crucial component of PCM, γTuRC 
to the centrosome is poorly understood. Here, we identify Nedd1, a novel 
centrosomal substrate of Plk1, the accumulation of which at centrosome is 
largely decreased with Plk1 depletion. The sequential phosphorylation of 
Nedd1 by Cdk1 and Plk1 promotes its interaction with γ-tubulin, which is 
important for targeting the γTuRC to the centrosome and for spindle 
formation. In our study, we also show that Plk1 accumulates at the matrix of 
centrosome. Plk1 colocalizes with PCM1, a centriolar satellite protein, at 
centrosome and binds PCM1 directly through its PBD domain. Both PCM1 
depletion and overexpression of a truncated mutant disrupt the localization 
of Plk1 on centrosome. Taken together, we propose that PCM1 is a key 
factor for targeting Plk1 to the centrosome, which later enhances the 
interaction of Nedd1 and γ-tubulin and promotes centrosome maturation 
and spindle assembly. 
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Mammalian cells exhibit complex cellular responses to DNA damage, 
including cell cycle arrest, DNA repair and apoptosis. Defects in any one of 
these responses can result in carcinogenesis. Absence of the chromatin 
remodeling complex SWI/SNF is found in many instances of cancer, and 
we have investigated its role in the DNA damage response. The human 
carcinoma cell line SW13 is deficient in SWI/SNF due to the lack its two 
mutually exclusive catalytic subunits, BRG1 and BRM. SW13 cells are 
very sensitive to UV radiation. In contrast, SW13 cells with ectopic Brg1 
expression regain active SWI/SNF and become significantly more resistant 
to UV radiation. Sensitivity to UV light correlates well with dramatic UV 
induced apoptosis in SW13 cells, but not in SW13 cells expressing Brg1. 
Additionally, using Affymetrix Human Genome U133 Plus 2.0 microarray, 
we have assessed BRG1-mediated alterations in over 47,000 transcripts. We 
have identified 1496 BRG1 up-regulated genes and 811 repressed genes. 
Importantly, a large amount of UV inducible genes require BRG1 for 
proper expression. Brg1 expression in SW13 cells restores expression of 
p21, ATF3 and Gadd45a, which are involved in DNA damage response and 
G1 cell cycle arrest. Finally, we show that re-expression of BRG1 in SW13 
cells stimulates nucleotide excision repair of UV induced DNA damage. We 
demonstrate that recruitment of the DNA damage recognition protein XPC, 
but not DDB2, to sites of UV lesions is significantly disrupted when BRG1 
is depleted. Our findings demonstrate that SWI/SNF protects genome 
stability by orchestrating cell cycle arrest and facilitating DNA damage 
repair.  
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p27 is a cell cycle regulator and an atypical tumor suppressor. However, 
p27 gene deletions or mutations are rarely observed in human cancers. 
Instead, p27 is frequently degraded or mislocalized to the cytoplasm in 
aggressive human cancers. We and others have shown that p27 is 
phosphorylated at T198 by different PI3K effector kinases (AKT, RSK and 
SGK) and this leads to p27 accumulation in the cytoplasm due to impaired 
nuclear import. Recent data suggest that cytoplasmic p27 may acquire cell 
cycle independent oncogenic function to promote tumor cell migration by 
inhibiting RhoA-ROCK activation. Until recently, the post-translational 
modifications that cause p27 to acquire this cytoplasmic gain-of-function 
were largely unknown. We recently showed that RSK1-mediated 
phosphorylation of p27 at T198 promotes its binding to RhoA in vitro and 
PI3K activation in cells is associated with increased p27:RhoA binding. 
Moreover, the increased cell motility caused by constitutive PI3K effector 
activation is reversed by p27 knockdown. To better understand the 
contributions of T157 and T198 phosphorylation with regard to p27’s gain 
of function and ability to promote cell migration and metastasis, we used a 
p27CK- mutant that fails to bind cyclins and cdks and prepared p27CK- 
phosphomimetic T157D, T198D or double phosphomimetic mutants. These 
were introduced into the MDA-MB-231 breast cancer cell line to generate 
multiple stable clones: p27CK-, p27CK-T157D, p27CK-T198D and 
p27CK-T157D/T198D. All stable lines show proliferation rates and cell 
cycle profiles similar to parental cells. Both p27CK-T157D and p27CK-
T198D cells show more cytoplasmic p27 localization, greater cell motility 
and increased matrigel invasion than either p27CK- or vector expressing 
cells. p27CK-T157D/T198D is predominantly cytoplasmic and confers 
even greater cell motility and matrigel invasion. The effects of p27 
T157D/T198D to alter the actin cytoskeleton and increase local orthotopic 
tumor invasion and metastasis in MDA-MB-231 xenografts will be 
presented. These data may illuminate how p27 deregulation contributes to 
cancer progression and metastasis. 
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Endocycles are variant cell cycles comprised of DNA Synthesis (S)- and 
Gap (G)-phases, but lacking mitoses. Endocycles are frequently found in 
invertebrates, plants and certain mammalin cell-types, where they facilitate 
post-mitotic growth. Since mitosis is bypassed, mitotic regulators are 
transcriptionally down regulated, while the same components are used for 
G-S control as in mitotically dividing cells. DNA replication during 
endoreplication in Drosophila is triggered by Cyclin E (CycE) / Cyclin 
Dependent Kinase 2 (Cdk2) activity, but this must be extinguished during 
each G-phase to allow activation of the Anaphase Promoting 
Complex/Cyclosome (APC/C). The APC/C targets the licensing inhibitor 
Geminin for proteasomal degradation and thus allows assembly of pre-
replication complexes (preRCs) for the next S-phase. However, the 
mechanism controlling CycE/Cdk2 oscillation during endocycle 
progression has not been established. We now provide evidence that 
endocycles in Drosophila salivary glands are driven by a molecular 
oscillator in which E2F1 promotes cycE transcription, CycE/Cdk2 triggers 
S-phase, and S-phase activates the Cul4-Ddb1-Cdt2 E3 ubiquitin ligase that 
promotes the destruction of E2F1. The loss of E2F1 during S-phase creates 
a window of low Cdk2 activity that allows APC activation and preRC 
formation. Consistent with this mechanism, overexpression of E2F1 
accelerated endoreplication, whereas stabilization of E2F1 blocked 
endocycle progression. This arrest was accompanied by elevated levels of 
CycE transcript and gradual accumulation of Geminin protein. In addition, 
we found that the mitotic regulators Cyclin A and Cdk1 accumulate upon 
overexpression of E2F1. Similar, ectopic expression of Cyclin A and Cdk1 
was observed in salivary gland cells mutant for the repressor E2F2. From 
these observations we conclude that E2F2-mediated repression might be 
required to prevent mitotic gene expression during endoreplication. 
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Embryos of every metazoan phylum undergo rapid cell cycles just prior to 
gastrulation. In frog and fly, and most organisms, these rapid cycles follow 
on the heals of fertilization, and run using maternally expressed genes 
without needing zygotic transcription. More than 25 years ago John 
Newport began to explore the nature of these early cycles and the 
remarkable transition called the mid blastula transition (MBT) at which the 
cycles slow and morphogenesis begins. Our studies in Drosophila, have 
revealed new views of these keystone cell cycles. I will describe recent 
work that reveals the basis of the timing of the early cycles, which are 
streamlined cycles of S phase and mitosis without gap phases, and how cell 
cycle events change at the MBT. Using genetics and RNAi to manipulate 
cyclin protein production, we show that the timing of interphase is not 
determined by a cyclin accumulation clock. Using injection of Geminin, an 
inhibitor of Cdt1 function that prvents preRC formation, we have entirely 
eliminated S phase rather than the more usual experimental manipulation in 
which its progress is inhibited. S phase duration governs interphase length 
in the early cycles, but does not time cycle progress after the MBT. S phase 
length dramatically increases at cycle 14, and this first long S phase serves 
as a transition time at which the numermous changes of the MBT occur. 
This S phase lengthens because of a reprogramming of DNA replication: 
replication of satellite sequences, which previously occurred in sync with all 
the other sequences, is deferred, and sequential “late replication” of each 
block of satellite prolongs S phase. Maternally provided Cdc25 phosphatase 
is eliminated during S phase 14 and this elimination results in the pause of 
cycle 14 in the first G2. If S phase 14 is deleted, cells very rapidly enter 
mitosis suggesting that the ability of S phase to defer mitosis via checkpoint 
processes provides a time interval in which the cell cycle regulation is 
retooled at the MBT. But how is S phase prolonged? Recruitment of HP1, a 
marker of heterochromatin, to satellite sequences occurs after the onset of S 
phase 14 suggesting that at selective localization of this protein is not 
required to consign origins to a late time of replication. By injection of 
Cdc25 mRNA, we show that the normal prolongation of S phase requires 
the decline in maternal Cdc25. This leads us to suggest a reinforcing 
feedback at the MBT in which declining Cdc25 prolongs S phase during 
which there is further decline of Cdc25 to introduce the G2 phase and the 
first dependency of the cell cycle on zygotic transcription. 
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Endocycles are variant cell cycles comprised of DNA Synthesis (S)- and 
Gap (G)-phases, but lacking mitoses. Endocycles occur in many 
invertebrate and plant cells, where they facilitate post-mitotic growth, and 
are so ubiquitous that they may account for nearly half the earth’s biomass. 
DNA replication in endocycling Drosophila cells is triggered by Cyclin E 
(CycE) / Cyclin Dependent Kinase 2 (Cdk2) activity, but this must be 
extinguished during each Gap phase to allow activation of the Anaphase 
Promoting Complex/Cyclosome (APC/C) and assembly of pre-Replication 
Complexes (preRCs) for the next S-phase. The mechanism controlling 
CycE/Cdk2 oscillation during endocycle progression has not been clearly 
established. We find that endocycles in Drosophila salivary glands are 
driven by a molecular oscillator in which the E2F1 transcription factor 
promotes CycE expression, CycE/Cdk2 triggers S-phase, and S-phase 
activates the Cul4/Cdt2, PCNA dependent E3 ubiquitin ligase that drives 
the destruction of E2F1. We propose that it is the loss of E2F1 during S-
phase that creates the window of low Cdk activity which allows APC 
activation and preRC formation. Consistent with this mechanism, over-
expression of wildtype E2F1 accelerates endocycling, whereas expressing a 
stabilized variant of E2F1 lacking the PCNA interaction (PIP) motif 
blocked endocycling. Further, we find that conditions that alter cell growth 
regulate E2F1 protein levels, thereby making endocycle progression 
growth-dependent. The regulatory interactions essential to the endocycle 
oscillator we describe are conserved in animals and plants, suggesting that 
elements of this mechanism may act in many different types of growth-
dependent cell cycles. 
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Classical cell cycle regulators must be coordinated with cell fate regulators 
to generate tissues during development and maintain them in adults. Defects 
in that coordination can shift the balance between proliferation and 
differentiation with devastating clinical effects. Yet our understanding of 
molecular mechanisms integrating cell cycle and stem cell controls remains 
in its infancy. We have found that Caenorhabditis elegans CYE-1 (cyclin 
E) and CDK-2 (Cdk2) shift the mitosis/meiosis balance towards continued 
mitotic divisions at the expense of meiotic entry, at least in part, by 
negatively regulating GLD-1, a member of the STAR protein family and a 
key developmental regulator of meiotic entry. GLD-1 is normally low in 
mitotically dividing germ cells, but when CYE-1 or CDK-2 is depleted, it 
becomes abundant. When CYE-1/CDK-2 and GLD-1 are both depleted, the 
mitosis/meiosis balance is not affected, suggesting that CYE-1 acts through 
GLD-1. Moreover, GLD-1 appears to be a direct substrate of CYE-1/CDK-
2 phosphorylation, revealing a distinct regulatory branch of mitosis/meiosis 
control. Because GLD-1 also represses cye-1 expression (Biedermann et al., 
2009), GLD-1 and CYE-1/CDK-2 form a loop of mutual repression in 
balancing between mitosis and meiosis. Furthermore, CYE-1/CDK-2 works 
synergistically with the FBF-1 stem cell regulator to lower GLD-1 and to 
prevent meiotic entry in the germline stem cell pool. Therefore, the CYE-
1/CDK-2 cell cycle regulator emerges as a key developmental regulator 
with a critical role in stem cell maintenance. 
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Within most diploid organisms, truncated endo- or endo-mitotic cell cycles 
programmed to prematurely exit S- or M-phase generate polyploid cells. As 
a result of these altered cell cycles, polyploid cells are thought to be 
incapable of mitosis. Further, studies of artificially-induced polyploidy 
suggest that polyploid mitosis is error-prone and tumorigenic. However, a 
small number of classic reports suggest that polyploid cells divide during 
normal development. We investigated one of these claims1 in the mosquito 
(Culex) hindgut. Convincingly, we find polyploid cells do in fact undergo 
multiple mitoses during Culex hindgut development. We then identified 
similar polyploid mitoses in the genetically tractable Drosophila hindgut. 
Using both live and fixed imaging, we defined the parameters of such 
polyploid divisions. During a brief window of development, polyploid cells 
undergo two mitoses and cycle together in localized domains to build 
important absorptive structures. Mitosis of these polyploid progenitors 
(PPPs) requires conserved cell cycle regulators and Notch signaling. Unlike 
previous claims of polyploid division, we find PPPs complete S-phase and 
retain ploidy (8C). Further, by examining when PPPs become polyploid, we 
found a key cell cycle difference that likely enables PPPs to divide. Unlike 
most endocycles, which truncate S-phase, PPPs fully replicate prior to 
undergoing a novel endo- to mitotic cycle switch. Further, we find evidence 
of diminished mitotic fidelity in polyploid cells. Compared to diploid cells, 
PPP mitosis length is increased two-fold, and ~10% of PPP anaphases 
contain lagging chromosomes. This latter observation suggests that 
polyploidy presents additional challenges during mitosis. Our 
characterization now permits identification of polyploid mitosis regulators 
and a means to test the accuracy of polyploid divisions in vivo. Coupled 
with our previous observation that adult hindgut cells divide following 
tissue damage2, our work establishes the hindgut as a valuable system to 
study previously under-appreciated plasticity in metazoan cell cycles.  
 
1 Berger, C. Carnegie Inst. Washington Publl. 496, 200-232 (1938). 
2 Fox, D. T. & Spradling, A. C. Cell Stem Cell 5, 290-297 (2009). 
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Checkpoint kinase-1 (CHK1) is essential for cell proliferation in mammals. 
In response to DNA damage, CHK1 regulates the cell division cycle by 
inhibiting the activities of both CDK1 and CDK2, the two cyclin dependent 
protein kinases that drive cells into mitosis and S-phase, respectively. Thus, 
activation of CHK1 inhibits progress through the cell cycle. Here we report 
a novel role for CHK1 in regulating the transition from cell proliferation to 
cell differentiation. When deprived of fibroblast growth factor-4 (FGF4), 
proliferating trophoblast stem (TS) cells differentiate into non-proliferating 
trophoblast giant (TG) cells that undergo ‘endocycles’ (multiple rounds of 
DNA replication without an intervening mitosis) and become polyploid. 
Previous studies demonstrated that this event rapidly induces expression of 
p57/KIP2 with concomitant inhibition of CDK1 activity (1). Subsequent 
studies have revealed that CHK1 activity regulates expression of p57/KIP2. 
The levels of CHK1 and p57 proteins are inversely correlated; CHK1 
protein levels are high in TS cells but suppressed in TG cells, whereas the 
opposite is true for p57 protein. Inhibition of CHK1 activity in TS cells 
rapidly induces the accumulation of p57 protein with concurrent 
differentiation into TG cells. Over expression of wild-type CHK1 in TG 
cells suppresses expression of p57 protein with the concurrent appearance 
of mitotic cells, whereas over-expression of a phosphorylation defective 
CHK1 mutant does not. This is not due to changes in p57 mRNA levels, but 
to ubiquitin dependent degradation of p57 protein. In vitro, CHK1 
phosphorylates p57 only at serine 19; CHK2 does not phosphorylate p57. In 
vivo, substitution of serine 19 with alanine stabilizes p57 protein whereas 
substitution with aspartic acid destabilizes it. Therefore, in the absence of 
induced DNA damage, CHK1 phosphorylates p57 in proliferating TS cells 
and targets it for degradation. In TG cells where CHK1 expression is 
suppressed, p57 inhibits CDK activity during G-phase to allow 
prereplication complex assembly, and then is targeted for degradation by 
CDK2 during S-phase to allow endocycles to occur. Thus, CHK1, a key 
intermediate in the DNA damage response pathway, also plays a critical 
role in regulating p57 dependent cell differentiation in mammals. 
 
(1) Ullah, Z, MJ Kohn, R Yagi, LT Vassilev and ML DePamphilis (2008) 
Genes Dev 22:3024-3036 
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Myc is a BHLH transcription factor that plays a critical role in major 
biological processes, such as proliferation, growth, apoptosis, and 
differentiation. Recently, we discovered Myc-nick, a transcriptionally 
inactive form of Myc that is localized in the cytoplasm. Myc-nick is 
generated by a proteolytic cleavage of the full-length Myc that is carried out 
by members of the calpain family of calcium dependant proteases. Myc-
nick lacks the C-terminal region (nuclear localization signal, Max 
dimerization domain, and DNA binding domain) of Myc but contains an 
intact N-terminus. Ectopic expression of Myc-nick in fibroblasts and 
epithelial cells promotes changes in cell morphology marked by the 
induction of cellular protrusions. We found that GCN5 functions is an 
alpha-tubulin acetyl transferase and it can cooperate with Myc-nick to 
promote alpha-tubulin acetylation. Since induction of alpha-tubulin 
acetylation, calpain activation, and decrease in full length Myc all occur 
during terminal differentiation we investigated the role of Myc-nick in cell 
differentiation. We found that Myc-nick is augmented during the 
differentiation of human and mouse primary myoblasts. In addition, we 
found that while full-length Myc levels diminish, Myc-nick levels remain 
elevated in adult mouse differentiated muscles, brain and cerebellum. 
Ectopic expression of Myc-nick accelerates myoblast fusion and the 
expression of myogenic markers in mouse and human myoblasts and in 
Rhaddomyosarcomas. Importantly, we found that the expression of Myc-
nick renders myc-null fibroblasts competent to MyoD induced 
transdifferentiation. Based on our results we propose that, while full-length 
Myc blocks differentiation at the transcriptional level, Myc-nick is involved 
in promoting differentiation through transcription independent mechanisms. 
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The response of cells to mitotic disruption caused by anti-cancer 
microtubule poisons involves a balance between cell cycle arrest through 
the action of the spindle assembly checkpoint, slippage out of mitosis or the 
induction of cell death by apoptosis. We have studied the regulation of the 
mitochondrial or intrinsic apoptotic pathway during the cell division cycle 
and in response to prolonged mitotic arrest induced by microtubule poisons. 
Previously, we have shown that caspase-9, a critical component of the 
intrinsic apoptotic pathway, is phosphorylated at an inhibitory site during 
mitosis by CDK1-cyclin B1. Inhibition of caspase-9 by CDK1-cyclin B 
restrains apoptosis and promotes cell survival during mitosis [1,2]. This 
work suggested that the pathway is activated upstream of caspase-9 during 
prolonged mitotic arrest. We hypothesized that the pathway is initiated by 
activation of a pro-apoptotic protein or the inhibition of an anti-apoptotic 
protein during mitotic arrest. Good candidates are members of the Bcl-2 
family of apoptotic regulators. We have confirmed that several of these 
proteins are highly phosphorylated during mitosis. Mcl-1, an inhibitor of 
apoptosis, is of particular interest. We have found that Mcl-1 is unstable 
during mitotic arrest and it undergoes proteasome-dependent destruction by 
a novel Cdc20-dependent mechanism that is directly linked to cell cycle 
control. Destruction of Mcl-1 requires phosphorylation at a single site 
targeted by CDK1-cyclin B1, but only occurs after >2 hours of mitotic 
arrest. Stabilisation of Mcl-1 by mutation of the critical phosphorylation site 
strongly enhances the resistance of cells to apoptosis induced by 
microtubule poisons. We propose that that Mcl-1 destruction provides a 
mechanism that controls apoptosis temporally and thereby distinguishes 
between normal mitosis and prolonged mitotic arrest. Our results also 
emphasize the dual role of CDK1-cyclin B1 in driving mitosis and 
controlling apoptosis during this phase of the cell cycle. 
 
References 
[1]. Allan, LA and Clarke, PR. (2007) Phosphorylation of caspase-9 by 
CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol. Cell, 26, 301-310. 
[2]. Clarke, P.R. and Allan, L.A. (2009) Cell-cycle control in the face of damage—a 
matter of life or death. Trends Cell Biol. 19, 89-98. 
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The primary cilium organizes critical functions in the postmitotic cell and its 
presence reflects the quiescent cell and competence for specific signaling pathways. 
Notably, sensory and signaling pathways are exquisitely organized in primary cilia. 
Resorption of cilia upon serum addition is linked to the activation of the Aurora A 
kinase and the HDAC6 tubulin deacetylase. Reformation of the cilia after mitosis 
requires serum withdrawal, but little is known about the molecular events coupling 
cell cycle exit to the elaboration of this important and highly conserved signaling 
organelle.  
 
Here, we define critical molecular steps in ciliary assembly and their control by 
serum and cell cycle exit. The primary cilium has recently been linked to a potential 
tumor suppressor function, but the molecular link between the cilium and 
maintenance of cell cycle arrest is not known.  
 
Among the critical structures in the primary cilium, a highly conserved set protein 
complexes define the molecular structures of the cilium and the structures allowing 
the dynamic trafficking of signaling receptors into the primary cilium. These include 
the intraflagellar transport complexes IFT-A and IFT-B, and proteins defined by 
mutations in rare human genetic diseases including Bardet-Biedl syndrome. Bardet-
Biedl syndrome (BBS) patients have compromised cilia and signaling, leading to 
retinal degeneration, cystic kidney disease, sensory loss, neurological deficits, and 
obesity. BBS proteins form the BBSome, a highly conserved seven protein complex, 
which binds Rabin8, a GEF activating the Rab8 GTPase, required for ciliary 
assembly. We now describe a detailed molecular pathway linking serum withdrawal 
to ciliary assembly. We find upon serum withdrawal, Rab11 vesicles associate with 
microtubules and begin trafficking to the centrosome. Rab11 associates with the 
Rab8GEF/Rabin8, and via Rab11, Rabin8 also relocalizes to vesicle and is then 
transported via microtubules to the centrosome. At the centrosome, Rabin8 binds the 
BBSome, which is required for organized assembly of the ciiary vesicle, a 
membranous precursor of the primary cilium. Rabin8 activates Rab8, a small 
GTPase essential for formation of the primary cilium, and over ~100 minutes Rab8 
assembles the ciliary membrane. We identify three Rabin8 regulators important for 
ciliation. First, Rab11-GTP controls Rabin8 membrane association and trafficking 
through the Rabin8 COOH-terminal region. At the centrosome Rab11 vesicles 
convert to Rab8 preciliary membranes. Second, BBS1 binds the Rabin8 GEF 
domain and regulates cilia length, whereas the disease-associated BBS1M390R 
mutant fails in Rabin8 binding, BBSome assembly, and centrosome/cilia 
localization. Lastly, TRAPPI/II targets Rabin8 to the centrosome through binding 
the Rabin8 NH2-terminal domain.  
 
We thus link serum withdrawal to regulated Rab11-dependent cargo delivery to the 
centrosome for preciliary vesicle formation. Additional mechanisms explaining the 
link between cell cycle exit and the elaboration of the primary cilium will be 
presented. 
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Pure populations of quiescent cells can be obtained from stationary phase 
(SP) cultures due to a shift in cell density as they undergo the diauxic shift. 
These quiescent (Q) cells account for about half the cells in SP cultures and 
they are all daughter cells. This suggests that there is an asymmetric 
division upon glucose exhaustion in which daughters adopt a protective Q 
state at the expense of the mothers, which accumulate reactive oxygen 
species and show signs of apoptosis (Allen et al. (2006) JCB 174,89.) We 
find that Ssd1V, a polymorphic RNA binding protein, enables both mothers 
and daughters to enter the Q state and significantly increases their 
chronological life span (CLS) in W303. We are investigating the role of 
Ssd1v in Q cell determination. We are also defining the genes required for 
entry, maintenance and recovery from the Q state. All quiescent cells exit 
the cell cycle from G1, so we have studied G1 regulators to see if they are 
important for entry or maintenance of the Q state. In cycling cells, the genes 
required for the G1 to S transition are held in a transcriptionally repressed 
state by Whi5 until Whi5 is phosphorylated and released by cyclin 
Cln3/Cdk activity. Initiation of S phase requires B type cyclin/Cdk activity, 
which is inhibited by Sic1 throughout G1. We find that Whi5 is not required 
for the G1 arrest in SP prototrophs, but whi5- reduces Q cell yield. Sic1 is 
required for G1 arrest as well as efficient formation and recovery of Q cells. 
Sic1 mutants remain viable but rapidly lose the ability to form colonies as 
nutrients are exhausted. Sic1 is highly expressed in Q cells and it persists 
through the unbudded interval of the Q recovery cycle. Five copies of the 
CLN3 gene (5XCLN3) also impair Q cell formation and these cells are 
completely dependent upon the DNA checkpoint kinase Rad53 for viability 
as nutrients are exhausted. 5XCLN3 is not sufficient to significantly 
accelerate the recovery cycle. Cln3 mutants produce high yields of Q cells, 
but they recover from it very slowly, maintaining very high Sic1 levels until 
after budding resumes. 
 211 
SPONTANEOUS CANCER CELL QUIESCENCE WITH EPIGENETIC 
REMODELING ARISING DURING MITOTIC TELOPHASE 
 
Sridhar Ramaswamy1,2, Anita Wolfer1,2, Ipsita Guha1,2, Ben S Wittner1,2, 
Albert Yeh1,2  
 
1Massachusetts General Hospital, Cancer Center, 185 Cambridge Street, 
Boston, MA, 02114, 2Harvard Medical School, Department of Medicine, 25 
Shattuck Street, Boston, MA, 02114 
 
Human cancer cells arise through genetic mutations that drive proliferation. 
Paradoxically, however, we find that highly mitotic cancer cells 
continuously produce rare progeny that spontaneously exit the cell cycle 
into a quiescent state without experimental manipulation. These "G0 cancer 
cells" are molecularly and functionally quiescent but capable of re-entering 
the cell cycle and proliferating normally. Spontaneous cancer cell 
quiescence is associated with the global, coordinate, selective, rapid, and 
asymmetric loss of multiple nuclear histone marks that occurs specifically 
during mitotic telophase. Quiescent cancer cells express a specific 
transcriptional program, which includes upregulation of the HES1 
transcription factor that is necessary for maintaining a quiescent state in 
nonmalignant cells. Furthermore, rare HES1+ G0 cancer cells are present 
within human breast tumors. These results reveal that highly proliferative 
cancer cells with extensive genetic mutation can become spontaneously 
dormant which might have potentially important clinical implications. 
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During mitosis, kinetochores attach to assembling and disassembling 
microtubule tips while withstanding tensile forces from the mitotic spindle. 
This attachment is key to progression through mitosis, and regulation from 
the spindle assembly checkpoint ensures the detachment of aberrant 
kinetochore-microtubule attachments. How this attachment is maintained 
and the mechanism of its regulation remains unclear. Genetic, biochemical, 
biophysical and structural studies implicate both the Ndc80 and Dam1 
complexes as essential points of direct contact between kinetochores and 
microtubules in budding yeast. However, the distinct contributions of each 
complex are not known. Using techniques for manipulating and tracking 
individual molecules in vitro, we demonstrated that the Dam1 complex is a 
processivity factor for the Ndc80 complex, enhancing its ability to form 
load-bearing attachments to and track with dynamic microtubule tips. 
Moreover, the interaction between the Ndc80 and Dam1 complexes is 
regulated by the yeast Aurora B kinase Ipl1. We show that Ipl1 
phosphorylation of Dam1 disrupts both kinetochore-microtubule and 
intrakinetochore interfaces. Therefore, we provide evidence for a 
mechanism by which Aurora B resets aberrant kinetochore-microtubule 
attachments. 
*These authors contributed equally 
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Chromosome segregation is directed by the kinetochore, the 
macromolecular protein complex that assembles onto centromeric DNA and 
captures spindle microtubules. The simplest characterized kinetochore is in 
budding yeast where 8 subcomplexes assemble onto the centromere to form 
a single microtubule-binding site. Conservation of kinetochore proteins 
suggests that the larger kinetochores of other eukaryotes that bind multiple 
microtubules are assembled from the repetition of the budding yeast-type 
kinetochores. A complete mechanistic understanding of kinetochore 
function requires biophysical and structural studies on purified 
kinetochores. However, such studies have been impossible to date due to 
the lack of a robust method for isolating functional kinetochores. To address 
this, we developed a method to purify functional kinetochore particles via 
purification of the budding yeast Dsn1 protein. The particles retain the 
majority of kinetochore proteins and bind microtubules in a manner that 
depends on conserved microtubule-binding subcomplexes. In optical trap 
assays, single particles can remain attached to assembling and 
disassembling microtubule tips for >20 minutes under tensile forces up to 6 
pN. This coupling is far more robust than attachments formed from 
individual subcomplexes, indicating that cooperative interactions between 
subcomplexes make a major contribution. Taken together, these studies lay 
the foundation for uncovering the mechanisms that underlie the key 
mechanical and regulatory functions of kinetochores. 
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The Chromosomal Passenger Complex (CPC), containing INCENP, 
Survivin, Borealin and the kinase Aurora B, plays key roles in kinetochore 
assembly, the formation of kinetochore-spindle attachments and 
cytokinesis. The CPC is found on chromosome arms early in mitosis, but 
concentrates at inner centromeres during prometaphase, and transfers to the 
central spindle at anaphase. Both Survivin and Borealin have been proposed 
as targeting components of the CPC, but the chromatin elements required to 
concentrate the CPC at inner centromeres are unknown. Phosphorylation of 
Histone H3 at Thr-3 (H3T3ph), a modification carried out by the kinase 
Haspin, co-localizes with the CPC at inner centromeres. We find that 
depletion of Haspin by RNAi decreases the centromeric accumulation of the 
CPC. Furthermore, recombinant CPC and Survivin bind preferentially to 
H3T3ph-containing peptides in vitro. A Survivin mutant (D70A/D71A) that 
does not bind preferentially to H3T3ph peptides does not support CPC 
concentration at inner centromeres in cells. Localization of the Aurora B 
substrate MCAK to centromeres and spindle assembly checkpoint signaling 
in taxol are diminished both by Haspin depletion and in cells in which 
endogenous Survivin is replaced by mutant Survivin (D70A/D71A). CPC 
formation and other functions of Aurora B, such as Histone H3 Ser-10 and 
CENP-A Ser-7 phosphorylation, are little changed. These studies suggest 
that H3T3ph generated by Haspin positions the CPC at centromeres to 
selectively regulate centromeric targets of Aurora B. 
 215 
HISTONE H3 PHOSPHORYLATED ON THREONINE 3 BINDS THE 
CPC TO ACTIVATE THE KINASE AURORA B 
 
Alexander E Kelly*1, Cristina Ghenoiu*1,2, John Z Xue1, Christian Zierhut1, 
Hiroshi Kimura3, Hironori Funabiki1  
 
1The Rockefeller University, Laboratory of Chromosome & Cell Biology, 
1230 York Ave, New York, NY, 10065, 2Cornell Medical School, Weill 
Cornell Graduate School of Biomedical Sciences, Department of Molecular 
Biology, New York, NY, 10065, 3Osaka University, Graduate School of 
Frontier Biosciences, 1-3 Yamadaoka, Suita, Osaka, 568-0871, Japan 
 
*These authors contributed equally to this work. 
 
Chromosomes show dramatic structural and functional changes upon entry 
into M phase to prepare for cell division. Although it has long been known 
that histones, the major protein component of the chromosomes, become 
highly phosphorylated at this cell cycle stage, it remains largely unclear 
whether and how these modifications affect the function of chromosomes 
during M phase. Here we provide a molecular explanation of how an M 
phase-specific histone phosphorylation is recognized and translated into 
dynamic control of mitotic architectures. We reveal that histone H3 
containing the M phase-specific phosphorylation of threonine 3 (H3T3ph) 
recruits a critical regulator of mitosis and meiosis, the chromosomal 
passenger complex (CPC), to chromosomes to activate its kinase subunit, 
Aurora B. We demonstrate that the CPC directly binds H3T3ph via its 
chromatin-targeting subcomplex composed of Survivin, Dasra A and the N-
terminal region of INCENP. In addition, we show that in Xenopus egg 
extracts depleted of the H3T3 kinase Haspin, chromosomal recruitment of 
the CPC and resulting Aurora B activation are severely impaired, causing a 
decrease in spindle size. Furthermore, constitutive activation of Haspin at 
the exit from M phase results in failure of the CPC to dissociate from 
chromosomes, leading to a delay in chromosome decondensation and 
nuclear re-formation. Our data suggest that H3T3ph acts as a spatiotemporal 
signal that triggers an Aurora B-dependent reaction cascade on 
chromosomes during M phase. Thus, this study demonstrates how the 
mitotic "histone code" can be read to coordinate cell cycle processes. 
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To equally segregate duplicated genetic material into daughter cells, sister 
chromatids have to align at the middle of the mitotic spindle. In metazoan 
cells, this alignment requires a stable cohesion at the sister centromeres 
before the final separation in anaphase. To protect centromeric cohesion, 
Sgo1 is recruited to the inner kinetochores. The recruitment depends on the 
Bub1 kinase, which phosphorylates at T121 of histone H2A around the 
entromeric regions. However, the downstream mechanism of this 
recruitment remains unclear. In this study, we found that TAF-Iβ is 
recruited to the inner kinetochores from prophase to metaphase. TAF-Iβ and 
Sgo1 physically interacts with each other and spatially colocalize to the 
inner kinetochore. Depletion of Sgo1 did not affect TAF-Iβ localization. On 
the other hand, depletion of TAF-Iβ caused a correlative decrease in 
centromeric Sgo1. Similar to Sgo1, the kinetochore localization of TAF-Iβ 
depends on Bub1. We conclude that TAF-Iβ functions downstream of Bub1 
and helps to recruit Sgo1 to the kinetochores. TAF-Iβ is a histone binding 
protein and has a signature earmuff domain shared by NAP family histone 
chaperones. We are testing the hypothesis that TAF-Iβ may bind directly to 
the T121-phosphorylated histone H2A and function as the reader of this 
histone code for sister chromatid cohesion. 
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Bub1 is an essential component of the mitotic checkpoint, a surveillance 
mechanism that delays anaphase onset until all chromosomes are attached 
stably to the mitotic spindle. As a master regulator of the mitotic 
checkpoint, Bub1 has been shown to be required for the binding of several 
checkpoint proteins to the kinetochore, for proper metaphase congression 
through correct attachment of microtubles to kinetochores and is thought to 
contribute to the soluble signaling pathway of the mitotic checkpoint. 
Moreover, we and others have noted that Bub1 overexpression is a frequent 
event in a variety of human cancers and a reliable marker for poor clinic 
outcome. However, the molecular, cellular, and physiological consequences 
of Bub1 overexpression are not known. The only way to directly test 
whether the relationship between Bub1 overexpression and the development 
of tumors is causal is to generate a Bub1 transgenic mouse model. As such, 
we engineered Bub1 transgenic mice in which Bub1 is overexpressed in a 
graded fashion. Here we demonstrate that Bub1 overexpression results in 
aneuploidy in both MEFs and splenocytes. Unlike loss of Bub1 protein, 
Bub1 overexpressing cells properly inhibit anaphase progression in 
response to either nocodazole or taxol. Moreover, kinetochores of Bub1 
overexpressing cells have a normal complement of BubR1, Cdc20, Mad1, 
Mad2, and CENP-E. Therefore, Bub1 overexpression does not deregulate 
mitotic checkpoint signaling or kinetochore assembly. Interestingly, Bub1 
overexpression exclusively causes lagging chromosomes in anaphase, 
indicating that high Bub1 levels disrupt the mechanism that detects and/or 
resolves aberrant, merotelically attached chromosomes. Finally, consistent 
with the observed chromosome missegregation and aneuploidy, Bub1 
transgenic mice are susceptible to spontaneous tumorigenesis and to Myc-
induced lymphomagenesis. These data demonstrate that Bub1 
overexpression is causally implicated in tumor development and suggest 
that merotelic attachments are driving this phenotype. Thus, our results 
identify Bub1 as a chromosomal instability gene with oncogenic properties 
and a potential critical target for anti-cancer therapies that may benefit 
patients otherwise refractory to treatment. 
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The kinetochore is a multi-protein assembly that connects mitotic spindle 
microtubules to chromosomes. The kinetochore transmits a poleward force 
from microtubules to the DNA to drive chromosome movement, and is also 
a central point of regulation to ensure that genome is distributed evenly to 
both daughter cells. In our ongoing effort to define the protein composition 
of the kinetochore, we have identified a complex comprised of the spindle 
and kinetochore associated proteins Astrin and SKAP. Astrin and SKAP 
show interdependent localization and this complex is required for proper 
chromosome segregation. Interestingly, the localization of the Astrin/SKAP 
complex is antagonized by Aurora B activity. This differs from previous 
studies that have suggested that Aurora B is instead required for proper 
kinetochore assembly and maintenance. Thus, Astrin/SKAP localization is 
prevented until the presence of tension reduces Aurora B activity at the 
outer kinetochore. Our phenotypic analysis indicates that the Astrin 
complex is not required for chromosome congression, but is required to 
maintain chromosome alignment. In total, Our results suggest that the 
Astrin/SKAP complex is targeted to sister kinetochores that are under 
tension to stabilize the attachment of correctly aligned chromosomes. 
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Replication of the human genome prior to each cell division is a highly 
coordinated process. Accurate inheritance of genetic information requires 
precise coordination of DNA replication and chromosome segregation during 
each cell division cycle. Loading of the ORC protein subunits onto replication 
origins is the earliest step in DNA replication and Orc2 and Orc3 serve as core 
subunits of the ORC complex. In addition to its role in DNA replication, Orc2 
localizes to centrosomes and centromeres during the entire chromosome 
inheritance cycle. Previous data indicated that Orc2 depletion by RNA 
interference causes 30% of the cells to arrest in a pseudo-mitotic state, with 
abnormally condensed chromosome structure and chromosomes not associated 
with the mitotic microtubule spindles. A similar phenotype is induced when 
Orc3 is depleted. Immuno-florescence demonstrates that the Orc2-depleted, 
mitotically arrested cells have many kinetochore proteins correctly localized, 
including Bub1, BubR1, CENP-F, and NDC80, but the spindle assembly 
checkpoint protein Mad2 and the anaphase regulator Cdc20 were absent from 
the kinetochores, even though the microtubule spindles were not attached to the 
condensed chromosomes. Live cell microscopy using cells with a GFP-tagged 
Mad2 protein showed, however, that the Mad2 proteins did transiently attach to 
kinetochores, suggesting that the spindle assembly checkpoint was satisfied. 
Consistent with this, Cyclin B and Securin, both of which are substrates of 
APC/C, are dramatically reduced and absent respectively. Live cell images 
following Orc2 depletion showed that the chromosomes attempt to align in 
metaphase, and then the cells try to execute anaphase and then chromosomes 
come off the spindle. The increased distances between sister centromeres in 
Orc2 depleted chromosome indicated that centromeres have been pulled apart 
while the sister chromosomes are still associated with each other. Furthermore, 
the spindle motor protein CENP-E, which provides a connection between the 
kinetochores and spindles were absent after Orc2 depletion. Co-immuno-
precipitation of Orc2/3 with both BubR1 and CENP-E occurs in mitotic cells 
and co-localization of Orc2 with BubR1 was observed on metaphase 
chromosomes. We suggest that in the absence of Orc2/3, spindles attach 
transiently, satisfying the spindle assembly checkpoint, but stable spindle 
attachment is lost, thereby arresting cells in an irreversible pseudo mitotic state. 
Since Orc2 and Orc3 participate directly centromere activity and chromosome 
segregation during mitosis beyond their known roles in the initiation of DNA 
replication, we suggest that there is an ancient link between origins of DNA 
replication and chromosome segregation. 
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Chromosome instability (CIN) is a common feature of tumor cells. By 
monitoring chromosome segregation, we show that pRB-depletion causes 
rates of mis-segregation comparable to those seen in CIN tumor cells. The 
retinoblastoma tumor suppressor is frequently inactivated in human cancers 
and is best known for its regulation of the G1/S-phase transition. Recent 
studies have shown that pRB inactivation also slows progression through 
mitosis and promotes aneuploidy, but reasons for these phenotypes are not 
well understood. Here we describe the underlying mitotic defects in pRB-
deficient cells that cause chromosome mis-segregation. Analysis of mitotic 
cells reveals that the loss of pRB increases inter-centromeric distance and 
deforms centromeric structure. These defects promote merotelic attachment 
resulting in failure of chromosome congression and an increased propensity 
for lagging chromosomes following mitotic delay. While complete loss of 
centromere function or chromosome cohesion would have catastrophic 
consequences, these more moderate defects allow pRB-deficient cells to 
proliferate but undermine the fidelity of mitosis, leading to whole 
chromosome gains and losses. These observations explain an important 
consequence of RB1 inactivation and suggest that subtle defects in 
centromere function are a frequent source of merotely and CIN in cancer. 
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Cancer is associated with aneuploidy, both structural defects in 
chromosomes and abnormal numbers of intact chromosomes. The 
contribution of chromosome breaks to tumorigenesis is well accepted 
because of the possibility of generating cancer-causing mutations. However, 
the role of whole chromosome aneuploidy remains a subject of debate, 
principally because mechanisms by which whole chromosome aneuploidy 
would affect cancer pathogenesis are poorly understood. We now have 
evidence supporting one mechanism by which whole chromosome 
aneuploidy can lead to DNA breaks, via mis-segregation of chromosomes 
into structures commonly observed in cancer cells called micronuclei. 
Focusing only on micronuclei that originate from mitotic errors and contain 
a whole chromosome, we will present evidence for a mechanism whereby 
whole chromosome micronuclei develop breaks due to aberrant DNA 
replication and repair. We identify changes in the chromatin state of 
micronuclei as well as defects in the assembly of nuclear pore complexes 
and will discuss the implications of these findings for the mechanism of 
DNA breakage. Together, these results suggest a mechanistic link between 
errors in mitosis and the generation of DNA breaks.  
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Accurate chromosome segregation during cell division depends on spatially and 
temporally controlled protein phosphorylation/dephosphorylation events. The 
serine/threonine kinase Aurora A (AurA) contributes to multiple aspects of 
mitosis with key roles in bipolar spindle formation and centrosome function. 
During spindle assembly promoted by chromatin, AurA is targeted to 
microtubules by its partner, the microtubule-binding protein TPX2. TPX2 also 
activates AurA, both allosterically and by protecting the activation loop of its 
kinase domain from dephosphorylation. The AurA-TPX2 complex participates 
in setting a proper spindle length, while it is not required for centrosome-
mediated spindle assembly. The mechanism underlying AurA recruitment and 
regulation at centrosomes remains unclear. 
 
We found that a core centrosome protein, Cep192, forms distinct complexes 
with AurA and acts as its specific cofactor in centrosome-driven spindle 
assembly. Binding to endogenous Cep192, unlike binding to TPX2, does not, in 
itself, activate AurA but renders it capable of activation following kinase 
dimerization. Cep192 targets AurA to centrosomes, where its high local 
concentration promotes AurA dimerization, which, in the presence of bound 
Cep192, activates the kinase. This, in turn, drives microtubule nucleation and 
assembly.  
 
The extent of Cep192/dimerization-induced AurA activation significantly 
exceeds that resulting from the AurA-TPX2 interaction, thus insuring that more 
potent AurA activation occurs at centrosomes than in other cellular 
compartments. This might be critical for the function of centrosomes as 
dominant microtubule-organizing centers. A “milder” AurA activation mode 
appears to be employed by TPX2 in chromatin-driven microtubule assembly. 
 
Thus, the role of AurA in the two independent pathways of spindle formation 
mediated by chromatin and centrosomes relies on spatial and quantitative 
control of its kinase activity by two distinct cofactors (TPX2 and Cep192 
respectively) that utilize different organelle-targeting and AurA regulation 
strategies. 
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When cells divide, it is essential that they segregate their newly duplicated 
chromosomes into two equal sets. The centrosome plays a fundamental role 
for nucleating and organizing cytoplasmic microtubules during interphase 
and promoting the assembly of the mitotic spindle during mitosis. 
Centrosomes assemble from centrioles that, like DNA, are duplicated once 
per cell cycle. Aberrant numbers of centrosomes directly promote 
chromosome missegregation thus contributing to chromosomal instability. 
Both gain- and loss-of-function studies have identified the Polo-like kinase 
Plk4/Sak as a crucial regulator of centriole biogenesis. We have identified 
the novel human centriolar protein, Cep152, the ortholog of Drosophila 
asterless, Asl, as a direct target and binding partner of Plk4. Cep152 
interacts with the cryptic Polo-box of Plk4 via its N-terminal domain. 
Ablation of Cep152 function by RNAi or expression of a dominant-negative 
form of Cep152 leads to loss of centrioles, formation of monopolar mitotic 
spindles and a failure in centriole duplication. Furthermore, we show that 
Cep152 is required for the Plk4 induced overduplication of centrosomes. 
Interfering with Plk4 or Cep152 function promotes loss of CPAP, a protein 
essential for the control of centriole length in Plk4 regulated centriole 
biogenesis, at the centrosome. The localization of other components of the 
centriole assembly pathway, hsSas6, CP110 or Cep135 was not impaired by 
Cep152 siRNA treatment of U2OS cells. Together, these findings 
demonstrate that Cep152 is an important component in Plk4-induced 
centriole biogenesis. 
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Work over the last decade has shown that chromosome segregation is 
dependent on a handful of mitotic kinases, among them Aurora A. 
However, which individual mitotic processes are regulated by Aurora A, 
and how they are coordinated on a molecular level, is still largely unknown. 
Aurora A is directed to act on spatially and temporally unique substrates in 
the cell as it proceeds through mitosis, complicating its study by protein 
depletion techniques such as RNAi. We have previously shown that point 
mutations in TPX2 disrupting the activation of Aurora A reveal one specific 
role for Aurora A, to facilitate spindle pole separation through modulation 
of microtubule (MT) nucleation and stability. Mass spectrometry-based 
phosphorylation analyses utilizing these mutants found that the spindle 
associated protein TACC3 is a TPX2-dependent target of Aurora A 
phosphorylation. When the Aurora A sites in TACC3 are mutated, TACC3 
is no longer targeted to the spindle, and the cells have consequent defects in 
spindle assembly. 
 
To investigate how phosphorylation of TACC3 targets it to spindles, we 
quantitatively compared proteins that interact with TACC3 normally with 
proteins that interact either with a phospho-site-mutated, or Aurora A 
inhibitor-treated TACC3 protein. This analysis led to the discovery of a 
clathrin-containing complex that interacts with TACC3 in a phospho-
dependent manner. Clathrin heavy chain (CLTC) targets TACC3 to 
spindles, suggesting an explanation for the observed role of clathrin in MT 
stability. We also uncovered a novel +TIP protein that associates with 
TACC3 in a phospho-dependent manner. This protein is required for 
progression through mitosis and tracks growing MTs in an EB1/EB3-
dependent manner in vitro.  
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OPPOSING PP2A-B55Δ IN XENOPUS EGG EXTRACTS 
 
Satoru Mochida, Tim Hunt  
 
Cancer Research UK, Clare Hall Laboratories, Blanche Lane, Potters Bar, 
Herts, EN6 3LD, United Kingdom 
 
CDK1 is the major cell-cycle controller essential for mitotic 
phosphorylation. Its activity is modulated through the phosphorylation 
status of its Tyr15 residue and by cyclin synthesis and degradation. We 
reported last year that PP2A-B55δ hetero-trimer complex is the major 
phosphatase for model CDK substrates in Xenopus egg extracts and has 
anti-mitotic activity. PP2A-B55δ activity is high in interphase and 
completely suppressed in mitosis, exactly opposite to CDK activity. Other 
groups have reported that Greatwall, a protein kinase required for proper 
mitosis in flies and frogs, is somehow responsible for the mitotic 
suppression of PP2A activity. We have discovered that α-Endosulfine and 
its close relative ARPP-19 are substrates of Greatwall, and find that 
phosphorylated endosulfine or ARPP-19 specifically inhibit PP2A-B55 in 
vitro. α-Endosulfine is quantitatively phosphorylated in mitotic Xenopus 
extracts and dephosphorylated in interphase. Immunodepletion of α-
Endosulfine strongly inhibited mitotic entry in extracts whereas addition of 
extra (thiophosphorylated) α-Endosulfine accelerated mitotic entry. These 
results suggest that CDK activation directs an inactivation of the opposing 
phosphatase activity via a pathway involving Greatwall and α-Endosulfine, 
helping to sharpen the transition of phosphorylation status from interphase 
to mitosis. These results account for the phenotype of endosulfine mutants 
in Drosophila (see Von Stetina JR, Tranguch S, Dey SK, Lee LA, Cha B, 
Drummond-Barbosa D. (2008). Development 135:3697). 
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Cdk1 promotes the metaphase to anaphase transition by phosphorylating the 
anaphase-promoting complex (APC), a multisubunit ubiquitin ligase that 
targets specific mitotic regulators for degradation by the proteasome. The 
degradation of these proteins is critical for accurate sister chromatid 
segregation and mitotic exit.  
 
Swe1 (the budding yeast homolog of Wee1) inhibits Cdk1 by 
phosphorylation on a conserved tyrosine residue. We believe that this 
inhibitory phosphorylation on Cdk1 plays a role in restraining APC 
activation in every cell cycle. Deletions of the kinase, Swe1, or the 
phosphatase, Mih1 (the budding yeast Cdc25) responsible for regulating the 
levels of Cdk1 inhibitory phosphorylation, both interact genetically with 
mutations in the APC activators CDC20 and CDH1. Furthermore, we have 
shown with live imaging that swe1∆ cells spend a shorter time in mitosis, 
while mih1∆ cells spend a longer time, indicating SWE1 may be important 
in the timing of the metaphase to anaphase transition. Consistent with this 
role of Swe1, activation of a Swe1-dependent checkpoint causes a 
prolonged arrest in metaphase.  
 
Overexpression of Swe1 stabilizes mitotic cyclins and Pds1 (securin), and 
impairs sister chromatid segregation. These effects depend on Swe1 
inhibition of Cdk1, and are not due to activation of the DNA damage or 
spindle checkpoint, which both act to inhibit the metaphase to anaphase 
transition. If Swe1 is overexpressed in anaphase, after Pds1 has been 
degraded, we see that Pds1 is re-stabilized, showing that Swe1 can block 
APC-mediated proteolysis throughout mitosis. Swe1 overexpression 
reduces APC phosphorylation in vivo, and we are currently testing if this 
decrease in phosphorylation causes a drop in the in vitro ubiquitination 
activity of the APC.  
 
We believe the effects of Swe1 are therefore caused by inhibition of Cdk1-
dependent phosphorylation of APC subunits, and suggest that Cdk1-
dependent phosphorylation of the APC may be essential for mitotic APC 
activity. Furthermore, our data suggest that SWE1 plays a role in the normal 
timing of the metaphase to anaphase transition, in addition to its well-
established role regulating mitotic entry. 
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Mitotic cyclin-dependent kinases (CDKs) promote entry in mitosis. In the 
budding yeast Saccharomyces cerevisiae, phosphatase Cdc14 orchestrates 
exit from mitosis by inactivating CDKs and reversing CDK-mediated 
phosphorylation events. During anaphase, Cdc14 is released from its 
inhibitor Cfi1/Net1 by two successive pathways: FEAR (CdcFourtheen 
Early Anaphase Release) and MEN (Mitotic Exit Network). Three sets of 
kinases play a critical role in the Cdc14-release process: the Polo-like 
kinase Cdc5, the mitotic CDKs themselves, and the most downstream MEN 
kinase Dbf2. The mechanism that coordinates these different kinases 
resulting in Cdc14 activation remains unclear. Here we show that Cdc14 
release is a two-hit process that requires Cdc5 plus either MEN or CDKs. 
Once released, Cdc14 triggers a negative feedback loop composed of Cdc5-
Cdc14-Cdh1-Cdc5. In the presence of stable levels of mitotic cyclins, this 
negative feedback generates cycles of Cdc14 release and sequestration. 
Interestingly this “mitotic oscillator” works also in presence of very high 
levels of mitotic cyclins. This observation suggests that next to the overall 
inactivation of mitotic cyclins, the completion of mitosis also relies on the 
temporally and spatially controlled phopshorylation status of different 
substrates determined by the mitotic-CDKs/Cdc14 ratio. 
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Cdc7-Dbf4 is a conserved, two-subunit kinase required for initiating 
eukaryotic DNA replication. Recent studies have shown that Cdc7-Dbf4 
also regulates the mitotic exit network (MEN) and monopolar homolog 
orientation in meiosis I1,2. Both activities likely involve a Cdc7-Dbf4 
interaction with Cdc5, the single Polo-like kinase in budding yeast. We 
previously showed that Dbf4 binds the Cdc5 polo-box domain (PBD) via a 
~40 residue N-terminal sequence, which lacks a PBD consensus binding 
site (S(pS/pT)P/X), and that Dbf4 inhibits Cdc5 function during mitosis1. 
Here we refine the requirements for binding and demonstrate that the PBD-
Dbf4 interaction occurs via a distinct PBD surface from that used to bind 
phospho-proteins. Genetic and biochemical analysis of multiple dbf4 
mutants indicates that Dbf4 inhibits Cdc5 function through direct binding. 
Surprisingly, mutation of invariant Cdc5 residues required for binding 
phosphorylated substrates has little effect on yeast viability or growth rate. 
Instead, cdc5 mutants defective for binding phospho-proteins exhibit 
increased resistance to microtubule disruption and have elongated spindles. 
This study therefore defines the molecular basis for a new mode of PBD 
binding and reveals that Cdc5 targeting to phosphorylated substrates 
regulates spindle dynamics. Our data also suggest that Cdc5 binding to 
phosphorylated substrates is not essential and raises the possibility that 
essential Cdc5 substrates might be recognized through a Dbf4-like binding 
site. 
 
 
1. Miller et al. (2009) PLoS Genetics 5:e1000498 
2. Matos et al. (2008) Cell 135:662-78 
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Proper cell division requires strict coordination between mitotic exit and 
cytokinesis. In the event of a mitotic error, cytokinesis must be inhibited to 
ensure each daughter cell receives the correct genetic material. In the fission 
yeast, Schizosaccharomyces pombe, the checkpoint protein and E3 ubiquitin 
ligase, Dma1, delays cytokinesis by inhibiting the septation initiation 
network (SIN) when the mitotic spindle is compromised. To elucidate the 
mechanism by which Dma1 inhibits the SIN, we screened all SIN 
components as potential Dma1 substrates. We found that the SIN scaffold 
protein, Sid4, is ubiquitinated in vivo in a Dma1 dependent manner, while 
we detected no evidence for ubiquitination of any other SIN component. To 
investigate the role of Sid4 ubiquitination in checkpoint function, we 
generated a ubiquitination deficient sid4 allele and our data suggest that 
Sid4 ubiquitination by Dma1 is required to maintain a checkpoint arrest. 
Furthermore, Sid4 ubiquitination appears to delay recruitment of the Polo-
like kinase and SIN activator, Plo1, to spindle pole bodies (SPBs) during 
checkpoint activation, providing a mechanistic link between Dma1 activity 
and cytokinesis inhibition. Collectively, we present a novel mechanism of 
cytokinesis inhibition by the checkpoint protein, Dma1. 
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The cell cycle inhibitor p27Kip1 (p27) also has cyclin-CDK independent 
functions. For instance, p27 binds to and prevents the activation of the 
GTPase RhoA, thereby regulating cell migration and actin cytoskeleton 
dynamics. To investigate the significance of the cyclin-CDK independent 
functions of p27 in vivo, we generated a knock-in mouse in which four 
amino acid substitutions in p27 prevent its interaction with cyclins and 
CDKs (p27CK-). The p27CK- mutation dominantly causes hyperplastic 
lesions and tumors in multiple organs compared to wild-type and p27-/- 
mice, revealing an oncogenic role for p27.  
We find that the p27CK- protein causes multinucleation, polyploidy and 
centrosome amplification in the liver, kidney and primary fibroblasts; a 
phenotype that resembles that of Skp2-/- mice, in which p27 levels are 
elevated during the S and G2/M phases of the cell cycle. The p27CK- 
protein is insensitive to Skp2-mediated degradation, also resulting in 
elevated levels of the protein during the cell cycle. Thus our data indicates 
an important role for p27 in G2/M that is independent of cyclin/CDK 
regulation. Further analysis revealed that the p27CK- protein causes a 
cytokinesis and abscission defect.  
We identified the Rho effector Citron-Kinase as a p27-interacting protein in 
a mass spectrometry screen. The phenotype caused by p27CK- is similar to 
that observed upon deletion or inhibition of Citron-Kinase. The interaction 
of the two proteins was confirmed and the interaction domain of p27 on 
Citron-Kinase was mapped. Over-expression of this minimal interaction 
domain was sufficient to suppress the phenotype caused by p27CK-. 
Finally, we find that by binding to Citron-Kinase, p27 prevents the 
interaction of Citron-Kinase with RhoA and its activation. Overall, we have 
identified a novel role for p27 during cytokinesis via the regulation of 
Citron-Kinase activity.  
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The accurate placement of the cell division plane during cell division is 
essential for error-free genome propagation. I will discuss two mechanisms 
that may contribute to this process. One involves a spatial Aurora-kinase 
dependent phosphorylation gradient that extends across the spindle 
midzone, an interdigitating array of anti-parallel microtubules that forms 
during anaphase. The second involves PRC1 (MAP65/Ase1), a non-motor 
microtubule crosslinking protein required for spindle midzone formation 
and successful cytokinesis in eukaryotes. I will discuss findings from 
biophysical and structural studies that suggest PRC1 functions as a dynamic 
tracker of antiparallel microtubule overlap, analogous to +TIP proteins that 
track plus-ends of growing microtubules. This functional specialization in a 
non-motor microtubule-associate protein could help ‘mark’ nano-scale 
geometric features in self-organizing cytoskeletal networks. Such ‘marks’ 
can recruit enzymes, such as kinases, to specific intracellular sites and 
establish micron-scale spatial patterns that may provide positional cues for 
proper cell cleavage. 
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Ubiquitination and phosphorylation are arguably the two post translational 
modifications most important for cell cycle progression. The evolutionary 
conserved COP9 Signalosome (CSN) acts at the interface between kinase 
signalling and protein degradation. It is known to associate with kinases 
which phosphorylate NF-κB and p53 among others. CSN is even better 
characterised as a regulator of cullin ring E3 ligases (CRL). The rate of 
CRL mediated ubiquitin transfer is increased by attachment of the 
ubiquitin-like protein Nedd8 (neddylation). CSN catalytically reverses this 
modification. Moreover, there is evidence that CSN is not a mere 
deneddylase in cells but also an assembly platform for its modular CRL 
substrates such as SCF. 
 
Despite its central role in cell metabolism, CSN was poorly understood at 
the structural level. In order to address this, we developed an insect cell co-
expression system from which we purify large amounts of homogenous, 
correctly assembled and catalytically active human CSN. We report the first 
structure of CSN using electron microscopy and single particle analysis and 
segment the map by localising the catalytic subunit CSN5 and some of its 
helical-repeat scaffold components. Furthermore, we show structural 
analysis of CSN in complex with its neddylated substrate SCF and propose 
a mechanism of Nedd8 chain deconjugation.  
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Cell proliferation depends on the timely synthesis and destruction of 
proteins at specific phases of the cell cycle. There is increasing evidence 
that several key cell cycle regulatory proteins must be destroyed during S 
phase to ensure normal cell cycle progression. Recently it was discovered 
that these proteins harbor a motif called a PIP degron that mediates binding 
to chromatin-bound PCNA at replication forks and recruits the CRL4Cdt2 E3 
ubiquitin ligase. These interactions comprise a mechanism for coupling 
DNA replication with ubiquitylation and subsequent proteolysis by the 26S 
proteasome. We developed a flow cytometry-based method using 
Drosophila S2 cells that recapitulates S phase-specific protein proteolysis. 
Using this assay we discovered a PIP degron within Drosophila E2f1 and 
demonstrated that PCNA and CRL4Cdt2 are necessary for S phase-specific 
destruction of E2f1, a member of the activating class of E2F transcription 
factors that controls cell cycle progression. We hypothesize that S phase-
specific destruction provides an important pRb-independent negative 
regulation of E2f1. We will present new data regarding the mechanism and 
function of replication-coupled E2f1 destruction. 
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Chromatin modifications play central role in various biological processes 
including cellular proliferation, differentiation, gene expression and DNA 
repair. The histone methyltransferase PR-Set7/Set8 is a cell-cycle-regulated 
enzyme that regulates chromosomal structure and stability through the 
monomethylation of lysine 20 of histone 4 (H4K20). It also 
monomethylates p53 on K382 to suppress transcriptional activation by p53. 
CRL4-Cdt2 is a Cullin complex that degrades several proteins involved in 
maintenance of genome stability, e.g. Cdt1, p21, pol eta (in C. elegans) and 
E2F1 (in Drosophila). We report that CRL4 is the principal E3 ubiquitin 
ligase responsible for Set8 proteolytic degradation in the S-phase of the 
cell-cycle. This activity requires the substrate recognition factor Cdt2/DTL 
and is dependent on the physical interaction of Set8 with chromatin-bound 
PCNA. We show that CRL4Cdt2 promotes Set8 degradation specifically in 
early and mid S-phase of the cell cycle and in cells irradiated with UV. 
Inactivation of the CRL4–Cdt2-PCNA-Set8 degradation machinery 
stabilizes Set8 in S-phase, inhibits cellular proliferation, and arrests the cells 
in the G2 phase of the cell cycle with chromatin de-condensation. All these 
effects are also seen in p53 mutant cell lines. The results indicate that the 
degradation of Set8 by CRL4-Cdt2 in early and mid S phase is essential for 
cellular proliferation and passage of cells through late S and G2 phases of 
the cell-cycle. 
 235 
CRL4CDT2 -DEPENDENT DESTRUCTION OF THE SET8 HISTONE 
METHYLTRANSFERASE IN S PHASE AND AFTER DNA DAMAGE 
 
Richard C Centore1, Courtney G Havens2, Alice Tse1, Johannes Walter2, 
Lee Zou1  
 
1Massachusetts General Hospital, Cancer Center, 149 13th St., Charlestown, 
MA, 02129, 2Harvard Medical School, Department of Biological Chemistry 
and Molecular Pharmacology, 240 Longwood Ave., Boston, MA, 02115 
 
The protein methyltransferase, Set8 (KMT5A /PR-Set7/SETD8), is 
important for the maintenance of genomic stability and essential for cell 
viability. Previous studies have shown that Set8 protein levels are cell 
cycle-regulated, being most abundant during G2 and mitosis, and low 
during S phase. Concomitant with its accumulation in G2 and M phases, 
Set8 promotes the monomethylation of histone H4 on lysine 20 
(H4K20me1), which is involved in chromatin compaction. While Set8 has a 
clear function in mitosis, why and how Set8 is down-regulated during S 
phase is not clear.  
 
Here, we show that Set8 is degraded in a DNA replication-coupled and a 
DNA damage-induced manner. We identify the E3 ubiquitin ligase, 
CRL4Cdt2, as a critical regulator of Set8 during S phase and in response to 
DNA damage. Treatment of cells with siRNAs targeting members of the 
CRL4Cdt2 complex increases the steady state levels of Set8 in unperturbed 
cells and inhibits its UV-induced destruction. Furthermore, disruption of a 
specific PCNA interacting protein motif (PIP box) within Set8 abolishes its 
interaction with CRL4Cdt2 and inhibits its degradation. The DNA damage-
induced and replication-coupled degradation of Set8 is conserved in 
Xenopus egg extracts, where destruction of Set8 is inhibited either by 
mutations in its PIP box or by depletion of PCNA or Cdt2. In this cell-free 
system, ubiquitylated forms of Set8 are detected on chromatin. In cells, Set8 
is rapidly degraded during S phase, but when Set8 expression is 
constitutively induced, proliferation is slowed, cells accumulate in the S and 
G2 phases, and the replication checkpoint is elicited. When expression of 
the non-degradable PIP box mutant of Set8 is constitutively induced, a 
dramatic loss of cells in S phase and accumulation of cells in G2 occurs. 
Transient expression of this Set8 mutant during recovery from a replication 
arrest results in an increase in H4K20me1 and recruitment of 53BP1 and 
L3MBTL1 to chromatin, as well as prolonged Chk1 activation. We propose 
a model whereby Set8 levels are suppressed during S phase to prevent 
aberrant monomethylation of H4K20, which interferes with DNA 
replication.  
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The Mdm2/p53 pathway is compromised in more than 50% of human 
cancers. The dynamics of the p53/Mdm2 pathway is influenced by DNA 
damage-induced turnover of the p53 ubiquitin ligase Mdm2 but the 
underlying molecular mechanisms remain unclear. Here we report that 
Mdm2 is unstable, and that phosphorylation of Mdm2 by Casein Kinase I 
(CKI) at multiple sites triggers its interaction with, and subsequent 
ubiquitination and destruction, by SCFβ-TRCP. Inactivation of either β-
TRCP or CKI results in accumulation of Mdm2 and decreased p53 activity, 
and resistance to apoptosis induced by DNA damaging agents. Furthermore, 
Mdm2C464A mutant could be efficiently degraded by SCFβ-TRCP. These 
findings reveal a novel pathway that controls Mdm2 stability independently 
of its own ubiquitin ligase activity, and thereby controls p53 activity in 
response to genotoxic stress. Hence, our results provide new insight into the 
signaling pathways controlling Mdm2 destruction and further suggest that 
compromised regulation of Mdm2 results in attenuated p53 activity, thereby 
facilitating tumor progression. 
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The anaphase-promoting complex or cyclosome (APC) is a multisubunit 
ubiquitin-protein ligase (E3) that catalyzes the ubiquitination of securin and 
cyclins, thereby promoting their destruction and driving the cell through the 
metaphase-anaphase transition. Like other E3s, the APC promotes 
ubiquitination by positioning the substrate adjacent to an E2-ubiquitin 
conjugate, allowing nucleophilic attack by a substrate lysine on a thioester 
bond linking the C-terminus of ubiquitin to a cysteine in the E2 active site. 
Conserved residues in the E2 active site are thought to catalyze this 
reaction.  
 
Different E2 family members display distinct specificities for substrate 
lysines in different contexts. In the case of the budding yeast APC, we 
showed in previous work that the initial monoubiquitination of lysines on 
the substrate is most efficiently catalyzed by the general E2, Ubc4. A 
different E2, Ubc1, then interacts with the APC to catalyze rapid 
ubiquitination of a specific lysine, K48, on pre-attached ubiquitin, resulting 
in K48-linked polyubiquitin chains that target the substrate to the 
proteaseome for destruction. In the current work, we addressed the 
mechanistic basis for the K48 selectivity of Ubc1. We identified polar 
residues near the Ubc1 active site, as well as a residue in ubiquitin itself, 
that catalyze K48-specific ubiquitin ligation but are not required for general 
activity toward other lysines. Our results suggest that the active site of 
Ubc1, as well as the surface of ubiquitin, contain specificity determinants 
that channel specific lysines to the central residues involved directly in 
catalysis. Our studies emphasize the central role of the E2 active site in the 
catalysis and specificity of protein ubiquitination. 
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We are trying to understand how cells divide to ensure that their two 
daughter cells receive an identical copy of the genome. The key to the 
control of chromosome segregation is the regulation of the Anaphase 
Promoting Complex/Cyclosome (APC/C) by the spindle assembly 
checkpoint. We have developed a live cell assay to monitor APC/C activity 
and its inhibition by the spindle checkpoint and have recently begun to use 
this to study the enzymology of the APC/C. This has revealed that the 
checkpoint is intrinsic to the timing of mitosis, and that to maintain 
checkpoint-arrested cells in mitosis the APC/C targets its own regulator, 
Cdc20, for destruction. We are particularly interested in how the spindle 
checkpoint acts on the APC/C, and how the APC/C is able to target some 
substrates when the checkpoint is active while others are stabilized. Our 
studies have revealed that some substrates are able to compete with the 
checkpoint proteins for Cdc20, and that these substrates are recognized in a 
different manner by the APC/C. 
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The Anaphase Promoting Complex (APC) is a multi-subunit ubiquitin 
ligase responsible for targeting cell cycle regulators for degradation by the 
26S proteasome. The WD40-containing proteins Cdc20 and Cdh1 function 
as APC co-activators that directly bind substrates via the latter’s destruction 
boxes (DB) and KEN boxes. Recently, Acm1 was identified as an APCCdh1 
inhibitor. Although Acm1 interacts with Cdh1 through a DB and a KEN 
Box, Acm1 is not an APCCdh1 substrate. Rather, it acts as a competitive 
(“pseudosubstrate”) inhibitor of substrate binding to Cdh1. We explored 
what properties make Acm1 an APC inhibitor rather than an APC substrate. 
Using alanine-scanning mutagenesis, we identified the Acm1 “A-motif”, 
distinct from its DB and KEN box, which is involved in its binding to Cdh1. 
The KEN box, DB and the A-motif were all required for APCCdh1 inhibition 
both in vivo and in vitro. A genetic screen identified Cdh1 WD40 residues 
that were important for A-motif recognition and Acm1-mediated inhibition. 
These residues are predicted to lie near those involved in recognition of 
DBs. We next explored the possibility that an APC substrate could be 
converted into an APC inhibitor by preventing its ubiquitination. We found 
that an APC substrate (Hsl1) lacking its ubiquitin-acceptor lysine residues 
bound tightly to Cdh1 and behaved as a potent APCCdh1 inhibitor. Together 
these findings suggest that tight Cdh1-binding combined with the absence 
of ubiquitination of the Cdh1-bound protein leads to APCCdh1 inhibition. 
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Most F-box proteins are the substrate recognition subunits of SCF (Skp1-
Cul1-F-box protein) ubiquitin ligase complexes, which mediate the timely 
proteolysis of important eukaryotic regulatory proteins. Mammalian 
genomes encode roughly 70 F-box proteins, but only a handful have 
established functions. The F-box protein family obtained its name from 
Cyclin F (also called Fbxo1), in which the F-box motif (the ~40 amino acid 
domain required for binding to Skp1) was first described. Cyclin F, which is 
encoded by an essential gene, also contains a cyclin box domain, but in 
contrast to most cyclins, it does not associate with - nor does it promote the 
activity of - any cyclin-dependent kinases (CDKs) or other 
kinases.However, like other cyclins, Cyclin F oscillates during the cell 
cycle, with protein levels peaking in G2. Despite its essential nature and 
status as the founding member of the F-box protein family, Cyclin F 
remains an orphan protein, whose functions are unknown. Using an 
unbiased screen, we identified CP110, a protein essential for centrosome 
duplication, as an interactor of Cyclin F. Utilizing a mode of substrate 
binding distinct from other F-box protein-substrate pairs, CP110 and Cyclin 
F physically associate on the centrioles, and CP110 is ubiquitylated via the 
SCFCyclin F ubiquitin ligase complex, leading to degradation during the 
G2 phase of the cell cycle. siRNA-mediated depletion of Cyclin F induces 
centriole amplification and mitotic abnormalities, such as multipolar 
spindles and asymmetric bipolar spindles. These phenotypes were reverted 
by co-silencing CP110 and were recapitulated by expressing a stable mutant 
of CP110 that is unable to bind Cyclin F. Cyclin F knockout (KO) MEFs 
show higher levels of CP110 and centrosomal amplification, as compared to 
WT MEFs. Finally, expression in cultured cells of a stable CP110 mutant 
also promotes the formation of micronuclei, a hallmark of chromosome 
instability. We propose that SCFCyclin F–mediated degradation of CP110 
is required for the fidelity of mitosis and genome integrity.  
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VISITOR INFORMATION 
 
EMERGENCY                CSHL                          BANBURY 
Fire (9) 742-3300 (9) 692-4747 
Ambulance (9) 742-3300 (9) 692-4747 
Poison (9) 542-2323 (9) 542-2323 
Police (9) 911 (9) 549-8800 
Safety-Security Extension 8870  
 
Emergency Room 
Huntington Hospital 
270 Park Avenue, Huntington 
631-351-2300 
(1037)  
Dentists 
Dr. William Berg 
Dr. Robert Zeman 
 
631-271-2310 
631-271-8090 
Doctor 
MediCenter 
234 W. Jericho Tpke., Huntington Station 
631-423-5400 
(1034) 
Drugs - 24 hours, 7 days 
Rite-Aid 
391 W. Main Street, Huntington 
631-549-9400 
(1039) 
Free Speed Dial 
Dial the four numbers (****) from any tan house phone to place a 
free call. 
GENERAL INFORMATION 
 
Books, Gifts, Snacks, Clothing, Newspapers 
 BOOKSTORE   367-8837 (hours posted on door) 
 Located in Grace Auditorium, lower level. 
 
Photocopiers, Journals, Periodicals, Books, Newspapers 
 Photocopying – Main Library 
 Hours:  8:00 a.m. – 9:00 p.m. Mon-Fri 
             10:00 a.m. – 6:00 p.m. Saturday 
Helpful tips - Obtain PIN from Meetings & Courses Office  
to enter Library after hours.  See Library staff for photocopier 
code. 
 
Computers, E-mail, Internet access 
 Grace Auditorium 
 Upper level: E-mail only 
 Lower level: Word processing and printing. 
 STMP server address: mail.optonline.net 
 To access your E-mail, you must know the name of your  
 home server.    
 
Dining, Bar 
 Blackford Hall 
  Breakfast  7:30–9:00, Lunch 11:30–1:30, Dinner  5:30–7:00 
  Bar  5:00 p.m. until late  
 Helpful tip - If there is a line at the upper dining area, try the  
 lower dining room 
 
 
 
Messages, Mail, Faxes 
 Message Board, Grace, lower level 
 
Swimming, Tennis, Jogging, Hiking 
June–Sept. Lifeguard on duty at the beach. 12:00 noon–6:00 p.m.  
Two tennis courts open daily. 
 
Russell Fitness Center 
 Dolan Hall, west wing, lower level 
 PIN#:  Press 64355 (then enter #) 
 
Concierge 
 On duty daily at Meetings & Courses Office. 
After hours – From tan house phones, dial x8870 for 
assistance 
  
Pay Phones, House Phones 
Grace, lower level; Cabin Complex; Blackford Hall; Dolan Hall, 
foyer  
 
CSHL’s Green Campus 
 
Cold Spring Harbor Laboratory is pledged to operate in an 
environmentally responsible fashion wherever possible.  In the past, 
we have removed underground oil tanks, remediated asbestos in 
historic buildings, and taken substantial measures to ensure the 
pristine quality of the waters of the harbor. Water used for irrigation 
comes from natural springs and wells on the property itself.  Lawns, 
trees, and planting beds are managed organically whenever possible.  
And trees are planted to replace those felled for construction 
projects.   
 
Two areas in which the Laboratory has focused recent efforts have 
been those of waste management and energy conservation.  The 
Laboratory currently recycles most waste.  Scrap metal, electronics, 
construction debris, batteries, fluorescent light bulbs, toner cartridges, 
and waste oil are all recycled.  For general waste, the Laboratory uses 
a “single stream waste management” system, removing recyclable 
materials and sending the remaining combustible trash to a 
cogeneration plant where it is burned to provide electricity, an 
approach considered among the most energy efficient, while providing 
a high yield of recyclable materials. 
 
Equal attention has been paid to energy conservation.  Most lighting 
fixtures have been replaced with high efficiency fluorescent fixtures, 
and thousands of incandescent bulbs throughout campus have been 
replaced with compact fluorescents.  The Laboratory has also 
embarked on a project that will replace all building management 
systems on campus, reducing heating and cooling costs by as much 
as twenty-five per cent. 
 
Cold Spring Harbor Laboratory continues to explore new ways in 
which we can reduce our environmental footprint, including 
encouraging our visitors and employees to use reusable containers, 
conserve energy, and suggest areas in which the Laboratory’s efforts 
can be improved. This book, for example, is printed on recycled 
paper. 
                       1-800 Access Numbers 
 
 AT&T  9-1-800-321-0288 
 MCI  9-1-800-674-7000 
 
Local Interest 
 Fish Hatchery   631-692-6768 
 Sagamore Hill   516-922-4447 
 Whaling Museum   631-367-3418 
 Heckscher Museum  631-351-3250 
 CSHL DNA Learning  x 5170 
   Center 
 
New York City 
 Helpful tip - 
 Take Syosset Taxi to Syosset Train Station 
 ($8.00 per person, 15 minute ride), then catch Long Island  
 Railroad to Penn Station (33rd Street & 7th Avenue).   
 Train ride about one hour. 
 
   TRANSPORTATION 
Limo, Taxi 
 Syosset Limousine  516-364-9681  (1031) 
 Super Shuttle  800-957-4533  (1033) 
  To head west of CSHL - Syosset train station 
  Syosset Taxi  516-921-2141  (1030) 
 To head east of CSHL - Huntington Village  
  Orange & White Taxi 631-271-3600  (1032) 
Executive Limo  631-696-8000  (1047) 
 
Trains 
 Long Island Rail Road   822-LIRR  
 Schedules available from the Meetings & Courses Office. 
 Amtrak   800-872-7245 
 MetroNorth   800-638-7646 
 New Jersey Transit  201-762-5100 
 
Ferries 
 Bridgeport / Port Jefferson 631-473-0286 (1036) 
 Orient Point/ New London 631-323-2525 (1038) 
 
Car Rentals 
 Avis   631-271-9300 
 Enterprise   631-424-8300 
 Hertz   631-427-6106 
  
Airlines 
 American   800-433-7300 
 America West  800-237-9292 
 British Airways  800-247-9297 
 Continental   800-525-0280 
 Delta   800-221-1212 
 Japan Airlines  800-525-3663 
 Jet Blue   800-538-2583 
 KLM   800-374-7747 
 Lufthansa   800-645-3880 
 Northwest   800-225-2525 
 United   800-241-6522 
 US Airways   800-428-4322 
